0001193125-21-244894.txt : 20210812 0001193125-21-244894.hdr.sgml : 20210812 20210812171919 ACCESSION NUMBER: 0001193125-21-244894 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210812 DATE AS OF CHANGE: 20210812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Markforged Holding Corp CENTRAL INDEX KEY: 0001816613 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER PERIPHERAL EQUIPMENT, NEC [3577] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39453 FILM NUMBER: 211168771 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (866) 496-1805 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: one DATE OF NAME CHANGE: 20200701 10-Q 1 d187897d10q.htm 10-Q 10-Q
0.25falseQ2--12-31Markforged Holding Corp0001816613MA 0001816613 2020-12-31 0001816613 2021-06-30 0001816613 2020-06-24 2020-06-30 0001816613 2021-01-01 2021-06-30 0001816613 2021-04-01 2021-06-30 0001816613 2020-01-01 2020-12-31 0001816613 2020-07-01 2020-09-30 0001816613 2021-01-01 2021-03-31 0001816613 2020-08-20 0001816613 2020-09-30 0001816613 2021-08-09 0001816613 2021-07-14 2021-07-14 0001816613 2021-07-14 0001816613 2020-06-23 0001816613 2020-06-30 0001816613 2021-03-31 0001816613 us-gaap:OverAllotmentOptionMember 2020-08-20 2020-08-20 0001816613 us-gaap:IPOMember 2020-08-20 2020-08-20 0001816613 us-gaap:CommonClassBMember 2020-08-20 2020-08-20 0001816613 us-gaap:PrivatePlacementMember 2020-08-20 2020-08-20 0001816613 us-gaap:PrincipalOwnerMember us-gaap:CommonClassBMember 2020-08-20 2020-08-20 0001816613 mkfg:PrivatePlacementWarrantMember 2020-12-31 0001816613 us-gaap:CommonClassAMember 2020-12-31 0001816613 us-gaap:CommonClassBMember 2020-12-31 0001816613 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryBillSecuritiesMember 2020-12-31 0001816613 us-gaap:FairValueInputsLevel1Member mkfg:PublicWarrantMember 2020-12-31 0001816613 us-gaap:FairValueInputsLevel3Member mkfg:PrivatePlacementWarrantMember 2020-12-31 0001816613 us-gaap:LineOfCreditMember us-gaap:PrincipalOwnerMember 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember us-gaap:CommonClassBMember 2020-06-26 0001816613 us-gaap:CommonClassBMember 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember 2020-09-01 2020-09-30 0001816613 us-gaap:PrincipalOwnerMember 2020-09-30 0001816613 us-gaap:OverAllotmentOptionMember 2020-09-30 0001816613 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001816613 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001816613 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001816613 us-gaap:PrivatePlacementMember 2020-08-20 0001816613 us-gaap:IPOMember 2020-08-20 0001816613 us-gaap:CommonClassBMember 2020-08-20 0001816613 us-gaap:PrincipalOwnerMember mkfg:FiveIndividualsMember 2020-08-10 2020-08-10 0001816613 us-gaap:PrincipalOwnerMember mkfg:OneIndividualMember 2020-08-10 2020-08-10 0001816613 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001816613 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001816613 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001816613 us-gaap:PrivatePlacementMember 2021-06-30 0001816613 mkfg:PublicWarrantMember 2021-06-30 0001816613 us-gaap:CommonClassAMember 2021-06-30 0001816613 us-gaap:CommonClassBMember 2021-06-30 0001816613 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-06-30 0001816613 us-gaap:FairValueInputsLevel1Member mkfg:PublicWarrantMember 2021-06-30 0001816613 us-gaap:FairValueInputsLevel3Member mkfg:PrivatePlacementWarrantMember 2021-06-30 0001816613 us-gaap:WarrantMember 2021-06-30 0001816613 us-gaap:IPOMember 2021-06-30 0001816613 us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001816613 us-gaap:CommonClassBMember 2021-04-01 2021-06-30 0001816613 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001816613 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-06-24 2020-06-30 0001816613 us-gaap:CommonClassBMember 2020-06-24 2020-06-30 0001816613 us-gaap:RetainedEarningsMember 2020-06-24 2020-06-30 0001816613 us-gaap:LineOfCreditMember us-gaap:PrincipalOwnerMember 2020-06-26 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember 2020-06-26 2020-06-26 0001816613 us-gaap:CommonClassBMember 2020-07-01 2020-09-30 0001816613 us-gaap:OverAllotmentOptionMember 2020-07-01 2020-09-30 0001816613 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001816613 us-gaap:CommonClassAMember mkfg:AfterDomesticationMember 2021-07-14 2021-07-14 0001816613 us-gaap:CommonClassBMember mkfg:AfterDomesticationMember 2021-07-14 2021-07-14 0001816613 mkfg:MarkforgedIncMember 2021-07-14 2021-07-14 0001816613 mkfg:AOneMember us-gaap:CommonClassAMember 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:VolumeWeightedAverageSharePriceAtleast12.50Member 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:VolumeWeightedAverageSharePriceAtleast15.00Member 2021-07-14 2021-07-14 0001816613 mkfg:VolumeWeightedAveragePriceAtleastTwelvePointFiveMember us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember 2021-07-14 2021-07-14 0001816613 mkfg:VolumeWeightedAveragePriceAtleastFifteenMember us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember 2021-07-14 2021-07-14 0001816613 mkfg:PipeInvestorsMember us-gaap:SubsequentEventMember mkfg:AOneMember 2021-07-14 2021-07-14 0001816613 us-gaap:CommonClassAMember mkfg:BeforeDomesticationMember 2021-07-14 0001816613 us-gaap:CommonClassAMember mkfg:AfterDomesticationMember 2021-07-14 0001816613 us-gaap:CommonClassBMember mkfg:BeforeDomesticationMember 2021-07-14 0001816613 mkfg:AfterDomesticationMember us-gaap:CommonClassBMember 2021-07-14 0001816613 mkfg:MarkforgedIncMember 2021-07-14 0001816613 mkfg:AOneMember us-gaap:CommonClassAMember 2021-07-14 0001816613 mkfg:VolumeWeightedAveragePriceAtleastTwelvePointFiveMember us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember 2021-07-14 0001816613 mkfg:VolumeWeightedAveragePriceAtleastFifteenMember us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember 2021-07-14 0001816613 mkfg:PipeInvestorsMember us-gaap:SubsequentEventMember mkfg:AOneMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember mkfg:MarkforgedHoldingCorporation2021EmployeeStockPurchasePlanMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember mkfg:MarkforgedEarnoutSharesAndEarnoutRsusmemberMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember mkfg:PrivatePlacementWarrantsMember 2021-07-14 0001816613 us-gaap:RetainedEarningsMember 2020-12-31 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001816613 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001816613 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001816613 us-gaap:RetainedEarningsMember 2021-03-31 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001816613 us-gaap:CommonClassBMember 2021-03-31 0001816613 us-gaap:CommonClassAMember 2021-03-31 0001816613 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001816613 us-gaap:RetainedEarningsMember 2021-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001816613 us-gaap:RetainedEarningsMember 2020-06-23 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-06-23 0001816613 us-gaap:CommonClassBMember 2020-06-23 0001816613 us-gaap:CommonClassAMember 2020-06-23 0001816613 us-gaap:RetainedEarningsMember 2020-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001816613 us-gaap:CommonClassBMember 2020-06-30 0001816613 us-gaap:CommonClassAMember 2020-06-30 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Year iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                    
 
 
MARKFORGED HOLDING CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
  
001-39453
  
98-1545859
(State or other jurisdiction
of incorporation or organization)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
   
480 Pleasant Street
Watertown, MA
  
02472
(Address Of Principal Executive Offices)
  
(Zip Code)
 
(866)
496-1805
Registrant’s telephone number, including area code
one
16 Funston Avenue, Suite A
The Presidio of San Francisco
San Francisco, California
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class:
  
Trading Symbol:
  
Name of Each Exchange on Which Registered:
Common Stock, $0.0001 par value per share
  
MKFG
  
New York Stock Exchange
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, $0.0001 par value
  
MKFG.WS
  
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☐    No  ☒
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated filer
   ☒    Smaller reporting company   ☒
       
Emerging growth company   ☒         
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of August
9
, 2021, the registrant had 185,251,837 shares of common stock, par value $0.0001 per share, issued and outstanding.
 
 
 
Markforged Holding Corporation
Form
10-Q
For The Three and Six Months Ended June 30, 2021
Table of Contents
 
 
 
 
  
Page
 
  
      
     
Item 1.
 
  
 
4
 
     
 
 
  
 
4
 
     
 
 
  
 
5
 
     
 
 
  
 
6
 
     
 
 
  
 
7
 
     
 
 
  
 
8
 
     
Item 2.
 
  
 
22
 
     
Item 3.
 
  
 
25
 
     
Item 4.
 
  
 
25
 
   
  
      
     
Item 1.
 
  
 
26
 
     
Item 1A.
 
  
 
26
 
     
Item 2.
 
  
 
55
 
     
Item 3.
 
  
 
55
 
     
Item 4.
 
  
 
55
 
     
Item 5.
 
  
 
55
 
     
Item 6.
 
  
 
55
 
Summary of the Material Risks Associated with Our Business
 
  •  
We have history of net losses and may not be able to achieve profitability for any period in the future or sustain cash flow from operating activities. We have a relatively limited operating history and have experienced rapid growth, which makes evaluating our current business and future prospects difficult and may increase the risk of your investment. Our operating results may fluctuate significantly from
period-to-period.
 
  •  
The additive manufacturing industry in which we operate is characterized by rapid technological change, which requires us to continue to develop new products and innovations to meet constantly evolving customer demands and which could adversely affect market adoption of our products.
 
  •  
A pandemic, epidemic, or outbreak of an infectious disease, such as the
COVID-19
pandemic, may materially and adversely affect our business and our financial results and could cause a disruption to the development of our products. The
COVID-19
pandemic has caused material disruption to our business in the second and third quarters of 2020.
 
  •  
We face significant competition in our industry. If we are unable to create new products or meet the demands of our customers, our business could be materially adversely affected.
 
  •  
We depend on our network of value-added resellers and our business could be materially adversely affected if they do not meet our expectations.
 
  •  
We depend heavily on third-party suppliers. If they or their facilities become unavailable or inadequate, our business could be adversely affected. We may experience significant delays in the design, production and launch of our additive manufacturing solutions and enhancements to existing products, and we may be unable to successfully commercialize products on our planned timelines.
 
  •  
We rely on a limited number of third-party logistics providers for distribution of our products, and their failure to distribute our products effectively would adversely affect our sales.
 
  •  
If demand for our products does not grow as expected, or if market adoption of additive manufacturing does not continue to develop, or develops more slowly than expected, our revenues may stagnate or decline, and our business may be adversely affected.
 
  •  
Defects in new products or in enhancements to our existing products that give rise to product returns or warranty or other claims could result in material expenses, diversion of management time and attention and damage to our reputation.
 
  •  
We may be unable to consistently manufacture our products to the necessary specifications or in quantities necessary to meet demand at an acceptable cost or at an acceptable performance level. As manufacturing becomes a larger part of our operations, we will become exposed to accompanying risks and liabilities. We depend on a limited number of third-party contract manufacturers for a substantial portion of all of our manufacturing needs and any delay, disruption or quality control problems in their operations, including due to the
COVID-19
pandemic, could cause harm to our operations, including loss of market share and damage to our brand.
 
  •  
We have experienced, and expect to continue to experience, rapid growth and organizational change since inception. If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service and customer satisfaction or attract new employees and customers.
 
  •  
A real or perceived defect, security vulnerability, error or performance failure in our software or technical problems or disruptions caused by our third-party service providers could cause us to lose revenue, damage our reputation and expose us to liability.
 
  •  
Our existing and planned global operations subject us to a variety of risks and uncertainties that could adversely affect our business and operating results. Our business is subject to risks associated with selling machines and other products in
non-United
States locations. Global economic, political and social conditions and uncertainties in the market that we serve may adversely impact our business.
 
  •  
A significant portion of our business depends on sales to the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business.
 
  •  
We are, and have been in the recent past, subject to business and intellectual property litigation. We could be subject to personal injury, property damage, product liability, warranty and other claims involving allegedly defective products that we supply. We could face liability if our additive manufacturing solutions are used by our customers to print dangerous objects.
 
  •  
If we are unable to adequately protect our proprietary technology or obtain and maintain patent protection for our technology and products or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully commercialize our technology and products may be impaired.
 
1
EXPLANATORY NOTE
Prior to July 14, 2021, we were a blank check company known as one (“one”) incorporated in the Cayman Islands on June 24, 2020 as a special purpose acquisition company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
one, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021 (the “Merger Agreement”), by and among one, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of AONE (“Merger Sub”), and MarkForged, Inc., a Delaware corporation (“Markforged”). On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
Domestication Proposal
” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 (the “Proxy Statement/Prospectus”) and filed with the Securities and Exchange Commission (the “SEC”), one filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which one was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”).
As used herein, the words “the Company,” “we,” “us,” and “our” refer to, for periods following the Business Combination, Markforged Holding Corporation, together with is direct and indirect subsidiaries, and for periods prior to the Business Combination, one, and its direct and indirect subsidiaries, as applicable. In addition, the word “one” refers to the Company prior to the completion of the Business Combination.
 
2
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form
10-Q
contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for our future operations of Markforged Holding Corporation. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this prospectus, words such as “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “might”, “plan”, “possible”, “potential”, “predict”, “project”, “should”, “strive”, “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Forward-looking statements in this Quarterly Report on Form
10-Q
include, for example, statements about:
 
  •  
the benefits of the Business Combination;
 
  •  
our financial performance;
 
  •  
the effect of uncertainties related to the
COVID-19
pandemic;
 
  •  
the expected growth of the additive manufacturing industry;
 
  •  
our anticipated growth and our ability to achieve and maintain profitability in the future;
 
  •  
the impact of the regulatory environment and complexities with compliance related to such environment on us;
 
  •  
our ability to respond to general economic, political and business conditions;
 
  •  
our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth;
 
  •  
the success of our marketing efforts and our ability to expand our customer base;
 
  •  
our ability to develop new products, features and functionality that are competitive and meet market needs;
 
  •  
our ability to maintain an effective system of internal controls over financial reporting; and its ability to grow and manage growth profitably and retain key employees;
 
  •  
our inability to realize the anticipated benefits of the Business Combination;
 
  •  
the outcome of legal or governmental proceedings that may be instituted against us; and
 
  •  
other factors detailed under the section titled “
Risk Factors
”.
These forward-looking statements are based on information available as of the date of this Quarterly Report on Form
10-Q
and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements.
 
3
PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements
Markforged Holding Company
(f/k/a ONE)
CONDENSED CONSOLIDATED BALANCE SHEETS
 
 
  
June 30, 2021
 
 
December 31, 2020
 
 
  
(Unaudited)
 
 
 
 
Assets
                 
Current assets:
                 
Cash
    $ 306,896     $ 919,823  
Prepaid expenses
      248,596       314,351  
    
 
 
    
 
 
  
Total current assets
      555,492       1,234,174  
Investments held in Trust Account
      215,099,354       215,076,225  
    
 
 
    
 
 
  
Total Assets
   
$
215,654,846
 
  
$
 216,310,399
 
    
 
 
    
 
 
  
Liabilities and Shareholders’ Equity
                 
Current liabilities:
                 
Accounts payable
    $ 4,921     $ 115,360  
Accrued expenses
      2,715,966       24,847  
    
 
 
    
 
 
  
Total current liabilities
      2,720,887       140,207  
Deferred underwriting commissions
      7,525,000       7,525,000  
Derivative warrant liabilities
      19,607,500       17,902,500  
    
 
 
    
 
 
  
Total liabilities
      29,853,387       25,567,707  
Commitments and Contingencies
             
Class A ordinary shares, $0.0001 par value; 18,080,145 and 18,574,269 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively
      180,801,450       185,742,690  
Shareholders’ Equity
                 
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2021 and December 31, 2020
      —         —    
Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 3,419,855 and 2,925,731 shares issued and outstanding (excluding 18,080,145 and 18,574,269 shares subject to 
      342       293  
possible redemption) at June 30, 2021 and December 31, 2020, respectively
  
      
 
      
Class B ordinary shares, $0.0001 par value; 10,000,000 shares authorized; 5,375,000 shares issued and outstanding at June 30, 2021 and December 31, 2020
      538       538  
Additional
paid-in
capital
      12,551,921       7,610,730  
Accumulated deficit
      (7,552,792 )      (2,611,559 ) 
    
 
 
    
 
 
  
Total shareholders’ equity
      5,000,009       5,000,002  
    
 
 
    
 
 
  
Total Liabilities and Shareholders’ Equity
   
$
215,654,846
 
  
$
216,310,399
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
4
Markforged Holding Company
(f/k/a ONE)
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
 
  
For the Three Months
Ended June 30, 2021
 
 
For the Six Months
Ended
June 30, 2021
 
 
For the period from
June 24, 2020
(inception) through
June 30, 2020
 
General and administrative expenses
    $ 1,104,977     $ 3,199,362     $ 11,030  
Administrative expenses - related party
      30,000       60,000       —    
    
 
 
    
 
 
    
 
 
  
Loss from operations
      (1,134,977 )      (3,259,362 )      (11,030 ) 
Other income (expenses)
                         
Change in fair value of derivative warrant liabilities
      3,069,000       (1,705,000 )      —    
Net gain from investments held in Trust Account
      3,248       23,129       —    
    
 
 
    
 
 
    
 
 
  
Net income (loss)
    $ 1,937,271     $ (4,941,233 )    $ (11,030 ) 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding of Class A ordinary shares
      21,500,000       21,500,000       —    
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income per share, Class A ordinary shares
    $ 0.00     $ 0.00     $ —    
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding of Class B ordinary shares
      5,375,000       5,375,000       5,000,000  
    
 
 
    
 
 
    
 
 
  
Basic and diluted net loss per share, Class B ordinary shares
    $ 0.36     $ (0.92 )    $ (0.00 ) 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
5
Markforged Holding Company
(f/k/a ONE)
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
For the Three and Six Months Ended June 30, 2021
 
     
                  
      
                  
      
                  
      
                  
      
                  
      
                  
      
                  
  
 
  
Ordinary Shares
 
  
 
 
 
 
 
 
 
 
 
  
Class A
 
 
Class B
 
  
Additional
Paid-in

Capital
 
 
Accumulated

Deficit
 
 
Total

Shareholders’

Equity
 
 
  
Shares
 
 
Amount
 
 
Shares
 
  
Amount
 
     
                  
      
                  
      
                  
      
                  
      
                  
      
                  
      
                  
  
Balance - December 31, 2020
   
 
2,925,731
 
  
$
 293
 
  
 
5,375,000
 
   
$
 538
 
   
$
7,610,730
 
  
$
(2,611,559
) 
  
$
5,000,002
 
Shares subject to possible redemption
      687,851       68       —          —          6,878,442       —         6,878,510  
Net loss
     
—
       —         —          —          —         (6,878,504 )      (6,878,504 ) 
    
 
 
    
 
 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance - March 31, 2021 (Unaudited)
   
 
3,613,582
 
  
$
361
 
  
 
5,375,000
 
   
$
538
 
   
$
14,489,172
 
  
$
(9,490,063
) 
  
$
5,000,008
 
Shares subject to possible redemption
      (193,727 )      (19 )      —          —          (1,937,251 )      —         (1,937,270 ) 
Net income
      —         —         —          —          —         1,937,271       1,937,271  
    
 
 
    
 
 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance - June 30, 2021 (Unaudited)
   
 
3,419,855
 
  
$
342
 
  
 
5,375,000
 
   
$
538
 
   
$
12,551,921
 
  
$
(7,552,792
) 
  
$
5,000,009
 
    
 
 
    
 
 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
For the Period from June 24, 2020 (inception) through June 30, 2020
 
     
                  
      
                  
      
                  
      
                  
      
                  
      
                  
      
                  
  
 
  
Ordinary Shares
 
  
 
 
  
 
 
 
 
 
 
  
Class A
 
  
Class B
 
  
Additional

Paid-in

Capital
 
  
Accumulated

Deficit
 
 
Total

Shareholders’

Equity
 
 
  
Shares
 
  
Amount
 
  
Shares
 
  
Amount
 
Balance - June 24, 2020 (inception)
   
 
—  
 
   
$
—  
 
   
 
—  
 
   
$
—  
 
   
$
—  
 
   
$
—  
 
  
$
—  
 
Issuance of Class B ordinary shares to Sponsor
      —          —          5,750,000        575        24,425        —         25,000  
Net loss
      —          —          —          —          —          (11,030 )      (11,030 ) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - June 30, 2020 (
u
naudited)
   
 
—  
 
   
$
 —  
 
   
 
5,750,000
 
   
$
 575
 
   
$
 24,425
 
   
$
(11,030
) 
  
$
13,970
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
The accompanying notes are an integral part of these condensed consolidated financial statements
 
6
Markforged Holding Company
(f/k/a ONE)
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
 
 
  
For the Six Months Ended
June 30, 2021
 
 
For the period from June 24,
2020 (inception) through
June 30, 202
0
 
Cash Flows from Operating Activities:
  
      
 
      
Net loss
    $ (4,941,233 )    $ (11,030 ) 
Adjustments to reconcile net loss to net cash used in operating activities:
 
        
Change in fair value of derivative warrant liabilities
      1,705,000       —    
Net gain from investments held in Trust Account
      (23,129 )      —    
Changes in operating assets and liabilities:
                 
Prepaid expenses
      65,755       —    
Accounts payable
      (110,439 )      —    
Accrued expenses
      2,691,119       11,030  
    
 
 
    
 
 
  
Net cash used in operating activities
      (612,927 )      —    
    
 
 
    
 
 
  
Net change in cash
      (612,927 )      —    
Cash - beginning of the period
      919,823       —    
    
 
 
    
 
 
  
Cash - end of the period
   
$
306,896
 
  
$
—  
 
    
 
 
    
 
 
  
Supplemental disclosure of
non-cash
investing and financing activities:
 
        
Deferred offering costs included in accrued expenses
    $ —       $  158,237  
Deferred offering costs included in accounts payable
    $ —       $ 8,000  
Deferred offering costs paid in exchange for issuance of Class B ordinary shares to Sponsor
    $ —       $ 25,000  
Change in value of Class A ordinary shares subject to possible redemption
    $ (4,941,240 )    $ —    
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
7
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 — Description of Organization and Business Operations
Organization and General
Markforged Holding Corporation is an additive manufacturing company. Our platform, The Digital Forge, is an intuitive additive manufacturing platform powering engineers, designers and manufacturing professionals globally. The Digital Forge combines precise and reliable 3D printers and metal and composite proprietary materials seamlessly with its cloud-based learning software offering to empower manufacturers to create more resilient and agile supply chains. Founded in 2013 by two
MIT-educated
engineers, we are a company of over 300 engineers, builders and problem solvers. We are based in greater Boston, Massachusetts, where we have our own
in-house
manufacturing facility and where we design all of our industrial 3D printers, software and metal and composite proprietary materials.
one (when referred to prior to the Business Combination, the “Company”) was an incorporated blank check company incorporated in the Cayman Islands on June 24, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
At June 30, 2021, the Company had not yet commenced operations. All activity for the period from June 24, 2020 (inception) through June 30, 2021 relates to the Company’s formation and its preparation for the initial public offering (“Initial Public Offering”), which is described below, and since the offering, the search for a prospective initial Business Combination. The Company did not generate any operating revenue prior to the completion of the Business Combination. The Company generateed
non-operating
income in the form of income earned on investments on cash and cash equivalents in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.
Sponsor and Initial Public Offering
The Company’s sponsor was
A-star,
a Cayman Islands
exempted limited partnership (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on August 17, 2020. On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,500,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions (Note 5).
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,150,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million (Note 4).
Trust Account
Upon the closing of the Initial Public Offering and the Private Placement, $215.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and will be invested by the trustee only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
of the Investment Company Act, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
Initial Business Combination
The Company’s management had broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds were intended to be applied generally toward consummating a Business Combination.
The Company provided its holders (the “Public Shareholders”) of its Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The Public Shareholders were entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The
per-share
amount distributed to Public Shareholders who redeemed their Public Shares was not be reduced by the deferred underwriting commissions the Company paid to the underwriters (as discussed in Note 5). These Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
 
8
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Business Combination
The Company, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021, by and among one, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of one, and MarkForged, Inc., a Delaware corporation. On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
Domestication Proposal
” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 filed with the Securities and Exchange Commission, the Company filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which one was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”).
Note 2 — Summary of Significant Accounting Policies
Basis of presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form
10-K/A
filed by the Company with the SEC on May 14, 2021.
Emerging growth company
As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The
9
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Principles of Consolidation
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had no cash equivalents.
Investments Held in the Trust Account
At June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
•
 
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
10
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
 
•
 
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
 
•
 
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measuremen
t
 is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
As of June 30, 2021, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. As of June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses NAV as a practical expedient to fair value for its investments in money market funds.
Offering Costs Associated with the Initial Public Offering
Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as
non-operating
expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC
815-15.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The 5,375,000
warrants
issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,150,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 18,080,145 and 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets.
 
11
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Income Taxes
ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve month
s
.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period.
At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
For the three and six months ended June 30, 2021, the Company’s unaudited condensed statements of operations includes a presentation of income (loss) per Class A ordinary share subject to redemption in a manner similar to the
two-class
method of income (loss) per share. Net income per Class A ordinary share, basic and diluted, is calculated by dividing the investment income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per Class B ordinary share, basic and diluted, is calculated by dividing the net loss, less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the periods.
The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary shares price for the period and therefore the inclusion of such warrants would be anti-dilutive.
 
12
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share:
 
 
 
For the Three Months
 
 
For the Six Months
 
 
 
Ended June 30, 2021
 
 
Ended June 30, 2021
 
Class A ordinary share
 
      
 
      
Numerator: Income allocable to Class A ordinary share
 
      
 
      
Income from investments held in Trust Account
 
$
3,248
 
 
$
23,129
 
Less: Company’s portion available to be withdrawn to pay taxes
 
 
—  
 
 
 
—  
 
 
 
 
 
 
 
 
 
 
Net income attributable to Class A ordinary share
 
$
3,248
 
 
$
23,129
 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class A ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class A ordinary share
 
 
        21,500,000
 
 
 
        21,500,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income per share, Class A ordinary share
 
$
0.00
 
 
$
0.00
 
 
 
 
 
 
 
 
 
 
     
Class B ordinary share
 
      
 
      
Numerator: Net income (loss) minus net income allocable to Class A ordinary share
 
      
 
      
Net income (loss)
 
$
1,937,271
 
 
$
(4,941,233
) 
Net income allocable to Class A ordinary share
 
 
3,248
 
 
 
23,129
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Class B ordinary share
 
$
1,934,023
 
 
$
(4,964,362
) 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class B ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class B ordinary share
 
 
5,375,000
 
 
 
5,375,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income (loss) per share, Class B ordinary share
 
$
0.36
 
 
$
(0.92
) 
 
 
 
 
 
 
 
 
 
Recent Accounting Pronouncements
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.
Note 3 — Initial Public Offering
On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 Units, including 1,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions.
Each Unit consists of one Class A ordinary share, and
one-fourth
of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary shares at a price of $11.50 per share, subject to adjustment (see Note 6).
Note 4 — Related Party Transactions
Founder Shares
On June 26, 2020, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). Up to 750,000 Founder Shares were subject to forfeiture to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On August 10, 2020, the Sponsor transferred 25,000 Founder Shares to each of Michelle Gill, Lachy Groom, Gautam Gupta, Trina Spear, and Laura de Petra, and 30,000 Founder Shares to Pierre Lamond. On August 20, 2020, the underwriters exercised their over-allotment option and, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly.
The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-
trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.
 
13
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Private Placement Warrants
Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 3,150,000 Private Placement Warrants at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million.
Prior to the consummation of the Business Combination, each warrant was exercisable to purchase
 one
 
Class A ordinary share at
$11.50
per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company did not complete a Business Combination within the Combination Period, the Private Placement Warrants would have expired worthless.
The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination.
Sponsor Loan
On June 26, 2020, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was
non-interest
bearing and payable on the earlier of December 31, 2020 or the completion of the Initial Public Offering. The Company borrowed approximately $163,000 under the Note, and fully repaid the Note on August 20, 2020.
Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $2.00 per warrant. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.
Administrative Support Agreement
The Company agreed to pay the Sponsor a total of $10,000 per month, commencing on date the Company’s securities are first listed on the New York Stock Exchange (the “listing date”), for office space, secretarial and administrative services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the three and six months ended June 30, 2021, the Company incurred $30,000 and $60,000, respectively for expenses in connection with the Administrative Support Agreement.
Note 5 — Commitments and Contingencies
Registration and Shareholder Rights
The holders of Founder Sha
r
es, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, were entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, these holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
14
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On August 20, 2020, the underwriters exercised their over-allotment option of 1,500,000 Units and, an aggregate of 375,000 Class B ordinary shares were forfeited by the Sponsor for no consideration accordingly.
The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $7.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Risks and Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 6 — Derivative Warrant Liabilities
As of June 30, 2021 and December 31, 2020, the Company has 5,375,000 and 3,150,000 Public Warrants and Private Placement Warrants, respectively, outstanding.
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants have an exercise price of at $11.50 per share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
 
15
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $
0.01
per warrant;
 
  •  
upon a minimum of
30 days
’ prior written notice of redemption; and
 
  •  
if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $
18.00
per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any
20
trading days within a
30
-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the warrants:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below);
 
  •  
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders;
 
  •  
if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and
 
  •  
if, and only if, there is an effective registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the
30-day
period after written notice of redemption is given.
The “fair market value” of the Class A ordinary shares shall mean the volume weighted average price of the Class A ordinary shares as reported during the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Note 7 — Shareholders’ Equity
Preference Shares
 - The Company is authorized to issue 1,000,000 preference with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding.
 
16
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Class
 A Ordinary Shares
 - The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2021, there were 21,500,000 Class A ordinary shares issued or outstanding, including 18,080,145 Class A ordinary shares subject to possible redemption. As of December 31, 2020, there were 21,500,000 Class A ordinary shares issued or outstanding, including 18,574,269 Class A ordinary shares subject to possible redemption.
Class
 B Ordinary Shares
 - The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. At August 20, 2020, there were 5,750,000 Class B ordinary shares issued and outstanding, of which an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On August 20, 2020, the underwriters exercised their over-allotment option in part and, accordingly, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly. As of June 30, 2021 and December 31, 2020, there were 5,375,000 Class B ordinary shares outstanding.
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination.
The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity- linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants that may be issued upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.
Note 8 — Fair Value Measurements
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
June 30, 2021
 
Description
  
Quoted
Prices in
Active
Markets
(Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
  
      
  
      
  
      
Money market fund
  
$
215,099,354
 
  
$
—  
 
  
$
—  
 
Liabilities:
  
      
  
      
  
      
Derivative warrant liabilities - Public
  
$
12,362,500
 
  
$
—  
 
  
$
—  
 
Derivative warrant liabilities - Private
  
$
—  
 
  
$
—  
 
  
$
7,245,000
 
 
17
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
December 31, 2020
 
Description
  
Quoted
Prices in
Active
Markets
(Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
  
      
  
      
  
      
U.S Treasury bills maturing on February 18, 2021
  
$
215,076,225
 
  
$
—  
 
  
$
—  
 
Liabilities:
  
      
  
      
  
      
Derivative warrant liabilities - Public
  
$
11,287,500
 
  
$
—  
 
  
$
—  
 
Derivative warrant liabilities - Private
  
$
—  
 
  
$
—  
 
  
$
6,615,000
 
Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in October 202
0
, when the Public Warrants were separately listed and traded.
Level 1 instruments include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The estimated fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model.
For the three months ended June 30, 2021, the Company recognized a gain to the condensed statement of operations resulting from an decrease in the fair value of liabilities of $3.1 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statement of operations. For the six months ended June 30, 2021, the Company recognized a charge to the statement of operations resulting from an increase in the fair value of liabilities of $1.7 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statement of operations.
The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Binomial Lattice model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
 
 
  
As of
December 31, 2020
 
 
As of
June 30, 2021
 
Volatility
  
 
25.8
% 
 
 
36.2
% 
Stock price
  
$
10.77
 
 
$
9.98
 
Risk-free rate
  
 
0.43
% 
 
 
0.88
% 
Dividend yield
  
 
0.0
% 
 
 
0.0
% 
The change in the fair value of the derivative warrant liabilities as classified level 3 for the three and six months ended June 30, 2021 is summarized as follows:
 
Level 3 - Derivative warrant liabilities at December 31, 2020
  
$
6,615,000
 
Change in fair value of derivative warrant liabilities
  
 
1,764,000
 
 
  
 
 
 
Level 3 - Derivative warrant liabilities at March 31, 2021
  
$
8,379,000
 
Change in fair value of derivative warrant liabilities
  
 
(1,134,000
) 
 
  
 
 
 
Level 3 - Derivative warrant liabilities at June 30, 2021
  
$
7,245,000
 
 
  
 
 
 
 
18
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Note 9 — Subsequent Events
The Company (“AONE”), a Cayman Islands exempted company, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021 (the “Merger Agreement”), by and among AONE, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of AONE (“Merger Sub”), and MarkForged, Inc., a Delaware corporation (“Markforged”).
On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
Domestication Proposal
” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 (the “Proxy Statement/Prospectus”) and filed with the Securities and Exchange Commission (the “SEC”), AONE filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which AONE was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”).
As a result of and upon the effective time of the Domestication, among other things, (i) each of the then issued and outstanding Class A ordinary shares, par value $0.0001 per share, of AONE (the “Class A Ordinary Shares”) automatically converted, on a
one-for-one
basis, into a share of common stock, par value $0.0001 per share, of Markforged Holding Corporation (the “New Common Stock”); (ii) each of the then issued and outstanding Class B ordinary shares, par value $0.0001 per share, of AONE (the “Class B Ordinary Shares”) automatically converted, on a
one-for-one
basis, into shares of New Common Stock; (iii) each of the then issued and outstanding redeemable warrants of AONE (the “AONE Warrants”) automatically converted, on a
one-for-one
basis, into redeemable warrants to acquire one share of New Common Stock (the “New Warrants”); and (iv) each of the then issued and outstanding units of AONE that had not been previously separated into the underlying Class A Ordinary Shares and underlying AONE Warrants upon the request of the holder thereof were cancelled and entitled the holder thereof to one share of New Common Stock and
one-fourth
of one New Warrant. No fractional New Warrants were issued, and no fractional shares of New Common Stock were issued or will be issuable upon the exercise of New Warrants.
On July 13, 2021, AONE held an extraordinary general meeting of stockholders (the “Special Meeting”), at which the AONE stockholders considered and adopted, among other matters, a proposal to approve the Merger (as defined below), including approving the other transactions contemplated by the Merger Agreement and related agreements described in the Proxy Statement/Prospectus.
On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
BCA Proposal
” beginning on page 98 of the Proxy Statement/Prospectus, Markforged Holding Corporation consummated the merger transaction contemplated by the Merger Agreement, whereby Merger Sub merged with and into Markforged, with the separate corporate existence of Merger Sub ceasing and Markforged being the surviving corporation and a wholly owned subsidiary of Markforged Holding Corporation (the “Merger” and, together with the Domestication, the “Transactions”).
Immediately prior to the effective time of the Merger (the “Effective Time”), Markforged purchased approximately $45.0 million of its securities from certain of its stockholders (the “Employee Transactions”), and each outstanding share of Markforged preferred stock was converted on a
one-for-one
basis into shares of Markforged common stock, par value $0.0001 per share (the “Markforged Common Stock”) (the “Preferred Stock Conversion”). Holders of 6,418,667 Class A Ordinary Shares sold in AONE’s initial public offering properly exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from AONE’s initial public offering, calculated as of two business days prior to the consummation of the Merger, which was approximately $10.005 per share, or $64,216,731.96 in the aggregate (the “Redemption”). The remaining approximately $150.9 million in AONE’s trust account was released to Markforged Holding Corporation, net of transaction expenses.
At the Effective Time, among other things, each outstanding share of Markforged Common Stock as of immediately prior to the effective time of the Merger (after giving effect to the Employee Transactions and the Preferred Stock Conversion), other than (x) any shares of Markforged Common Stock subject to Markforged Awards (as defined below) and (y) any shares of Markforged capital stock held in treasury by Markforged, which treasury shares were canceled as part of the Merger, was canceled and converted into the right to receive a number of shares of New Common Stock equal to the product of one share of Markforged Common Stock multiplied by the Exchange Ratio (as defined below). No fractional shares were issued in the Merger, and any fractional shares that a holder of Markforged securities would have otherwise been entitled to in the Merger were eliminated in accordance with the terms of the Merger Agreement.
At the Effective Time, all options to purchase shares of Markforged Common Stock and all restricted stock units based on shares of Markforged Common Stock outstanding as of immediately prior to the Merger (together, the “Markforged Awards”) were converted into (a) options to purchase shares of New Common Stock (“New Options”), and (b) restricted stock units based on shares of New Common Stock (“New RSUs”), respectively.
 
19
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The “Exchange Ratio,” defined as (i) $1.7 billion minus the aggregate amount paid pursuant to the Employee Transactions (the “Equity Value,” or $1.655 billion), divided by (ii) $10.00, divided by (iii) the number of issued and outstanding shares of Markforged Common Stock, on a fully diluted and
as-converted
basis (including shares subject to outstanding Markforged Awards and shares available for issuance in respect of Markforged Awards not yet granted under Markforged’s existing incentive plan), was approximately 0.9522514.
The holders of Markforged Common Stock and Markforged Awards (whether vested or not) immediately prior to the Effective Time are entitled to receive, on a pro rata basis, up to 14,666,667 additional shares of New Common Stock (“Markforged Earnout Shares”) as follows: (i) if the volume-weighted average price of New Common Stock is at least $12.50 for any 20 trading days in a consecutive
30-trading
day period, 8,000,000 Markforged Earnout Shares will be issued, (ii) if the volume-weighted average price of New Common Stock is at least $15.00 for any 20 trading days in a consecutive
30-trading
day period, 6,666,667 Markforged Earnout Shares will be issued and (iii) upon a change of control or a liquidation of Markforged Holding Corporation, all previously unearned Markforged Earnout Shares will be issued. Markforged stockholders will not receive any Markforged Earnout Shares not earned as of July 14, 2026. Any Markforged Earnout Share that would otherwise be distributed to a holder of a Markforged Award that is unvested as of the date of distribution will be distributed in the form of a New RSU, which will vest subject to the same vesting conditions as the underlying award. If such Markforged Award holder forfeits the underlying Markforged Award, then such holder’s right to receive the allocable Markforged Earnout Shares will immediately terminate (and such Markforged Earnout Shares would instead be distributed on a pro rata basis to the other eligible former holders of Markforged Common Stock and Markforged Awards).
Concurrently with the execution of the Merger Agreement, AONE entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”), by and among AONE, Markforged,
A-star,
a Cayman Islands limited liability company and AONE’s sponsor (the “Sponsor”), and the other holders of the Class B Ordinary Shares (collections, the “Sponsor parties”), which provides, among other things, that 50% of the shares of New Common Stock held by the Sponsor as a result of the conversion of its Class B Ordinary Shares in connection with the Domestication (the “Sponsor Earnout Shares”) will be subject to the following vesting conditions: (i) 50% of the Sponsor Earnout Shares (25% of the Sponsor’s total shares) will vest if the volume-weighted average price of New Common Stock is at least $12.50 for any 20 trading days in a consecutive
30-trading
day period and (ii) 50% of the Sponsor Earnout Shares (25% of the Sponsor’s total shares) will vest if the volume-weighted average price of New Common Stock is at least $15.00 for any 20 trading days in a consecutive
30-trading
day period. Any Sponsor Earnout Shares not vested as of July 14, 2026 will be forfeited.
PIPE Investment
As previously announced, on February 23, 2021, concurrently with the execution of the Merger Agreement, AONE entered into subscription agreements with certain investors (collectively, the “PIPE Investors”) pursuant to which, on the terms and subject to the conditions therein, the PIPE Investors collectively subscribed for 21,000,000 shares of New Common Stock at $10.00 per share for an aggregate purchase price equal to $210,000,000 (the “PIPE Investment”). The PIPE Investment was consummated substantially concurrently with the closing of the Transactions.
Post-Closing Capitalization
On July 14, 2021 immediately following the Transactions and after giving effect to the Merger, the Employee Transactions, the Preferred Stock Conversion, the PIPE Investment and the Redemption, Markforged Holding Corporation’s capitalization consisted of:
 
 
185,251,837
 
   
Shares of New Common Stock outstanding
  8,524,984      Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor)
  18,434,577      Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the “2021 Plan”)
 
212,211,398
 
   
Total outstanding equity at closing, including vested and unvested options and RSUs
  24,065,423      Shares of New Common Stock reserved for issuance under the 2021 Plan
  4,700,000      Shares of New Common Stock reserved for future issuance under the Markforged Holding Corporation 2021 Employee Stock Purchase Plan
  14,666,667      Shares of New Common Stock reserved for future issuance as Markforged Earnout Shares and/or Earnout RSUs
 
20
Markforged Holding Company
(f/k/a ONE)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Upon the consummation of the Transactions, AONE’s units ceased trading on the New York Stock Exchange (the “NYSE”) and, on July 15, 2021, the shares of New Common Stock and the New Warrants began trading under the symbols “MKFG” and “MKFG.WS,” respectively.
Terms used but not defined herein, or for which definitions are not otherwise incorporated by reference herein, shall have the meaning given to such terms in the Proxy Statement/Prospectus and such definitions are incorporated herein by reference. Unless the context otherwise requires, all references to “we”, “us” or “our” refer to Markforged Holding Corporation.
Registration Rights Agreement
On July 14, 2021, in connection with the consummation of the Transactions and as contemplated by the Merger Agreement, Markforged Holding Corporation, the Sponsor Parties and certain former stockholders of Markforged entered into the Registration Rights Agreement.
Lock-up
Agreements
On July 14, 2021, in connection with the consummation of the Transactions and as contemplated by the Merger Agreement, Markforged Holding Corporation entered into separate
Lock-Up
agreements with certain of stockholders of Markforged Holding Corporation, which agreements are identical except for, as indicated in the Form of
Lock-Up
Agreement filed as Exhibit 10.8, an additional provision applicable only to those stockholders who are also party to the Registration Rights Agreement (the Sponsor Parties and certain former holders of the preferred stock of Markforged), and an additional provision applicable only to the Sponsor Parties.
The material terms of the Registration Rights Agreement and
Lock-up
Agreement are described in the section of the Proxy Statement/Prospectus beginning on page 115 under the section entitled “
BCA Proposal—Related Agreements
.” Such descriptions are qualified in their entirety by the text of such agreements, which are included as Exhibit 10.8 to this Report and are incorporated herein by reference.
Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
 
21
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Unless otherwise noted, as used herein, the words “the Company,” “we,” “us,” and “our” refer to, for periods following the Business Combination, Markforged Holding Corporation, together with is direct and indirect subsidiaries, and for periods prior to the Business Combination, one, and its direct and indirect subsidiaries, as applicable
. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed consolidated financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
Our platform, The Digital Forge, is an intuitive additive manufacturing platform powering engineers, designers and manufacturing professionals globally. The Digital Forge combines precise and reliable 3D printers and metal and composite proprietary materials seamlessly with its cloud-based learning software offering to empower manufacturers to create more resilient and agile supply chains. Founded in 2013 by two
MIT-educated
engineers, Markforged is a company of over 300 engineers, builders and problem solvers. We are based in greater Boston, Massachusetts, where we have our own
in-house
manufacturing facility and where we design all of our industrial 3D printers, software and metal and composite proprietary materials.
Prior to the consummation of the Business Combination, we were a blank check company incorporated as a Cayman Islands exempted company on June 24, 2020. one was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Recent Developments
Merger agreement
On July 14, 2021, we consummated the previously announced Business Combination pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 23, 2021 between one, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of one (“Merger Sub”), and MarkForged, Inc., a Delaware corporation (“Markforged”), under which Merger Sub merged with and into Markforged, with Markforged being the surviving corporation as a wholly-owned subsidiary of one. In connection with the Business Combination, one changed its name to “Markforged Holding Corporation”.
Impact of the
COVID-19
Pandemic
In December 2019, a novel coronavirus disease
(“COVID-19”)
was identified and on March 11, 2020, the World Health Organization characterized
COVID-19
as a pandemic. We are continuing to closely monitor the impact of the
COVID-19
pandemic on all aspects of our business, including how it is impacting our customers, employees, supply chain, and distribution network, as well as the demand for our products in the markets that we serve.
As governments worldwide scrambled to control the
COVID-19
pandemic, local governments imposed restrictions on facilities in order to contain the spread of
COVID-19.
As a result of these facilities closures, we experienced delays in shipments and installations as well as decreased utilization of our installed products, leading to a decrease in sales of consumables materials, which had an adverse effect on our revenue. While vaccines have become publicly available and states, including Massachusetts where our headquarters is located, have begun to ease restrictions, the extent to which our operations may be impacted by the
COVID-19
pandemic will depend largely on future developments, which are uncertain and cannot be accurately predicted, including the timing, pace and scale of the recovery of global economic conditions. Furthermore, the impacts of a potential worsening of global economic conditions and the continued disruptions to and volatility in the financial markets remain unknown.
 
22
In the near term, we have undertaken certain measures to mitigate the impacts of the
COVID-19
pandemic on our financial position, cash flows and supply chain. We executed a reduction in force to control headcount related costs. Additionally, we have continued to work closely with our suppliers to ensure sufficient inventory is procured for our manufacturing and sales forecasts. While the health and safety of our employees has been our priority, we have continued to operate our manufacturing facilities with the implementation of additional safety measures, appropriate social distancing protocol, and in compliance with government regulations.
Our focus on longer term profitability is based on our investments in research and development, our VAR network, and go to market strategy. Research and development are core to our growth strategy to enable our platform to expand customer use cases and additive technology. We endeavor to expand and optimize our network of VARs which has been key to our expanding unit economics and global distribution.
For more information on operations and risks related to the pandemic, please see the section of this registration statement titled “
Risk Factors — General Risk Factors, The global
COVID-19
pandemic has significantly affected our business and operations
”.
Liquidity and Capital Resources
As of June 30, 2021, we had approximately $0.3 million in our operating bank account, and a working capital deficit of approximately $2.2 million.
Our liquidity needs up to June 30, 2021 had been satisfied through the payment of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares, the loan of approximately $163,000 from the Sponsor pursuant to the Note (see Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on August 20, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of June 30, 2021 and December 31, 2020, there were no amounts outstanding under any Working Capital Loan.
On February 23, 20
2
1
, we
entered into the Merger Agreement with Merger Sub and Markforged and closed the Business Combination on July 14, 2021.
Management continues to evaluate the impact of the
COVID-19
pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Results of Operations
Our entire activity since inception up to June 30, 2021 was in preparation for our formation and the Initial Public Offering. We did not generate any operating revenues prior to the closing and completion of the Business Combination.
For the three months ended June 30, 2021, we had net income of approximately $1.9 million, which consisted of approximately $3.1 million in change in fair value of derivative warrant liabilities and approximately $20,000 in net gain from investments held in Trust Account, partly offset by approximately $1.1 million in general and administrative expenses and $30,000 in administrative expenses – related party.
For the six months ended June 30, 2021, we had a net loss of approximately $4.9 million, which consisted of approximately $3.2 million in general and administrative expenses, $60,000 in administrative expenses – related party, approximately $1.7 million in change in fair value of derivative warrant liabilities, offset by approximately $23,000 in net gain from investments held in Trust Account.
For the period from June 24, 2020 (inception) through June 30, 2020, we had a net loss of approximately $11,000, which consisted solely of administrative expenses.
Contractual Obligations
Registration and Shareholder Rights
The holders of Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, were entitled to registration rights pursuant to a
 
23
registration rights agreement. These holders are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, these holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
We granted the underwriters a
45-day
option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On August 20, 2020, the underwriters exercised their over-allotment option of 1,500,000 Units and, an aggregate of 375,000 Class B ordinary shares were forfeited by the Sponsor for no consideration accordingly.
The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $7.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee became payable to the underwriters from the amounts held in the Trust Account solely upon the completion of the Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
Derivative Warrant Liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC
815-15.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The 5,375,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,150,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in our condensed statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with our Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continues to be estimated using a Binomial Lattice model.
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events.
Net Income (Loss) per Ordinary Shares
We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period.
At June 30, 2020, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of our Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
For the three and six months ended June 30, 2021, our unaudited condensed statements of operations include a presentation of income (loss) per Class A ordinary share subject to redemption in a manner similar to the
two-class
method of income (loss) per share. Net income per Class A ordinary share, basic and diluted, is calculated by dividing the investment income earned on the Trust Account by
 
24
 
the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per Class B ordinary share, basic and diluted, is calculated by dividing the net loss, less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the periods.
The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary shares price for the period and therefore the inclusion of such warrants would be anti-dilutive.
Recent Accounting Pronouncements
Our management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.
Off-Balance
Sheet Arrangements
As of June 30, 2021, we did not have any
off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation
S-K.
JOBS Act
The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for
non-emerging
growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule
12b-2
of the Exchange Act and are not required to provide the information otherwise required under this item. As of June 30, 2021, we were not subject to any market or interest rate risk. The net proceeds of the Initial Public Offering, including amounts in the Trust Account, will be invested in U.S. government securities with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule
2a-7
under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
We have not engaged in any hedging activities since our inception and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.
 
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2021, as such term is defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act. Based upon that evaluation and in light of the SEC Staff Statement, our warrants as liabilities, our disclosure controls and procedures were not effective as of June 30, 2021.
 
25
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2021 covered by this Quarterly Report on Form
10-Q
that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
 
Item 1.
Legal Proceedings
From time to time we are involved in claims that arise during the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, we do not currently believe that the outcome of any of these other legal matters (including the matter involving Continuous Composites Inc., which the Company previously disclosed) will have a material adverse effect on our results of operation or financial condition. Regardless of the outcome, litigation can be costly and time consuming, as it can divert management’s attention from important business matters and initiatives, negatively impacting our overall operations.
 
Item 1A.
Risk Factors
A description of the risks and uncertainties associated with our business and industry is set forth below. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Quarterly Report on Form
10-Q,
including our unaudited consolidated financial statements and notes thereto and the “Management’s discussion and analysis of financial condition and results of operations” section of this Quarterly Report on Form
10-Q
before deciding whether to purchase shares of our common stock. If any of the following risks are realized, our business, financial condition, operating results and prospects could be materially and adversely affected. In that event, the price of our common stock could decline, perhaps significantly. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operation.
Risks Related to Markforged’s Business and Industry
Risks Related to Our Operating History
We have a history of net losses and may not be able to achieve profitability for any period in the future or sustain cash flow from operating activities.
We have a history of losses since our inception in 2013 and have funded our cash flow deficits primarily through the issuance of capital stock. As of June 30, 2021, we had an accumulated deficit of $100.7 million, including net losses of $21.0 million for the six months ended June 30, 2021, and $10.9 million for 2020 and $29.9 million for 2019. We expect to continue to incur operating losses and negative cash flow as we continue to invest significantly in research and development efforts, sales and marketing and other aspects of our business.
 
26
We cannot make any assurances that these investments will result in increased revenue or growth in our business. Additionally, as a public company, we expect our legal, accounting and other expenses to be substantially higher than the expenses we incurred as a private company. Furthermore, we may encounter unforeseen issues that require us to incur additional costs. Any such increased expenditures make it harder for us to achieve and maintain future profitability. Revenue growth and growth in our customer base may not be sustainable, and we may not achieve sufficient revenue to achieve or maintain profitability. While we have a revenue history, we expect to bring new additive manufacturing products to market that we anticipate will generate a substantial portion of our future revenue, and it is difficult for us to predict our future operating results. We may incur significant losses in the future for a number of reasons, including due to the other risks described in this prospectus, and we may encounter unforeseen expenses, difficulties, complications and delays and other unknown events. As a result, our losses may exceed forecasts, we may incur significant losses for the foreseeable future, and we may not achieve profitability when expected, or at all, and even if we do, we may not be able to maintain or increase profitability. Accordingly, if we are not able to achieve or maintain profitability and we incur significant losses in the future, the market price of our common stock may decline, and you could lose part or all of your investment.
We have a relatively limited operating history and have experienced rapid growth, which makes evaluating our current business and future prospects difficult and may increase the risk of your investment.
Our ability to forecast our future operating results is subject to a number of uncertainties, including our ability to plan for and model future growth. We have encountered, and will continue to encounter, risks and uncertainties frequently experienced by growing companies in rapidly evolving industries, as we continue to grow our business. If our assumptions regarding these uncertainties, which we use to plan our business, are incorrect or change in reaction to changes in our markets, or if we do not address these risks successfully, our operating and financial results could differ materially from our expectations, our business could suffer and the trading price of our stock may decline. We intend to derive a substantial portion of our revenues from sales of new and existing hardware products, which sales are
non-recurring
and subject to significant risk and fluctuation.
It is difficult to predict our future revenues and appropriately budget for our expenses, and we have limited insight into trends that may emerge and affect our business. If actual results differ from our estimates or we adjust our estimates in future periods, our operating results and financial position could be materially affected.
 
27
The financial projections included in this prospectus are based on our estimates and assumptions as of the dates indicated in this prospectus concerning various factors, which are subject to significant risks and uncertainties, many of which are beyond our control, and therefore actual results may differ materially. These estimates and assumptions include, among others: the continuing effects of the
COVID-19
pandemic, projections of the size and growth of the overall additive manufacturing industry, revenue growth for our existing products, our ability to develop and successfully commercialize new products and services, the mix of hardware, services and consumables revenue, the performance of our VARs, and cost assessments. These estimates and assumptions require the exercise of judgment and may not occur and are subject to various economic, business, competitive, regulatory, legislative, political and other factors beyond our control, including, for example, changes in customer demand, increased costs in our supply chain, and market acceptance of our products and services. There can be no assurance that the prospective results will be realized or that actual results will not be significantly higher or lower than estimated. Our failure to achieve our projected results could harm the trading price of our securities and financial position.
Our operating results may fluctuate significantly from
period-to-period
and may fall below expectations in any particular period, which could adversely affect the market price of our common stock.
Our quarterly results of operations may fluctuate significantly from
period-to-period.
Accordingly, the results of any one quarter should not be relied upon as an indication of future performance. If our revenue or operating results fall below the expectations of investors or any securities analysts that follow our company in any period, the price of our common stock would likely decline. Each of the risks described in this section, as well as other factors, may affect our operating results. For example, factors that may cause our operating results to fluctuate include:
 
  •  
the degree of market acceptance of our products;
 
  •  
our ability to compete with competitors and new entrants into our markets;
 
  •  
changes in our pricing policies or those of our competitors, including our response to price competition;
 
  •  
the effectiveness of our securing new orders and fulfilling existing orders;
 
  •  
the impact of the
COVID-19
pandemic on our customers, suppliers, manufacturers and operations;
 
  •  
the mix of products that we sell during any period;
 
  •  
the timing of our sales and deliveries of our products to customers;
 
  •  
changes in the amount that we spend to develop and manufacture new products or technologies;
 
  •  
timing of expenditures to develop and bring to market new or enhanced products and the generation of revenue from those products;
 
  •  
changes in the amounts that we and our value added resellers (“VARs”) spend to promote our products;
 
  •  
changes in the cost of satisfying our warranty obligations and servicing our products, including with respect to our obligations related to our “success plan” offerings;
 
  •  
litigation-related expenses and/or liabilities;
 
  •  
unforeseen liabilities or difficulties in integrating our acquisitions or newly acquired businesses;
 
  •  
disruptions to our internal and third-party manufacturing facilities and processes;
 
  •  
disruptions to our information technology systems or our third-party contract manufacturers;
 
  •  
disruptions to our global supply chain;
 
  •  
the geographic distribution of our sales;
 
28
  •  
general economic and industry conditions that affect customer demand; and
 
  •  
changes in accounting rules and tax laws.
In addition, sales of our products are subject to the adoption and capital expenditure cycles of our customers sales cycle, and seasonality among our customers may cause our revenues and operating results to fluctuate from period to period. Accordingly, we typically experience increased sales during the fourth quarter and, to a lesser extent, the third quarter of our fiscal year relative to the first and second quarters. Additionally, for our more complex solutions, which may require additional facilities investment and installation support, potential customers may spend a substantial amount of time performing internal assessments prior to making a purchase decision. This may cause us to devote significant effort in advance of a potential sale without any guarantee of receiving any related revenues. As a result, revenues and operating results for future periods are difficult to predict with any significant degree of certainty, which could lead to adverse effects on our inventory levels and overall financial condition. Accordingly, you should not rely on quarter-over-quarter and year-over-year comparisons of our results as an indicator of our future performance.
The global
COVID-19
pandemic has significantly affected our business and operations.
The
COVID-19
pandemic and efforts to control its spread have significantly curtailed the movement of people, goods and services worldwide. In light of the uncertain situation relating to the spread of
COVID-19,
we have taken precautionary measures intended to minimize the risk of the virus to our employees, our customers and the communities in which we operate. These measures include temporarily closing our offices to visitors and limiting the number of employees in our offices to those that are deemed essential for manufacturing and research purposes, as well as virtualizing, postponing or canceling customer, employee and industry events.
The
COVID-19
pandemic has also created many negative headwinds that present risks to our business and results of operations. For example, it has generally disrupted the operations of our customers and prospective customers, and may continue to disrupt their operations, including as a result of travel restrictions and/or business shutdowns, uncertainty in the financial markets or other harm to their business and financial results. These disruptions have caused reduced capital expenditures by our existing customers and potential new customers, which negatively impacted our sales, especially during the period between March 2020 and May 2020 in which we experienced a decrease in sales compared to the relevant period in 2019. This reduction was particularly prevalent among customers that are large companies purchasing our more expensive products that require greater
on-site
installation support. Further, in April 2020, we conducted a reduction in force as a result of reduced demand for our products and uncertainty about future revenues. Because the future effects of the
COVID-19
pandemic are unpredictable, the impact could be more prolonged and significant in the future. These disruptions could result in further reductions to capital expenditure budgets, delayed purchasing decisions, longer sales cycles, extended payment terms or missed payments, and postponed or canceled projects, any of which would negatively impact our business and operating results, including sales and cash flows. We cannot predict the long-term impact that the
COVID-19
pandemic may have on our business and cannot guarantee that it will not be materially negative. Although vaccines have recently become available to the public and states, including Massachusetts where our headquarters is located, have begun to ease certain restrictions, we continue to monitor the situation and may adjust our current policies as more information and public health guidance become available, the ongoing effects of the
COVID-19
pandemic and/or the precautionary measures that we have adopted may create operational and other challenges, any of which could harm our business and results of operations.
 
29
Historically, a significant portion of our field sales, customer training events and other application services have been conducted in person, and the rollout of our new products has historically been supported by our participation at industry conferences. Currently, as a result of the work and travel restrictions related to the
COVID-19
pandemic, and the precautionary measures that we have adopted, most of our field sales and professional services activities are being conducted remotely, which has resulted in a decrease in our travel expenditures. However, we have begun
in-person
interactions at trade shows and other customer events where permitted. We expect our travel expenditures to increase in the future, which could negatively impact our financial condition and results of operations. As of the date of this prospectus, we do not yet know the extent of the negative impact of such restrictions and precautionary measures on our ability to attract new customers or retain and expand our relationships with existing customers over the near and long term.
In addition, many of our suppliers are experiencing operational challenges as a result of
COVID-19,
which in turn may destabilize our supply chain or otherwise have an adverse effect on our ability to provide products to our customers. Our suppliers may have to temporarily close a facility for disinfecting after employees tested positive for
COVID-19,
face staffing shortages from employees who are sick or apprehensive about coming to work or be overwhelmed by unexpected demand. Because of measures we took to increase inventory, the difficulties experienced by our suppliers have had minimal impact on our ability to ship products to our customers; however, these measures had a negative impact on short-term profitability and if the
COVID-19
pandemic continues, it may negatively affect our inventory and delay delivery to our customers, which in turn will adversely affect our revenue and results of operations. If our suppliers are unable to deliver the materials we require on a timely basis, we cannot guarantee that we will be able to locate alternative sources of supply for our products on acceptable terms, or at all. If we are unable to adequately purchase appropriate amounts of inventory, our business and results of operations may be materially and adversely affected.
Additionally, the
COVID-19
pandemic has impacted, and may continue to impact, our headquarters, which is our primary corporate office, sales and marketing center and has also impacted our
in-house
manufacturing location, including through the effects of facility closures, reductions in operating hours and other social distancing efforts. For example, if even a small number of our employees who work in clusters relating to critical functions such as manufacturing, procurement, supply chain, and research and development, test positive for
COVID-19,
the entire business function could be temporarily shut down to ensure the safety of our employees and the effectiveness of business would be severely impacted. Additionally, while Massachusetts and other states have begun to ease restrictions on
in-person
operations, we cannot predict whether these conditions and concerns will continue or whether we will experience more significant or frequent disruptions in the future, including the complete closure of one or more of our facilities. Furthermore, as a result of the
COVID-19
pandemic, we have required all employees who are able to do so to work remotely on a full-time or partial basis. It is possible that widespread remote work arrangements may have a negative impact on our operations, the execution of our business plans, the productivity and availability of key personnel and other employees necessary to conduct our business, and on third party service providers who perform critical services for us, or otherwise cause operational failures due to changes in our normal business practices necessitated by the outbreak and related governmental actions. If a natural disaster, power outage, connectivity issue or other event occurred that impacted our employees’ ability to work remotely, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The increase in remote working may also result in increased consumer privacy, data security and fraud risks, and our understanding of applicable legal and regulatory requirements, as well as the latest guidance from regulatory authorities in connection with the
COVID-19
pandemic, may be subject to legal or regulatory challenge, particularly as regulatory guidance evolves in response to future developments.
More generally, the
COVID-19
pandemic has had, and is expected to continue to have, an adverse effect on economies and financial markets globally, leading to a continued economic downturn, which is expected to decrease technology spending generally and could adversely affect demand for our platforms and services. It is not possible at this time to estimate the full impact that
COVID-19
will have on our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.
To the extent the
COVID-19
pandemic adversely affects our business, financial condition and results of operations, it may also have the effect of heightening many of the other risks described in this “Risk Factors” section, including but not limited to, those related to our ability to increase sales to existing and new customers, continue to perform on existing contracts, develop and deploy new technologies, expand our marketing capabilities and sales organization, generate sufficient cash flow to service our indebtedness, and comply with the covenants in the agreements that govern our indebtedness.
 
30
Risks Related to the Additive Manufacturing Industry
The additive manufacturing industry in which we operate is characterized by rapid technological change, requiring continual innovation and development of new products and innovations to meet constantly evolving customer demands.
Our revenues are derived from the sale of 3D printers and related materials and services. The additive manufacturing market is subject to rapid innovation and technological change and our customers’ needs are rapidly evolving. While we intend to invest substantial resources to remain on the forefront of technological development, continuing advances in additive manufacturing technology, changes in customer requirements and preferences and the emergence of new standards, regulations and certifications could adversely affect adoption of our products. Our ability to compete in the additive manufacturing market depends, in large part, on our success in developing and introducing new 3D printers and technology, in improving our existing products and technology and qualifying new materials which our systems can support. We believe that we must continuously enhance and expand the functionality and features of our products and technologies in order to remain competitive. However, we may not be able to:
 
  •  
predict future customer demand;
 
  •  
develop cost effective new products and technologies that address the increasingly complex needs of prospective customers;
 
  •  
enhance our existing products and technologies;
 
  •  
respond to technological advances and emerging industry standards and certifications on a cost-effective and timely basis;
 
  •  
adequately protect our intellectual property as we develop new products and technologies;
 
  •  
identify the appropriate technology or product to which to devote our resources; or
 
  •  
ensure the availability of cash resources to fund research and development.
Even if we successfully introduce new additive manufacturing products and technologies and enhance our existing products and technologies, it is possible that these will eventually supplant our existing products or that our competitors will develop new products and technologies that will replace our own. As a result, any of our products may be rendered obsolete or uneconomical by our or our competitors’ technological advances, leading to a loss in market share, decline in revenue and adverse effects to our business and prospects.
We face intense and growing competition in the additive manufacturing industry. Our inability to compete effectively with our competitors could affect our ability to achieve our anticipated market penetration and achieve or sustain profitability.
The additive manufacturing industry in which we operate is highly competitive. We compete for customers with a wide variety of producers of additive manufacturing equipment that creates 3D objects and
end-use
parts, as well as with providers of materials and services for this equipment. Some of our existing and potential competitors are researching, designing, developing and marketing other types of products and services that may render our existing or future products obsolete, uneconomical or less competitive. Existing and potential competitors may also have substantially greater financial, technical, marketing and sales, manufacturing, distribution and other resources than us, including name recognition, as well as experience and expertise in intellectual property rights and operating within certain international markets or industry verticals, any of which may enable them to compete effectively against us. Moreover, many of our competitors have more extensive customer and partner relationships than we do, and may therefore be in a better position to identify and respond to market developments or changes in customer demands, including successfully developing technologies that outperform our technologies. Potential customers may also prefer to purchase from their existing suppliers rather than a new supplier regardless of product performance or features. For example, a number of companies that have substantial resources have announced that they are beginning production of 3D printers, which will further enhance the competition we face.
 
31
Future competition may arise from the development of allied or related techniques for equipment, materials, software and services that are not encompassed by our patents, from the issuance of patents to other companies that may inhibit our ability to develop certain products and from improvements to existing technologies.
We intend to continue to follow a strategy of continuing product development, VAR and distribution network expansion to enhance our competitive position to the extent practicable. But we cannot assure you that we will be able to maintain our current position or continue to compete successfully against current and future sources of competition. If we do not keep pace with technological change and introduce new products and technologies, demand for our products may decline, and our operating results may suffer.
Declines in the prices of our products and services, or in our volume of sales, together with our relatively inflexible cost structure, may adversely affect our financial results.
Our business is subject to price competition. Such price competition may adversely affect our results of operation, especially during periods of decreased demand. Decreased demand also adversely impacts the volume of our sales. If our business is not able to offset price reductions resulting from these pressures, or decreased volume of sales due to contractions in the market, by improved operating efficiencies and reduced expenditures, then our operating results will be adversely affected.
Although we generally do not have long-term supply agreements, certain of our operating costs are fixed and cannot readily be reduced, which has an impact on our operating results. To the extent the demand for our products slows, or the additive manufacturing market contracts, we may be faced with excess manufacturing capacity and related costs that cannot readily be reduced, which will adversely impact our financial condition and results of operations. Conversely, because we generally do not have long-term supply agreements, we are subject to the risk of significant cost increases by our suppliers.
Increased consolidation among our customers, suppliers and competitors in the additive manufacturing industry may have an adverse effect on our business and results of operations.
Increased consolidation in the additive manufacturing industry among our customers, suppliers and competitors may adversely affect our business and results of operations. Customer consolidation could lead to changes in buying patterns, slowdowns in spending, and impact our distribution channels. Moreover, the significant purchasing power of these large companies can increase pricing and competitive pressures for us, including the potential for decreases in our average selling prices. If one of our customers is acquired by another company that does not rely on us to provide it with products or relies on another provider of similar products, we may lose that customer’s business. Any of the foregoing results will adversely affect our business, financial condition and results of operations.
In addition, supplier consolidation may lead to increased prices of materials for our products, deployment delays and/or a disruption in output. In addition, such consolidation may exacerbate the risks relating to our dependence on a small number of suppliers for certain materials that are required to manufacture our products.
We may experience significant delays in the design, production and launch of our additive manufacturing solutions and enhancements to existing products, and we may be unable to successfully commercialize products on our planned timelines.
We have several additive manufacturing solutions and enhancements to existing products that are still under development. There are often delays in the design, testing, manufacture and commercial release of new products, and any delay in the launch of our products could materially damage our brand, business, growth prospects, financial condition and operating results. Even if we successfully complete the design, testing and manufacture for one or all of our products or enhancements under development, we may fail to develop a commercially successful product on the timeline we expect for a number of reasons, including:
 
32
  •  
misalignment between the products and customer needs; 
 
  •  
length of sales cycles;
 
  •  
insufficient product innovation;
 
  •  
product quality and performance issues;
 
  •  
insufficient resources or qualified personnel to develop the product;
 
  •  
failure of the product to perform in accordance with the customer’s expectations and industry standards;
 
  •  
inability to procure parts of adequate quality needed to build the product on commercially acceptable terms, or at all;
 
  •  
insufficient labor or process stability to build the product to required specifications;
 
  •  
ineffective distribution, sales and marketing;
 
  •  
delay in obtaining any required regulatory approvals;
 
  •  
the impact of the
COVID-19
pandemic on production and demand for our products;
 
  •  
unexpected production costs and delays; or
 
  •  
release of competitive products.
Our success in the market for the new products we develop will depend in part on our ability to prove our new products’ capabilities in a timely manner. Until demonstration, our customers may not believe that our products and/or technology have the capabilities they were designed to have or that we believe they have. Furthermore, even if we do successfully demonstrate our products’ capabilities, potential customers may be more comfortable doing business with a competitor, including another larger and more established company, may take longer than expected to make the decision to order our products, or may not have the budget or decision making authority to purchase the product. Significant revenue from new product investments may not be achieved for a number of years, if at all. If the timing of our launch of new products and/or of our customers’ acceptance of such products is different than our assumptions, our revenue and results of operations may be adversely affected.
Changes in our product mix may impact our gross margins and financial performance.
Our financial performance may be affected by the mix of products and services we sell during a given period. We expect to continue to offer products at a variety of price points. Sales of certain of our products have, or are expected to have, higher gross margin contributions than others. If our product mix shifts too far into lower gross margin products, or we are unable to maintain or increase gross margins, and we are not able to sufficiently reduce the engineering, production and other costs associated with those products or substantially increase the sales of our higher gross margin products, our profitability could be reduced. Additionally, the introduction of new products or services may further heighten quarterly fluctuations in gross profit and gross profit margins due to manufacturing
ramp-up
and
start-up
costs. Relatedly, if our product mix shifts such that our production rates decrease, our product costs and margins may be negatively impacted. We may experience significant quarterly fluctuations in gross profit margins or operating income or loss due to the impact of the mix of products, channels or geographic areas in which we sell our products from period to period.
Forecasts of our market and market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, there can be no assurance that our business will grow at similar rates, or at all.
Market opportunity estimates and growth forecasts included in this prospectus, including the expected size and growth of the markets for additive manufacturing technology and other markets in which we participate, are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Even if these markets experience the forecasted growth described in this prospectus, we may not grow our business at similar rates, or at all. Our future growth is subject to many factors, including market adoption of our products, which is subject to many risks and uncertainties. Accordingly, the forecasts and estimates of market size and growth described in this prospectus, including internally generated estimates and the third-party estimate that the size of the total addressable market is expected to be approximately $115 billion in 2030, should not be taken as indicative of our future growth. In addition, these forecasts may not adequately consider the impact of the current global
COVID-19
pandemic, and we cannot assure you that these forecasts will not be materially and adversely affected as a result.
 
33
Risks Related to Our Business Operations
Our failure to meet our customers’ price expectations would adversely affect our business and results of operations.
Demand for our product lines is sensitive to price. We believe our competitive pricing has been an important factor in our results to date. Therefore, changes in our pricing strategies can have a significant impact on our business and ability to generate revenue. Many factors, including our production and personnel costs, our competitors’ pricing and marketing strategies, our customers’ budgets, the value our products bring to our customers and our desire to hit revenue goals can significantly impact our pricing strategies. If we fail to meet our customers’ price expectations in any given period, demand for our products and product lines could be negatively impacted and our business, results of operations and brand could suffer.
Our revenue model is evolving and we may introduce new revenue models or avenues that may not be accepted by our customers and as such will not materialize.
We depend on our network of VARs and other distribution partners and if we fail to maintain successful relationships, or if they fail to perform, our ability to market, sell and distribute our products will be limited, and our business, financial position and results of operations will be harmed.
We rely heavily on our global network of VARs and other distribution partners to sell our products and to provide installation and support services to customers in their respective geographic regions. These VARs and other distribution partners may not be as effective in selling our products or installing and supporting our customers as we expect. Moreover, a VAR or other distribution partner may misrepresent the capabilities of our products without our knowledge either intentionally or unintentionally due to the inherent complexity of our products. Further, our VARs and other distribution partners can terminate their contracts with us at any time, and if our contracts with a significant number of VARs and other distribution partners, or with the most effective VARs and other distribution partners, were to terminate or if they would otherwise fail or refuse to sell certain of our products, we may not be able to find replacements that are as qualified or as successful in a timely manner, if at all.
Recruiting and retaining qualified VARs and other distribution partners and training them in our technologies requires significant time and resources. These VARs and other distribution partners may also market, sell and support other technologies in unrelated markets and may devote more resources to the marketing, sales and support of such products.
In addition, if our VARs and other distribution partners do not perform as anticipated, or if we are unable to secure qualified and successful VARs and other distribution partners, our sales will suffer, which would have an adverse effect on our revenues and operating results. Because we also depend upon our VARs and other distribution partners to provide installation and support services for products, if our VAR or distribution partner relationships were terminated or limited to certain products, we may face disruption in providing support for our customers, which would adversely affect our brand, reputation and our results of operations. Any failure to offer high-quality technical support services may adversely affect our relationships with our customers and adversely affect our financial results and brand.
 
34
Further, we require that our VARs and other distribution partners adhere to all local laws and regulations, but it is possible that a VAR or other distribution partner could violate such laws or regulations, which could adversely impact our business, reputation and financial results and brand. Our indirect sales and distribution model could subject us to lawsuits, potential liability and brand and reputational harm if, for example, any of our VARs and other distribution partners misrepresent the functionality of our products or services to customers or violate laws or our corporate policies.
Additionally, while none of our VARS or other distribution partners represents more than 10% of our sales, a default by one or more VARs or other distribution partners with whom we have a significant receivables balance could have an adverse financial impact on our financial results. We have reviewed our policies that govern credit and collections and will continue to monitor them in light of current payment status and economic conditions. In addition, we try to reduce the credit exposures of our accounts receivable by instituting credit limits and additional checks. However, there can be no assurance that our efforts to identify potential credit risks will be successful. Our inability to timely identify VARs and other distribution partners that are credit risks could result in defaults at a time when such VARs and other distribution partners have high accounts receivable balances with us. Any such default would result in a significant charge against our earnings and adversely affect our results of operations and financial condition. Furthermore, a significant portion of our accounts receivable payment periods are greater than 90 days. During that time, the VAR or distribution partner may default on its obligations or we may otherwise be unable to collect the payments due to us, which could adversely affect our results of operations and financial condition.
If our suppliers become unavailable or inadequate, our customer relationships, results of operations and financial condition may be adversely affected.
We acquire certain of our materials, which are critical to the ongoing operation and future growth of our business, from several third parties. Generally, our third-party contract manufacturers contract directly with component suppliers with our guidance. We rely on our contract manufacturers to manage their supply chains. If one of our contract manufacturers has supply chain disruption, or our relationship with our contract manufacturer terminates, we could experience delays. We also source some materials directly from suppliers. While most manufacturing equipment and materials for our products are available from multiple suppliers, certain of those items are only available from limited sources. Should any of these suppliers become unavailable or inadequate, or impose terms unacceptable to us, such as increased pricing terms, we could be required to spend a significant amount of time and expense to develop alternate sources of supply, and we may not be successful in doing so on terms acceptable to us, or at all. As a result, the loss of a limited source supplier could adversely affect our brand and relationship with our customers as well as our results of operations and financial condition.
In the case of certain materials, we have specified a certain grade of a product to be used in our manufacturing process. While there are several potential suppliers of most of these component materials that we use, we currently choose to use only one or a limited number of suppliers for several of these components and materials. For those materials, we could be impacted by any changes our suppliers make to such materials, which could include specification changes, lead time or cancellation of the material. If there is not an alternate product available, replacement thereof would require significant engineering and manufacturing efforts by us to qualify a replacement. Additionally, if a supplier of such materials decided to terminate their relationship with us, we may face delays in our production as we seek out a replacement supplier. Our reliance on a single or limited number of vendors involves a number of risks, including:
 
  •  
potential shortages of some key components;
 
  •  
product performance shortfalls, if traceable to particular product components, since the supplier of the faulty component cannot readily be replaced;
 
  •  
discontinuation of a product or certain materials on which we rely;
 
  •  
potential insolvency of these vendors; and
 
  •  
reduced control over delivery schedules, manufacturing capabilities, quality and costs.
 
35
In addition, we evaluate new suppliers pursuant to our internal procedures. This process involves evaluations of varying durations, which may cause production delays if we were required to qualify a new supplier unexpectedly. We generally assemble our systems and parts based on our internal forecasts and the availability of raw materials, assemblies, components and finished goods that are supplied to us by third parties, which are subject to various lead times. If certain suppliers were to decide to discontinue production of an assembly, component or raw material that we use, the unanticipated change in the availability of supplies, or unanticipated supply limitations, could cause delays in, or loss of, sales, increased production or related costs and consequently reduced margins, and damage to our reputation. If we were unable to find a suitable supplier for a particular component, material or compound, we could be required to modify our existing products or the
end-parts
that we offer to accommodate substitute components, material or compounds. While we monitor risk internally related to our sourcing (particularly concerning raw materials), there is no guarantee that will sufficiently protect us if we suddenly lose access to supplies unexpectedly.
Any shortage of a particular component, material or compound could materially and adversely affect our ability to manufacture our products and could lead to increased costs to acquire such resources which could adversely affect our business and financial condition. We have in the past experienced and may in the future experience materials shortages and price fluctuations of certain key components, materials and compounds, and the predictability of the availability and pricing of these components, materials and compounds may be limited. Shortages of components, materials or compounds or pricing fluctuations could be material in the future. In the event of a components, materials or compounds shortage, supply interruption or material pricing change from suppliers of these components, materials or compounds, we may not be able to develop alternate sources in a timely manner or at all in the case of sole or limited sources. Developing alternate sources of supply for these components, materials or compounds may be time-consuming, difficult, and costly and we may not be able to source these components, materials or compounds on terms that are acceptable to us, or at all, which may undermine our ability to meet our requirements or to fill customer orders in a timely manner. Any interruption or delay in the supply of any of these components, materials or compounds, or the inability to obtain these components, materials or compounds from alternate sources at acceptable prices and within a reasonable amount of time, would adversely affect our ability to meet our scheduled product deliveries to our customers. This could adversely affect our relationships with our customers and VARs and could cause delays in shipment of our products and adversely affect our operating results. In addition, increased component, material or compound costs could result in lower gross margins. Even where we are able to pass increased costs along to our customers, there may be a lapse of time before we are able to do so such that we must absorb the increased cost. If we are unable to buy these components, materials or compounds in quantities sufficient to meet our requirements on a timely basis, we will not be able to deliver products to our customers, which may result in such customers using competitive products instead of ours.
Our business model is predicated, in part, on developing or expanding recurring revenues through the sale of our hardware, consumables, and services. If that recurring stream of revenues does not develop as expected, or if our business model changes as the industry evolves, our operating results may be adversely affected.
Our business model is dependent, in part, on our ability to develop, maintain and increase sales of our hardware, consumables, and services as they generate recurring revenues. Existing and future customers of our systems may not purchase our consumables and services at the same rate at which customers currently purchase those offerings. If our current and future customers purchase a lower volume of our consumables and services, resulting overall in lower purchases of consumables and services on average than with our current installed customer base, our recurring revenue stream relative to our total revenues would be reduced and our operating results would be adversely affected.
 
36
We rely on a limited number of third-party logistics providers for distribution of our products, and their failure to distribute our products effectively would adversely affect our sales.
We rely on a limited number of third-party logistics providers for shipping our products. Each third-party logistics provider stores our products in a limited number of warehouses where they prepare and ship our products based on digital instructions. The use of a limited number of third-party logistics providers increases the risk that a fire or damage from another type of disaster at any of the warehouses may result in a disruption of our commercialization efforts. Additionally, because we use a limited number of third-party logistics providers, if there is a disruption in the distribution channels of such third-party logistics providers, our business and financial condition could be adversely impacted.
If our third-party logistics providers do not fulfill their contractual obligations to us, or refuse or fail to adequately distribute our products, such as by shipping our products to the incorrect recipient, or the agreements are terminated without adequate notice, shipments of our products, and associated revenues, would be adversely affected. In addition, we expect that it may take a significant amount of time if we were required to change our third-party logistics providers and would require significant efforts to provide the systems support required for a new provider to effectively support our operations.
If demand for our products does not grow as expected, or if market adoption of additive manufacturing does not continue to develop, or develops more slowly than expected, our revenues may stagnate or decline, and our business may be adversely affected.
We believe that the industrial manufacturing market, which today is dominated by conventional manufacturing processes that do not involve additive manufacturing technology, is undergoing a shift towards additive manufacturing. We may not be able to develop effective strategies to raise awareness among potential customers of the benefits of additive manufacturing technologies or our products may not address the specific needs or provide the level of functionality required by potential customers to encourage the continuation of this shift towards additive manufacturing. We must anticipate, sometimes several years in advance, the direction that the additive market is taking. We may not correctly anticipate the direction, which may lead us to invest in the wrong products, which may adversely affect our results of operation and financial condition. If additive manufacturing technology does not continue to gain broader market acceptance as an alternative to conventional manufacturing processes, or if the marketplace adopts additive manufacturing technologies that differ from our technologies, we may not be able to increase or sustain the level of sales of our products, and our operating results would be adversely affected as a result.
Defects in new products or in enhancements to our existing products that give rise to product returns or warranty or other claims could result in material expenses, diversion of management time and attention and damage to our reputation.
Our additive manufacturing solutions are complex and may contain undetected defects or errors when first introduced or as enhancements are released that, despite testing, are not discovered until after a machine has been used. We may not know which products are affected by defects. These defects could be systemic and could affect all of the products we shipped prior to discovery thereof. It may not be economically feasible to identify, replace or repair all affected products. In the event that the defect is severe enough or impacts customer safety, a product recall may be required. This could result in delayed market acceptance of those products or claims from VARs, customers or others, which may result in litigation, increased customer warranty, support and repair or replacement costs, damage to our reputation and business, or significant costs and diversion of support, management and engineering personnel to correct the defect or error. We may from time to time become subject to warranty or product liability claims related to product quality issues that may require us to take remedial action and could, regardless of merit, lead us to incur significant expenses, result in diversion of management time and attention, damage to our business and reputation and brand, and cause us to fail to retain existing customers or fail to attract new customers.
We attempt to include provisions in our agreements with customers that are designed to manage our exposure to potential liability for damages arising from defects or errors in our products. However, it is possible that these provisions may not be effective as a result of unfavorable judicial decisions or laws enacted in the future.
 
37
We may be unable to consistently manufacture our products to the necessary specifications or in quantities necessary to meet demand at an acceptable cost or at an acceptable performance level.
Our products are integrated solutions with many different components that work together. As such, a quality defect in a single component can compromise the performance of the entire solution. As we continue to grow and introduce new products, and as our products incorporate increasingly sophisticated technology, it will be increasingly difficult to ensure our products are produced in the necessary quantities without sacrificing quality. There is no assurance that we or our third-party manufacturers and any component suppliers will be able to continue to manufacture our products so that they consistently achieve the product specifications and quality that our customers expect. Relatedly, certain of our components are sourced by a single supplier and, if the supply became disrupted as a result of insufficient quality, service delays or any other factor, our manufacturing efforts may be adversely affected. Any future design issues, unforeseen manufacturing problems, such as contamination of our or such third-party facilities, equipment malfunctions, aging components, component obsolescence, business continuity issues, quality issues with components and materials sourced from third party suppliers, or failures to strictly follow procedures or meet specifications, may have a material adverse effect on our brand, business, financial condition and operating results. Furthermore, we or our third-party manufacturers may not be able to increase manufacturing to meet anticipated demand or may experience downtime.
In order to meet our customers’ needs, we attempt to forecast demand for our products and components used for the manufacture of our products. If we fail to accurately forecast this demand, we could incur additional costs or experience manufacturing delays and may experience lost sales or significant inventory carrying costs.
The risk of manufacturing defects or quality control issues is generally higher for new products, whether produced by us or a third-party manufacturer, products that are transitioned from one manufacturer to another, particularly if manufacturing is transitioned or initiated with a manufacturer we have not worked with in the past, and products that are transferred from one manufacturing facility to another. We cannot assure investors that we and our third-party manufacturers will be able to launch new products on time, transition manufacturing of existing products to new manufacturers, transition our manufacturing capabilities to a new location or transition manufacturing of any additional materials
in-house
without manufacturing defects. An inability to manufacture products and components that consistently meet specifications, in necessary quantities and at commercially acceptable costs will have a negative impact and may have a material adverse effect on our brand, business, financial condition and results of operations.
Our commercial contracts generally contain product warranties and limitations on liability and we carry liability insurance in amounts that we believe are adequate for our risk exposure and commensurate with industry norms. However, commercial terms and our insurance coverage may not be adequate or available to protect our company in all circumstances, and we might not be able to maintain adequate insurance coverage for our business in the future at an acceptable cost. Any liability claim against us that is not covered by adequate insurance could adversely affect our consolidated results of operations and financial condition. Finally, any liability claim against us may cause harm to our brand, reputation and adversely impact our business.
We are dependent on the continued services and performance of our senior management and other key employees, as well as on our ability to successfully hire, train, manage and retain qualified personnel.
Our future performance depends on the continued services and contributions of our executive team, founders and other key employees to execute on our business plan and to identify and pursue new opportunities and product innovations. Such persons may resign at any time and the loss of their services could delay or prevent the successful implementation of our strategy, commercialization of new applications for our systems or other products, or could otherwise adversely affect our ability to manage our company effectively and carry out our business plan. There is no assurance that if any senior executive, founder or other key employee leaves in the future, we will be able to rapidly replace him or her and transition smoothly towards his or her successor, without any adverse impact on our operations.
 
38
Our ability to successfully pursue our growth strategy will also depend on our ability to attract, motivate and retain existing and new personnel. We experience intense competition for qualified senior management and other key personnel (including scientific, technical, manufacturing, engineering, financial and sales personnel) in the additive manufacturing industry, especially in the greater Boston area. Our personnel are generally employed on an
at-will
basis, which means that they could terminate their employment with us at any time. There can be no assurance that we will be able to retain our current key personnel or attract new persons to join our organization in the future. Some of our competitors for these employees have greater resources and more experience, making it difficult for us to compete successfully for key personnel. These pressures could result in increased costs in order to provide competitive compensation packages to attract and retain key personnel. Moreover, new employees may not be as productive as we expect since we may face challenges in adequately integrating them into our workforce and culture. If we cannot attract and retain sufficiently qualified technical employees for our research product development activities, as well as experienced sales and marketing personnel, we may be unable to develop and commercialize new products and enhancements to existing products.
As manufacturing becomes a larger part of our operations, we will become exposed to accompanying risks and liabilities.
In-house
and outsourced manufacturing has been and continues to be a significant part of our business. As a result, we expect to continue to be subject to various risks associated with the manufacturing and supply of products, including the following:
 
  •  
If we fail to supply products in accordance with contractual terms, including terms related to time of delivery and performance specifications, we may be required to repair or replace defective products and may become liable for direct, special, consequential and other damages, even if manufacturing or delivery was outsourced;
 
  •  
Raw materials used in the manufacturing process, labor and other key inputs may become scarce, obsolete and expensive, causing our costs to exceed cost projections and associated revenues;
 
  •  
Manufacturing processes typically involve large machinery, fuels and chemicals, any or all of which may lead to accidents involving bodily harm, destruction of facilities and environmental contamination and associated liabilities;
 
  •  
As our manufacturing operations expand, we expect that a significant portion of our manufacturing will be done in regions outside the United States, either by third-party contractors or in a plant owned by the Company. Any manufacturing done in such locations presents risks associated with quality control, currency exchange rates, foreign laws and customs, timing and loss risks associated with international transportation and potential adverse changes in the political, legal and social environment in the host county;
 
  •  
We have made, and may be required to make, representations as to our right to supply and/or license intellectual property and to our compliance with laws. Such representations are usually supported by indemnification provisions requiring us to defend our customers and otherwise make them whole if we license or supply products that infringe on third-party technologies or violate government regulations;
 
  •  
As our manufacturing operations scale, so will our dependence on skilled labor at both
in-house
and third-party manufacturing facilities. If we are unable to obtain and maintain skilled labor resources, we may unable to meet customer production demands; and
 
  •  
With scaling production volume, demand for our products may make up a significant percentage of global volume in select categories or commodities. Such commodities could be subject to large pricing swings due to the global political, legal and social environment and could cause our costs to exceed productions and associated revenues.
Any failure to adequately manage risks associated with the manufacture and supply of materials and products could adversely affect profits from that segment of our business and/or lead to significant liabilities, which would harm our brand, business, operations and financial condition.
 
39
Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees.
We generally enter into
non-competition
agreements with our employees. These agreements prohibit our employees from competing directly with us or working for our competitors or clients for a limited period after they cease working for us. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work and it may be difficult for us to restrict our competitors from benefiting from the expertise that our former employees or consultants developed while working for us. For example, in Massachusetts, where most of our employees are based, applicable law imposes a number of requirements to enter into a valid
non-competition
agreement, and in California
non-competition
agreements with employees are generally unenforceable after termination of employment.
We expect to continue to experience rapid growth and organizational change. If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service and customer satisfaction or attract new employees and customers.
We expect to continue to experience growth in our number of customers, sales, revenues and headcount. We expect to continue to make significant investments in our business, including investments in our infrastructure, software, technology, personnel headcount, facilities, marketing and sales efforts. If our business does not generate the level of revenue required to support our investment, our net sales and profitability will be adversely affected.
To manage growth in our operations and personnel, we will need to continue to scale and improve our operational, financial, and management controls, and our reporting systems and procedures, which will require significant capital expenditures, increasing our cost of operations and the reallocation of valuable management resources. As we scale, it may become more difficult and will require additional capital expenditures to maintain and increase the productivity of our employees, expand production, to address the needs of our actual and prospective customers, to further develop and enhance our products, and remain competitive against our competitors’ products. These enhancements and improvements will require significant capital expenditures, investments in additional headcount and other operating expenditures and allocation of valuable management and employee resources. Our future financial performance and our ability to execute on our business plan will depend, in part, on our ability to effectively manage any future growth and expansion. There are no guarantees we will be able to do so in an efficient or timely manner, or at all.
As we acquire and invest in companies or technologies, we may not realize expected business, technological or financial benefits and the acquisitions or investments could prove difficult to integrate, disrupt our business, dilute stockholder value and adversely affect our business, results of operations, and financial condition.
As part of our business strategy, we may evaluate and make investments in, or acquisitions of, complementary companies, products, software and technologies, to further grow and augment our business and product offerings. The success of any attempts to grow our business through acquisitions to complement our business depends in part on the availability of, our ability to identify, and our ability to engage and pursue suitable acquisition candidates. We may not be able to find suitable acquisition candidates, and we may not be able to complete acquisitions on favorable terms, if at all.
If we do complete future acquisitions, we cannot assure you that they will ultimately strengthen our competitive position or that they will be viewed positively by customers, financial markets or investors. Furthermore, future acquisitions could pose numerous additional risks to our operations, including:
 
  •  
diversion of management’s attention from existing operations;
 
  •  
unanticipated costs or liabilities associated with the acquisition, including risks associated with acquired intellectual property and/or technologies;
 
40
  •  
incurrence of acquisition-related costs, which would be recognized as a current period expense; 
 
  •  
difficulties in, and the cost of, integrating personnel and cultures, operations, technologies, products and services which may lead to failure to achieve the expected benefits on a timely basis or at all;
 
  •  
challenges in achieving strategic objectives, cost savings and other anticipated benefits;
 
  •  
inability to maintain relationships with key customers, suppliers, vendors and other third parties on which the purchased business relies;
 
  •  
the difficulty of incorporating acquired technology and rights into our products and product portfolio and of maintaining quality and security standards consistent with our brand;
 
  •  
ineffective controls, procedures and policies inherited from the acquired company or during the transition and integration;
 
  •  
inability to generate sufficient revenue to offset acquisition and/or investment costs;
 
  •  
negative impact to our results of operations because of the depreciation of amounts related to acquired intangible assets, fixed assets, and deferred compensation;
 
  •  
requirements to record certain acquisition-related costs and other items as current period expenses, which would have the effect of reducing our reported earnings in the period in which an acquisition is consummated;
 
  •  
the loss of acquired unearned revenue and unbilled unearned revenue;
 
  •  
recording goodwill or other long-lived asset impairment charges (if any) in the periods in which they occur, which could result in a significant charge to our earnings in any such period;
 
  •  
use of substantial portions of our available cash, issuance of dilutive equity or the incurrence of debt to consummate the acquisition;
 
  •  
potential write-offs of acquired assets or investments, and potential financial and credit risks associated with acquired customers;
 
  •  
tax effects and costs of any such acquisitions, including the related integration into our tax structure and assessment of the impact on the realizability of our future tax assets or liabilities;
 
  •  
the potential entry into new markets in which we have little or no experience or where competitors may have stronger market positions; and
 
  •  
currency and regulatory risks associated with conducting operations in foreign countries.
In addition, acquired technologies and intellectual property may be rendered obsolete or uneconomical by our own or our competitors’ technological advances. Management resources may also be diverted from operating our existing businesses to certain acquisition integration challenges. If we are unable to successfully integrate acquired businesses, our anticipated revenues and profits may be lower. Our profit margins may also be lower, or diluted, following the acquisition of companies whose profit margins are less than those of our existing businesses.
We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.
We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges and opportunities, including the need to develop new features or enhance our products, improve our operating infrastructure or acquire complementary businesses and technologies. Accordingly, we may need to engage in equity or debt financings to secure additional funds if our existing sources of cash and any funds generated from operations do not provide us with sufficient capital. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges and opportunities could be significantly impaired, and our business may be adversely affected.
 
41
Risks Related to Third Parties
A real or perceived defect, security vulnerability, error or performance failure in our software or technical problems or disruptions caused by our third-party service providers could cause us to lose revenue, damage our reputation and expose us to liability.
Our hardware products rely upon our complementary software products which are inherently complex and, despite extensive testing and quality control, have in the past and may in the future contain defects or errors, especially when first introduced, or otherwise not perform as contemplated. As the use of our products, including products that were recently acquired or developed, expands to more sensitive, secure or mission critical uses by our customers, we may be subject to increased scrutiny, potential reputational risk or potential liability should our software fail to perform as contemplated in such deployments. We have in the past and may in the future need to issue corrective releases of our software to fix these defects, errors or performance failures and we may encounter technical problems when we attempt to perform routine maintenance or enhance our software, internal applications, and systems, which could require us to allocate significant research and development and customer support resources to address these problems and divert the focus of our management and research and development teams. In addition, our platform may be negatively impacted by technical issues experienced by our third-party service providers.
Our business, brands, reputation and ability to attract and retain customers depend upon the satisfactory performance, reliability and availability of our software products, which in turn, with respect to our planned software as a service (“SaaS”) offerings depend upon the availability of the internet and our third-party service providers. For example, for our SaaS offerings we outsource our cloud infrastructure to Amazon Web Services (“AWS”), our hosting provider, which hosts our software products. Our hosting provider runs its own platforms upon which our products depend, and we are, therefore, vulnerable to service interruptions at the hosting provider level. We do not control the operation of any of AWS’ data center hosting facilities, and they may be subject to damage or interruption from earthquakes, floods, fires, power loss, telecommunications failures, terrorist attacks and similar events. They may also be subject to interruptions due to system failures, computer viruses, software errors or subject to breaches of computer hardware and software security,
break-ins,
sabotage, intentional acts of vandalism and similar misconduct. And while we rely on service level agreements with our hosting provider, if they do not properly maintain their infrastructure or if they incur unplanned outages, our customers may experience performance issues or unexpected interruptions and we may not meet our service level agreement terms with our customers. We have experienced, and expect that in the future we may experience interruptions, delays and outages in service and availability from time to time due to a variety of factors, including infrastructure changes, human or software errors, website hosting disruptions and capacity constraints.
Any inefficiencies, security vulnerabilities, errors, defects, technical problems or performance failures with our software, internal applications and systems could reduce the quality of our products or interfere with our customers’ (and their users’) use of our products, which could negatively impact our brand and reputation, reduce demand, lead to a loss of customers or revenue, adversely affect our results of operations and financial condition, increase our costs to resolve such issues and subject us to financial penalties and liabilities under our service level agreements. Any limitation of liability provisions that may be contained in our customer agreements may not be effective as a result of existing or future applicable law or unfavorable judicial decisions. The sale and support of our products entail the risk of liability claims, which could be substantial in light of the use of our products in enterprise-wide environments. In addition, our insurance against this liability may not be adequate to cover a potential claim.
 
42
We depend on a limited number of third-party contract manufacturers for a substantial portion of all of our manufacturing needs and any delay, disruption or quality control problems in their operations, including due to the
COVID-19
pandemic, could cause harm to our operations, including loss of market share and damage to our brand.
We depend on third-party contract manufacturers for the production of our 3D printers and on third-party suppliers for the components and raw materials used in our products. While there are several potential manufacturers for most of these products, all of our products are manufactured, assembled, tested and generally packaged by a limited number of third-party manufacturers and several single source providers of certain supplies. In most cases, we rely on these manufacturers to procure components and, in some cases, subcontract engineering work. Our reliance on a limited number of contract manufacturers involves a number of risks, including:
 
  •  
unexpected increases in manufacturing and repair costs;
 
  •  
inability to control the quality and reliability of products;
 
  •  
inability to control delivery schedules;
 
  •  
potential liability for expenses incurred by third-party contract manufacturers in reliance on our forecasts that later prove to be inaccurate;
 
  •  
potential lack of adequate capacity to manufacture all or a part of the products we require;
 
  •  
potential labor unrest affecting the ability of the third-party manufacturers to produce our products; and
 
  •  
unexpected component or process obsolescence making key components unavailable.
If any of our third-party contract manufacturers experience a delay, disruption or quality control problems in their operations, including due to the
COVID-19
pandemic, or if a primary third-party contract manufacturer does not renew its agreement with us, our operations could be significantly disrupted and our product shipments could be delayed. Qualifying a new manufacturer and commencing volume production is expensive and time consuming. Ensuring that a contract manufacturer is qualified to manufacture our products to our standards is time consuming. In addition, there is no assurance that a contract manufacturer can scale its production of our products at the volumes and in the quality that we require. If a contract manufacturer is unable to do these things, we may have to move production for the products to a new or existing third-party manufacturer, which would take significant effort and our brand, business, results of operations and financial condition could be materially adversely affected. Finally, if a contract manufacturer producing a highly specified product changes its materials or is unable to meet our production demands, it could lead to specification changes, increased lead time or cancellation of the product.
As we contemplate moving manufacturing into different jurisdictions, we may be subject to additional significant challenges in ensuring that quality, processes, and costs, among other issues, are consistent with our expectations.
In addition, because we use a limited number of third-party contract manufacturers, increases in the prices charged may have an adverse effect on our results of operations, as we may be unable to find a contract manufacturer who can supply us at a lower price. As a result, the loss of a limited source supplier could adversely affect our relationships with our customers and our results of operations and financial condition.
All of our products must satisfy safety and regulatory standards and some of our products must also receive government certifications. We rely on third-party providers to conduct the tests that support our applications for most regulatory approvals for our products. As part of the certification process, our third-party contract manufacturers are subject to audit and must receive approvals from third-parties providing such certifications. Failure to meet these certifications by our third-party contract manufacturers could adversely impact our business. Moreover, if our third-party contract manufacturers fail to timely and accurately conduct the tests supporting our applications for regulatory approvals, we may be unable to obtain the necessary domestic or foreign regulatory approvals or certifications to sell our products in certain jurisdictions. As a result, we would be unable to sell our products and our sales and profitability could be reduced, our relationships with our sales channel could be harmed and our reputation and brand would suffer.
 
43
Our manufacturing facility and those of our third-party contract manufacturers and suppliers, as well as our customers’ facilities and our third-party logistics providers, are vulnerable to disruption due to natural or other disasters, strikes and other events beyond our control.
A major earthquake, fire, tsunami, hurricane, cyclone or other disaster, such as a major flood, seasonal storms, nuclear event or terrorist attack affecting our facilities or the areas in which they are located, or affecting those of our customers or third-party manufacturers, suppliers or fulfillment centers, could significantly disrupt our or their operations and delay or prevent product shipment or installation during the time required to repair, rebuild or replace our or their damaged manufacturing facilities. These delays could be lengthy and costly. If any of our facilities, or those of our third-party contract manufacturers, suppliers, third-party logistics providers or customers are negatively impacted by such a disaster, production, shipment and installation of our additive manufacturing machines could be delayed, which can impact the period in which we recognize the revenue related to that additive manufacturing machine sale. Additionally, customers may delay purchases of our products until operations return to normal. Even if we are able to respond quickly to a disaster, the continued effects of the disaster could create uncertainty in our business operations. In addition, concerns about terrorism, the effects of a terrorist attack, political turmoil, labor strikes, war or the outbreak of epidemic or pandemic diseases (including the outbreak of the coronavirus disease
COVID-19)
could have a negative effect on our operations and sales.
Risks Related to International Operations
Our existing and planned global operations subject us to a variety of risks and uncertainties that could adversely affect our business and operating results. Our business is subject to risks associated with selling machines and other products in
non-United
States locations.
As of August 2021, our products and services are distributed across the world, and we derive a substantial percentage of our sales from these international markets. Accordingly, we face significant operational risks from doing business internationally.
Our operating results may be affected by volatility in currency exchange rates and our ability to effectively manage our currency transaction risks. Although we currently invoice customers in United States dollars, increases in the value of the dollar relative to foreign currencies may make our products less attractive to foreign customers. We may also incur currency transaction risks if we were to enter into either a purchase or a sale transaction using a different currency from the currency in which we report revenues. In such cases we may suffer an exchange loss because we do not currently engage in currency swaps or other currency hedging strategies to address this risk. As we realize our strategy to expand internationally, our exposure to currency risks may increase. Given the volatility of exchange rates, we can give no assurance that we will be able to effectively manage our currency transaction risks or that any volatility in currency exchange rates will not have an adverse effect on our results of operations.
The shipments of our products to foreign customers and/or
end-users
may be subject to tariffs and other restrictions imposed by the destination countries. As we procure equipment and materials from foreign suppliers, we may be required to pay import duties and comply with regulations imposed by the U.S. Customs and Border Protection. Both the U.S. and foreign tariff rates and import restrictions may change from time to time, which could adversely impact our global operations, for example, by decreasing the price competitiveness of our products in foreign markets and/or by increasing our manufacturing costs.
 
44
Other risks and uncertainties we face from our global operations include:
 
  •  
difficulties in staffing and managing foreign operations;
 
  •  
limited protection for the enforcement of contract and intellectual property rights in certain countries where we may sell our products or work with suppliers or other third parties;
 
  •  
potentially longer sales and payment cycles and potentially greater difficulties in collecting accounts receivable;
 
  •  
costs and difficulties of customizing products for foreign countries;
 
  •  
challenges in providing solutions across a significant distance, in different languages and among different cultures;
 
  •  
laws and business practices favoring local competition;
 
  •  
being subject to a wide variety of complex foreign laws, treaties and regulations and adjusting to any unexpected changes in such laws, treaties and regulations, including local labor laws;
 
  •  
strict laws and regulations governing privacy and data security, including the European Union’s General Data Protection Regulation;
 
  •  
uncertainty and resultant political, financial and market instability arising from the United Kingdom’s exit from the European Union;
 
  •  
compliance with U.S. laws affecting activities of U.S. companies abroad, including the U.S. Foreign Corrupt Practices Act;
 
  •  
tariffs, trade barriers and other regulatory or contractual limitations on our ability to sell or develop our products in certain foreign markets;
 
  •  
operating in countries with a higher incidence of corruption and fraudulent business practices;
 
  •  
changes in regulatory requirements, including export controls, tariffs and embargoes, other trade restrictions, competition, corporate practices and data privacy concerns;
 
  •  
failure by our VARs or other distribution partners to comply with local laws or regulations, export controls, tariffs and embargoes or other trade restrictions;
 
  •  
potential adverse tax consequences arising from global operations;
 
  •  
seasonal reductions in business activity in certain parts of the world, particularly during the summer months in Europe and at year end globally;
 
  •  
rapid changes in government, economic and political policies and conditions; and
 
  •  
political or civil unrest or instability, terrorism or epidemics and other similar outbreaks or events.
In addition, additive manufacturing has been identified by the U.S. government as an emerging technology and is currently being further evaluated for national security impacts. We expect additional regulatory changes to be implemented that will result in increased and/or new export controls related to additive manufacturing technologies, components and related materials and software. These changes, if implemented, may result in our being required to obtain additional approvals and/or licenses to sell 3D printers in the global market.
Our failure to effectively manage the risks and uncertainties associated with our global operations could limit the future growth of our business and adversely affect our business and operating results.
 
45
Global economic, political and social conditions and uncertainties in the market that we serve may adversely impact our business.
Our performance depends on the financial health and strength of our customers, which in turn is dependent on the economic conditions of the markets in which we and our customers operate. Declines in the global economy, difficulties in the financial services sector and credit markets, continuing geopolitical uncertainties and other macroeconomic factors all affect the spending behavior of potential customers. Economic uncertainty in Europe, the United States, India, Japan, China and other countries may cause customers and potential customers to further delay or reduce technology purchases.
We also face risks from financial difficulties or other uncertainties experienced by our suppliers, distributors or other third parties on which we rely. If third parties are unable to supply us with required materials or components or otherwise assist us in operating our business, our business could be harmed.
Other changes in U.S. social, political, regulatory and economic conditions or in laws and policies governing foreign trade, manufacturing, development and investment could also adversely affect our business. In particular, on June 23, 2016, the U.K. held a referendum in which a majority of the eligible members of the electorate voted to leave the EU, commonly referred to as Brexit. Pursuant to Article 50 of the Treaty on EU, the U.K. ceased being a member state of the EU on January 31, 2020. The implementation period began February 1, 2020 and continued until December 31, 2020, during which U.K. continued to follow all of the EU’s rules, the EU’s pharmaceutical law remained applicable to the U.K. and the U.K.’s trading relationship remained the same. The U.K. and the EU have signed an
EU-UK
Trade and Cooperation Agreement, or TCA, which became provisionally applicable on January 1, 2021 and will become formally applicable once ratified by both the U.K. and the EU. This agreement provides details on how some aspects of the U.K. and EU’s relationship will operate going forwards however there are still many uncertainties and how the TCA will take effect in practice is still largely unknown. Additionally, there is a risk that other countries may decide to leave the European Union. This uncertainty surrounding this transition not only potentially affects our business in the United Kingdom and the European Union, but also may have an effect on global economic conditions and the stability of global financial markets, which in turn could have a material adverse effect on our business, financial condition and results of operations. In extreme cases, we could experience interruptions in production due to the processing of customs formalities or reduced customer spending in the wake of weaker economic performance. If global economic conditions remain volatile for a prolonged period or if European economies experience further disruptions, our results of operations could be adversely affected.
The effects of regulations relating to conflict minerals may adversely affect our business.
On August 22, 2012, under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the SEC adopted new requirements for companies that use certain minerals and metals, known as conflict minerals, in their products, whether or not these products are manufactured by third parties. These requirements require companies to research, disclose and report whether or not such minerals originate from the Democratic Republic of Congo and adjoining countries. The implementation of these requirements could adversely affect the sourcing, availability and pricing of such minerals if they are found to be used in the manufacture of our products, including our 3D printers or materials. In addition, we expect to continue to incur additional costs to comply with the disclosure requirements, including costs related to determining the source of any of the relevant minerals and metals used in our products. Since our supply chain is complex, we may not be able to sufficiently verify the origins for these minerals and metals used in our products through the due diligence procedures that we implement, which may harm our reputation. In such event, we may also face difficulties in satisfying customers who require that all of the components of our products are certified as conflict mineral free.
 
46
Risks Related to Sales of Products to U.S. and Foreign Governments
A significant portion of our business depends on sales to the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business.
We derive a significant portion of our revenue from contracts that we have, either directly or through distribution partners and VARs, with federal, state, local and foreign governments and government agencies, and we believe that the success and growth of our business will continue to depend on our successful procurement of government contracts. For example, we have historically derived, and expect to continue to derive, a significant portion of our revenue from sales to agencies of the U.S. federal government and governments of other nations, either directly by us or through other distribution partners. Sales to such governments and their agencies are subject to a number of challenges and risks. The procurement process for governments and their agencies is highly competitive, time-consuming, and may, in certain circumstances, be subject to political influence. We incur significant
up-front
time and expense, which subjects us to additional compliance risks and costs, without any assurance that we (or a third-party distributor or reseller) will win a contract.
Accordingly, our business, financial condition, results of operations, and prospects may be adversely affected by certain events or activities, including, but not limited to:
 
  •  
changes in fiscal or contracting policies or decrease in available government funding;
 
  •  
changes in government programs or applicable requirements;
 
  •  
changes in the political environment, including before or after a change to the leadership within the government administration, and any resulting uncertainty or changes in policy or priorities and resultant funding;
 
  •  
appeals, disputes or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government;
 
  •  
the adoption of new laws or regulations or changes to existing laws or regulations;
 
  •  
budgetary constraints, including automatic reductions as a result of “sequestration” or similar measures and constraints imposed by lapses in appropriations for the federal government or certain of its departments and agencies;
 
  •  
influence by, or competition from, third parties with respect to pending, new or existing contracts with government customers;
 
  •  
potential delays or changes in the government appropriations or procurement processes, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics, such as the
COVID-19
pandemic; and
 
  •  
increased or unexpected costs or unanticipated delays caused by other factors outside of our control, such as performance failures of our partners and subcontractors.
Any such event or activity, among others, could cause governments and governmental agencies to delay or refrain from purchasing our products and services in the future, reduce the size or payment amounts of purchases from existing or new government customers, or otherwise have an adverse effect on our business, results of operations, financial condition and prospects.
Government programs are limited by budgetary constraints and political considerations and are subject to uncertain future funding levels that could result in the termination of programs.
Government agency and department purchases are often strategic in nature and large in size. Therefore, reductions in funding levels that impact our customers could negatively affect the size of our customers’ orders or lead to cancellation of orders. Government contracts are often subject to more extensive scrutiny and publicity than commercial contracts. The number and terms of new government contracts signed can be affected significantly by political and economic factors, such as pending elections and revisions to government tax policies. Negative publicity related to our government contracts, regardless of its accuracy, may damage our business by affecting our ability to compete for new contracts. A decline in security-related government spending for any reason, or a shift away from programs that we address, could hurt our sales, put pressure on our prices and reduce our revenue and margins. Relatedly, the use of our products by militaries or other government agencies or departments in a way that is perceived negatively by the public could adversely affect our business and reputation.
 
47
A multi-year U.S. government program may be implemented through the award of many different individual contracts, grants, cooperative agreements and subcontracts or other subawards. For U.S. government programs, program funding is subject to congressional appropriations. Congress generally appropriates funds on a fiscal year basis even though a program may continue for several years. Government programs are often only partially funded initially, and additional funds are committed only as Congress makes further appropriations. The termination of a program or failure to commit funds to a program would result in a loss of anticipated future revenue attributable to that program, which could materially harm our business.
We are subject to audits by the U.S. government which could adversely affect our business.
U.S. government agencies routinely audit and investigate government contractors to monitor performance, cost allocations, cost accounting and compliance with applicable laws, regulations and standards. Since some of our contracts provide for cost reimbursement, the U.S. government has the right to audit our costs even after job completion and after we have billed and recognized the corresponding revenue. The U.S. government also may review the adequacy of, and a contractor’s compliance with, its internal control systems and policies, including the contractor’s purchasing, property, estimating, compensation and management information systems. Any costs found to be improperly allowed or improperly allocated to a specific contract will not be reimbursed, and any such costs that have already been reimbursed must be refunded, which would affect associated revenue that had already been recognized. While we intend to implement uniform procurement and compliance programs for all of our business, we may be subject to more risks from these audits until we are able to implement such a program effectively.
Responding to governmental audits, inquiries or investigations may involve significant expense and divert the attention of our management. If a government review or investigation uncovers improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions, including termination of contracts, forfeiture of profits, suspension of payments, damages, fines and suspension or debarment from doing business with U.S. government agencies. In addition, our reputation could be seriously harmed by allegations of impropriety, even if unfounded. Our internal controls may not prevent or detect all improper or illegal activities.
Our business is subject to laws and regulations that are more restrictive because we are a contractor and subcontractor to the U.S. government.
As a contractor and subcontractor to the U.S. government, we are subject to various laws and regulations that are more restrictive than those applicable to
non-government
contractors, including the Federal Acquisition Regulations and its supplements, which comprehensively regulate the formation, administration and performance of U.S. government contracts, and the Truth in Negotiations Act and various other laws, which require certain certifications and disclosures. These laws and regulations, among other things:
 
  •  
require that we obtain and maintain material governmental authorizations and approvals to conduct our business as it is currently conducted;
 
  •  
require certification and disclosure of cost and pricing data in connection with certain contract negotiations;
 
48
  •  
impose rules that define allowable and unallowable costs and otherwise govern our right to reimbursement under certain cost-based U.S. government contracts;
 
  •  
restrict the use and dissemination of information classified for national security purposes and the export of certain products and technical data; and
 
  •  
impose requirements relating to ethics and business practices, which carry penalties for noncompliance ranging from monetary fines and damages to loss of the ability to do business with the U.S. government as a prime contractor or subcontractor.
In addition, we may be subject to industrial security regulations of the U.S. Department of Defense and other federal agencies that are designed to safeguard against unauthorized access by foreigners and others to classified and other sensitive U.S. government information. If we were to come under foreign ownership, control or influence, our U.S. government customers could terminate, or decide not to renew, our contracts, or we may be subjected to burdensome industrial security compliance measures. Such a situation could impair our ability to obtain new contracts and subcontracts. The government may also change its procurement practices or adopt new contracting rules and regulations that could be costly to satisfy or that could impair our ability to obtain new contracts.
Our contracts and those of our VARs with governments may impose requirements that may be unfavorable to us and that may have a material adverse effect on our growth prospects and operating results.
Most of our sales to government entities have been made indirectly through our VARs and other distribution partners. In some cases, we have entered contracts directly with government customers. There are inherent risks in contracting with governments and their agencies. Government customers can typically terminate, reduce orders under or otherwise modify any of its contracts with us or our VARs for its convenience (
i.e.
, without cause) whether or not we have failed to perform under the terms of the applicable contract. In such case, the government would not be required to pay our VARs or us for the lost profits for the unperformed work. A termination arising out of our VARs or our default could expose our VARs or us to liability and harm our VARs or our ability to compete for future contracts and orders. In addition to unfavorable termination provisions, our VARs or our U.S. government contracts and related regulations contain provisions that allow the U.S. government to unilaterally suspend our VARs or us from receiving new contracts pending resolution of alleged violations of procurement laws or regulations, reduce the value of existing contracts, issue modifications to a contract and potentially restrict exports of our products, services and associated materials.
Our VARs or our contracts with government agencies may subject our VARs or us to other risks and give the government additional rights and remedies not typically found in commercial contracts, including rights that allow the government to, for example:
 
  •  
obtain detailed cost or pricing information;
 
  •  
receive “most favored customer” pricing;
 
  •  
require us to prioritize orders from our government customers above our other customers’ existing orders, which we may fail to do and, even if we do prioritize such orders, may impact our relationships with our other customers;
 
  •  
perform routine audits;
 
  •  
impose equal employment and hiring standards;
 
  •  
require products to be manufactured in specified countries;
 
  •  
restrict
non-U.S.
ownership or investment in our company; and/or
 
  •  
pursue administrative, civil or criminal remedies for contractual violations.
 
49
These rights and remedies have the potential to limit our VARs or our sales to, and increase our VARs or our costs of, doing business with both government and commercial customers, which could materially adversely affect our growth prospects and operating results.
Additionally, we sometimes rely on our VARs and other distribution partners to satisfy certain regulatory obligations that we would otherwise have to satisfy if we sold directly to the government entities, and our VARs and other distribution partners may be unable or unwilling to satisfy these obligations in the future. In the event of such termination or change, it may be difficult for us to arrange for another VAR or other distribution partner to sell our solutions to these government entities in a timely manner, and we could lose sales opportunities during the transition.
Risks Related to Litigation and Liability
We are, and have been in the recent past, subject to business and intellectual property litigation.
We have been in the recent past involved in litigation, and we could be involved in additional litigation in the future. In March 2018, Desktop Metal, Inc. (“Desktop Metal”), a direct competitor in the additive manufacturing industry, brought a claim in Massachusetts federal court against us regarding patent infringement and trade secret misappropriation. We counterclaimed for trade secret misappropriation, breach of fiduciary duty, and other matters. A jury trial was held in July 2018 on Desktop Metal’s claims for patent infringement. We prevailed against Desktop Metal’s claims of patent infringement via a jury verdict that found no infringement of the asserted patents. A second jury trial began in September 2018 primarily in connection with our counterclaims, and the parties entered into a confidential settlement agreement (the “Settlement Agreement”) covering the disputes between them in October 2018. In October 2019, we submitted an Arbitration Demand with JAMS against Desktop Metal alleging breach of the parties’ Settlement Agreement pursuant to the
non-disparagement
obligations therein, as well as a violation of M.G.L. c. 93A. Desktop Metal counterclaimed against us for breach of the parties’ Settlement Agreement pursuant to the confidentiality provision therein. The matter proceeded in confidential arbitration and a hearing was held in December 2020. The Arbitration decision was issued on February 26, 2021, and the Arbitrator ruled that neither we nor Desktop Metal were liable pursuant to their respective claims, and that neither party therefore owed any damages to the other.
In July 2021, Continuous Composites Inc. (“Continuous Composites”), a company based out of Idaho, brought a claim in the United States District Court for the District of Delaware against us regarding patent infringement. We intend to mount a vigorous defense against Continuous Composites in court. However, we can provide no assurance as to the outcome of any such disputes, and any such actions may result in judgments against us for significant damages. Resolution of any such matters can be prolonged and costly, and the ultimate results or judgments are uncertain due to the inherent uncertainty in litigation and other proceedings.
In addition, the additive manufacturing industry has been, and may continue to be, litigious, particularly with respect to intellectual property claims. Moreover, our potential liabilities are subject to change over time due to new developments, changes in settlement strategy or the impact of evidentiary requirements. Regardless of the outcome, litigation has resulted in the past, and may result in the future, in significant legal expenses and require significant attention and resources of management. As a result, any present or future litigation that may be brought against us by any third party could result in reputational harm, losses, damages and expenses that may have a significant adverse effect on our financial condition.
 
50
We could be subject to personal injury, property damage, product liability, warranty and other claims involving allegedly defective products that we supply.
The products we supply are sometimes used in potentially hazardous or critical applications, such as the assembled parts of an aircraft, medical device or automobile. The sale of our products and the provision of related services in general, and to customers in the foregoing industries in particular, exposes us to possible claims for property damage and personal injury or death, which may result from the use of these
end-use
parts. While we have not experienced any such claims to date, actual or claimed defects in the products we supply could result in our being named as a defendant in lawsuits asserting potentially large claims. We may be potentially liable, in significant amounts, and face significant harm to our reputation if an aircraft, medical or automotive part, component or accessory or any other aviation, medical or automotive product that we have sold, produced or repaired fails due to our fault, in whole or in part, or if an aircraft or automobile for which we have provided services or in which their parts are installed crashes, and the cause can be linked to those parts or cannot be determined. A similar risk arises in connection with sales of our products to customers in the aerospace industry to the extent that the parts produced by those products do not function properly and are responsible for damages. Our commercial contracts generally contain product warranties and limitations on liability and we carry liability insurance in amounts that we believe are adequate for our risk exposure and commensurate with industry norms. While we intend to monitor our insurance coverage as our business continues to grow, claims may arise in the future, and that insurance coverage may not be adequate or available to protect our consolidated company in all circumstances. Additionally, we might not be able to maintain adequate insurance coverage for our business in the future at an acceptable cost. Any liability claim against us that is not covered by adequate insurance could adversely affect our consolidated results of operations and financial condition. Finally, any liability claim against us may cause harm to our brand, reputation and adversely impact our business.
We could face liability if our additive manufacturing solutions are used by our customers to print dangerous objects.
Customers may use our 3D printers to print parts that could be used in a harmful way or could otherwise be dangerous. For example, there have been news reports that additive manufacturing machines were used to print guns or other weapons. We have little, if any, control over what objects our customers print using our products, and it may be difficult, if not impossible, for us to monitor and prevent customers from printing weapons with our products. Additionally, individuals or entities unaffiliated with us could disseminate plans or digital files that could be used with our products to produce parts and items that could be deemed illegal or harmful. While we have never printed weapons on any printers in our offices, there can be no assurance that we will not be held liable if someone were injured or killed by a weapon printed by a customer using one of our products. Additionally, association of such an incident with our products may cause harm to our brand reputation and adversely impact our business.
Third parties may produce or sell counterfeit or imitation versions of our materials.
Third parties may sell counterfeit or imitation versions of our materials that are inferior or pose safety risks. If consumers confuse these counterfeit products or materials for our products or materials or have a bad experience with the counterfeit products or materials, they might refrain from purchasing our products or materials in the future, which could harm our reputation and sales. Further, if third parties develop materials that compete favorably on price, and/or meet or exceed the quality and performance of our own materials, we may lose recurring revenue from lost sales of our materials. If we do not maintain favorable perceptions of our products and materials, and if we are unable to compete successfully with third party manufacturers of materials, our brand, business, financial condition, results of operations and cash flows could be adversely impacted.
Failure of our global operations to comply with anti-corruption laws and various trade restrictions, such as sanctions and export controls, could have an adverse effect on our business.
We operate in a number of countries throughout the world, including countries known to have a reputation for corruption. Doing business on a global basis requires us to comply with anti-corruption laws and regulations imposed by governments around the world with jurisdiction over our operations, including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act 2010, as well as the laws of the countries where we do business.
 
51
We are also subject to various trade restrictions, including trade and economic sanctions and export controls, imposed by governments around the world with jurisdiction over our operations. For example, in accordance with trade sanctions administered by the Office of Foreign Assets Control and the U.S. Department of Commerce, we are prohibited from engaging in transactions involving certain persons and certain designated countries or territories, including Cuba, Iran, Syria, North Korea and the Crimea Region of Ukraine. In addition, our products are subject to export regulations that can involve significant compliance time and may add additional overhead cost to our products. In recent years the United States government has a renewed focus on export matters. For example, the Export Control Reform Act of 2018 and regulatory guidance thereunder have imposed additional controls, and may result in the imposition of further additional controls, on the export of certain “emerging and foundational technologies.” Our current and future products may be subject to these heightened regulations, which could increase our compliance costs. For instance, recent amendments to the U.S. Export Administration Regulations (“EAR”) increased restrictions on exports to certain “military
end-users”
and for “military
end-uses”
by certain persons in China, Russia, or Venezuela, which requires us to perform due diligence on customers and
end-users
in those countries for potential military connections.
We also need to monitor the changes in export-related laws and regulations, such as International Traffic in Arms Regulations (“ITAR”), and their applicability to our products and services. If our products or services become subject to the ITAR, we may be required to obtain licenses, clearances, or authorizations from various regulatory entities. If we are not allowed to export our products or services, or if the clearance process is burdensome, our ability to generate revenue would be adversely affected and our operating costs could increase.
In addition, international sales of certain of our products may be subject to local laws and regulations in foreign jurisdictions which we may not be familiar with. We may not be allowed to ship our products to certain countries without meeting their local laws and regulations. The failure to comply with any of these laws or regulations could adversely affect our ability to conduct our business and generate revenues.
We are committed to doing business in accordance with applicable anti-corruption laws and regulations and with applicable trade restrictions. We are subject, however, to the risk that our affiliated entities or our and our affiliates’ respective officers, directors, employees and agents (including distributors and VARs of our products) may take action determined to be in violation of such laws and regulations. Any violation by us or by any of these persons could result in substantial fines, sanctions, civil and/or criminal penalties, or curtailment of operations in certain jurisdictions, and might adversely affect our operating results. In addition, actual or alleged violations could damage our reputation and ability to do business.
Although we take precautions to prevent violations of applicable anti-corruption laws and regulations and applicable trade restrictions, we may have exported products in the past in apparent violation of the EAR. If we are found to be in violation of U.S. export control laws, it could result in substantial fines and penalties for us and for the individuals working for us. We may also be adversely affected through other penalties, reputational harm, loss of access to certain markets or otherwise.
We are subject to environmental, health and safety laws and regulations related to our operations and the use of our 3D printers and materials, which could subject us to compliance costs and/or potential liability.
We are subject to domestic and foreign environmental, health and safety laws and regulations governing our operations. A certain risk of environmental liability is inherent in our production activities. These laws and regulations govern, among other things, the generation, use, storage, registration, handling, transport and disposal of chemicals and waste materials, the presence of specified substances in electrical products; the emission and discharge of hazardous materials into the ground, air or water; the investigation and cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of chemicals and other waste materials and the health and safety of our employees. As such, our operations, including our production activities, carry an inherent risk of environmental, health and safety liabilities. Under these laws and regulations, we could be subject to liability for improper disposal of chemicals and waste materials, including those resulting from the use of our systems and accompanying materials by
end-users.
Accidents or other incidents that occur at our facilities or involve our personnel or operations could result in claims for damages against us. In the event we are found to be financially responsible, as a result of environmental or other laws or by court order, for environmental damages alleged to have been caused by us or occurring on our premises, we could be required to pay substantial monetary damages or undertake expensive remedial obligations. If our operations fail to comply with such laws or regulations, we may be subject to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary to continue our business activities, or may be required to make significant expenditures to achieve compliance. In addition, we may be required to pay damages or civil judgments in respect of third-party claims, including those relating to personal injury (including exposure to hazardous substances that we generate, use, store, handle, transport, manufacture or dispose of), property damage or contribution claims. Some environmental laws allow for strict, joint and several liabilities for remediation costs, regardless of fault. We may be identified as a potentially responsible party under such laws. The amount of any costs, including fines or damages payments that we might incur under such circumstances could substantially exceed any insurance we have to cover such losses. Any of these events, alone or in combination, could have a material adverse effect on our business, financial condition and results of operations and could adversely affect our reputation.
 
52
We may be subject to environmental laws and regulations concerning the import and export of chemicals and hazardous substances including, without limitation, the United States Toxic Substances Control Act (“TSCA”) and the Registration, Evaluation, Authorization and Restriction of Chemical Substances (“REACH”). These laws and regulations require the testing and registration of some chemicals that we ship along with, or that form a part of, our systems and other products. If we fail to comply with these or similar laws and regulations, we may be required to make significant expenditures to reformulate the chemicals that we use in our products and materials or incur costs to register such chemicals to gain and/or regain compliance. Additionally, we could be subject to significant fines or other civil and criminal penalties should we not achieve such compliance.
The cost of complying with current and future environmental, health and safety laws applicable to our operations, or the liabilities arising from releases of, or exposure to, hazardous substances, may result in future expenditures. Any of these developments, alone or in combination, could have an adverse effect on our business, financial condition and results of operations.
Aspects of our business are subject to laws and regulations governing privacy and data security. Changes in laws, regulations, and public perception concerning data protection and privacy, or changes in the interpretation or patterns of enforcement of existing laws and regulations, could impair our efforts to maintain and expand our customer base or the ability of our customers to use our services. Breaches of laws and regulations concerning data protection and privacy could expose us to significant fines and other penalties.
We hold personal information about a variety of individuals, such as our employees, prospects, and our customers. Processing of personal information is increasingly subject to legislation and regulation in numerous jurisdictions around the world.
For example, relevant applicable laws and regulations governing the collection, use, disclosure or other processing of personal information include, in the United States, rules and regulations promulgated under the authority of the Federal Trade Commission, the California Consumer Privacy Act of 2018 (the “CCPA”) and state breach notification laws. In particular, the CCPA, among other things, requires covered ‘Businesses’ to provide new disclosures to California consumers and afford such consumers new rights with respect to their personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches that result in the loss of personal information. This private right of action may increase the likelihood of, and risks associated with, data breach litigation.
The CCPA has prompted a number of proposals for new federal and state-level privacy legislation. Such proposed legislation, if enacted, may add additional complexity, variation in requirements, restrictions and potential legal risk, require additional investment of resources in compliance programs, impact strategies and the availability of previously useful data and could result in increased compliance costs and/or changes in business practices and policies.
Moreover, we maintain offices in the European Union (“EU”) (Ireland) and we have customers in the EU and the United Kingdom (“UK”). Accordingly, we are subject to the General Data Protection Regulation (EU) 2016/679 (the “GDPR”), and related member state implementing legislation, and to the UK’s Data Protection Act 2018 (collectively, “European Data Protection Law”). European Data Protection Law places obligations on controllers and processors of personal data, while establishing rights for individuals with respect to their personal data. European Data Protection Law is also explicitly extraterritorial in its application, and could affect our business activities in jurisdictions outside the EU and the UK. Additionally, European Data Protection Law imposes strict rules on the transfer of personal data outside of the EU to countries that do not ensure an adequate level of protection, like the United States. These transfers are prohibited unless an appropriate safeguard specified by the GDPR is implemented, such as the Standard Contractual Clauses (SCCs) or binding corporate rules. The Court of Justice of the European Union (the “CJEU”) recently deemed that these transfers need to be analyzed on a
case-by-case
basis to ensure EU standards of data protection are met in the jurisdiction where the data importer is based. European regulators have issued recent guidance following the CJEU case that imposes significant new diligence requirements on transferring data outside the EU. Complying with this guidance is and will continue to be expensive and time consuming and may ultimately prevent us from transferring personal data outside the EU, which would cause significant business disruption. The GDPR imposes sanctions for violations up to the greater of €20 million and 4% of worldwide gross annual revenue, enables individuals to claim damages for violations and introduces the right for
non-profit
organizations to bring claims on behalf of data subjects.
 
53
The regulatory framework governing the collection, processing, storage, use and sharing of personal information is rapidly evolving and is likely to continue to be subject to uncertainty and varying interpretations. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our existing data management practices or the features of our services and platform capabilities. We cannot yet fully determine the impact these or future laws, rules, regulations and industry standards may have on our business or operations. Additionally, our customers may be subject to differing privacy laws, rules and legislation, which may mean that they require us to be bound by varying contractual requirements applicable to certain other jurisdictions. Adherence to such contractual requirements may impact our collection, use, processing, storage, sharing and disclosure of personal information and may mean we become bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters that may further change as laws, rules and regulations evolve. We have incurred, and may continue to incur, significant expenses to comply with evolving mandatory privacy and security standards and protocols imposed by law, regulation, industry standards, shifting merchant and customer expectations, or contractual obligations, and we may not be able to respond quickly or effectively to regulatory, legislative and other developments. These changes may in turn impair our ability to offer our existing or planned features, products and services and/or increase our cost of doing business.
We publicly post documentation regarding our privacy practices. Although we endeavor to comply with our published policies and documentation, we may at times fail to do so or be alleged to have failed to do so. Any failure or perceived failure by us to comply with our privacy policies or any applicable privacy, security or data protection, information security or consumer-protection related laws, regulations, orders or industry standards could expose us to costly litigation, significant awards, fines or judgments, civil and/or criminal penalties or negative publicity, and could materially and adversely affect our business, financial condition and results of operations. The publication of our privacy policy and other documentation that provide promises and assurances about privacy and security can subject us to potential state and federal action if they are found to be deceptive, unfair, or misrepresentative of our actual practices, which could, individually or in the aggregate, materially and adversely affect our business, financial condition and results of operations.
 
54
We rely on our software and information technology systems to manage numerous aspects of our business and a disruption of these systems could adversely affect our business.
We rely on our information technology systems to manage numerous aspects of our business, including to efficiently purchase products from our suppliers, provide procurement and logistic services, ship products to our customers, receive orders from our customers, manage our accounting and financial functions, including our internal controls, and maintain our research and development data. Our information technology systems are an essential component of our business and any disruption could significantly limit our ability to manage and operate our business efficiently. A failure of our information technology systems to perform properly could disrupt our supply chain, product development and customer experience, which may lead to increased overhead costs and decreased sales and have an adverse effect on our reputation and our financial condition. In particular, our integrated software platform is an essential system that virtually all of our customers depend on for their design needs. If our integrated software platform were to fail, we could face adverse consequences to our results of operations, financial condition and business reputation. In addition, during the
COVID-19
pandemic, a substantial portion of our employees have conducted work remotely, making us more dependent on potentially vulnerable communications systems and making us more vulnerable to cyberattacks.
Although we take steps and incur significant costs to secure our information technology systems, including our computer systems, intranet and internet sites, email and other telecommunications and data networks, our security measures may not be effective and our systems may be vulnerable to damage or interruption. Disruption to our information technology systems could result from power outages, computer and telecommunications failures, computer viruses, cyber-attack or other security breaches, catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes, acts of war, terrorism and usage errors by our employees.
Our reputation and financial condition could be adversely affected if, as a result of a significant cyber-event or otherwise:
 
  •  
our operations are disrupted or shut down;
 
  •  
our confidential, proprietary information is stolen or disclosed;
 
  •  
we incur costs or are required to pay fines in connection with stolen customer, employee or other confidential information; or
 
  •  
we must dedicate significant resources to system repairs or increase cyber security protection.
In addition, any unauthorized access, disclosure or other loss or unauthorized use of information or data could result in legal claims or proceedings, regulatory investigations or actions, and other types of liability under laws that protect the privacy and security of personal information, including federal, state and foreign data protection and privacy regulations, violations of which could result in significant penalties and fines. In addition, although we seek to detect and investigate all data security incidents, security breaches and other incidents of unauthorized access to our information technology systems and data can be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure.
The cost of investigating, mitigating and responding to potential data security breaches and complying with applicable breach notification obligations to individuals, regulators, partners and others can be significant. Our insurance policies may not be adequate to compensate us for the potential costs and other losses arising from such disruptions, failures or security breaches. In addition, such insurance may not be available to us in the future on economically reasonable terms, or at all. Further, defending a suit, regardless of its merit, could be costly, divert management attention and harm our reputation.
If our computer systems are damaged or cease to function properly, or, if we do not replace or upgrade certain systems, we may incur substantial costs to repair or replace them and may experience an interruption of our normal business activities or loss of critical data. Any such disruption could adversely affect our reputation and financial condition.
 
55
We also rely on information technology systems maintained by third parties, including third-party cloud computing services and the computer systems of our suppliers for both our internal operations and our customer-facing infrastructure related to our additive manufacturing solutions. These systems are also vulnerable to the types of interruption and damage described above but we have less ability to take measures to protect against such disruptions or to resolve them if they were to occur. Information technology problems faced by third parties on which we rely could adversely impact our business and financial condition as well as negatively impact our brand reputation.
Any unauthorized control or manipulation of our products’ systems could result in loss of confidence in us and our products and harm our business.
Our products contain complex information technology systems. For example, our additive manufacturing machines are designed with
built-in
data connectivity to accept and install periodic remote updates from us to monitor, improve and update their functionality. We have designed, implemented and tested security measures intended to prevent unauthorized access to our information technology networks, our products and their systems. However, hackers may attempt to gain unauthorized access to modify, alter and use such networks, products and systems to gain control of, or to change, our products’ functionality, user interface and performance characteristics, or to gain access to data stored in or generated by our products. We encourage reporting of potential vulnerabilities in the security of our products and we aim to remedy any reported and verified vulnerability. Accordingly, we have received reports of potential vulnerabilities in the past and have attempted to remedy them. However, there can be no assurance that vulnerabilities will not be exploited in the future before they can be identified, or that our remediation efforts are or will be successful.
Any unauthorized access to or control of our products or their systems or any loss of data could result in legal claims or proceedings. In addition, regardless of their veracity, reports of unauthorized access to our products, their systems or data, as well as other factors that may result in the perception that our products, their systems or data are capable of being “hacked,” could negatively affect our brand and harm our business, prospects, financial condition and operating results.
Our business has risks that may not be adequately covered by insurance or indemnity.
We may face unanticipated risks of legal liability for damages caused by the actual or alleged failure of our products. While we have attempted to secure liability insurance coverage at an appropriate cost, it is impossible to adequately insure against all risks inherent in our industry, nor can we assure you that our insurers will pay a particular claim, or that we will be able to maintain coverage at reasonable rates in the future. Our insurance policies also contain deductibles, limitations and exclusions, which increase our costs in the event of a claim. Even a partially uninsured claim of significant size, if successful, could have an adverse effect on our financial condition. In addition, we may not be able to continue to obtain insurance coverage on commercially reasonable terms, or at all, and our existing policies may be cancelled or otherwise terminated by the insurer. Maintaining adequate insurance and successfully accessing insurance coverage that may be due for a claim can require a significant amount of our management’s time, and we may be forced to spend a substantial amount of money in that process. Substantial claims in excess of or not otherwise covered by indemnity or insurance could harm our financial condition and operating results.
Risks Related to Intellectual Property
We may not be able to adequately protect our proprietary and intellectual property rights in our data or technology.
Our success is dependent, in part, upon protecting our proprietary information and technology. Our intellectual property portfolio primarily consists of patents, patent applications, registered and unregistered trademarks, unregistered copyrights, domain names,
know-how,
and trade secrets. We may be unsuccessful in adequately protecting our intellectual property.
 
56
Our trade secrets,
know-how
and other unregistered proprietary rights are a key aspect of our intellectual property portfolio. While we take reasonable steps to protect our trade secrets and confidential information and enter into confidentiality and invention assignment agreements intended to protect such rights, such agreements can be difficult and costly to enforce or may not provide adequate remedies if violated, and we may not have entered into such agreements with all relevant parties. Such agreements may be breached and trade secrets or confidential information may be willfully or unintentionally disclosed, including by employees who may leave our company and join our competitors, or our competitors or other parties may learn of the information in some other way. Additionally, certain unauthorized use of our intellectual property may go undetected, or we may face legal or practical barriers to enforcing our legal rights even where unauthorized use is detected. The disclosure to, or independent development by, a competitor of any of our trade secrets,
know-how
or other technology not protected by a patent or other intellectual property system could materially reduce or eliminate any competitive advantage that we may have over such competitor. This concern could manifest itself in particular with respect to our proprietary materials that are used with our systems. Portions of our proprietary materials may not be afforded patent protection. Chemical companies or other producers of raw materials used in our materials may be able to develop materials that are compatible to a large extent with our products, whether independently or in contravention of our trade secret rights and related proprietary and contractual rights. If such materials are made available to owners of our systems, and are purchased in place of our proprietary materials, our revenues and profitability would be reduced, and we could be forced to reduce prices for our proprietary materials.
Current laws may not provide for adequate protection of our products, especially in foreign jurisdictions which may have laws that provide insufficient protections to companies. In addition, legal standards relating to the validity, enforceability, and scope of protection of proprietary rights in internet-related businesses are uncertain and evolving, and changes in these standards may adversely impact the viability or value of our proprietary rights. Some license provisions protecting against unauthorized use, copying, transfer, and disclosure of our products, or certain aspects of our products may be unenforceable under the laws of certain jurisdictions. Further, the laws of some countries do not protect proprietary rights to the same extent as the laws of the United States, and the laws and mechanisms for protection and enforcement of intellectual property rights in some foreign countries may be inadequate. As we continue to operate in foreign countries and expand our international activities, we have encountered and may in the future encounter challenges in navigating the laws of foreign countries, which may adversely affect our ability to protect our proprietary rights. Further, competitors, foreign governments, foreign government-backed actors, criminals, or other third parties may gain unauthorized access to our proprietary information and technology. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our technology and intellectual property or claiming that we infringe upon or misappropriate their technology and intellectual property.
To protect our intellectual property rights, we may be required to spend significant resources to monitor, protect, and defend these rights, and we may or may not be able to detect infringement by our customers or third parties. Litigation has been and may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Such litigation could be costly, time consuming, and distracting to management and could result in the impairment or loss of portions of our intellectual property. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay further sales or the implementation of our platform, impair the functionality of our platform, delay introductions of new features, integrations, and capabilities, result in our substituting inferior or more costly technologies into our platform, or injure our reputation. In addition, we may be required to license additional technology from third parties to develop and market new features, integrations, and capabilities, and we cannot be certain that we could license that technology on commercially reasonable terms or at all, and our inability to license this technology could harm our ability to compete.
 
57
If third parties claim that we infringe upon or otherwise violate their intellectual property rights, our business could be adversely affected.
We have in the past and may in the future be subject to claims that we have infringed or otherwise violated third parties’ intellectual property rights. There is patent, copyright and other intellectual property development and enforcement activity in our industry and relating to the additive manufacturing technology we use in our business. Our future success depends in part on not infringing upon or otherwise violating the intellectual property rights of others. From time to time, our competitors or other third parties (including
non-practicing
entities and patent holding companies) may claim that we are infringing upon or otherwise violating their intellectual property rights, and we may be found to be infringing upon or otherwise violating such rights. We may be unaware of the intellectual property rights of others that may cover some or all of our current or future technology or conflict with our rights, and the patent, copyright, and other intellectual property rights of others may limit our ability to improve our technology and compete effectively. Any claims of intellectual property infringement or other intellectual property violations, even those without merit, could:
 
  •  
be expensive and time consuming to defend;
 
  •  
cause us to cease making, licensing or using our platform or products that incorporate the challenged intellectual property;
 
  •  
require us to modify, redesign, reengineer or rebrand our platform or products, if feasible;
 
  •  
divert management’s attention and resources; or
 
  •  
require us to enter into royalty or licensing agreements to obtain the right to use a third-party’s intellectual property.
Any royalty or licensing agreements, if required, may not be available to us on acceptable terms or at all. A successful claim of infringement against us could result in our being required to pay significant damages, enter into costly settlement agreements, or prevent us from offering our platform or products, any of which could have a negative impact on our operating profits and harm our future prospects. We may also be obligated to indemnify our customers or business partners in connection with any such litigation and to obtain licenses, modify our platform or products, or refund premium subscription fees, which could further exhaust our resources. Such disputes could also disrupt our platform or products, adversely affecting our customer satisfaction and ability to attract customers.
If we are unable to adequately protect or enforce our intellectual property rights, such information may be used by others to compete against us, in particular in developing materials that could be used with our printing systems in place of our proprietary materials.
We have devoted substantial resources to the development of our technology and related intellectual property rights. Our success and future revenue growth will depend, in part, on our ability to protect our intellectual property. We rely on a combination of registered and unregistered intellectual property and protect our rights using patents, licenses, trademarks, trade secrets, confidentiality and assignment of invention agreements and other methods.
Despite our efforts to protect our proprietary rights, it is possible that competitors or other unauthorized third parties may obtain, copy, use or disclose our technologies, inventions, processes or improvements. We cannot assure you that any of our existing or future patents or other intellectual property rights will not be challenged, invalidated or circumvented, or will otherwise provide us with meaningful protection. Our pending patent applications may not be granted, and we may not be able to obtain foreign patents or pending applications corresponding to our U.S. patents. Even if foreign patents are granted, effective enforcement in foreign countries may not be available.
Our trade secrets,
know-how
and other unregistered proprietary rights are a key aspect of our intellectual property portfolio. While we take reasonable steps to protect our trade secrets and confidential information and enter into confidentiality and invention assignment agreements intended to protect such rights, such agreements can be difficult and costly to enforce or may not provide adequate remedies if violated, and we may not have entered into such agreements with all relevant parties. Such agreements may be breached and trade secrets or confidential information may be willfully or unintentionally disclosed, including by employees who may leave our company and join our competitors, or our competitors or other parties may learn of the information in some other way. The disclosure to, or independent development by, a competitor of any of our trade secrets,
know-how
or other technology not protected by a patent or other intellectual property system could materially reduce or eliminate any competitive advantage that we may have over such competitor. This concern could manifest itself in particular with respect to our proprietary materials that are used with our systems. Portions of our proprietary materials may not be afforded patent protection. Chemical companies or other producers of raw materials used in our materials may be able to develop materials that are compatible to a large extent with our products, whether independently or in contravention of our trade secret rights and related proprietary and contractual rights. If such materials are made available to owners of our systems, and are purchased in place of our proprietary materials, our revenues and profitability would be reduced, and we could be forced to reduce prices for our proprietary materials.
 
58
If our patents and other intellectual property do not adequately protect our technology, our competitors may be able to offer products similar to ours. Our competitors may also be able to develop similar technology independently or design around our patents and other intellectual property. Any of the foregoing events would lead to increased competition and reduce our revenue or gross margin, which would adversely affect our operating results.
If we attempt enforcement of our intellectual property rights, we may be, and have been in the past, subject or party to claims, negotiations or complex, protracted litigation. Intellectual property disputes and litigation, regardless of merit, can be costly and disruptive to our business operations by diverting attention and energies of management and key technical personnel and by increasing our costs of doing business. Any of the foregoing could adversely affect our business and financial condition.
As part of any settlement or other compromise to avoid complex, protracted litigation, we may agree not to pursue future claims against a third party, including related to alleged infringement of our intellectual property rights. Part of any settlement or other compromise with another party may resolve a potentially costly dispute but may also have future repercussions on our ability to defend and protect our intellectual property rights, which in turn could adversely affect our business.
Our additive manufacturing technology contains third-party open-source software components, and failure to comply with the terms of the underlying open-source software licenses could restrict our ability to commercialize our products.
Our additive manufacturing technology contains components that are licensed under
so-called
“open source,” “free” or other similar licenses. Open source software is made available to the general public on an
“as-is”
basis under the terms of a
non-negotiable
license. We currently combine our proprietary software with open source software and intend to continue doing so in the future. Additionally, we make some of our source code available under open source licenses, which may limit our ability to protect our intellectual property rights in our source code and prevent our competitors or others from using such source code. Our use and distribution of open source software may entail greater risks than use of third-party commercial software because open source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. In addition, if we combine our proprietary software with open source software in a certain manner, we could, under certain open source licenses, be required to disclose or make available the source code of our proprietary software to third parties. We may also face claims alleging noncompliance with open source license terms or infringement or misappropriation of third-party intellectual property rights in open source software. These claims could result in litigation, require us to purchase a costly license or remove the software. In addition, if the license terms for open source software that we use change, we may be forced to
re-engineer
our solutions, incur additional costs or discontinue the sale of our offerings if
re-engineering
could not be accomplished on a timely basis. Although we monitor our use of open source software to avoid subjecting our offerings to unintended conditions, there is a risk that these licenses could be construed in a way that could impose unanticipated conditions or restrictions on our ability to commercialize our offerings. We cannot guarantee that we have incorporated open source software in our software in a manner that will not subject us to liability or in a manner that is consistent with our current policies and procedures.
 
59
General Risk Factors
We will continue to incur increased costs as a result of operating as a public company, and our management are required to devote substantial time to new compliance initiatives.
As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes Oxley Act of 2002 and rules subsequently implemented by the Securities and Exchange Commission and NYSE have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance.
Pursuant to Section 404 of the Sarbanes Oxley Act of 2002 (the “Sarbanes Oxley Act”), we are required to furnish a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we remain an emerging growth company, we are not required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section 404 of the Sarbanes Oxley Act within the prescribed period, we are engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section 404 of the Sarbanes Oxley Act. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. In addition, if we are not able to continue to meet these requirements, we may not be able to remain listed on NYSE.
Changes in accounting rules and regulations, or interpretations thereof, could result in unfavorable accounting charges or require us to change our compensation policies.
Accounting methods and policies for public companies are subject to review, interpretation and guidance from our independent registered accounting firm and relevant accounting authorities, including the SEC. Changes to accounting methods or policies, or interpretations thereof, may require us to reclassify, restate or otherwise change or revise our consolidated financial statements.
Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.
We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls.
 
60
Our management team has limited experience managing a public company.
Our management team has limited experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws, rules and regulations that govern public companies. As a public company, we are subject to significant obligations relating to reporting, procedures and internal controls, and our management team may not successfully or efficiently manage such obligations. These obligations and scrutiny require significant attention from our management and could divert their attention away from the
day-to-day
management of our business, which could adversely affect our business, financial condition and results of operations.
Our internal controls over financial reporting currently do not meet all of the standards contemplated by Section 404 of the Sarbanes Oxley Act, and failure to achieve and maintain effective internal controls over financial reporting in accordance with Section 404 of the Sarbanes Oxley Act could impair our ability to produce timely and accurate financial statements or comply with applicable regulations and have a material adverse effect on our business.
We operated as a private company until July 2021. Our management has significant requirements for enhanced financial reporting and internal controls as a public company. The process of designing and implementing effective internal controls is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a system of internal controls that is adequate to satisfy our reporting obligations as a public company. If we are unable to establish or maintain appropriate internal financial reporting controls and procedures, it could cause us to fail to meet our reporting obligations on a timely basis or result in material misstatements in our consolidated financial statements, which could harm our operating results. In addition, we are required, pursuant to Section 404 of the Sarbanes Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment needs to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting.
The rules governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation. Testing and maintaining internal controls may divert management’s attention from other matters that are important to our business. Our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting on an annual basis. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. If we are not able to complete our initial assessment of our internal controls and otherwise implement the requirements of Section 404 of the Sarbanes Oxley Act in a timely manner or with adequate compliance, our independent registered public accounting firm may not be able to certify as to the adequacy of our internal control over financial reporting.
In addition to our results determined in accordance with GAAP, we believe certain
non-GAAP
measures may be useful in evaluating our operating performance. We present certain
non-GAAP
financial measures in this prospectus and intend to continue to present certain
non-GAAP
financial measures in future filings with the SEC and other public statements. Any failure to accurately report and present our
non-GAAP
financial measures could cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our common stock.
 
61
We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain effective internal control over financial reporting, which may result in material misstatements of our consolidated financial statements or cause us to fail to meet our periodic reporting obligations.
We have identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. These material weaknesses are as follows:
 
  •  
We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we lacked a sufficient complement of resources with (i) an appropriate level of accounting knowledge, experience and training to appropriately analyze, record and disclose accounting matters timely and accurately, and (ii) an appropriate level of knowledge and experience to establish effective processes and controls. Additionally, the lack of a sufficient number of professionals resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuit of our financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. This material weakness contributed to the following additional material weaknesses:
 
  •  
We did not design and maintain effective controls related to the
period-end
financial reporting process, including designing and maintaining formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures. Additionally, we did not design and maintain controls over the preparation and review of account reconciliations and journal entries, including maintaining appropriate segregation of duties.
 
  •  
We did not design and maintain effective controls related to the identification of and accounting for certain
non-routine,
unusual or complex transactions, including the proper application of U.S. GAAP of such transactions. Specifically, we did not design and maintain controls to timely identify and account for share repurchase transactions and warrant instruments.
These material weaknesses resulted in audit adjustments to the following financial statement line items in the historical Markforged financial statements: operating expense, other expense, interest expense, other assets, other liabilities, additional paid in capital, treasury stock, retained earnings, note receivable—equity, and series D preferred stock. These adjustments were recorded prior to the issuance of the consolidated financial statements as of and for the years ended December 31, 2020 and 2019. The material weakness related to accounting for warrant instruments resulted in the restatement of the previously issued financial statements of the entity acquired as part of the July 14, 2021 merger agreement related to warrant liabilities and equity. Additionally, these material weaknesses could result in a misstatement of substantially all of our accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
 
  •  
We did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of our financial statements. Specifically, we did not design and maintain (i) program change management controls for financial systems to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate Company personnel; (iii) computer operations controls to ensure that critical batch jobs are monitored, privileges are appropriately granted, and data backups are authorized and monitored; and (iv) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements. These IT deficiencies did not result in any misstatements to the financial statements, however, the deficiencies, when aggregated, could impact our ability to maintain effective segregation of duties, as well as the effectiveness of
IT-dependent
controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.
 
62
We will take certain measures to remediate the material weaknesses described above, including the following:
 
  •  
Hiring additional accounting and IT personnel, including a new chief financial officer, to bolster our reporting, technical accounting and IT capabilities.
 
  •  
Engaging a third party to assist in designing and implementing controls related to
period-end
financial reporting, segregation of duties, and IT general controls.
 
  •  
Designing and implementing controls to formalize roles and review responsibilities to align with the our team’s skills and experience and designing and implementing controls over segregation of duties.
 
  •  
Designing and implementing controls to timely identify and account for
non-routine,
unusual or complex transactions and other technical accounting and financial reporting matters, including controls over the preparation and review of accounting memoranda addressing these matters.
 
  •  
Designing and implementing formal accounting policies, procedures and controls supporting our
period-end
financial reporting process, including controls over the preparation and review of account reconciliations and journal entries.
 
  •  
Designing and implementing IT general controls, including controls over change management, the review and update of user access rights and privileges, controls over batch jobs and data backups, and program development approvals and testing.
We have begun to hire additional accounting and IT personnel, including the hiring of a new chief financial officer in March 2021, engaged third party resources to assist it in designing and implementing controls related to
period-end
financial reporting, segregation of duties, and IT general controls, and begun to implement appropriate segregation of duties in the operation of manual controls. The material weaknesses will not be considered remediated until management completes the design and implementation of the measures described above and the controls operate for a sufficient period of time and management has concluded, through testing, that these controls are effective.
We are working to remediate the material weaknesses as efficiently and effectively as possible and expects full remediation could potentially go beyond December 31, 2021. At this time, we cannot provide an estimate of costs expected to be incurred in connection with implementing this remediation plan; however, these remediation measures will be time consuming, will result in us incurring significant costs, and will place significant demands on our financial and operational resources.
Comprehensive tax reform legislation could adversely affect our business and financial condition.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation that includes significant changes to the taxation of business entities. These changes include, among others, a permanent reduction to the corporate income tax rate. Notwithstanding the reduction in the corporate income tax rate, the overall impact of this tax reform is uncertain, and our business and financial condition could be adversely affected. The U.S. government in the future may enact additional legislation that affects the taxation of business entities, including with respect to the treatment of NOLs.
 
63
Further, the changes in tax laws could negatively impact our effective tax rate. Prior to the U.S. presidential election, President Biden proposed an increase in the U.S. corporate income tax rate from 21% to 28%, doubling the rate of tax on certain earnings of foreign subsidiaries, the creation of a 10% surtax on certain imports and a 15% minimum tax on worldwide book income. If any or all of these (or similar) proposals are ultimately enacted into law, in whole or in part, they could have a negative impact to our effective tax rate. Holders of our securities are urged to consult with their legal and tax advisors with respect to any such legislation and the potential tax consequences of holding our securities.
Currently, we incur losses in certain countries where we do not receive a financial statement benefit, and we operate in countries which have different statutory rates. Consequently, changes in the mix and source of earnings between countries could have a material impact on our overall effective tax rate.
The historical financial results of Markforged and unaudited pro forma financial information included elsewhere in this prospectus may not be indicative of what Markforged Holding Corporation’s actual financial position or results of operations would have been.
The historical financial results of Markforged included in this prospectus do not reflect the financial condition, results of operations or cash flows they would have achieved as a standalone company during the periods presented or those Markforged Holding Corporation will achieve in the future. This is primarily the result of the following factors: (i) Markforged Holding Corporation will incur additional ongoing costs as a result of the Merger, including costs related to public company reporting, investor relations and compliance with the Sarbanes-Oxley Act; and (ii) Markforged Holding Corporation’s capital structure is different from that reflected in Markforged’s historical financial statements. Markforged Holding Corporation’s financial condition and future results of operations could be materially different from amounts reflected in its historical financial statements included elsewhere in this prospectus, so it may be difficult for investors to compare Markforged Holding Corporation’s future results to historical results or to evaluate its relative performance or trends in its business.
Similarly, the unaudited pro forma financial information in this prospectus is presented for illustrative purposes only and has been prepared based on a number of assumptions including, but not limited to, AONE being treated as the “acquired” company for financial reporting purposes in the Merger and the total debt obligations and the cash and cash equivalents of Markforged on the Closing Date. Accordingly, such pro forma financial information may not be indicative of Markforged Holding Corporation’s future operating or financial performance and Markforged Holding Corporation’s actual financial condition and results of operations may vary materially from Markforged Holding Corporation’s pro forma results of operations and balance sheet contained elsewhere in this prospectus, including as a result of such assumptions not being accurate. See “
Unaudited Pro Forma Condensed Combined Financial Information
”.
Additional Risks Related to Ownership of Our Common Stock and Us Operating as a Public Company
The price of our common stock and warrants may be volatile.
The price of our Common Stock as well as our Warrants may fluctuate due to a variety of factors, including:
 
  •  
changes in the industries in which we and our customers operate;
 
  •  
developments involving our competitors;
 
  •  
changes in laws and regulations affecting its business;
 
  •  
variations in its operating performance and the performance of its competitors in general;
 
  •  
actual or anticipated fluctuations in our quarterly or annual operating results;
 
  •  
publication of research reports by securities analysts about us or our competitors or its industry;
 
  •  
the public’s reaction to our press releases, its other public announcements and its filings with the SEC;
 
  •  
actions by stockholders, including the sale by the PIPE Investors of any of their shares of our common stock;
 
  •  
additions and departures of key personnel;
 
64
  •  
commencement of, or involvement in, litigation involving the combined company;
 
  •  
changes in its capital structure, such as future issuances of securities or the incurrence of additional debt;
 
  •  
the volume of shares of our Common Stock available for public sale; and
 
  •  
general economic and political conditions, such as the effects of the
COVID-19
pandemic, recessions, interest rates, local and national elections, fuel prices, international currency fluctuations, corruption, political instability and acts of war or terrorism.
These market and industry factors may materially reduce the market price of our Common Stock and warrants regardless of the operating performance of us.
We do not intend to pay cash dividends for the foreseeable future.
We currently intend to retain our future earnings, if any, to finance the further development and expansion of our business and do not intend to pay cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as its board of directors deems relevant.
If analysts do not publish research about our business or if they publish inaccurate or unfavorable research, our stock price and trading volume could decline.
The trading market for our common stock depends in part on the research and reports that analysts publish about our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, the price of our common stock would likely decline. If few analysts cover us, demand for our common stock could decrease and our common stock price and trading volume may decline. Similar results may occur if one or more of these analysts stop covering us in the future or fail to publish reports on us regularly.
We may be subject to securities litigation, which is expensive and could divert management attention.
The market price of our common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert management’s attention from other business concerns, which could seriously harm our business.
Future resales of common stock may cause the market price of our securities to drop significantly, even if our business is doing well.
Pursuant to the
lock-up
restrictions agreed to into in connection with the Merger Agreement, subject to certain exceptions, the Sponsor and certain related parties and certain of our Stockholders (who collectively own approximately 77.6% of our outstanding Common Stock) are contractually restricted from selling or transferring any of its or their shares of common stock (the
“Lock-up
Shares”). Such restrictions began at Closing and end 180 days after Closing. The
lock-up
restrictions described above supersede the
lock-up
provisions set forth in Section 7 of that certain letter agreement, dated as of August 17, 2020, by and among AONE, the Sponsor and each of the other parties thereto (the “Insider Letter”) which provisions in Section 7 of the Insider Letter shall be of no further force or effect as of the date of the Registration Rights Agreement and the
Lock-Up
Agreement. However, following the expiration of the respective lockups described above, the Sponsor and our Stockholders will not be restricted from selling shares of our Common Stock held by them, other than by applicable securities laws. In addition, upon certain events, up to 2,610,000 Sponsor Earnout Shares will vest and become salable by Sponsor or its transferees. Additionally, the PIPE Investors will not be restricted from selling any of the shares of our Common Stock acquired in the PIPE Investment, other than by applicable securities laws. As such, sales of a substantial number of shares of our Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock. The Sponsor and the Markforged Stockholders collectively own approximately 80.1% of the outstanding shares of our Common Stock.
 
65
The shares held by Sponsor and our Stockholders may be sold after the expiration of the applicable
lock-up
periods agreed to in connection with the Merger Agreement. As restrictions on resale end, and registration statements (filed after the Closing to provide for the resale of such shares from time to time) are available for use, the sale or possibility of sale of these shares could have the effect of increasing the volatility in our share price, or the market price of our Common Stock could decline if the holders of currently restricted shares sell them or are perceived by the market as intending to sell them.
The obligations associated with being a public company involve significant expenses and require significant resources and management attention, which may divert from our business operations.
As a public company, we are subject to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act. The Exchange Act requires the filing of annual, quarterly and current reports with respect to a public company’s business and financial condition. The Sarbanes-Oxley Act requires, among other things, that a public company establish and maintain effective internal control over financial reporting. As a result, we incur significant legal, accounting and other expenses that we did not previously incur. Our entire management team and many of its other employees will need to devote substantial time to compliance, and may not effectively or efficiently manage its transition into a public company.
These rules and regulations result in us incurring substantial legal and financial compliance costs and make some activities more time-consuming and costly. For example, these rules and regulations will likely continue to make it more difficult and more expensive for us to obtain director and officer liability insurance, and it may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be difficult for us to attract and retain qualified people to serve on its board of directors, its board committees or as executive officers.
We are currently an emerging growth company within the meaning of the Securities Act, and to the extent we have taken advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
We are currently an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.
 
66
When we cease to be an emerging growth company, we will no longer be able to take advantage of certain exemptions from reporting, and, absent other exemptions or relief available from the SEC, we will also be required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We will incur additional expenses in connection with such compliance and our management will need to devote additional time and effort to implement and comply with such requirements.
Delaware law and the Organizational Documents contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
The Organizational Documents and the DGCL contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, and therefore depress the trading price of our Common Stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of our board of directors or taking other corporate actions, including effecting changes in our management. Among other things, the Organizational Documents include provisions regarding:
 
  •  
the ability of our board of directors to issue shares of preferred stock, including “blank check” preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
 
  •  
the board of directors are classified into three classes, with only one class being elected each year to serve three-year terms. As a result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual stockholders meetings;
 
  •  
the certificate of incorporation will prohibit cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;
 
  •  
the limitation of the liability of, and the indemnification of, our directors and officers;
 
  •  
the ability of our board of directors to amend the bylaws, which may allow our board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and
 
  •  
advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our board of directors and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of us.
These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our board of directors or management.
 
67
The provisions of the Bylaws requiring exclusive forum in the Court of Chancery of the State of Delaware and the federal district courts of the United States for certain types of lawsuits may have the effect of discouraging certain lawsuits, including derivative lawsuits and lawsuits against the directors and officers of us, by limiting plaintiffs’ ability to bring a claim in a judicial forum that they find favorable.
The Bylaws provide that, to the fullest extent permitted by law, and unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that such court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on behalf of us, (ii) any action asserting a claim for or based on a breach of a fiduciary duty owed by any current or former director, officer or other employee of us to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL or the Bylaws or Certificate of Incorporation (as either may be amended from time to time) (including the interpretation, validity and enforceability thereof), (iv) any action asserting a claim related to or involving us that is governed by the internal affairs doctrine, and (v) any action asserting an “internal corporate claim” as that term is defined in Section 115 of the DGCL (the “Delaware Forum Provision”). The Delaware Forum Provision, however, does not apply to actions or claims arising under the Exchange Act. The Bylaws also provide that, unless we consent in writing to the selection of an alternate forum, the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act, and the rules and regulations promulgated thereunder, will be the Federal District Courts of the United States (the “Federal Forum Provision,” and with the Delaware Forum Provision, the “Exclusive Forum Provisions”). In addition, the Bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision. However, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder; our cannot and will not be deemed to have waived compliance with the U.S. federal securities laws and the rules and regulations thereunder.
These provisions may impose additional litigation costs on stockholders in pursuing any such claims and have the effect of discouraging certain lawsuits, including derivative lawsuits and lawsuits against our directors and officers of, by limiting plaintiffs’ ability to bring a claim in a judicial forum that they find favorable. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are “facially valid” under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid, and if the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Court of Chancery of the State of Delaware and the Federal District Courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.
The private placement warrants are being accounted for as a warrant liability and are being recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our Common Stock.
Under U.S. GAAP, we are required to evaluate our warrants to determine whether they should be accounted for as a warrant liability or as equity. We have concluded that the warrants contain provisions requiring liability classification. Therefore, as described in the financial statements of AONE included herein, we are accounting for the warrants as a warrant liability and are recording that liability at fair value upon issuance. We will record any subsequent changes in fair value as of the end of each period for which earnings are reported. The impact of changes in fair value on earnings may have an adverse effect on the market price of our common stock and may cause fluctuations in our results of operations based on factors that are outside of our control.
 
68
We have a history of net losses and may not be able to achieve profitability for any period in the future or sustain cash flow from operating activities.
We have a history of losses since our inception in 2013 and have funded our cash flow deficits primarily through the issuance of capital stock. As of June 30, 2021, we had an accumulated deficit of $100.7 million, including net losses of $6 million for the six months ended June 30, 2021, and $18.0 million for 2020 and $29.9 million for 2019. We expect to continue to incur operating losses and negative cash flow as we continue to invest significantly in research and development efforts, sales and marketing and other aspects of our business.
We cannot make any assurances that these investments will result in increased revenue or growth in our business. Additionally, as a public company, we expect our legal, accounting and other expenses to be substantially higher than the expenses we incurred as a private company. Furthermore, we may encounter unforeseen issues that require us to incur additional costs. Any such increased expenditures make it harder for us to achieve and maintain future profitability. Revenue growth and growth in our customer base may not be sustainable, and we may not achieve sufficient revenue to achieve or maintain profitability. While we have a revenue history, we expect to bring new additive manufacturing products to market that we anticipate will generate a substantial portion of our future revenue, and it is difficult for us to predict our future operating results. We may incur significant losses in the future for a number of reasons, including due to the other risks described in this prospectus, and we may encounter unforeseen expenses, difficulties, complications and delays and other unknown events. As a result, our losses may exceed forecasts, we may incur significant losses for the foreseeable future, and we may not achieve profitability when expected, or at all, and even if we do, we may not be able to maintain or increase profitability. Accordingly, if we are not able to achieve or maintain profitability and we incur significant losses in the future, the market price of our common stock may decline, and you could lose part or all of your investment.
 
69
We have a relatively limited operating history and have experienced rapid growth, which makes evaluating our current business and future prospects difficult and may increase the risk of your investment.
Our ability to forecast our future operating results is subject to a number of uncertainties, including our ability to plan for and model future growth. We have encountered, and will continue to encounter, risks and uncertainties frequently experienced by growing companies in rapidly evolving industries, as we continue to grow our business. If our assumptions regarding these uncertainties, which we use to plan our business, are incorrect or change in reaction to changes in our markets, or if we do not address these risks successfully, our operating and financial results could differ materially from our expectations, our business could suffer and the trading price of our stock may decline. We intend to derive a substantial portion of our revenues from sales of new and existing hardware products, which sales are
non-recurring
and subject to significant risk and fluctuation.
It is difficult to predict our future revenues and appropriately budget for our expenses, and we have limited insight into trends that may emerge and affect our business. If actual results differ from our estimates or we adjust our estimates in future periods, our operating results and financial position could be materially affected. The financial projections included in this prospectus are based on our estimates and assumptions as of the dates indicated in this prospectus concerning various factors, which are subject to significant risks and uncertainties, many of which are beyond our control, and therefore actual results may differ materially. These estimates and assumptions include, among others: the continuing effects of the
COVID-19
pandemic, projections of the size and growth of the overall additive manufacturing industry, revenue growth for our existing products, our ability to develop and successfully commercialize new products and services, the mix of hardware, services and consumables revenue, the performance of our VARs, and cost assessments. These estimates and assumptions require the exercise of judgment and may not occur and are subject to various economic, business, competitive, regulatory, legislative, political and other factors beyond our control, including, for example, changes in customer demand, increased costs in our supply chain, and market acceptance of our products and services. There can be no assurance that the prospective results will be realized or that actual results will not be significantly higher or lower than estimated. Our failure to achieve our projected results could harm the trading price of our securities and financial position.
Our operating results may fluctuate significantly from
period-to-period
and may fall below expectations in any particular period, which could adversely affect the market price of our common stock.
Our quarterly results of operations may fluctuate significantly from
period-to-period.
Accordingly, the results of any one quarter should not be relied upon as an indication of future performance. If our revenue or operating results fall below the expectations of investors or any securities analysts that follow our company in any period, the price of our common stock would likely decline. Each of the risks described in this section, as well as other factors, may affect our operating results. For example, factors that may cause our operating results to fluctuate include:
 
  •  
the degree of market acceptance of our products;
 
  •  
our ability to compete with competitors and new entrants into our markets;
 
  •  
changes in our pricing policies or those of our competitors, including our response to price competition;
 
  •  
the effectiveness of our securing new orders and fulfilling existing orders;
 
  •  
the impact of the
COVID-19
pandemic on our customers, suppliers, manufacturers and operations;
 
  •  
the mix of products that we sell during any period;
 
  •  
the timing of our sales and deliveries of our products to customers;
 
  •  
changes in the amount that we spend to develop and manufacture new products or technologies;
 
  •  
timing of expenditures to develop and bring to market new or enhanced products and the generation of revenue from those products;
 
  •  
changes in the amounts that we and our value added resellers (“VARs”) spend to promote our products;
 
  •  
changes in the cost of satisfying our warranty obligations and servicing our products, including with respect to our obligations related to our “success plan” offerings;
 
  •  
litigation-related expenses and/or liabilities;
 
  •  
unforeseen liabilities or difficulties in integrating our acquisitions or newly acquired businesses;
 
  •  
disruptions to our internal and third-party manufacturing facilities and processes;
 
  •  
disruptions to our information technology systems or our third-party contract manufacturers;
 
  •  
disruptions to our global supply chain;
 
  •  
the geographic distribution of our sales;
 
  •  
general economic and industry conditions that affect customer demand; and
 
  •  
changes in accounting rules and tax laws.
 
70
In addition, sales of our products are subject to the adoption and capital expenditure cycles of our customers sales cycle, and seasonality among our customers may cause our revenues and operating results to fluctuate from period to period. Accordingly, we typically experience increased sales during the fourth quarter and, to a lesser extent, the third quarter of our fiscal year relative to the first and second quarters. Additionally, for our more complex solutions, which may require additional facilities investment and installation support, potential customers may spend a substantial amount of time performing internal assessments prior to making a purchase decision. This may cause us to devote significant effort in advance of a potential sale without any guarantee of receiving any related revenues. As a result, revenues and operating results for future periods are difficult to predict with any significant degree of certainty, which could lead to adverse effects on our inventory levels and overall financial condition. Accordingly, you should not rely on quarter-over-quarter and year-over-year comparisons of our results as an indicator of our future performance.
The global
COVID-19
pandemic has significantly affected our business and operations.
The
COVID-19
pandemic and efforts to control its spread have significantly curtailed the movement of people, goods and services worldwide. In light of the uncertain situation relating to the spread of
COVID-19,
we have taken precautionary measures intended to minimize the risk of the virus to our employees, our customers and the communities in which we operate. These measures include temporarily closing our offices to visitors and limiting the number of employees in our offices to those that are deemed essential for manufacturing and research purposes, as well as virtualizing, postponing or canceling customer, employee and industry events.
The
COVID-19
pandemic has also created many negative headwinds that present risks to our business and results of operations. For example, it has generally disrupted the operations of our customers and prospective customers, and may continue to disrupt their operations, including as a result of travel restrictions and/or business shutdowns, uncertainty in the financial markets or other harm to their business and financial results. These disruptions have caused reduced capital expenditures by our existing customers and potential new customers, which negatively impacted our sales, especially during the period between March 2020 and May 2020 in which we experienced a decrease in sales compared to the relevant period in 2019. This reduction was particularly prevalent among customers that are large companies purchasing our more expensive products that require greater
on-site
installation support. Further, in April 2020, we conducted a reduction in force as a result of reduced demand for our products and uncertainty about future revenues. Because the future effects of the
COVID-19
pandemic are unpredictable, the impact could be more prolonged and significant in the future. These disruptions could result in further reductions to capital expenditure budgets, delayed purchasing decisions, longer sales cycles, extended payment terms or missed payments, and postponed or canceled projects, any of which would negatively impact our business and operating results, including sales and cash flows. We cannot predict the long-term impact that the
COVID-19
pandemic may have on our business and cannot guarantee that it will not be materially negative. Although vaccines have recently become available to the public and states, including Massachusetts where our headquarters is located, have begun to ease certain restrictions, we continue to monitor the situation and may adjust our current policies as more information and public health guidance become available, the ongoing effects of the
COVID-19
pandemic and/or the precautionary measures that we have adopted may create operational and other challenges, any of which could harm our business and results of operations.
Historically, a significant portion of our field sales, customer training events and other application services have been conducted in person, and the rollout of our new products has historically been supported by our participation at industry conferences. Currently, as a result of the work and travel restrictions related to the
COVID-19
pandemic, and the precautionary measures that we have adopted, most of our field sales and professional services activities are being conducted remotely, which has resulted in a decrease in our travel expenditures. However, we have begun
in-person
interactions at trade shows and other customer events where permitted. We expect our travel expenditures to increase in the future, which could negatively impact our financial condition and results of operations. As of the date of this prospectus, we do not yet know the extent of the negative impact of such restrictions and precautionary measures on our ability to attract new customers or retain and expand our relationships with existing customers over the near and long term.
In addition, many of our suppliers are experiencing operational challenges as a result of
COVID-19,
which in turn may destabilize our supply chain or otherwise have an adverse effect on our ability to provide products to our customers. Our suppliers may have to temporarily close a facility for disinfecting after employees tested positive for
COVID-19,
face staffing shortages from employees who are sick or apprehensive about coming to work or be overwhelmed by unexpected demand. Because of measures we took to increase inventory, the difficulties experienced by our suppliers have had minimal impact on our ability to ship products to our customers; however, these measures had a negative impact on short-term profitability and if the
COVID-19
pandemic continues, it may negatively affect our inventory and delay delivery to our customers, which in turn will adversely affect our revenue and results of operations. If our suppliers are unable to deliver the materials we require on a timely basis, we cannot guarantee that we will be able to locate alternative sources of supply for our products on acceptable terms, or at all. If we are unable to adequately purchase appropriate amounts of inventory, our business and results of operations may be materially and adversely affected.
 
71
Additionally, the
COVID-19
pandemic has impacted, and may continue to impact, our headquarters, which is our primary corporate office, sales and marketing center and has also impacted our
in-house
manufacturing location, including through the effects of facility closures, reductions in operating hours and other social distancing efforts. For example, if even a small number of our employees who work in clusters relating to critical functions such as manufacturing, procurement, supply chain, and research and development, test positive for
COVID-19,
the entire business function could be temporarily shut down to ensure the safety of our employees and the effectiveness of business would be severely impacted. Additionally, while Massachusetts and other states have begun to ease restrictions on
in-person
operations, we cannot predict whether these conditions and concerns will continue or whether we will experience more significant or frequent disruptions in the future, including the complete closure of one or more of our facilities. Furthermore, as a result of the
COVID-19
pandemic, we have required all employees who are able to do so to work remotely on a full-time or partial basis. It is possible that widespread remote work arrangements may have a negative impact on our operations, the execution of our business plans, the productivity and availability of key personnel and other employees necessary to conduct our business, and on third party service providers who perform critical services for us, or otherwise cause operational failures due to changes in our normal business practices necessitated by the outbreak and related governmental actions. If a natural disaster, power outage, connectivity issue or other event occurred that impacted our employees’ ability to work remotely, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The increase in remote working may also result in increased consumer privacy, data security and fraud risks, and our understanding of applicable legal and regulatory requirements, as well as the latest guidance from regulatory authorities in connection with the
COVID-19
pandemic, may be subject to legal or regulatory challenge, particularly as regulatory guidance evolves in response to future developments.
More generally, the
COVID-19
pandemic has had, and is expected to continue to have, an adverse effect on economies and financial markets globally, leading to a continued economic downturn, which is expected to decrease technology spending generally and could adversely affect demand for our platforms and services. It is not possible at this time to estimate the full impact that
COVID-19
will have on our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.
To the extent the
COVID-19
pandemic adversely affects our business, financial condition and results of operations, it may also have the effect of heightening many of the other risks described in this “Risk Factors” section, including but not limited to, those related to our ability to increase sales to existing and new customers, continue to perform on existing contracts, develop and deploy new technologies, expand our marketing capabilities and sales organization, generate sufficient cash flow to service our indebtedness, and comply with the covenants in the agreements that govern our indebtedness.
Risks Related to the Additive Manufacturing Industry
The additive manufacturing industry in which we operate is characterized by rapid technological change, requiring continual innovation and development of new products and innovations to meet constantly evolving customer demands.
Our revenues are derived from the sale of 3D printers and related materials and services. The additive manufacturing market is subject to rapid innovation and technological change and our customers’ needs are rapidly evolving. While we intend to invest substantial resources to remain on the forefront of technological development, continuing advances in additive manufacturing technology, changes in customer requirements and preferences and the emergence of new standards, regulations and certifications could adversely affect adoption of our products. Our ability to compete in the additive manufacturing market depends, in large part, on our success in developing and introducing new 3D printers and technology, in improving our existing products and technology and qualifying new materials which our systems can support. We believe that we must continuously enhance and expand the functionality and features of our products and technologies in order to remain competitive. However, we may not be able to:
 
  •  
predict future customer demand;
 
  •  
develop cost effective new products and technologies that address the increasingly complex needs of prospective customers;
 
  •  
enhance our existing products and technologies;
 
  •  
respond to technological advances and emerging industry standards and certifications on a cost-effective and timely basis;
 
  •  
adequately protect our intellectual property as we develop new products and technologies;
 
  •  
identify the appropriate technology or product to which to devote our resources; or
 
  •  
ensure the availability of cash resources to fund research and development.
Even if we successfully introduce new additive manufacturing products and technologies and enhance our existing products and technologies, it is possible that these will eventually supplant our existing products or that our competitors will develop new products and technologies that will replace our own. As a result, any of our products may be rendered obsolete or uneconomical by our or our competitors’ technological advances, leading to a loss in market share, decline in revenue and adverse effects to our business and prospects.
 
72
We face intense and growing competition in the additive manufacturing industry. Our inability to compete effectively with our competitors could affect our ability to achieve our anticipated market penetration and achieve or sustain profitability.
The additive manufacturing industry in which we operate is highly competitive. We compete for customers with a wide variety of producers of additive manufacturing equipment that creates 3D objects and
end-use
parts, as well as with providers of materials and services for this equipment. Some of our existing and potential competitors are researching, designing, developing and marketing other types of products and services that may render our existing or future products obsolete, uneconomical or less competitive. Existing and potential competitors may also have substantially greater financial, technical, marketing and sales, manufacturing, distribution and other resources than us, including name recognition, as well as experience and expertise in intellectual property rights and operating within certain international markets or industry verticals, any of which may enable them to compete effectively against us. Moreover, many of our competitors have more extensive customer and partner relationships than we do, and may therefore be in a better position to identify and respond to market developments or changes in customer demands, including successfully developing technologies that outperform our technologies. Potential customers may also prefer to purchase from their existing suppliers rather than a new supplier regardless of product performance or features. For example, a number of companies that have substantial resources have announced that they are beginning production of 3D printers, which will further enhance the competition we face.
Future competition may arise from the development of allied or related techniques for equipment, materials, software and services that are not encompassed by our patents, from the issuance of patents to other companies that may inhibit our ability to develop certain products and from improvements to existing technologies.
We intend to continue to follow a strategy of continuing product development, VAR and distribution network expansion to enhance our competitive position to the extent practicable. But we cannot assure you that we will be able to maintain our current position or continue to compete successfully against current and future sources of competition. If we do not keep pace with technological change and introduce new products and technologies, demand for our products may decline, and our operating results may suffer.
Declines in the prices of our products and services, or in our volume of sales, together with our relatively inflexible cost structure, may adversely affect our financial results.
Our business is subject to price competition. Such price competition may adversely affect our results of operation, especially during periods of decreased demand. Decreased demand also adversely impacts the volume of our sales. If our business is not able to offset price reductions resulting from these pressures, or decreased volume of sales due to contractions in the market, by improved operating efficiencies and reduced expenditures, then our operating results will be adversely affected.
Although we generally do not have long-term supply agreements, certain of our operating costs are fixed and cannot readily be reduced, which has an impact on our operating results. To the extent the demand for our products slows, or the additive manufacturing market contracts, we may be faced with excess manufacturing capacity and related costs that cannot readily be reduced, which will adversely impact our financial condition and results of operations. Conversely, because we generally do not have long-term supply agreements, we are subject to the risk of significant cost increases by our suppliers.
Increased consolidation among our customers, suppliers and competitors in the additive manufacturing industry may have an adverse effect on our business and results of operations.
Increased consolidation in the additive manufacturing industry among our customers, suppliers and competitors may adversely affect our business and results of operations. Customer consolidation could lead to changes in buying patterns, slowdowns in spending, and impact our distribution channels. Moreover, the significant purchasing power of these large companies can increase pricing and competitive pressures for us, including the potential for decreases in our average selling prices. If one of our customers is acquired by another company that does not rely on us to provide it with products or relies on another provider of similar products, we may lose that customer’s business. Any of the foregoing results will adversely affect our business, financial condition and results of operations.
In addition, supplier consolidation may lead to increased prices of materials for our products, deployment delays and/or a disruption in output. In addition, such consolidation may exacerbate the risks relating to our dependence on a small number of suppliers for certain materials that are required to manufacture our products.
We may experience significant delays in the design, production and launch of our additive manufacturing solutions and enhancements to existing products, and we may be unable to successfully commercialize products on our planned timelines.
We have several additive manufacturing solutions and enhancements to existing products that are still under development. There are often delays in the design, testing, manufacture and commercial release of new products, and any delay in the launch of our products could materially damage our brand, business, growth prospects, financial condition and operating results. Even if we successfully complete the design, testing and manufacture for one or all of our products or enhancements under development, we may fail to develop a commercially successful product on the timeline we expect for a number of reasons, including:
 
  •  
misalignment between the products and customer needs;
 
  •  
length of sales cycles;
 
  •  
insufficient product innovation;
 
  •  
product quality and performance issues;
 
  •  
insufficient resources or qualified personnel to develop the product;
 
  •  
failure of the product to perform in accordance with the customer’s expectations and industry standards;
 
  •  
inability to procure parts of adequate quality needed to build the product on commercially acceptable terms, or at all;
 
  •  
insufficient labor or process stability to build the product to required specifications;
 
  •  
ineffective distribution, sales and marketing;
 
  •  
delay in obtaining any required regulatory approvals;
 
  •  
the impact of the
COVID-19
pandemic on production and demand for our products;
 
  •  
unexpected production costs and delays; or
 
  •  
release of competitive products.
 
 
73
Our success in the market for the new products we develop will depend in part on our ability to prove our new products’ capabilities in a timely manner. Until demonstration, our customers may not believe that our products and/or technology have the capabilities they were designed to have or that we believe they have. Furthermore, even if we do successfully demonstrate our products’ capabilities, potential customers may be more comfortable doing business with a competitor, including another larger and more established company, may take longer than expected to make the decision to order our products, or may not have the budget or decision making authority to purchase the product. Significant revenue from new product investments may not be achieved for a number of years, if at all. If the timing of our launch of new products and/or of our customers’ acceptance of such products is different than our assumptions, our revenue and results of operations may be adversely affected.
Changes in our product mix may impact our gross margins and financial performance.
Our financial performance may be affected by the mix of products and services we sell during a given period. We expect to continue to offer products at a variety of price points. Sales of certain of our products have, or are expected to have, higher gross margin contributions than others. If our product mix shifts too far into lower gross margin products, or we are unable to maintain or increase gross margins, and we are not able to sufficiently reduce the engineering, production and other costs associated with those products or substantially increase the sales of our higher gross margin products, our profitability could be reduced. Additionally, the introduction of new products or services may further heighten quarterly fluctuations in gross profit and gross profit margins due to manufacturing
ramp-up
and
start-up
costs. Relatedly, if our product mix shifts such that our production rates decrease, our product costs and margins may be negatively impacted. We may experience significant quarterly fluctuations in gross profit margins or operating income or loss due to the impact of the mix of products, channels or geographic areas in which we sell our products from period to period.
Forecasts of our market and market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, there can be no assurance that our business will grow at similar rates, or at all.
Market opportunity estimates and growth forecasts included in this prospectus, including the expected size and growth of the markets for additive manufacturing technology and other markets in which we participate, are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Even if these markets experience the forecasted growth described in this prospectus, we may not grow our business at similar rates, or at all. Our future growth is subject to many factors, including market adoption of our products, which is subject to many risks and uncertainties. Accordingly, the forecasts and estimates of market size and growth described in this prospectus, including internally generated estimates and the third-party estimate that the size of the total addressable market is expected to be approximately $115 billion in 2030, should not be taken as indicative of our future growth. In addition, these forecasts may not adequately consider the impact of the current global
COVID-19
pandemic, and we cannot assure you that these forecasts will not be materially and adversely affected as a result.
Risks Related to Our Business Operations
Our failure to meet our customers’ price expectations would adversely affect our business and results of operations.
Demand for our product lines is sensitive to price. We believe our competitive pricing has been an important factor in our results to date. Therefore, changes in our pricing strategies can have a significant impact on our business and ability to generate revenue. Many factors, including our production and personnel costs, our competitors’ pricing and marketing strategies, our customers’ budgets, the value our products bring to our customers and our desire to hit revenue goals can significantly impact our pricing strategies. If we fail to meet our customers’ price expectations in any given period, demand for our products and product lines could be negatively impacted and our business, results of operations and brand could suffer.
Our revenue model is evolving and we may introduce new revenue models or avenues that may not be accepted by our customers and as such will not materialize.
We depend on our network of VARs and other distribution partners and if we fail to maintain successful relationships, or if they fail to perform, our ability to market, sell and distribute our products will be limited, and our business, financial position and results of operations will be harmed.
We rely heavily on our global network of VARs and other distribution partners to sell our products and to provide installation and support services to customers in their respective geographic regions. These VARs and other distribution partners may not be as effective in selling our products or installing and supporting our customers as we expect. Moreover, a VAR or other distribution partner may misrepresent the capabilities of our products without our knowledge either intentionally or unintentionally due to the inherent complexity of our products. Further, our VARs and other distribution partners can terminate their contracts with us at any time, and if our contracts with a significant number of VARs and other distribution partners, or with the most effective VARs and other distribution partners, were to terminate or if they would otherwise fail or refuse to sell certain of our products, we may not be able to find replacements that are as qualified or as successful in a timely manner, if at all.
Recruiting and retaining qualified VARs and other distribution partners and training them in our technologies requires significant time and resources. These VARs and other distribution partners may also market, sell and support other technologies in unrelated markets and may devote more resources to the marketing, sales and support of such products.
 
74
In addition, if our VARs and other distribution partners do not perform as anticipated, or if we are unable to secure qualified and successful VARs and other distribution partners, our sales will suffer, which would have an adverse effect on our revenues and operating results. Because we also depend upon our VARs and other distribution partners to provide installation and support services for products, if our VAR or distribution partner relationships were terminated or limited to certain products, we may face disruption in providing support for our customers, which would adversely affect our brand, reputation and our results of operations. Any failure to offer high-quality technical support services may adversely affect our relationships with our customers and adversely affect our financial results and brand.
Further, we require that our VARs and other distribution partners adhere to all local laws and regulations, but it is possible that a VAR or other distribution partner could violate such laws or regulations, which could adversely impact our business, reputation and financial results and brand. Our indirect sales and distribution model could subject us to lawsuits, potential liability and brand and reputational harm if, for example, any of our VARs and other distribution partners misrepresent the functionality of our products or services to customers or violate laws or our corporate policies.
Additionally, while none of our VARS or other distribution partners represents more than 10% of our sales, a default by one or more VARs or other distribution partners with whom we have a significant receivables balance could have an adverse financial impact on our financial results. We have reviewed our policies that govern credit and collections and will continue to monitor them in light of current payment status and economic conditions. In addition, we try to reduce the credit exposures of our accounts receivable by instituting credit limits and additional checks. However, there can be no assurance that our efforts to identify potential credit risks will be successful. Our inability to timely identify VARs and other distribution partners that are credit risks could result in defaults at a time when such VARs and other distribution partners have high accounts receivable balances with us. Any such default would result in a significant charge against our earnings and adversely affect our results of operations and financial condition. Furthermore, a significant portion of our accounts receivable payment periods are greater than 90 days. During that time, the VAR or distribution partner may default on its obligations or we may otherwise be unable to collect the payments due to us, which could adversely affect our results of operations and financial condition.
If our suppliers become unavailable or inadequate, our customer relationships, results of operations and financial condition may be adversely affected.
We acquire certain of our materials, which are critical to the ongoing operation and future growth of our business, from several third parties. Generally, our third-party contract manufacturers contract directly with component suppliers with our guidance. We rely on our contract manufacturers to manage their supply chains. If one of our contract manufacturers has supply chain disruption, or our relationship with our contract manufacturer terminates, we could experience delays. We also source some materials directly from suppliers. While most manufacturing equipment and materials for our products are available from multiple suppliers, certain of those items are only available from limited sources. Should any of these suppliers become unavailable or inadequate, or impose terms unacceptable to us, such as increased pricing terms, we could be required to spend a significant amount of time and expense to develop alternate sources of supply, and we may not be successful in doing so on terms acceptable to us, or at all. As a result, the loss of a limited source supplier could adversely affect our brand and relationship with our customers as well as our results of operations and financial condition.
In the case of certain materials, we have specified a certain grade of a product to be used in our manufacturing process. While there are several potential suppliers of most of these component materials that we use, we currently choose to use only one or a limited number of suppliers for several of these components and materials. For those materials, we could be impacted by any changes our suppliers make to such materials, which could include specification changes, lead time or cancellation of the material. If there is not an alternate product available, replacement thereof would require significant engineering and manufacturing efforts by us to qualify a replacement. Additionally, if a supplier of such materials decided to terminate their relationship with us, we may face delays in our production as we seek out a replacement supplier. Our reliance on a single or limited number of vendors involves a number of risks, including:
 
  •  
potential shortages of some key components;
 
  •  
product performance shortfalls, if traceable to particular product components, since the supplier of the faulty component cannot readily be replaced;
 
  •  
discontinuation of a product or certain materials on which we rely;
 
  •  
potential insolvency of these vendors; and
 
  •  
reduced control over delivery schedules, manufacturing capabilities, quality and costs.
In addition, we evaluate new suppliers pursuant to our internal procedures. This process involves evaluations of varying durations, which may cause production delays if we were required to qualify a new supplier unexpectedly. We generally assemble our systems and parts based on our internal forecasts and the availability of raw materials, assemblies, components and finished goods that are supplied to us by third parties, which are subject to various lead times. If certain suppliers were to decide to discontinue production of an assembly, component or raw material that we use, the unanticipated change in the availability of supplies, or unanticipated supply limitations, could cause delays in, or loss of, sales, increased production or related costs and consequently reduced margins, and damage to our reputation. If we were unable to find a suitable supplier for a particular component, material or compound, we could be required to modify our existing products or the
end-parts
that we offer to accommodate substitute components, material or compounds. While we monitor risk internally related to our sourcing (particularly concerning raw materials), there is no guarantee that will sufficiently protect us if we suddenly lose access to supplies unexpectedly.
 
75
Any shortage of a particular component, material or compound could materially and adversely affect our ability to manufacture our products and could lead to increased costs to acquire such resources which could adversely affect our business and financial condition. We have in the past experienced and may in the future experience materials shortages and price fluctuations of certain key components, materials and compounds, and the predictability of the availability and pricing of these components, materials and compounds may be limited. Shortages of components, materials or compounds or pricing fluctuations could be material in the future. In the event of a components, materials or compounds shortage, supply interruption or material pricing change from suppliers of these components, materials or compounds, we may not be able to develop alternate sources in a timely manner or at all in the case of sole or limited sources. Developing alternate sources of supply for these components, materials or compounds may be time-consuming, difficult, and costly and we may not be able to source these components, materials or compounds on terms that are acceptable to us, or at all, which may undermine our ability to meet our requirements or to fill customer orders in a timely manner. Any interruption or delay in the supply of any of these components, materials or compounds, or the inability to obtain these components, materials or compounds from alternate sources at acceptable prices and within a reasonable amount of time, would adversely affect our ability to meet our scheduled product deliveries to our customers. This could adversely affect our relationships with our customers and VARs and could cause delays in shipment of our products and adversely affect our operating results. In addition, increased component, material or compound costs could result in lower gross margins. Even where we are able to pass increased costs along to our customers, there may be a lapse of time before we are able to do so such that we must absorb the increased cost. If we are unable to buy these components, materials or compounds in quantities sufficient to meet our requirements on a timely basis, we will not be able to deliver products to our customers, which may result in such customers using competitive products instead of ours.
Our business model is predicated, in part, on developing or expanding recurring revenues through the sale of our hardware, consumables, and services. If that recurring stream of revenues does not develop as expected, or if our business model changes as the industry evolves, our operating results may be adversely affected.
Our business model is dependent, in part, on our ability to develop, maintain and increase sales of our hardware, consumables, and services as they generate recurring revenues. Existing and future customers of our systems may not purchase our consumables and services at the same rate at which customers currently purchase those offerings. If our current and future customers purchase a lower volume of our consumables and services, resulting overall in lower purchases of consumables and services on average than with our current installed customer base, our recurring revenue stream relative to our total revenues would be reduced and our operating results would be adversely affected.
We rely on a limited number of third-party logistics providers for distribution of our products, and their failure to distribute our products effectively would adversely affect our sales.
We rely on a limited number of third-party logistics providers for shipping our products. Each third-party logistics provider stores our products in a limited number of warehouses where they prepare and ship our products based on digital instructions. The use of a limited number of third-party logistics providers increases the risk that a fire or damage from another type of disaster at any of the warehouses may result in a disruption of our commercialization efforts. Additionally, because we use a limited number of third-party logistics providers, if there is a disruption in the distribution channels of such third-party logistics providers, our business and financial condition could be adversely impacted.
If our third-party logistics providers do not fulfill their contractual obligations to us, or refuse or fail to adequately distribute our products, such as by shipping our products to the incorrect recipient, or the agreements are terminated without adequate notice, shipments of our products, and associated revenues, would be adversely affected. In addition, we expect that it may take a significant amount of time if we were required to change our third-party logistics providers and would require significant efforts to provide the systems support required for a new provider to effectively support our operations.
If demand for our products does not grow as expected, or if market adoption of additive manufacturing does not continue to develop, or develops more slowly than expected, our revenues may stagnate or decline, and our business may be adversely affected.
We believe that the industrial manufacturing market, which today is dominated by conventional manufacturing processes that do not involve additive manufacturing technology, is undergoing a shift towards additive manufacturing. We may not be able to develop effective strategies to raise awareness among potential customers of the benefits of additive manufacturing technologies or our products may not address the specific needs or provide the level of functionality required by potential customers to encourage the continuation of this shift towards additive manufacturing. We must anticipate, sometimes several years in advance, the direction that the additive market is taking. We may not correctly anticipate the direction, which may lead us to invest in the wrong products, which may adversely affect our results of operation and financial condition. If additive manufacturing technology does not continue to gain broader market acceptance as an alternative to conventional manufacturing processes, or if the marketplace adopts additive manufacturing technologies that differ from our technologies, we may not be able to increase or sustain the level of sales of our products, and our operating results would be adversely affected as a result.
 
76
Defects in new products or in enhancements to our existing products that give rise to product returns or warranty or other claims could result in material expenses, diversion of management time and attention and damage to our reputation.
Our additive manufacturing solutions are complex and may contain undetected defects or errors when first introduced or as enhancements are released that, despite testing, are not discovered until after a machine has been used. We may not know which products are affected by defects. These defects could be systemic and could affect all of the products we shipped prior to discovery thereof. It may not be economically feasible to identify, replace or repair all affected products. In the event that the defect is severe enough or impacts customer safety, a product recall may be required. This could result in delayed market acceptance of those products or claims from VARs, customers or others, which may result in litigation, increased customer warranty, support and repair or replacement costs, damage to our reputation and business, or significant costs and diversion of support, management and engineering personnel to correct the defect or error. We may from time to time become subject to warranty or product liability claims related to product quality issues that may require us to take remedial action and could, regardless of merit, lead us to incur significant expenses, result in diversion of management time and attention, damage to our business and reputation and brand, and cause us to fail to retain existing customers or fail to attract new customers.
We attempt to include provisions in our agreements with customers that are designed to manage our exposure to potential liability for damages arising from defects or errors in our products. However, it is possible that these provisions may not be effective as a result of unfavorable judicial decisions or laws enacted in the future.
We may be unable to consistently manufacture our products to the necessary specifications or in quantities necessary to meet demand at an acceptable cost or at an acceptable performance level.
Our products are integrated solutions with many different components that work together. As such, a quality defect in a single component can compromise the performance of the entire solution. As we continue to grow and introduce new products, and as our products incorporate increasingly sophisticated technology, it will be increasingly difficult to ensure our products are produced in the necessary quantities without sacrificing quality. There is no assurance that we or our third-party manufacturers and any component suppliers will be able to continue to manufacture our products so that they consistently achieve the product specifications and quality that our customers expect. Relatedly, certain of our components are sourced by a single supplier and, if the supply became disrupted as a result of insufficient quality, service delays or any other factor, our manufacturing efforts may be adversely affected. Any future design issues, unforeseen manufacturing problems, such as contamination of our or such third-party facilities, equipment malfunctions, aging components, component obsolescence, business continuity issues, quality issues with components and materials sourced from third party suppliers, or failures to strictly follow procedures or meet specifications, may have a material adverse effect on our brand, business, financial condition and operating results. Furthermore, we or our third-party manufacturers may not be able to increase manufacturing to meet anticipated demand or may experience downtime.
In order to meet our customers’ needs, we attempt to forecast demand for our products and components used for the manufacture of our products. If we fail to accurately forecast this demand, we could incur additional costs or experience manufacturing delays and may experience lost sales or significant inventory carrying costs.
The risk of manufacturing defects or quality control issues is generally higher for new products, whether produced by us or a third-party manufacturer, products that are transitioned from one manufacturer to another, particularly if manufacturing is transitioned or initiated with a manufacturer we have not worked with in the past, and products that are transferred from one manufacturing facility to another. We cannot assure investors that we and our third-party manufacturers will be able to launch new products on time, transition manufacturing of existing products to new manufacturers, transition our manufacturing capabilities to a new location or transition manufacturing of any additional materials
in-house
without manufacturing defects. An inability to manufacture products and components that consistently meet specifications, in necessary quantities and at commercially acceptable costs will have a negative impact and may have a material adverse effect on our brand, business, financial condition and results of operations.
Our commercial contracts generally contain product warranties and limitations on liability and we carry liability insurance in amounts that we believe are adequate for our risk exposure and commensurate with industry norms. However, commercial terms and our insurance coverage may not be adequate or available to protect our company in all circumstances, and we might not be able to maintain adequate insurance coverage for our business in the future at an acceptable cost. Any liability claim against us that is not covered by adequate insurance could adversely affect our consolidated results of operations and financial condition. Finally, any liability claim against us may cause harm to our brand, reputation and adversely impact our business.
 
77
We are dependent on the continued services and performance of our senior management and other key employees, as well as on our ability to successfully hire, train, manage and retain qualified personnel.
Our future performance depends on the continued services and contributions of our executive team, founders and other key employees to execute on our business plan and to identify and pursue new opportunities and product innovations. Such persons may resign at any time and the loss of their services could delay or prevent the successful implementation of our strategy, commercialization of new applications for our systems or other products, or could otherwise adversely affect our ability to manage our company effectively and carry out our business plan. There is no assurance that if any senior executive, founder or other key employee leaves in the future, we will be able to rapidly replace him or her and transition smoothly towards his or her successor, without any adverse impact on our operations.
Our ability to successfully pursue our growth strategy will also depend on our ability to attract, motivate and retain existing and new personnel. We experience intense competition for qualified senior management and other key personnel (including scientific, technical, manufacturing, engineering, financial and sales personnel) in the additive manufacturing industry, especially in the greater Boston area. Our personnel are generally employed on an
at-will
basis, which means that they could terminate their employment with us at any time. There can be no assurance that we will be able to retain our current key personnel or attract new persons to join our organization in the future. Some of our competitors for these employees have greater resources and more experience, making it difficult for us to compete successfully for key personnel. These pressures could result in increased costs in order to provide competitive compensation packages to attract and retain key personnel. Moreover, new employees may not be as productive as we expect since we may face challenges in adequately integrating them into our workforce and culture. If we cannot attract and retain sufficiently qualified technical employees for our research product development activities, as well as experienced sales and marketing personnel, we may be unable to develop and commercialize new products and enhancements to existing products.
As manufacturing becomes a larger part of our operations, we will become exposed to accompanying risks and liabilities.
In-house
and outsourced manufacturing has been and continues to be a significant part of our business. As a result, we expect to continue to be subject to various risks associated with the manufacturing and supply of products, including the following:
 
  •  
If we fail to supply products in accordance with contractual terms, including terms related to time of delivery and performance specifications, we may be required to repair or replace defective products and may become liable for direct, special, consequential and other damages, even if manufacturing or delivery was outsourced;
 
  •  
Raw materials used in the manufacturing process, labor and other key inputs may become scarce, obsolete and expensive, causing our costs to exceed cost projections and associated revenues;
 
  •  
Manufacturing processes typically involve large machinery, fuels and chemicals, any or all of which may lead to accidents involving bodily harm, destruction of facilities and environmental contamination and associated liabilities;
 
  •  
As our manufacturing operations expand, we expect that a significant portion of our manufacturing will be done in regions outside the United States, either by third-party contractors or in a plant owned by the Company. Any manufacturing done in such locations presents risks associated with quality control, currency exchange rates, foreign laws and customs, timing and loss risks associated with international transportation and potential adverse changes in the political, legal and social environment in the host county;
 
  •  
We have made, and may be required to make, representations as to our right to supply and/or license intellectual property and to our compliance with laws. Such representations are usually supported by indemnification provisions requiring us to defend our customers and otherwise make them whole if we license or supply products that infringe on third-party technologies or violate government regulations;
 
  •  
As our manufacturing operations scale, so will our dependence on skilled labor at both
in-house
and third-party manufacturing facilities. If we are unable to obtain and maintain skilled labor resources, we may unable to meet customer production demands; and
 
  •  
With scaling production volume, demand for our products may make up a significant percentage of global volume in select categories or commodities. Such commodities could be subject to large pricing swings due to the global political, legal and social environment and could cause our costs to exceed productions and associated revenues.
Any failure to adequately manage risks associated with the manufacture and supply of materials and products could adversely affect profits from that segment of our business and/or lead to significant liabilities, which would harm our brand, business, operations and financial condition.
Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees.
We generally enter into
non-competition
agreements with our employees. These agreements prohibit our employees from competing directly with us or working for our competitors or clients for a limited period after they cease working for us. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work and it may be difficult for us to restrict our competitors from benefiting from the expertise that our former employees or consultants developed while working for us. For example, in Massachusetts, where most of our employees are based, applicable law imposes a number of requirements to enter into a valid
non-competition
agreement, and in California
non-competition
agreements with employees are generally unenforceable after termination of employment.
 
78
We expect to continue to experience rapid growth and organizational change. If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service and customer satisfaction or attract new employees and customers.
We expect to continue to experience growth in our number of customers, sales, revenues and headcount. We expect to continue to make significant investments in our business, including investments in our infrastructure, software, technology, personnel headcount, facilities, marketing and sales efforts. If our business does not generate the level of revenue required to support our investment, our net sales and profitability will be adversely affected.
To manage growth in our operations and personnel, we will need to continue to scale and improve our operational, financial, and management controls, and our reporting systems and procedures, which will require significant capital expenditures, increasing our cost of operations and the reallocation of valuable management resources. As we scale, it may become more difficult and will require additional capital expenditures to maintain and increase the productivity of our employees, expand production, to address the needs of our actual and prospective customers, to further develop and enhance our products, and remain competitive against our competitors’ products. These enhancements and improvements will require significant capital expenditures, investments in additional headcount and other operating expenditures and allocation of valuable management and employee resources. Our future financial performance and our ability to execute on our business plan will depend, in part, on our ability to effectively manage any future growth and expansion. There are no guarantees we will be able to do so in an efficient or timely manner, or at all.
As we acquire and invest in companies or technologies, we may not realize expected business, technological or financial benefits and the acquisitions or investments could prove difficult to integrate, disrupt our business, dilute stockholder value and adversely affect our business, results of operations, and financial condition.
As part of our business strategy, we may evaluate and make investments in, or acquisitions of, complementary companies, products, software and technologies, to further grow and augment our business and product offerings. The success of any attempts to grow our business through acquisitions to complement our business depends in part on the availability of, our ability to identify, and our ability to engage and pursue suitable acquisition candidates. We may not be able to find suitable acquisition candidates, and we may not be able to complete acquisitions on favorable terms, if at all.
If we do complete future acquisitions, we cannot assure you that they will ultimately strengthen our competitive position or that they will be viewed positively by customers, financial markets or investors. Furthermore, future acquisitions could pose numerous additional risks to our operations, including:
 
  •  
diversion of management’s attention from existing operations;
 
  •  
unanticipated costs or liabilities associated with the acquisition, including risks associated with acquired intellectual property and/or technologies;
 
  •  
incurrence of acquisition-related costs, which would be recognized as a current period expense;
 
  •  
difficulties in, and the cost of, integrating personnel and cultures, operations, technologies, products and services which may lead to failure to achieve the expected benefits on a timely basis or at all;
 
  •  
challenges in achieving strategic objectives, cost savings and other anticipated benefits;
 
  •  
inability to maintain relationships with key customers, suppliers, vendors and other third parties on which the purchased business relies;
 
  •  
the difficulty of incorporating acquired technology and rights into our products and product portfolio and of maintaining quality and security standards consistent with our brand;
 
  •  
ineffective controls, procedures and policies inherited from the acquired company or during the transition and integration;
 
  •  
inability to generate sufficient revenue to offset acquisition and/or investment costs;
 
  •  
negative impact to our results of operations because of the depreciation of amounts related to acquired intangible assets, fixed assets, and deferred compensation;
 
  •  
requirements to record certain acquisition-related costs and other items as current period expenses, which would have the effect of reducing our reported earnings in the period in which an acquisition is consummated;
 
  •  
the loss of acquired unearned revenue and unbilled unearned revenue;
 
  •  
recording goodwill or other long-lived asset impairment charges (if any) in the periods in which they occur, which could result in a significant charge to our earnings in any such period;
 
  •  
use of substantial portions of our available cash, issuance of dilutive equity or the incurrence of debt to consummate the acquisition;
 
  •  
potential write-offs of acquired assets or investments, and potential financial and credit risks associated with acquired customers;
 
  •  
tax effects and costs of any such acquisitions, including the related integration into our tax structure and assessment of the impact on the realizability of our future tax assets or liabilities;
 
79
  •  
the potential entry into new markets in which we have little or no experience or where competitors may have stronger market positions; and
 
  •  
currency and regulatory risks associated with conducting operations in foreign countries.
In addition, acquired technologies and intellectual property may be rendered obsolete or uneconomical by our own or our competitors’ technological advances. Management resources may also be diverted from operating our existing businesses to certain acquisition integration challenges. If we are unable to successfully integrate acquired businesses, our anticipated revenues and profits may be lower. Our profit margins may also be lower, or diluted, following the acquisition of companies whose profit margins are less than those of our existing businesses.
We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.
We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges and opportunities, including the need to develop new features or enhance our products, improve our operating infrastructure or acquire complementary businesses and technologies. Accordingly, we may need to engage in equity or debt financings to secure additional funds if our existing sources of cash and any funds generated from operations do not provide us with sufficient capital. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges and opportunities could be significantly impaired, and our business may be adversely affected.
Risks Related to Third Parties
A real or perceived defect, security vulnerability, error or performance failure in our software or technical problems or disruptions caused by our third-party service providers could cause us to lose revenue, damage our reputation and expose us to liability.
Our hardware products rely upon our complementary software products which are inherently complex and, despite extensive testing and quality control, have in the past and may in the future contain defects or errors, especially when first introduced, or otherwise not perform as contemplated. As the use of our products, including products that were recently acquired or developed, expands to more sensitive, secure or mission critical uses by our customers, we may be subject to increased scrutiny, potential reputational risk or potential liability should our software fail to perform as contemplated in such deployments. We have in the past and may in the future need to issue corrective releases of our software to fix these defects, errors or performance failures and we may encounter technical problems when we attempt to perform routine maintenance or enhance our software, internal applications, and systems, which could require us to allocate significant research and development and customer support resources to address these problems and divert the focus of our management and research and development teams. In addition, our platform may be negatively impacted by technical issues experienced by our third-party service providers.
Our business, brands, reputation and ability to attract and retain customers depend upon the satisfactory performance, reliability and availability of our software products, which in turn, with respect to our planned software as a service (“SaaS”) offerings depend upon the availability of the internet and our third-party service providers. For example, for our SaaS offerings we outsource our cloud infrastructure to Amazon Web Services (“AWS”), our hosting provider, which hosts our software products. Our hosting provider runs its own platforms upon which our products depend, and we are, therefore, vulnerable to service interruptions at the hosting provider level. We do not control the operation of any of AWS’ data center hosting facilities, and they may be subject to damage or interruption from earthquakes, floods, fires, power loss, telecommunications failures, terrorist attacks and similar events. They may also be subject to interruptions due to system failures, computer viruses, software errors or subject to breaches of computer hardware and software security,
break-ins,
sabotage, intentional acts of vandalism and similar misconduct. And while we rely on service level agreements with our hosting provider, if they do not properly maintain their infrastructure or if they incur unplanned outages, our customers may experience performance issues or unexpected interruptions and we may not meet our service level agreement terms with our customers. We have experienced, and expect that in the future we may experience interruptions, delays and outages in service and availability from time to time due to a variety of factors, including infrastructure changes, human or software errors, website hosting disruptions and capacity constraints.
Any inefficiencies, security vulnerabilities, errors, defects, technical problems or performance failures with our software, internal applications and systems could reduce the quality of our products or interfere with our customers’ (and their users’) use of our products, which could negatively impact our brand and reputation, reduce demand, lead to a loss of customers or revenue, adversely affect our results of operations and financial condition, increase our costs to resolve such issues and subject us to financial penalties and liabilities under our service level agreements. Any limitation of liability provisions that may be contained in our customer agreements may not be effective as a result of existing or future applicable law or unfavorable judicial decisions. The sale and support of our products entail the risk of liability claims, which could be substantial in light of the use of our products in enterprise-wide environments. In addition, our insurance against this liability may not be adequate to cover a potential claim.
 
80
We depend on a limited number of third-party contract manufacturers for a substantial portion of all of our manufacturing needs and any delay, disruption or quality control problems in their operations, including due to the
COVID-19
pandemic, could cause harm to our operations, including loss of market share and damage to our brand.
We depend on third-party contract manufacturers for the production of our 3D printers and on third-party suppliers for the components and raw materials used in our products. While there are several potential manufacturers for most of these products, all of our products are manufactured, assembled, tested and generally packaged by a limited number of third-party manufacturers and several single source providers of certain supplies. In most cases, we rely on these manufacturers to procure components and, in some cases, subcontract engineering work. Our reliance on a limited number of contract manufacturers involves a number of risks, including:
 
  •  
unexpected increases in manufacturing and repair costs;
 
  •  
inability to control the quality and reliability of products;
 
  •  
inability to control delivery schedules;
 
  •  
potential liability for expenses incurred by third-party contract manufacturers in reliance on our forecasts that later prove to be inaccurate;
 
  •  
potential lack of adequate capacity to manufacture all or a part of the products we require;
 
  •  
potential labor unrest affecting the ability of the third-party manufacturers to produce our products; and
 
  •  
unexpected component or process obsolescence making key components unavailable.
If any of our third-party contract manufacturers experience a delay, disruption or quality control problems in their operations, including due to the
COVID-19
pandemic, or if a primary third-party contract manufacturer does not renew its agreement with us, our operations could be significantly disrupted and our product shipments could be delayed. Qualifying a new manufacturer and commencing volume production is expensive and time consuming. Ensuring that a contract manufacturer is qualified to manufacture our products to our standards is time consuming. In addition, there is no assurance that a contract manufacturer can scale its production of our products at the volumes and in the quality that we require. If a contract manufacturer is unable to do these things, we may have to move production for the products to a new or existing third-party manufacturer, which would take significant effort and our brand, business, results of operations and financial condition could be materially adversely affected. Finally, if a contract manufacturer producing a highly specified product changes its materials or is unable to meet our production demands, it could lead to specification changes, increased lead time or cancellation of the product.
As we contemplate moving manufacturing into different jurisdictions, we may be subject to additional significant challenges in ensuring that quality, processes, and costs, among other issues, are consistent with our expectations.
In addition, because we use a limited number of third-party contract manufacturers, increases in the prices charged may have an adverse effect on our results of operations, as we may be unable to find a contract manufacturer who can supply us at a lower price. As a result, the loss of a limited source supplier could adversely affect our relationships with our customers and our results of operations and financial condition.
All of our products must satisfy safety and regulatory standards and some of our products must also receive government certifications. We rely on third-party providers to conduct the tests that support our applications for most regulatory approvals for our products. As part of the certification process, our third-party contract manufacturers are subject to audit and must receive approvals from third-parties providing such certifications. Failure to meet these certifications by our third-party contract manufacturers could adversely impact our business. Moreover, if our third-party contract manufacturers fail to timely and accurately conduct the tests supporting our applications for regulatory approvals, we may be unable to obtain the necessary domestic or foreign regulatory approvals or certifications to sell our products in certain jurisdictions. As a result, we would be unable to sell our products and our sales and profitability could be reduced, our relationships with our sales channel could be harmed and our reputation and brand would suffer.
Our manufacturing facility and those of our third-party contract manufacturers and suppliers, as well as our customers’ facilities and our third-party logistics providers, are vulnerable to disruption due to natural or other disasters, strikes and other events beyond our control.
A major earthquake, fire, tsunami, hurricane, cyclone or other disaster, such as a major flood, seasonal storms, nuclear event or terrorist attack affecting our facilities or the areas in which they are located, or affecting those of our customers or third-party manufacturers, suppliers or fulfillment centers, could significantly disrupt our or their operations and delay or prevent product shipment or installation during the time required to repair, rebuild or replace our or their damaged manufacturing facilities. These delays could be lengthy and costly. If any of our facilities, or those of our third-party contract manufacturers, suppliers, third-party logistics providers or customers are negatively impacted by such a disaster, production, shipment and installation of our additive manufacturing machines could be delayed, which can impact the period in which we recognize the revenue related to that additive manufacturing machine sale. Additionally, customers may delay purchases of our products until operations return to normal. Even if we are able to respond quickly to a disaster, the continued effects of the disaster could create uncertainty in our business operations. In addition, concerns about terrorism, the effects of a terrorist attack, political turmoil, labor strikes, war or the outbreak of epidemic or pandemic diseases (including the outbreak of the coronavirus disease
COVID-19)
could have a negative effect on our operations and sales.
 
81
Risks Related to International Operations
Our existing and planned global operations subject us to a variety of risks and uncertainties that could adversely affect our business and operating results. Our business is subject to risks associated with selling machines and other products in
non-United
States locations.
As of August 2021, our products and services are distributed across the world, and we derive a substantial percentage of our sales from these international markets. Accordingly, we face significant operational risks from doing business internationally.
Our operating results may be affected by volatility in currency exchange rates and our ability to effectively manage our currency transaction risks. Although we currently invoice customers in United States dollars, increases in the value of the dollar relative to foreign currencies may make our products less attractive to foreign customers. We may also incur currency transaction risks if we were to enter into either a purchase or a sale transaction using a different currency from the currency in which we report revenues. In such cases we may suffer an exchange loss because we do not currently engage in currency swaps or other currency hedging strategies to address this risk. As we realize our strategy to expand internationally, our exposure to currency risks may increase. Given the volatility of exchange rates, we can give no assurance that we will be able to effectively manage our currency transaction risks or that any volatility in currency exchange rates will not have an adverse effect on our results of operations.
The shipments of our products to foreign customers and/or
end-users
may be subject to tariffs and other restrictions imposed by the destination countries. As we procure equipment and materials from foreign suppliers, we may be required to pay import duties and comply with regulations imposed by the U.S. Customs and Border Protection. Both the U.S. and foreign tariff rates and import restrictions may change from time to time, which could adversely impact our global operations, for example, by decreasing the price competitiveness of our products in foreign markets and/or by increasing our manufacturing costs.
Other risks and uncertainties we face from our global operations include:
 
  •  
difficulties in staffing and managing foreign operations;
 
  •  
limited protection for the enforcement of contract and intellectual property rights in certain countries where we may sell our products or work with suppliers or other third parties;
 
  •  
potentially longer sales and payment cycles and potentially greater difficulties in collecting accounts receivable;
 
  •  
costs and difficulties of customizing products for foreign countries;
 
  •  
challenges in providing solutions across a significant distance, in different languages and among different cultures;
 
  •  
laws and business practices favoring local competition;
 
  •  
being subject to a wide variety of complex foreign laws, treaties and regulations and adjusting to any unexpected changes in such laws, treaties and regulations, including local labor laws;
 
  •  
strict laws and regulations governing privacy and data security, including the European Union’s General Data Protection Regulation;
 
  •  
uncertainty and resultant political, financial and market instability arising from the United Kingdom’s exit from the European Union;
 
  •  
compliance with U.S. laws affecting activities of U.S. companies abroad, including the U.S. Foreign Corrupt Practices Act;
 
  •  
tariffs, trade barriers and other regulatory or contractual limitations on our ability to sell or develop our products in certain foreign markets;
 
  •  
operating in countries with a higher incidence of corruption and fraudulent business practices;
 
  •  
changes in regulatory requirements, including export controls, tariffs and embargoes, other trade restrictions, competition, corporate practices and data privacy concerns;
 
  •  
failure by our VARs or other distribution partners to comply with local laws or regulations, export controls, tariffs and embargoes or other trade restrictions;
 
  •  
potential adverse tax consequences arising from global operations;
 
  •  
seasonal reductions in business activity in certain parts of the world, particularly during the summer months in Europe and at year end globally;
 
  •  
rapid changes in government, economic and political policies and conditions; and
 
  •  
political or civil unrest or instability, terrorism or epidemics and other similar outbreaks or events.
In addition, additive manufacturing has been identified by the U.S. government as an emerging technology and is currently being further evaluated for national security impacts. We expect additional regulatory changes to be implemented that will result in increased and/or new export controls related to additive manufacturing technologies, components and related materials and software. These changes, if implemented, may result in our being required to obtain additional approvals and/or licenses to sell 3D printers in the global market.
 
82
Our failure to effectively manage the risks and uncertainties associated with our global operations could limit the future growth of our business and adversely affect our business and operating results.
Global economic, political and social conditions and uncertainties in the market that we serve may adversely impact our business.
Our performance depends on the financial health and strength of our customers, which in turn is dependent on the economic conditions of the markets in which we and our customers operate. Declines in the global economy, difficulties in the financial services sector and credit markets, continuing geopolitical uncertainties and other macroeconomic factors all affect the spending behavior of potential customers. Economic uncertainty in Europe, the United States, India, Japan, China and other countries may cause customers and potential customers to further delay or reduce technology purchases.
We also face risks from financial difficulties or other uncertainties experienced by our suppliers, distributors or other third parties on which we rely. If third parties are unable to supply us with required materials or components or otherwise assist us in operating our business, our business could be harmed.
Other changes in U.S. social, political, regulatory and economic conditions or in laws and policies governing foreign trade, manufacturing, development and investment could also adversely affect our business. In particular, on June 23, 2016, the U.K. held a referendum in which a majority of the eligible members of the electorate voted to leave the EU, commonly referred to as Brexit. Pursuant to Article 50 of the Treaty on EU, the U.K. ceased being a member state of the EU on January 31, 2020. The implementation period began February 1, 2020 and continued until December 31, 2020, during which U.K. continued to follow all of the EU’s rules, the EU’s pharmaceutical law remained applicable to the U.K. and the U.K.’s trading relationship remained the same. The U.K. and the EU have signed an
EU-UK
Trade and Cooperation Agreement, or TCA, which became provisionally applicable on January 1, 2021 and will become formally applicable once ratified by both the U.K. and the EU. This agreement provides details on how some aspects of the U.K. and EU’s relationship will operate going forwards however there are still many uncertainties and how the TCA will take effect in practice is still largely unknown. Additionally, there is a risk that other countries may decide to leave the European Union. This uncertainty surrounding this transition not only potentially affects our business in the United Kingdom and the European Union, but also may have an effect on global economic conditions and the stability of global financial markets, which in turn could have a material adverse effect on our business, financial condition and results of operations. In extreme cases, we could experience interruptions in production due to the processing of customs formalities or reduced customer spending in the wake of weaker economic performance. If global economic conditions remain volatile for a prolonged period or if European economies experience further disruptions, our results of operations could be adversely affected.
The effects of regulations relating to conflict minerals may adversely affect our business.
On August 22, 2012, under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the SEC adopted new requirements for companies that use certain minerals and metals, known as conflict minerals, in their products, whether or not these products are manufactured by third parties. These requirements require companies to research, disclose and report whether or not such minerals originate from the Democratic Republic of Congo and adjoining countries. The implementation of these requirements could adversely affect the sourcing, availability and pricing of such minerals if they are found to be used in the manufacture of our products, including our 3D printers or materials. In addition, we expect to continue to incur additional costs to comply with the disclosure requirements, including costs related to determining the source of any of the relevant minerals and metals used in our products. Since our supply chain is complex, we may not be able to sufficiently verify the origins for these minerals and metals used in our products through the due diligence procedures that we implement, which may harm our reputation. In such event, we may also face difficulties in satisfying customers who require that all of the components of our products are certified as conflict mineral free.
Risks Related to Sales of Products to U.S. and Foreign Governments
A significant portion of our business depends on sales to the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business.
We derive a significant portion of our revenue from contracts that we have, either directly or through distribution partners and VARs, with federal, state, local and foreign governments and government agencies, and we believe that the success and growth of our business will continue to depend on our successful procurement of government contracts. For example, we have historically derived, and expect to continue to derive, a significant portion of our revenue from sales to agencies of the U.S. federal government and governments of other nations, either directly by us or through other distribution partners. Sales to such governments and their agencies are subject to a number of challenges and risks. The procurement process for governments and their agencies is highly competitive, time-consuming, and may, in certain circumstances, be subject to political influence. We incur significant
up-front
time and expense, which subjects us to additional compliance risks and costs, without any assurance that we (or a third-party distributor or reseller) will win a contract.
 
83
Accordingly, our business, financial condition, results of operations, and prospects may be adversely affected by certain events or activities, including, but not limited to:
 
  •  
changes in fiscal or contracting policies or decrease in available government funding;
 
  •  
changes in government programs or applicable requirements;
 
  •  
changes in the political environment, including before or after a change to the leadership within the government administration, and any resulting uncertainty or changes in policy or priorities and resultant funding;
 
  •  
appeals, disputes or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government;
 
  •  
the adoption of new laws or regulations or changes to existing laws or regulations;
 
  •  
budgetary constraints, including automatic reductions as a result of “sequestration” or similar measures and constraints imposed by lapses in appropriations for the federal government or certain of its departments and agencies;
 
  •  
influence by, or competition from, third parties with respect to pending, new or existing contracts with government customers;
 
  •  
potential delays or changes in the government appropriations or procurement processes, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics, such as the
COVID-19
pandemic; and
 
  •  
increased or unexpected costs or unanticipated delays caused by other factors outside of our control, such as performance failures of our partners and subcontractors.
Any such event or activity, among others, could cause governments and governmental agencies to delay or refrain from purchasing our products and services in the future, reduce the size or payment amounts of purchases from existing or new government customers, or otherwise have an adverse effect on our business, results of operations, financial condition and prospects.
Government programs are limited by budgetary constraints and political considerations and are subject to uncertain future funding levels that could result in the termination of programs.
Government agency and department purchases are often strategic in nature and large in size. Therefore, reductions in funding levels that impact our customers could negatively affect the size of our customers’ orders or lead to cancellation of orders. Government contracts are often subject to more extensive scrutiny and publicity than commercial contracts. The number and terms of new government contracts signed can be affected significantly by political and economic factors, such as pending elections and revisions to government tax policies. Negative publicity related to our government contracts, regardless of its accuracy, may damage our business by affecting our ability to compete for new contracts. A decline in security-related government spending for any reason, or a shift away from programs that we address, could hurt our sales, put pressure on our prices and reduce our revenue and margins. Relatedly, the use of our products by militaries or other government agencies or departments in a way that is perceived negatively by the public could adversely affect our business and reputation.
A multi-year U.S. government program may be implemented through the award of many different individual contracts, grants, cooperative agreements and subcontracts or other subawards. For U.S. government programs, program funding is subject to congressional appropriations. Congress generally appropriates funds on a fiscal year basis even though a program may continue for several years. Government programs are often only partially funded initially, and additional funds are committed only as Congress makes further appropriations. The termination of a program or failure to commit funds to a program would result in a loss of anticipated future revenue attributable to that program, which could materially harm our business.
We are subject to audits by the U.S. government which could adversely affect our business.
U.S. government agencies routinely audit and investigate government contractors to monitor performance, cost allocations, cost accounting and compliance with applicable laws, regulations and standards. Since some of our contracts provide for cost reimbursement, the U.S. government has the right to audit our costs even after job completion and after we have billed and recognized the corresponding revenue. The U.S. government also may review the adequacy of, and a contractor’s compliance with, its internal control systems and policies, including the contractor’s purchasing, property, estimating, compensation and management information systems. Any costs found to be improperly allowed or improperly allocated to a specific contract will not be reimbursed, and any such costs that have already been reimbursed must be refunded, which would affect associated revenue that had already been recognized. While we intend to implement uniform procurement and compliance programs for all of our business, we may be subject to more risks from these audits until we are able to implement such a program effectively.
Responding to governmental audits, inquiries or investigations may involve significant expense and divert the attention of our management. If a government review or investigation uncovers improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions, including termination of contracts, forfeiture of profits, suspension of payments, damages, fines and suspension or debarment from doing business with U.S. government agencies. In addition, our reputation could be seriously harmed by allegations of impropriety, even if unfounded. Our internal controls may not prevent or detect all improper or illegal activities.
 
84
Our business is subject to laws and regulations that are more restrictive because we are a contractor and subcontractor to the U.S. government.
As a contractor and subcontractor to the U.S. government, we are subject to various laws and regulations that are more restrictive than those applicable to
non-government
contractors, including the Federal Acquisition Regulations and its supplements, which comprehensively regulate the formation, administration and performance of U.S. government contracts, and the Truth in Negotiations Act and various other laws, which require certain certifications and disclosures. These laws and regulations, among other things:
 
  •  
require that we obtain and maintain material governmental authorizations and approvals to conduct our business as it is currently conducted;
 
  •  
require certification and disclosure of cost and pricing data in connection with certain contract negotiations;
 
  •  
impose rules that define allowable and unallowable costs and otherwise govern our right to reimbursement under certain cost-based U.S. government contracts;
 
  •  
restrict the use and dissemination of information classified for national security purposes and the export of certain products and technical data; and
 
  •  
impose requirements relating to ethics and business practices, which carry penalties for noncompliance ranging from monetary fines and damages to loss of the ability to do business with the U.S. government as a prime contractor or subcontractor.
In addition, we may be subject to industrial security regulations of the U.S. Department of Defense and other federal agencies that are designed to safeguard against unauthorized access by foreigners and others to classified and other sensitive U.S. government information. If we were to come under foreign ownership, control or influence, our U.S. government customers could terminate, or decide not to renew, our contracts, or we may be subjected to burdensome industrial security compliance measures. Such a situation could impair our ability to obtain new contracts and subcontracts. The government may also change its procurement practices or adopt new contracting rules and regulations that could be costly to satisfy or that could impair our ability to obtain new contracts.
Our contracts and those of our VARs with governments may impose requirements that may be unfavorable to us and that may have a material adverse effect on our growth prospects and operating results.
Most of our sales to government entities have been made indirectly through our VARs and other distribution partners. In some cases, we have entered contracts directly with government customers. There are inherent risks in contracting with governments and their agencies. Government customers can typically terminate, reduce orders under or otherwise modify any of its contracts with us or our VARs for its convenience (
i.e.
, without cause) whether or not we have failed to perform under the terms of the applicable contract. In such case, the government would not be required to pay our VARs or us for the lost profits for the unperformed work. A termination arising out of our VARs or our default could expose our VARs or us to liability and harm our VARs or our ability to compete for future contracts and orders. In addition to unfavorable termination provisions, our VARs or our U.S. government contracts and related regulations contain provisions that allow the U.S. government to unilaterally suspend our VARs or us from receiving new contracts pending resolution of alleged violations of procurement laws or regulations, reduce the value of existing contracts, issue modifications to a contract and potentially restrict exports of our products, services and associated materials.
Our VARs or our contracts with government agencies may subject our VARs or us to other risks and give the government additional rights and remedies not typically found in commercial contracts, including rights that allow the government to, for example:
 
  •  
obtain detailed cost or pricing information;
 
  •  
receive “most favored customer” pricing;
 
  •  
require us to prioritize orders from our government customers above our other customers’ existing orders, which we may fail to do and, even if we do prioritize such orders, may impact our relationships with our other customers;
 
  •  
perform routine audits;
 
  •  
impose equal employment and hiring standards;
 
  •  
require products to be manufactured in specified countries;
 
  •  
restrict
non-U.S.
ownership or investment in our company; and/or
 
  •  
pursue administrative, civil or criminal remedies for contractual violations.
These rights and remedies have the potential to limit our VARs or our sales to, and increase our VARs or our costs of, doing business with both government and commercial customers, which could materially adversely affect our growth prospects and operating results.
Additionally, we sometimes rely on our VARs and other distribution partners to satisfy certain regulatory obligations that we would otherwise have to satisfy if we sold directly to the government entities, and our VARs and other distribution partners may be unable or unwilling to satisfy these obligations in the future. In the event of such termination or change, it may be difficult for us to arrange for another VAR or other distribution partner to sell our solutions to these government entities in a timely manner, and we could lose sales opportunities during the transition.
 
85
Risks Related to Litigation and Liability
We are, and have been in the recent past, subject to business and intellectual property litigation.
We have been in the recent past involved in litigation, and we could be involved in additional litigation in the future. In March 2018, Desktop Metal, Inc. (“Desktop Metal”), a direct competitor in the additive manufacturing industry, brought a claim in Massachusetts federal court against us regarding patent infringement and trade secret misappropriation. We counterclaimed for trade secret misappropriation, breach of fiduciary duty, and other matters. A jury trial was held in July 2018 on Desktop Metal’s claims for patent infringement. We prevailed against Desktop Metal’s claims of patent infringement via a jury verdict that found no infringement of the asserted patents. A second jury trial began in September 2018 primarily in connection with our counterclaims, and the parties entered into a confidential settlement agreement (the “Settlement Agreement”) covering the disputes between them in October 2018. In October 2019, we submitted an Arbitration Demand with JAMS against Desktop Metal alleging breach of the parties’ Settlement Agreement pursuant to the
non-disparagement
obligations therein, as well as a violation of M.G.L. c. 93A. Desktop Metal counterclaimed against us for breach of the parties’ Settlement Agreement pursuant to the confidentiality provision therein. The matter proceeded in confidential arbitration and a hearing was held in December 2020. The Arbitration decision was issued on February 26, 2021, and the Arbitrator ruled that neither we nor Desktop Metal were liable pursuant to their respective claims, and that neither party therefore owed any damages to the other.
In July 2021, Continuous Composites Inc. (“Continuous Composites”), a company based out of Idaho, brought a claim in the United States District Court for the District of Delaware federal court against us regarding patent infringement. While we take any claims of infringement seriously, we believe that Continuous Composite’s claims are baseless and without merit. We intend to mount a vigorous defense against Continuous Composites in court. However, we can provide no assurance as to the outcome of any such disputes, and any such actions may result in judgments against us for significant damages. Resolution of any such matters can be prolonged and costly, and the ultimate results or judgments are uncertain due to the inherent uncertainty in litigation and other proceedings.
In addition, the additive manufacturing industry has been, and may continue to be, litigious, particularly with respect to intellectual property claims. Moreover, our potential liabilities are subject to change over time due to new developments, changes in settlement strategy or the impact of evidentiary requirements. Regardless of the outcome, litigation has resulted in the past, and may result in the future, in significant legal expenses and require significant attention and resources of management. As a result, any present or future litigation that may be brought against us by any third party could result in reputational harm, losses, damages and expenses that may have a significant adverse effect on our financial condition.
We could be subject to personal injury, property damage, product liability, warranty and other claims involving allegedly defective products that we supply.
The products we supply are sometimes used in potentially hazardous or critical applications, such as the assembled parts of an aircraft, medical device or automobile. The sale of our products and the provision of related services in general, and to customers in the foregoing industries in particular, exposes us to possible claims for property damage and personal injury or death, which may result from the use of these
end-use
parts. While we have not experienced any such claims to date, actual or claimed defects in the products we supply could result in our being named as a defendant in lawsuits asserting potentially large claims. We may be potentially liable, in significant amounts, and face significant harm to our reputation if an aircraft, medical or automotive part, component or accessory or any other aviation, medical or automotive product that we have sold, produced or repaired fails due to our fault, in whole or in part, or if an aircraft or automobile for which we have provided services or in which their parts are installed crashes, and the cause can be linked to those parts or cannot be determined. A similar risk arises in connection with sales of our products to customers in the aerospace industry to the extent that the parts produced by those products do not function properly and are responsible for damages. Our commercial contracts generally contain product warranties and limitations on liability and we carry liability insurance in amounts that we believe are adequate for our risk exposure and commensurate with industry norms. While we intend to monitor our insurance coverage as our business continues to grow, claims may arise in the future, and that insurance coverage may not be adequate or available to protect our consolidated company in all circumstances. Additionally, we might not be able to maintain adequate insurance coverage for our business in the future at an acceptable cost. Any liability claim against us that is not covered by adequate insurance could adversely affect our consolidated results of operations and financial condition. Finally, any liability claim against us may cause harm to our brand, reputation and adversely impact our business.
We could face liability if our additive manufacturing solutions are used by our customers to print dangerous objects.
Customers may use our 3D printers to print parts that could be used in a harmful way or could otherwise be dangerous. For example, there have been news reports that additive manufacturing machines were used to print guns or other weapons. We have little, if any, control over what objects our customers print using our products, and it may be difficult, if not impossible, for us to monitor and prevent customers from printing weapons with our products. Additionally, individuals or entities unaffiliated with us could disseminate plans or digital files that could be used with our products to produce parts and items that could be deemed illegal or harmful. While we have never printed weapons on any printers in our offices, there can be no assurance that we will not be held liable if someone were injured or killed by a weapon printed by a customer using one of our products. Additionally, association of such an incident with our products may cause harm to our brand reputation and adversely impact our business.
 
86
Third parties may produce or sell counterfeit or imitation versions of our materials.
Third parties may sell counterfeit or imitation versions of our materials that are inferior or pose safety risks. If consumers confuse these counterfeit products or materials for our products or materials or have a bad experience with the counterfeit products or materials, they might refrain from purchasing our products or materials in the future, which could harm our reputation and sales. Further, if third parties develop materials that compete favorably on price, and/or meet or exceed the quality and performance of our own materials, we may lose recurring revenue from lost sales of our materials. If we do not maintain favorable perceptions of our products and materials, and if we are unable to compete successfully with third party manufacturers of materials, our brand, business, financial condition, results of operations and cash flows could be adversely impacted.
Failure of our global operations to comply with anti-corruption laws and various trade restrictions, such as sanctions and export controls, could have an adverse effect on our business.
We operate in a number of countries throughout the world, including countries known to have a reputation for corruption. Doing business on a global basis requires us to comply with anti-corruption laws and regulations imposed by governments around the world with jurisdiction over our operations, including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act 2010, as well as the laws of the countries where we do business.
We are also subject to various trade restrictions, including trade and economic sanctions and export controls, imposed by governments around the world with jurisdiction over our operations. For example, in accordance with trade sanctions administered by the Office of Foreign Assets Control and the U.S. Department of Commerce, we are prohibited from engaging in transactions involving certain persons and certain designated countries or territories, including Cuba, Iran, Syria, North Korea and the Crimea Region of Ukraine. In addition, our products are subject to export regulations that can involve significant compliance time and may add additional overhead cost to our products. In recent years the United States government has a renewed focus on export matters. For example, the Export Control Reform Act of 2018 and regulatory guidance thereunder have imposed additional controls, and may result in the imposition of further additional controls, on the export of certain “emerging and foundational technologies.” Our current and future products may be subject to these heightened regulations, which could increase our compliance costs. For instance, recent amendments to the U.S. Export Administration Regulations (“EAR”) increased restrictions on exports to certain “military
end-users”
and for “military
end-uses”
by certain persons in China, Russia, or Venezuela, which requires us to perform due diligence on customers and
end-users
in those countries for potential military connections.
We also need to monitor the changes in export-related laws and regulations, such as International Traffic in Arms Regulations (“ITAR”), and their applicability to our products and services. If our products or services become subject to the ITAR, we may be required to obtain licenses, clearances, or authorizations from various regulatory entities. If we are not allowed to export our products or services, or if the clearance process is burdensome, our ability to generate revenue would be adversely affected and our operating costs could increase.
In addition, international sales of certain of our products may be subject to local laws and regulations in foreign jurisdictions which we may not be familiar with. We may not be allowed to ship our products to certain countries without meeting their local laws and regulations. The failure to comply with any of these laws or regulations could adversely affect our ability to conduct our business and generate revenues.
We are committed to doing business in accordance with applicable anti-corruption laws and regulations and with applicable trade restrictions. We are subject, however, to the risk that our affiliated entities or our and our affiliates’ respective officers, directors, employees and agents (including distributors and VARs of our products) may take action determined to be in violation of such laws and regulations. Any violation by us or by any of these persons could result in substantial fines, sanctions, civil and/or criminal penalties, or curtailment of operations in certain jurisdictions, and might adversely affect our operating results. In addition, actual or alleged violations could damage our reputation and ability to do business.
Although we take precautions to prevent violations of applicable anti-corruption laws and regulations and applicable trade restrictions, we may have exported products in the past in apparent violation of the EAR. If we are found to be in violation of U.S. export control laws, it could result in substantial fines and penalties for us and for the individuals working for us. We may also be adversely affected through other penalties, reputational harm, loss of access to certain markets or otherwise.
 
87
We are subject to environmental, health and safety laws and regulations related to our operations and the use of our 3D printers and materials, which could subject us to compliance costs and/or potential liability.
We are subject to domestic and foreign environmental, health and safety laws and regulations governing our operations. A certain risk of environmental liability is inherent in our production activities. These laws and regulations govern, among other things, the generation, use, storage, registration, handling, transport and disposal of chemicals and waste materials, the presence of specified substances in electrical products; the emission and discharge of hazardous materials into the ground, air or water; the investigation and cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of chemicals and other waste materials and the health and safety of our employees. As such, our operations, including our production activities, carry an inherent risk of environmental, health and safety liabilities. Under these laws and regulations, we could be subject to liability for improper disposal of chemicals and waste materials, including those resulting from the use of our systems and accompanying materials by
end-users.
Accidents or other incidents that occur at our facilities or involve our personnel or operations could result in claims for damages against us. In the event we are found to be financially responsible, as a result of environmental or other laws or by court order, for environmental damages alleged to have been caused by us or occurring on our premises, we could be required to pay substantial monetary damages or undertake expensive remedial obligations. If our operations fail to comply with such laws or regulations, we may be subject to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary to continue our business activities, or may be required to make significant expenditures to achieve compliance. In addition, we may be required to pay damages or civil judgments in respect of third-party claims, including those relating to personal injury (including exposure to hazardous substances that we generate, use, store, handle, transport, manufacture or dispose of), property damage or contribution claims. Some environmental laws allow for strict, joint and several liabilities for remediation costs, regardless of fault. We may be identified as a potentially responsible party under such laws. The amount of any costs, including fines or damages payments that we might incur under such circumstances could substantially exceed any insurance we have to cover such losses. Any of these events, alone or in combination, could have a material adverse effect on our business, financial condition and results of operations and could adversely affect our reputation.
We may be subject to environmental laws and regulations concerning the import and export of chemicals and hazardous substances including, without limitation, the United States Toxic Substances Control Act (“TSCA”) and the Registration, Evaluation, Authorization and Restriction of Chemical Substances (“REACH”). These laws and regulations require the testing and registration of some chemicals that we ship along with, or that form a part of, our systems and other products. If we fail to comply with these or similar laws and regulations, we may be required to make significant expenditures to reformulate the chemicals that we use in our products and materials or incur costs to register such chemicals to gain and/or regain compliance. Additionally, we could be subject to significant fines or other civil and criminal penalties should we not achieve such compliance.
The cost of complying with current and future environmental, health and safety laws applicable to our operations, or the liabilities arising from releases of, or exposure to, hazardous substances, may result in future expenditures. Any of these developments, alone or in combination, could have an adverse effect on our business, financial condition and results of operations.
Aspects of our business are subject to laws and regulations governing privacy and data security. Changes in laws, regulations, and public perception concerning data protection and privacy, or changes in the interpretation or patterns of enforcement of existing laws and regulations, could impair our efforts to maintain and expand our customer base or the ability of our customers to use our services. Breaches of laws and regulations concerning data protection and privacy could expose us to significant fines and other penalties.
We hold personal information about a variety of individuals, such as our employees, prospects, and our customers. Processing of personal information is increasingly subject to legislation and regulation in numerous jurisdictions around the world.
For example, relevant applicable laws and regulations governing the collection, use, disclosure or other processing of personal information include, in the United States, rules and regulations promulgated under the authority of the Federal Trade Commission, the California Consumer Privacy Act of 2018 (the “CCPA”) and state breach notification laws. In particular, the CCPA, among other things, requires covered ‘Businesses’ to provide new disclosures to California consumers and afford such consumers new rights with respect to their personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches that result in the loss of personal information. This private right of action may increase the likelihood of, and risks associated with, data breach litigation.
The CCPA has prompted a number of proposals for new federal and state-level privacy legislation. Such proposed legislation, if enacted, may add additional complexity, variation in requirements, restrictions and potential legal risk, require additional investment of resources in compliance programs, impact strategies and the availability of previously useful data and could result in increased compliance costs and/or changes in business practices and policies.
 
88
Moreover, we maintain offices in the European Union (“EU”) (Ireland) and we have customers in the EU and the United Kingdom (“UK”). Accordingly, we are subject to the General Data Protection Regulation (EU) 2016/679 (the “GDPR”), and related member state implementing legislation, and to the UK’s Data Protection Act 2018 (collectively, “European Data Protection Law”). European Data Protection Law places obligations on controllers and processors of personal data, while establishing rights for individuals with respect to their personal data. European Data Protection Law is also explicitly extraterritorial in its application, and could affect our business activities in jurisdictions outside the EU and the UK. Additionally, European Data Protection Law imposes strict rules on the transfer of personal data outside of the EU to countries that do not ensure an adequate level of protection, like the United States. These transfers are prohibited unless an appropriate safeguard specified by the GDPR is implemented, such as the Standard Contractual Clauses (SCCs) or binding corporate rules. The Court of Justice of the European Union (the “CJEU”) recently deemed that these transfers need to be analyzed on a
case-by-case
basis to ensure EU standards of data protection are met in the jurisdiction where the data importer is based. European regulators have issued recent guidance following the CJEU case that imposes significant new diligence requirements on transferring data outside the EU. Complying with this guidance is and will continue to be expensive and time consuming and may ultimately prevent us from transferring personal data outside the EU, which would cause significant business disruption. The GDPR imposes sanctions for violations up to the greater of €20 million and 4% of worldwide gross annual revenue, enables individuals to claim damages for violations and introduces the right for
non-profit
organizations to bring claims on behalf of data subjects.
The regulatory framework governing the collection, processing, storage, use and sharing of personal information is rapidly evolving and is likely to continue to be subject to uncertainty and varying interpretations. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our existing data management practices or the features of our services and platform capabilities. We cannot yet fully determine the impact these or future laws, rules, regulations and industry standards may have on our business or operations. Additionally, our customers may be subject to differing privacy laws, rules and legislation, which may mean that they require us to be bound by varying contractual requirements applicable to certain other jurisdictions. Adherence to such contractual requirements may impact our collection, use, processing, storage, sharing and disclosure of personal information and may mean we become bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters that may further change as laws, rules and regulations evolve. We have incurred, and may continue to incur, significant expenses to comply with evolving mandatory privacy and security standards and protocols imposed by law, regulation, industry standards, shifting merchant and customer expectations, or contractual obligations, and we may not be able to respond quickly or effectively to regulatory, legislative and other developments. These changes may in turn impair our ability to offer our existing or planned features, products and services and/or increase our cost of doing business.
We publicly post documentation regarding our privacy practices. Although we endeavor to comply with our published policies and documentation, we may at times fail to do so or be alleged to have failed to do so. Any failure or perceived failure by us to comply with our privacy policies or any applicable privacy, security or data protection, information security or consumer-protection related laws, regulations, orders or industry standards could expose us to costly litigation, significant awards, fines or judgments, civil and/or criminal penalties or negative publicity, and could materially and adversely affect our business, financial condition and results of operations. The publication of our privacy policy and other documentation that provide promises and assurances about privacy and security can subject us to potential state and federal action if they are found to be deceptive, unfair, or misrepresentative of our actual practices, which could, individually or in the aggregate, materially and adversely affect our business, financial condition and results of operations.
We rely on our software and information technology systems to manage numerous aspects of our business and a disruption of these systems could adversely affect our business.
We rely on our information technology systems to manage numerous aspects of our business, including to efficiently purchase products from our suppliers, provide procurement and logistic services, ship products to our customers, receive orders from our customers, manage our accounting and financial functions, including our internal controls, and maintain our research and development data. Our information technology systems are an essential component of our business and any disruption could significantly limit our ability to manage and operate our business efficiently. A failure of our information technology systems to perform properly could disrupt our supply chain, product development and customer experience, which may lead to increased overhead costs and decreased sales and have an adverse effect on our reputation and our financial condition. In particular, our integrated software platform is an essential system that virtually all of our customers depend on for their design needs. If our integrated software platform were to fail, we could face adverse consequences to our results of operations, financial condition and business reputation. In addition, during the
COVID-19
pandemic, a substantial portion of our employees have conducted work remotely, making us more dependent on potentially vulnerable communications systems and making us more vulnerable to cyberattacks.
Although we take steps and incur significant costs to secure our information technology systems, including our computer systems, intranet and internet sites, email and other telecommunications and data networks, our security measures may not be effective and our systems may be vulnerable to damage or interruption. Disruption to our information technology systems could result from power outages, computer and telecommunications failures, computer viruses, cyber-attack or other security breaches, catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes, acts of war, terrorism and usage errors by our employees.
Our reputation and financial condition could be adversely affected if, as a result of a significant cyber-event or otherwise:
 
  •  
our operations are disrupted or shut down;
 
  •  
our confidential, proprietary information is stolen or disclosed;
 
  •  
we incur costs or are required to pay fines in connection with stolen customer, employee or other confidential information; or
 
  •  
we must dedicate significant resources to system repairs or increase cyber security protection.
In addition, any unauthorized access, disclosure or other loss or unauthorized use of information or data could result in legal claims or proceedings, regulatory investigations or actions, and other types of liability under laws that protect the privacy and security of personal information, including federal, state and foreign data protection and privacy regulations, violations of which could result in significant penalties and fines. In addition, although we seek to detect and investigate all data security incidents, security breaches and other incidents of unauthorized access to our information technology systems and data can be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure.
 
89
The cost of investigating, mitigating and responding to potential data security breaches and complying with applicable breach notification obligations to individuals, regulators, partners and others can be significant. Our insurance policies may not be adequate to compensate us for the potential costs and other losses arising from such disruptions, failures or security breaches. In addition, such insurance may not be available to us in the future on economically reasonable terms, or at all. Further, defending a suit, regardless of its merit, could be costly, divert management attention and harm our reputation.
If our computer systems are damaged or cease to function properly, or, if we do not replace or upgrade certain systems, we may incur substantial costs to repair or replace them and may experience an interruption of our normal business activities or loss of critical data. Any such disruption could adversely affect our reputation and financial condition.
We also rely on information technology systems maintained by third parties, including third-party cloud computing services and the computer systems of our suppliers for both our internal operations and our customer-facing infrastructure related to our additive manufacturing solutions. These systems are also vulnerable to the types of interruption and damage described above but we have less ability to take measures to protect against such disruptions or to resolve them if they were to occur. Information technology problems faced by third parties on which we rely could adversely impact our business and financial condition as well as negatively impact our brand reputation.
Any unauthorized control or manipulation of our products’ systems could result in loss of confidence in us and our products and harm our business.
Our products contain complex information technology systems. For example, our additive manufacturing machines are designed with
built-in
data connectivity to accept and install periodic remote updates from us to monitor, improve and update their functionality. We have designed, implemented and tested security measures intended to prevent unauthorized access to our information technology networks, our products and their systems. However, hackers may attempt to gain unauthorized access to modify, alter and use such networks, products and systems to gain control of, or to change, our products’ functionality, user interface and performance characteristics, or to gain access to data stored in or generated by our products. We encourage reporting of potential vulnerabilities in the security of our products and we aim to remedy any reported and verified vulnerability. Accordingly, we have received reports of potential vulnerabilities in the past and have attempted to remedy them. However, there can be no assurance that vulnerabilities will not be exploited in the future before they can be identified, or that our remediation efforts are or will be successful.
Any unauthorized access to or control of our products or their systems or any loss of data could result in legal claims or proceedings. In addition, regardless of their veracity, reports of unauthorized access to our products, their systems or data, as well as other factors that may result in the perception that our products, their systems or data are capable of being “hacked,” could negatively affect our brand and harm our business, prospects, financial condition and operating results.
Our business has risks that may not be adequately covered by insurance or indemnity.
We may face unanticipated risks of legal liability for damages caused by the actual or alleged failure of our products. While we have attempted to secure liability insurance coverage at an appropriate cost, it is impossible to adequately insure against all risks inherent in our industry, nor can we assure you that our insurers will pay a particular claim, or that we will be able to maintain coverage at reasonable rates in the future. Our insurance policies also contain deductibles, limitations and exclusions, which increase our costs in the event of a claim. Even a partially uninsured claim of significant size, if successful, could have an adverse effect on our financial condition. In addition, we may not be able to continue to obtain insurance coverage on commercially reasonable terms, or at all, and our existing policies may be cancelled or otherwise terminated by the insurer. Maintaining adequate insurance and successfully accessing insurance coverage that may be due for a claim can require a significant amount of our management’s time, and we may be forced to spend a substantial amount of money in that process. Substantial claims in excess of or not otherwise covered by indemnity or insurance could harm our financial condition and operating results.
Risks Related to Intellectual Property
We may not be able to adequately protect our proprietary and intellectual property rights in our data or technology.
Our success is dependent, in part, upon protecting our proprietary information and technology. Our intellectual property portfolio primarily consists of patents, patent applications, registered and unregistered trademarks, unregistered copyrights, domain names,
know-how,
and trade secrets. We may be unsuccessful in adequately protecting our intellectual property.
 
90
Our trade secrets,
know-how
and other unregistered proprietary rights are a key aspect of our intellectual property portfolio. While we take reasonable steps to protect our trade secrets and confidential information and enter into confidentiality and invention assignment agreements intended to protect such rights, such agreements can be difficult and costly to enforce or may not provide adequate remedies if violated, and we may not have entered into such agreements with all relevant parties. Such agreements may be breached and trade secrets or confidential information may be willfully or unintentionally disclosed, including by employees who may leave our company and join our competitors, or our competitors or other parties may learn of the information in some other way. Additionally, certain unauthorized use of our intellectual property may go undetected, or we may face legal or practical barriers to enforcing our legal rights even where unauthorized use is detected. The disclosure to, or independent development by, a competitor of any of our trade secrets,
know-how
or other technology not protected by a patent or other intellectual property system could materially reduce or eliminate any competitive advantage that we may have over such competitor. This concern could manifest itself in particular with respect to our proprietary materials that are used with our systems. Portions of our proprietary materials may not be afforded patent protection. Chemical companies or other producers of raw materials used in our materials may be able to develop materials that are compatible to a large extent with our products, whether independently or in contravention of our trade secret rights and related proprietary and contractual rights. If such materials are made available to owners of our systems, and are purchased in place of our proprietary materials, our revenues and profitability would be reduced, and we could be forced to reduce prices for our proprietary materials.
Current laws may not provide for adequate protection of our products, especially in foreign jurisdictions which may have laws that provide insufficient protections to companies. In addition, legal standards relating to the validity, enforceability, and scope of protection of proprietary rights in internet-related businesses are uncertain and evolving, and changes in these standards may adversely impact the viability or value of our proprietary rights. Some license provisions protecting against unauthorized use, copying, transfer, and disclosure of our products, or certain aspects of our products may be unenforceable under the laws of certain jurisdictions. Further, the laws of some countries do not protect proprietary rights to the same extent as the laws of the United States, and the laws and mechanisms for protection and enforcement of intellectual property rights in some foreign countries may be inadequate. As we continue to operate in foreign countries and expand our international activities, we have encountered and may in the future encounter challenges in navigating the laws of foreign countries, which may adversely affect our ability to protect our proprietary rights. Further, competitors, foreign governments, foreign government-backed actors, criminals, or other third parties may gain unauthorized access to our proprietary information and technology. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our technology and intellectual property or claiming that we infringe upon or misappropriate their technology and intellectual property.
To protect our intellectual property rights, we may be required to spend significant resources to monitor, protect, and defend these rights, and we may or may not be able to detect infringement by our customers or third parties. Litigation has been and may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Such litigation could be costly, time consuming, and distracting to management and could result in the impairment or loss of portions of our intellectual property. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay further sales or the implementation of our platform, impair the functionality of our platform, delay introductions of new features, integrations, and capabilities, result in our substituting inferior or more costly technologies into our platform, or injure our reputation. In addition, we may be required to license additional technology from third parties to develop and market new features, integrations, and capabilities, and we cannot be certain that we could license that technology on commercially reasonable terms or at all, and our inability to license this technology could harm our ability to compete.
If third parties claim that we infringe upon or otherwise violate their intellectual property rights, our business could be adversely affected.
We have in the past and may in the future be subject to claims that we have infringed or otherwise violated third parties’ intellectual property rights. There is patent, copyright and other intellectual property development and enforcement activity in our industry and relating to the additive manufacturing technology we use in our business. Our future success depends in part on not infringing upon or otherwise violating the intellectual property rights of others. From time to time, our competitors or other third parties (including
non-practicing
entities and patent holding companies) may claim that we are infringing upon or otherwise violating their intellectual property rights, and we may be found to be infringing upon or otherwise violating such rights. We may be unaware of the intellectual property rights of others that may cover some or all of our current or future technology or conflict with our rights, and the patent, copyright, and other intellectual property rights of others may limit our ability to improve our technology and compete effectively. Any claims of intellectual property infringement or other intellectual property violations, even those without merit, could:
 
  •  
be expensive and time consuming to defend;
 
  •  
cause us to cease making, licensing or using our platform or products that incorporate the challenged intellectual property;
 
  •  
require us to modify, redesign, reengineer or rebrand our platform or products, if feasible;
 
  •  
divert management’s attention and resources; or
 
  •  
require us to enter into royalty or licensing agreements to obtain the right to use a third-party’s intellectual property.
Any royalty or licensing agreements, if required, may not be available to us on acceptable terms or at all. A successful claim of infringement against us could result in our being required to pay significant damages, enter into costly settlement agreements, or prevent us from offering our platform or products, any of which could have a negative impact on our operating profits and harm our future prospects. We may also be obligated to indemnify our customers or business partners in connection with any such litigation and to obtain licenses, modify our platform or products, or refund premium subscription fees, which could further exhaust our resources. Such disputes could also disrupt our platform or products, adversely affecting our customer satisfaction and ability to attract customers.
 
91
If we are unable to adequately protect or enforce our intellectual property rights, such information may be used by others to compete against us, in particular in developing materials that could be used with our printing systems in place of our proprietary materials.
We have devoted substantial resources to the development of our technology and related intellectual property rights. Our success and future revenue growth will depend, in part, on our ability to protect our intellectual property. We rely on a combination of registered and unregistered intellectual property and protect our rights using patents, licenses, trademarks, trade secrets, confidentiality and assignment of invention agreements and other methods.
Despite our efforts to protect our proprietary rights, it is possible that competitors or other unauthorized third parties may obtain, copy, use or disclose our technologies, inventions, processes or improvements. We cannot assure you that any of our existing or future patents or other intellectual property rights will not be challenged, invalidated or circumvented, or will otherwise provide us with meaningful protection. Our pending patent applications may not be granted, and we may not be able to obtain foreign patents or pending applications corresponding to our U.S. patents. Even if foreign patents are granted, effective enforcement in foreign countries may not be available.
Our trade secrets,
know-how
and other unregistered proprietary rights are a key aspect of our intellectual property portfolio. While we take reasonable steps to protect our trade secrets and confidential information and enter into confidentiality and invention assignment agreements intended to protect such rights, such agreements can be difficult and costly to enforce or may not provide adequate remedies if violated, and we may not have entered into such agreements with all relevant parties. Such agreements may be breached and trade secrets or confidential information may be willfully or unintentionally disclosed, including by employees who may leave our company and join our competitors, or our competitors or other parties may learn of the information in some other way. The disclosure to, or independent development by, a competitor of any of our trade secrets,
know-how
or other technology not protected by a patent or other intellectual property system could materially reduce or eliminate any competitive advantage that we may have over such competitor. This concern could manifest itself in particular with respect to our proprietary materials that are used with our systems. Portions of our proprietary materials may not be afforded patent protection. Chemical companies or other producers of raw materials used in our materials may be able to develop materials that are compatible to a large extent with our products, whether independently or in contravention of our trade secret rights and related proprietary and contractual rights. If such materials are made available to owners of our systems, and are purchased in place of our proprietary materials, our revenues and profitability would be reduced, and we could be forced to reduce prices for our proprietary materials.
If our patents and other intellectual property do not adequately protect our technology, our competitors may be able to offer products similar to ours. Our competitors may also be able to develop similar technology independently or design around our patents and other intellectual property. Any of the foregoing events would lead to increased competition and reduce our revenue or gross margin, which would adversely affect our operating results.
If we attempt enforcement of our intellectual property rights, we may be, and have been in the past, subject or party to claims, negotiations or complex, protracted litigation. Intellectual property disputes and litigation, regardless of merit, can be costly and disruptive to our business operations by diverting attention and energies of management and key technical personnel and by increasing our costs of doing business. Any of the foregoing could adversely affect our business and financial condition.
As part of any settlement or other compromise to avoid complex, protracted litigation, we may agree not to pursue future claims against a third party, including related to alleged infringement of our intellectual property rights. Part of any settlement or other compromise with another party may resolve a potentially costly dispute but may also have future repercussions on our ability to defend and protect our intellectual property rights, which in turn could adversely affect our business.
Our additive manufacturing technology contains third-party open-source software components, and failure to comply with the terms of the underlying open-source software licenses could restrict our ability to commercialize our products.
Our additive manufacturing technology contains components that are licensed under
so-called
“open source,” “free” or other similar licenses. Open source software is made available to the general public on an
“as-is”
basis under the terms of a
non-negotiable
license. We currently combine our proprietary software with open source software and intend to continue doing so in the future. Additionally, we make some of our source code available under open source licenses, which may limit our ability to protect our intellectual property rights in our source code and prevent our competitors or others from using such source code. Our use and distribution of open source software may entail greater risks than use of third-party commercial software because open source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. In addition, if we combine our proprietary software with open source software in a certain manner, we could, under certain open source licenses, be required to disclose or make available the source code of our proprietary software to third parties. We may also face claims alleging noncompliance with open source license terms or infringement or misappropriation of third-party intellectual property rights in open source software. These claims could result in litigation, require us to purchase a costly license or remove the software. In addition, if the license terms for open source software that we use change, we may be forced to
re-engineer
our solutions, incur additional costs or discontinue the sale of our offerings if
re-engineering
could not be accomplished on a timely basis. Although we monitor our use of open source software to avoid subjecting our offerings to unintended conditions, there is a risk that these licenses could be construed in a way that could impose unanticipated conditions or restrictions on our ability to commercialize our offerings. We cannot guarantee that we have incorporated open source software in our software in a manner that will not subject us to liability or in a manner that is consistent with our current policies and procedures.
 
92
General Risk Factors
We will continue to incur increased costs as a result of operating as a public company, and our management are required to devote substantial time to new compliance initiatives.
As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes Oxley Act of 2002 and rules subsequently implemented by the Securities and Exchange Commission and NYSE have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance.
Pursuant to Section 404 of the Sarbanes Oxley Act of 2002 (the “Sarbanes Oxley Act”), we are required to furnish a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we remain an emerging growth company, we are not required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section 404 of the Sarbanes Oxley Act within the prescribed period, we are engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm are able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section 404 of the Sarbanes Oxley Act. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. In addition, if we are not able to continue to meet these requirements, we may not be able to remain listed on NYSE.
Changes in accounting rules and regulations, or interpretations thereof, could result in unfavorable accounting charges or require us to change our compensation policies.
Accounting methods and policies for public companies are subject to review, interpretation and guidance from our independent registered accounting firm and relevant accounting authorities, including the SEC. Changes to accounting methods or policies, or interpretations thereof, may require us to reclassify, restate or otherwise change or revise our consolidated financial statements.
Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.
We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls.
Our management team has limited experience managing a public company.
Our management team has limited experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws, rules and regulations that govern public companies. As a public company, we are subject to significant obligations relating to reporting, procedures and internal controls, and our management team may not successfully or efficiently manage such obligations. These obligations and scrutiny require significant attention from our management and could divert their attention away from the
day-to-day
management of our business, which could adversely affect our business, financial condition and results of operations.
 
93
Our internal controls over financial reporting currently do not meet all of the standards contemplated by Section 404 of the Sarbanes Oxley Act, and failure to achieve and maintain effective internal controls over financial reporting in accordance with Section 404 of the Sarbanes Oxley Act could impair our ability to produce timely and accurate financial statements or comply with applicable regulations and have a material adverse effect on our business.
We operated as a private company until July 2021. Our management has significant requirements for enhanced financial reporting and internal controls as a public company. The process of designing and implementing effective internal controls is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a system of internal controls that is adequate to satisfy our reporting obligations as a public company. If we are unable to establish or maintain appropriate internal financial reporting controls and procedures, it could cause us to fail to meet our reporting obligations on a timely basis or result in material misstatements in our consolidated financial statements, which could harm our operating results. In addition, we are required, pursuant to Section 404 of the Sarbanes Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment needs to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting.
The rules governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation. Testing and maintaining internal controls may divert management’s attention from other matters that are important to our business. Our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting on an annual basis. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal control over financing reporting issued by our independent registered public accounting firm. If we are not able to complete our initial assessment of our internal controls and otherwise implement the requirements of Section 404 of the Sarbanes Oxley Act in a timely manner or with adequate compliance, our independent registered public accounting firm may not be able to certify as to the adequacy of our internal control over financial reporting.
In addition to our results determined in accordance with GAAP, we believe certain
non-GAAP
measures may be useful in evaluating our operating performance. We present certain
non-GAAP
financial measures in this prospectus and intend to continue to present certain
non-GAAP
financial measures in future filings with the SEC and other public statements. Any failure to accurately report and present our
non-GAAP
financial measures could cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our common stock.
We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain effective internal control over financial reporting, which may result in material misstatements of our consolidated financial statements or cause us to fail to meet its periodic reporting obligations
.
In connection with the preparation of our consolidated financial statements, material weaknesses in our internal control over financial reporting were identified as of December 31, 2020. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. These material weaknesses are as follows:
 
  •  
We did not design and maintain an effective control environment commensurate with its financial reporting requirements. Specifically, we lacked a sufficient complement of resources with (i) an appropriate level of accounting knowledge, experience and training to appropriately analyze, record and disclose accounting matters timely and accurately, and (ii) an appropriate level of knowledge and experience to establish effective processes and controls. Additionally, the lack of a sufficient number of professionals resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuit of its financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. This material weakness contributed to the following additional material weaknesses:
 
  •  
We did not design and maintain effective controls related to the
period-end
financial reporting process, including designing and maintaining formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures. Additionally, we did not design and maintain controls over the preparation and review of account reconciliations and journal entries, including maintaining appropriate segregation of duties.
 
  •  
We did not design and maintain effective controls related to the identification of and accounting for certain
non-routine,
unusual or complex transactions, including the proper application of U.S. GAAP of such transactions. Specifically, we did not design and maintain controls to timely identify and account for share repurchase transactions and issuance of stock warrants.
These material weaknesses resulted in audit adjustments to the following financial statement line items: operating expense, other expense, interest expense, other assets, other liabilities, additional paid in capital, treasury stock, retained earnings, note receivable - equity, and series D preferred stock. These adjustments were recorded prior to the issuance of the consolidated financial statements as of and for the years ended December 31, 2020 and 2019. Additionally, these material weaknesses could result in a misstatement of substantially all of our accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
 
94
  •  
We did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of its financial statements. Specifically, we did not design and maintain (i) program change management controls for financial systems to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate Company personnel; (iii) computer operations controls to ensure that critical batch jobs are monitored, privileges are appropriately granted, and data backups are authorized and monitored; and (iv) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements. These IT deficiencies did not result in any misstatements to the financial statements, however, the deficiencies, when aggregated, could impact our ability to maintain effective segregation of duties, as well as the effectiveness of
IT-dependent
controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.
We will take certain measures to remediate the material weaknesses described above, including the following:
 
  •  
Hiring additional accounting and IT personnel, including a new chief financial officer, to bolster its reporting, technical accounting and IT capabilities.
 
  •  
Engaging a third party to assist in designing and implementing controls related to
period-end
financial reporting, segregation of duties, and IT general controls.
 
  •  
Designing and implementing controls to formalize roles and review responsibilities to align with the our team’s skills and experience and designing and implementing controls over segregation of duties.
 
  •  
Designing and implementing controls to timely identify and account for
non-routine,
unusual or complex transactions and other technical accounting and financial reporting matters, including controls over the preparation and review of accounting memoranda addressing these matters.
 
  •  
Designing and implementing formal accounting policies, procedures and controls supporting our
period-end
financial reporting process, including controls over the preparation and review of account reconciliations and journal entries.
 
  •  
Designing and implementing IT general controls, including controls over change management, the review and update of user access rights and privileges, controls over batch jobs and data backups, and program development approvals and testing.
We have begun to hire additional accounting and IT personnel, including the hiring of a new chief financial officer in March 2021, engaged third party resources to assist it in designing and implementing controls related to
period-end
financial reporting, segregation of duties, and IT general controls, and begun to implement appropriate segregation of duties in the operation of manual controls. The material weaknesses will not be considered remediated until management completes the design and implementation of the measures described above and the controls operate for a sufficient period of time and management has concluded, through testing, that these controls are effective.
We are working to remediate the material weaknesses as efficiently and effectively as possible and expects full remediation could potentially go beyond December 31, 2021. At this time, we cannot provide an estimate of costs expected to be incurred in connection with implementing this remediation plan; however, these remediation measures will be time consuming, will result in us incurring significant costs, and will place significant demands on our financial and operational resources.
Our ability to use net operating loss (“NOL”) carryforwards and other tax attributes may be limited in connection with the proposed business combination and other ownership changes.
We have incurred substantial losses during our history and our ability to become profitable in the near future is uncertain. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire (if at all). As of December 31, 2020, we had federal NOL carryforwards of approximately $65.3 million, of which $15.0 million are subject to expire at various times beginning in 2033, and $50.3 million that have no expiration date and will be carried forward indefinitely. We also had state NOL carryforwards of approximately $33.1 million that will begin to expire in 2027, unless previously utilized. On December 31, 2020, we had federal and state research and development credit carryforwards of approximately $2.0 million and $1.3 million, respectively. The federal research and development credit carryforwards will begin expiring in 2033 while the state credit carryforwards will begin expiring in 2029, unless previously utilized.
Federal NOLs incurred in tax years beginning after December 31, 2017 and before January 1, 2021 may be carried back to each of the five tax years preceding such loss, and NOLs arising in tax years beginning after December 31, 2020 may not be carried back. Because we have had no taxable income in prior years, we do not anticipate carrying back any of our net operating losses. Moreover, federal NOLs generated in taxable years ending after December 31, 2017, may be carried forward indefinitely, but the deductibility of such federal NOLs may be limited to 80% of our taxable income annually for tax years beginning after December 31, 2020. Our NOL carryforwards are subject to review and possible adjustment by the IRS, and state tax authorities. In addition, in general, under Sections 382 and 383 of the Code, a corporation that undergoes an “ownership change” is subject to limitations on its ability to utilize its pre-change NOLs or tax credits to offset future taxable income or taxes. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation’s stock increases their ownership by more than 50 percentage points over their lowest ownership percentage within a specified testing period. Our existing NOLs or credits may be subject to limitations arising from previous ownership changes, and if we undergo an ownership change in connection with, or undergo an ownership change following, the proposed business combination, our ability to utilize NOLs or credits could be further limited by Sections 382 and 383 of the Code. In addition, future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Sections 382 and 383 of the Code. Our NOLs or credits may also be impaired under state law. Accordingly, we may not be able to utilize a material portion of our NOLs or credits. If we determine that an ownership change has occurred and our ability to use our historical NOLs or credits is materially limited, it would harm our future operating results by effectively increasing our future tax obligations. Section 382 and 383 of the Code would apply to all net operating loss and tax credit carryforwards, whether the carryforward period is indefinite or not. If we earn taxable income, such limitations could result in increased future tax liability to us and our future cash flows could be adversely affected. We have recorded a full valuation allowance related to our NOLs and other deferred tax assets due to the uncertainty of the ultimate realization of the future benefits of those assets.
Comprehensive tax reform legislation could adversely affect our business and financial condition.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation that includes significant changes to the taxation of business entities. These changes include, among others, a permanent reduction to the corporate income tax rate. Notwithstanding the reduction in the corporate income tax rate, the overall impact of this tax reform is uncertain, and our business and financial condition could be adversely affected. The U.S. government in the future may enact additional legislation that affects the taxation of business entities, including with respect to the treatment of NOLs.
Further, the changes in tax laws could negatively impact our effective tax rate. Prior to the U.S. presidential election, President Biden proposed an increase in the U.S. corporate income tax rate from 21% to 28%, doubling the rate of tax on certain earnings of foreign subsidiaries, the creation of a 10% surtax on certain imports and a 15% minimum tax on worldwide book income. If any or all of these (or similar) proposals are ultimately enacted into law, in whole or in part, they could have a negative impact to our effective tax rate. Holders of our securities are urged to consult with their legal and tax advisors with respect to any such legislation and the potential tax consequences of holding our securities.
Currently, we incur losses in certain countries where we do not receive a financial statement benefit, and we operate in countries which have different statutory rates. Consequently, changes in the mix and source of earnings between countries could have a material impact on our overall effective tax rate.
 
95
Additional Risks Related to Ownership of Our Common Stock and Us Operating as a Public Company
The price of our common stock and warrants may be volatile.
The price of our Common Stock as well as our Warrants may fluctuate due to a variety of factors, including:
 
  •  
changes in the industries in which we and our customers operate;
 
  •  
developments involving our competitors;
 
  •  
changes in laws and regulations affecting its business;
 
  •  
variations in its operating performance and the performance of its competitors in general;
 
  •  
actual or anticipated fluctuations in our quarterly or annual operating results;
 
  •  
publication of research reports by securities analysts about us or our competitors or its industry;
 
  •  
the public’s reaction to our press releases, its other public announcements and its filings with the SEC;
 
  •  
actions by stockholders, including the sale by the PIPE Investors of any of their shares of our common stock;
 
  •  
additions and departures of key personnel;
 
  •  
commencement of, or involvement in, litigation involving the combined company;
 
  •  
changes in its capital structure, such as future issuances of securities or the incurrence of additional debt;
 
  •  
the volume of shares of our Common Stock available for public sale; and
 
  •  
general economic and political conditions, such as the effects of the
COVID-19
pandemic, recessions, interest rates, local and national elections, fuel prices, international currency fluctuations, corruption, political instability and acts of war or terrorism.
These market and industry factors may materially reduce the market price of our Common Stock and warrants regardless of the operating performance of us.
We do not intend to pay cash dividends for the foreseeable future.
We currently intend to retain our future earnings, if any, to finance the further development and expansion of our business and do not intend to pay cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as its board of directors deems relevant.
If analysts do not publish research about our business or if they publish inaccurate or unfavorable research, our stock price and trading volume could decline.
The trading market for our common stock depends in part on the research and reports that analysts publish about our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, the price of our common stock would likely decline. If few analysts cover us, demand for our common stock could decrease and our common stock price and trading volume may decline. Similar results may occur if one or more of these analysts stop covering us in the future or fail to publish reports on us regularly.
We may be subject to securities litigation, which is expensive and could divert management attention.
The market price of our common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert management’s attention from other business concerns, which could seriously harm our business.
Future resales of common stock may cause the market price of our securities to drop significantly, even if our business is doing well.
Pursuant to the
lock-up
restrictions agreed to into in connection with the Merger Agreement, subject to certain exceptions, the Sponsor and certain related parties and certain of our Stockholders (who collectively own approximately 77.6% of our outstanding Common Stock) are contractually restricted from selling or transferring any of its or their shares of common stock (the
“Lock-up
Shares”). Such restrictions began at Closing and end 180 days after Closing. The
lock-up
restrictions described above supersede the
lock-up
provisions set forth in Section 7 of that certain letter agreement, dated as of August 17, 2020, by and among AONE, the Sponsor and each of the other parties thereto (the “Insider Letter”) which provisions in Section 7 of the Insider Letter shall be of no further force or effect as of the date of the Registration Rights Agreement and the
Lock-Up
Agreement.
However, following the expiration of the respective lockups described above, the Sponsor and our Stockholders will not be restricted from selling shares of our Common Stock held by them, other than by applicable securities laws. In addition, upon certain events, up to 2,610,000 Sponsor Earnout Shares will vest and become salable by Sponsor or its transferees. Additionally, the PIPE Investors will not be restricted from selling any of the shares of our Common Stock acquired in the PIPE Investment, other than by applicable securities laws. As such, sales of a substantial number of shares of our Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock. The Sponsor and the Markforged Stockholders collectively own approximately 80.1% of the outstanding shares of our Common Stock.
 
96
The shares held by Sponsor and our Stockholders may be sold after the expiration of the applicable
lock-up
periods agreed to in connection with the Merger Agreement. As restrictions on resale end, and registration statements (filed after the Closing to provide for the resale of such shares from time to time) are available for use, the sale or possibility of sale of these shares could have the effect of increasing the volatility in our share price, or the market price of our Common Stock could decline if the holders of currently restricted shares sell them or are perceived by the market as intending to sell them.
The obligations associated with being a public company involve significant expenses and require significant resources and management attention, which may divert from our business operations.
As a public company, we are subject to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act. The Exchange Act requires the filing of annual, quarterly and current reports with respect to a public company’s business and financial condition. The Sarbanes-Oxley Act requires, among other things, that a public company establish and maintain effective internal control over financial reporting. As a result, we incur significant legal, accounting and other expenses that we did not previously incur. Our entire management team and many of its other employees will need to devote substantial time to compliance, and may not effectively or efficiently manage its transition into a public company.
These rules and regulations result in us incurring substantial legal and financial compliance costs and make some activities more time-consuming and costly. For example, these rules and regulations will likely make it more difficult and more expensive for us to obtain director and officer liability insurance, and it may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be difficult for us to attract and retain qualified people to serve on its board of directors, its board committees or as executive officers.
We are currently an emerging growth company within the meaning of the Securities Act, and to the extent we have taken advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
We are currently an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.
When we cease to be an emerging growth company, we will no longer be able to take advantage of certain exemptions from reporting, and, absent other exemptions or relief available from the SEC, we will also be required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We will incur additional expenses in connection with such compliance and our management will need to devote additional time and effort to implement and comply with such requirements.
Delaware law and the Organizational Documents contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
The Organizational Documents and the DGCL contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, and therefore depress the trading price of our Common Stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of our board of directors or taking other corporate actions, including effecting changes in our management. Among other things, the Organizational Documents include provisions regarding:
 
  •  
the ability of our board of directors to issue shares of preferred stock, including “blank check” preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
 
  •  
the board of directors are classified into three classes, with only one class being elected each year to serve three-year terms. As a result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual stockholders meetings;
 
  •  
the certificate of incorporation will prohibit cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;
 
97
  •  
the limitation of the liability of, and the indemnification of, our directors and officers;
 
  •  
the ability of our board of directors to amend the bylaws, which may allow our board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and
 
  •  
advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our board of directors and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of us.
These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our board of directors or management.
The provisions of the Bylaws requiring exclusive forum in the Court of Chancery of the State of Delaware and the federal district courts of the United States for certain types of lawsuits may have the effect of discouraging certain lawsuits, including derivative lawsuits and lawsuits against the directors and officers of us, by limiting plaintiffs’ ability to bring a claim in a judicial forum that they find favorable.
The Bylaws provide that, to the fullest extent permitted by law, and unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that such court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on behalf of us, (ii) any action asserting a claim for or based on a breach of a fiduciary duty owed by any current or former director, officer or other employee of us to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL or the Bylaws or Certificate of Incorporation (as either may be amended from time to time) (including the interpretation, validity and enforceability thereof), (iv) any action asserting a claim related to or involving us that is governed by the internal affairs doctrine, and (v) any action asserting an “internal corporate claim” as that term is defined in Section 115 of the DGCL (the “Delaware Forum Provision”). The Delaware Forum Provision, however, does not apply to actions or claims arising under the Exchange Act. The Bylaws also provide that, unless we consent in writing to the selection of an alternate forum, the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act, and the rules and regulations promulgated thereunder, will be the Federal District Courts of the United States (the “Federal Forum Provision,” and with the Delaware Forum Provision, the “Exclusive Forum Provisions”). In addition, the Bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision. However, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder; our cannot and will not be deemed to have waived compliance with the U.S. federal securities laws and the rules and regulations thereunder.
These provisions may impose additional litigation costs on stockholders in pursuing any such claims and have the effect of discouraging certain lawsuits, including derivative lawsuits and lawsuits against our directors and officers of, by limiting plaintiffs’ ability to bring a claim in a judicial forum that they find favorable. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are “facially valid” under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid, and if the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Court of Chancery of the State of Delaware and the Federal District Courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.
The private placement warrants are being accounted for as a warrant liability and are being recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our Common Stock.
Under U.S. GAAP, we are required to evaluate our warrants to determine whether they should be accounted for as a warrant liability or as equity. We have concluded that the warrants contain provisions requiring liability classification. Therefore, as described in the financial statements of AONE included herein, we are accounting for the warrants as a warrant liability and are recording that liability at fair value upon issuance. We will record any subsequent changes in fair value as of the end of each period for which earnings are reported. The impact of changes in fair value on earnings may have an adverse effect on the market price of our common stock and may cause fluctuations in our results of operations based on factors that are outside of our control.
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
None.
 
Item 3.
Defaults upon Senior Securities
None.
 
Item 4.
Mine Safety Disclosures.
Not applicable.
 
Item 5.
Other Information.
None.
 
98
Item 6.
Exhibits.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form
10-Q.
 
Exhibit

Number
   
Description
   
2.1    Agreement and Plan of Merger, dated as of February 23, 2021, by and among one, Caspian Merger Sub Inc., and MarkForged, Inc. (incorporated by reference to Exhibit 2.1 to one’s Registration Statement on Form S-4/A filed June 4, 2021).
   
3.1    Certificate of Incorporation of Markforged Holding Corporation (incorporated by reference to Exhibit 3.1 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
3.2    Bylaws of Markforged Holding Corporation (incorporated by reference to Exhibit 3.2 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
4.1    Specimen Common Stock Certificate of Markforged Holding Corporation (incorporated by reference to Exhibit 4.5 to one’s Registration Statement on Form S-4/A filed June 4, 2021).
   
4.2    Warrant Agreement, dated as of August 17, 2020, between one and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.4 to one’s Registration Statement on Form S-4/A filed June 4, 2021).
   
10.1    Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
10.2    2021 Stock Option and Incentive Plan of Markforged Holding Corporation and forms of agreement thereunder. (incorporated by reference to Exhibit 10.2 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
10.3    Form of Subscription Agreement, by and between the Registrant and the undersigned subscriber party thereto (incorporated by reference to Exhibit 10.17 to one’s Registration Statement on Form S-4/A filed June 4, 2021).
   
10.4    Registration Rights Agreement, dated as of July 14, 2021, by and among Markforged Holding Corporation, A-star, certain affiliates of A-star and certain former stockholders of MarkForged, Inc. (incorporated by reference to Exhibit 10.5 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
10.5    Sponsor Support Agreement, dated February 23, 2021, by and among A-Star LLC, one, each director and officer of one and MarkForged, Inc. (incorporated by reference to Exhibit 10.15 to one’s Registration Statement on Form S-4/A filed June 4, 2021).
   
10.6    Lock-Up Agreement, dated as of July 14, 2021, by and between Markforged Holding Corporation, Inc. and the undersigned parties thereto (incorporated by reference to Exhibit 10.8 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
10.7    Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.9 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
10.8    2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.10 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
10.9    Senior Executive Incentive Cash Bonus Plan (incorporated by reference to Exhibit 10.11 to Markforged Holding Corporation’s Current Report on Form 8-K filed July 20, 2021).
   
31.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS*    Inline XBRL Instance Document
   
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
   
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB*    Inline XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
*
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
99
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: August 12, 2021    
Markforged Holding Corporation
    By:   /s/ Shai Terem
    Name:   Shai Terem
    Title:   President and Chief Executive Officer (Principal Executive Officer)
    By:   /s/ Mark Schwartz
    Name:  
Mark Schwartz
    Title:   Chief Financial Officer (Principal Financial and Accounting Officer)
 
100
EX-31.1 2 d187897dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shai Terem, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 of Markforged Holding Corporation;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: August 12, 2021     By:   /s/ Shai Terem
            Shai Terem
            Chief Executive Officer
            (Principal Executive Officer)
 EX-31.2 3 d187897dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark Schwartz, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 of Markforged Holding Corporation;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: August 12, 2021     By:   /s/ Mark Schwartz
            Mark Schwartz
            Chief Financial Officer
            (Principal Financial and Accounting Officer)
 EX-32.1 4 d187897dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Markforged Holding Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Shai Terem, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2021

 

/s/ Shai Terem

Name:   Shai Terem
Title:   Chief Executive Officer
    (Principal Executive Officer)
 EX-32.2 5 d187897dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Markforged Holding Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Schwartz, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2021

 

/s/ Mark Schwartz

Name:   Mark Schwartz
Title:   Chief Financial Officer
    (Principal Financial and Accounting Officer)
 EX-101.SCH 6 mkfg-20210630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Unaudited Condensed Consolidated Statements Of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Unaudited Condensed Consolidated Statement Of Changes In Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Unaudited Condensed Consolidated Statement Of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - DERIVATIVE WARRANT LIABILITIES link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Reconciliation of Net Loss Per Ordinary Share (Details) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - INITIAL PUBLIC OFFERING (Details) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - RELATED PARTY TRANSACTIONS - Working Capital and Support (Details) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - SHAREHOLDERS' EQUITY - Preference Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - SHAREHOLDERS' EQUITY - Ordinary Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Detail) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 mkfg-20210630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 mkfg-20210630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 mkfg-20210630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 mkfg-20210630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 d187897d10q_htm.xml IDEA: XBRL DOCUMENT 0001816613 2020-12-31 0001816613 2021-06-30 0001816613 2020-06-24 2020-06-30 0001816613 2021-01-01 2021-06-30 0001816613 2021-04-01 2021-06-30 0001816613 2020-01-01 2020-12-31 0001816613 2020-07-01 2020-09-30 0001816613 2021-01-01 2021-03-31 0001816613 2020-08-20 0001816613 2020-09-30 0001816613 2021-08-09 0001816613 2021-07-14 2021-07-14 0001816613 2021-07-14 0001816613 2020-06-23 0001816613 2020-06-30 0001816613 2021-03-31 0001816613 us-gaap:OverAllotmentOptionMember 2020-08-20 2020-08-20 0001816613 us-gaap:IPOMember 2020-08-20 2020-08-20 0001816613 us-gaap:CommonClassBMember 2020-08-20 2020-08-20 0001816613 us-gaap:PrivatePlacementMember 2020-08-20 2020-08-20 0001816613 us-gaap:PrincipalOwnerMember us-gaap:CommonClassBMember 2020-08-20 2020-08-20 0001816613 mkfg:PrivatePlacementWarrantMember 2020-12-31 0001816613 us-gaap:CommonClassAMember 2020-12-31 0001816613 us-gaap:CommonClassBMember 2020-12-31 0001816613 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryBillSecuritiesMember 2020-12-31 0001816613 mkfg:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001816613 mkfg:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001816613 us-gaap:LineOfCreditMember us-gaap:PrincipalOwnerMember 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember us-gaap:CommonClassBMember 2020-06-26 0001816613 us-gaap:CommonClassBMember 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember 2020-09-01 2020-09-30 0001816613 us-gaap:PrincipalOwnerMember 2020-09-30 0001816613 us-gaap:OverAllotmentOptionMember 2020-09-30 0001816613 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001816613 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001816613 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001816613 us-gaap:PrivatePlacementMember 2020-08-20 0001816613 us-gaap:IPOMember 2020-08-20 0001816613 us-gaap:CommonClassBMember 2020-08-20 0001816613 mkfg:FiveIndividualsMember us-gaap:PrincipalOwnerMember 2020-08-10 2020-08-10 0001816613 mkfg:OneIndividualMember us-gaap:PrincipalOwnerMember 2020-08-10 2020-08-10 0001816613 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001816613 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001816613 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001816613 us-gaap:PrivatePlacementMember 2021-06-30 0001816613 mkfg:PublicWarrantMember 2021-06-30 0001816613 us-gaap:CommonClassAMember 2021-06-30 0001816613 us-gaap:CommonClassBMember 2021-06-30 0001816613 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001816613 mkfg:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001816613 mkfg:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001816613 us-gaap:WarrantMember 2021-06-30 0001816613 us-gaap:IPOMember 2021-06-30 0001816613 us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001816613 us-gaap:CommonClassBMember 2021-04-01 2021-06-30 0001816613 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001816613 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-06-24 2020-06-30 0001816613 us-gaap:CommonClassBMember 2020-06-24 2020-06-30 0001816613 us-gaap:RetainedEarningsMember 2020-06-24 2020-06-30 0001816613 us-gaap:LineOfCreditMember us-gaap:PrincipalOwnerMember 2020-06-26 2020-06-26 0001816613 us-gaap:PrincipalOwnerMember 2020-06-26 2020-06-26 0001816613 us-gaap:CommonClassBMember 2020-07-01 2020-09-30 0001816613 us-gaap:OverAllotmentOptionMember 2020-07-01 2020-09-30 0001816613 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001816613 mkfg:AfterDomesticationMember us-gaap:CommonClassAMember 2021-07-14 2021-07-14 0001816613 mkfg:AfterDomesticationMember us-gaap:CommonClassBMember 2021-07-14 2021-07-14 0001816613 mkfg:MarkforgedIncMember 2021-07-14 2021-07-14 0001816613 us-gaap:CommonClassAMember mkfg:AOneMember 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember 2021-07-14 2021-07-14 0001816613 mkfg:VolumeWeightedAverageSharePriceAtleast12.50Member us-gaap:SubsequentEventMember 2021-07-14 2021-07-14 0001816613 mkfg:VolumeWeightedAverageSharePriceAtleast15.00Member us-gaap:SubsequentEventMember 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember mkfg:VolumeWeightedAveragePriceAtleastTwelvePointFiveMember 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember mkfg:VolumeWeightedAveragePriceAtleastFifteenMember 2021-07-14 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:PipeInvestorsMember mkfg:AOneMember 2021-07-14 2021-07-14 0001816613 mkfg:BeforeDomesticationMember us-gaap:CommonClassAMember 2021-07-14 0001816613 mkfg:AfterDomesticationMember us-gaap:CommonClassAMember 2021-07-14 0001816613 mkfg:BeforeDomesticationMember us-gaap:CommonClassBMember 2021-07-14 0001816613 mkfg:AfterDomesticationMember us-gaap:CommonClassBMember 2021-07-14 0001816613 mkfg:MarkforgedIncMember 2021-07-14 0001816613 us-gaap:CommonClassAMember mkfg:AOneMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember mkfg:VolumeWeightedAveragePriceAtleastTwelvePointFiveMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:SponsorSupportAgreementMember mkfg:VolumeWeightedAveragePriceAtleastFifteenMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:PipeInvestorsMember mkfg:AOneMember 2021-07-14 0001816613 us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember 2021-07-14 0001816613 mkfg:MarkforgedHoldingCorporation2021EmployeeStockPurchasePlanMember us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember 2021-07-14 0001816613 mkfg:MarkforgedEarnoutSharesAndEarnoutRsusmemberMember us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember 2021-07-14 0001816613 mkfg:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember mkfg:MarkforgedHoldingCorporationMember 2021-07-14 0001816613 us-gaap:RetainedEarningsMember 2020-12-31 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001816613 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001816613 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001816613 us-gaap:RetainedEarningsMember 2021-03-31 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001816613 us-gaap:CommonClassBMember 2021-03-31 0001816613 us-gaap:CommonClassAMember 2021-03-31 0001816613 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001816613 us-gaap:RetainedEarningsMember 2021-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001816613 us-gaap:RetainedEarningsMember 2020-06-23 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-06-23 0001816613 us-gaap:CommonClassBMember 2020-06-23 0001816613 us-gaap:CommonClassAMember 2020-06-23 0001816613 us-gaap:RetainedEarningsMember 2020-06-30 0001816613 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001816613 us-gaap:CommonClassBMember 2020-06-30 0001816613 us-gaap:CommonClassAMember 2020-06-30 iso4217:USD shares pure utr:Day utr:Year iso4217:USD shares 0.25 false Q2 --12-31 Markforged Holding Corp 0001816613 MA 10-Q true 2021-06-30 2021 false DE 001-39453 98-1545859 480 Pleasant Street Watertown 02472 866 496-1805 Common Stock, $0.0001 par value per share MKFG NYSE Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, $0.0001 par value MKFG.WS NYSE No Yes Non-accelerated Filer true true false true 185251837 306896 919823 248596 314351 555492 1234174 215099354 215076225 215654846 216310399 4921 115360 2715966 24847 2720887 140207 7525000 7525000 19607500 17902500 29853387 25567707 0.0001 0.0001 18080145 18574269 10.00 10.00 180801450 185742690 0.0001 0.0001 1000000 1000000 0 0 0 0 0 0.0001 0.0001 400000000 400000000 3419855 3419855 2925731 2925731 18080145 18574269 342 293 0.0001 0.0001 10000000 10000000 5375000 5375000 5375000 5375000 538 538 12551921 7610730 -7552792 -2611559 5000009 5000002 215654846 216310399 1104977 3199362 11030 30000 60000 -1134977 -3259362 -11030 -3069000 1705000 3248 23129 1937271 -4941233 -11030 21500000 21500000 0.00 0.00 5375000 5375000 5000000 0.36 -0.92 0.00 2925731 293 5375000 538 7610730 -2611559 5000002 -687851 -68 -6878442 -6878510 -6878504 -6878504 3613582 361 5375000 538 14489172 -9490063 5000008 193727 19 1937251 1937270 1937271 1937271 3419855 342 5375000 538 12551921 -7552792 5000009 0 0 0 0 0 0 0 5750000 575 24425 25000 -11030 -11030 0 0 5750000 575 24425 -11030 13970 -4941233 -11030 1705000 23129 -65755 -110439 2691119 11030 -612927 -612927 919823 306896 158237 8000 25000 4941240 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1 — Description of Organization and Business Operations </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and General </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Markforged Holding Corporation is an additive manufacturing company. Our platform, The Digital Forge, is an intuitive additive manufacturing platform powering engineers, designers and manufacturing professionals globally. The Digital Forge combines precise and reliable 3D printers and metal and composite proprietary materials seamlessly with its cloud-based learning software offering to empower manufacturers to create more resilient and agile supply chains. Founded in 2013 by two <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">MIT-educated</div> engineers, we are a company of over 300 engineers, builders and problem solvers. We are based in greater Boston, Massachusetts, where we have our own <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-house</div> manufacturing facility and where we design all of our industrial 3D printers, software and metal and composite proprietary materials. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">one (when referred to prior to the Business Combination, the “Company”) was an incorporated blank check company incorporated in the Cayman Islands on June 24, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021, the Company had not yet commenced operations. All activity for the period from June 24, 2020 (inception) through June 30, 2021 relates to the Company’s formation and its preparation for the initial public offering (“Initial Public Offering”), which is described below, and since the offering, the search for a prospective initial Business Combination. The Company did not generate any operating revenue prior to the completion of the Business Combination. The Company generateed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of income earned on investments on cash and cash equivalents in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Sponsor and Initial Public Offering </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s sponsor was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-star,</div> a Cayman Islands </div>exempted limited partnership (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on August 17, 2020. On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,500,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions (Note 5). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,150,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million (Note 4). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Trust Account </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">Upon the closing of the Initial Public Offering and the Private Placement, $215.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States, with Continental Stock Transfer &amp; Trust Company acting as trustee, and will be invested by the trustee only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> of the Investment Company Act, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Initial Business Combination </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management had broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds were intended to be applied generally toward consummating a Business Combination. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company provided its holders (the “Public Shareholders”) of its Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The Public Shareholders were entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount distributed to Public Shareholders who redeemed their Public Shares was not be reduced by the deferred underwriting commissions the Company paid to the underwriters (as discussed in Note 5). These Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021, by and among one, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of one, and MarkForged, Inc., a Delaware corporation. On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Domestication Proposal</div></div>” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 filed with the Securities and Exchange Commission, the Company filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which one was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”). </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> 21500000 1500000 10.00 215000000.0 12400000 7500000 3150000 2.00 6300000 215000000.0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2 — Summary of Significant Accounting Policies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of presentation </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K/A</div> filed by the Company with the SEC on May 14, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging growth company </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had no cash equivalents. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments Held in the Trust Account </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></div></td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measuremen<div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div> is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2021, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. As of June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses NAV as a practical expedient to fair value for its investments in money market funds. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Warrant Liabilities </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15.</div> The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The 5,375,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">warrants </div>issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,150,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 18,080,145 and 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 10pt; text-align: left;;font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve month<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div>. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) per Ordinary Share </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">For the three and six months ended June 30, 2021, the Company’s unaudited condensed statements of operations includes a presentation of income (loss) per Class A ordinary share subject to redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of income (loss) per share. Net income per Class A ordinary share, basic and diluted, is calculated by dividing the investment income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per Class B ordinary share, basic and diluted, is calculated by dividing the net loss, less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the periods. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary shares price for the period and therefore the inclusion of such warrants would be anti-dilutive. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share: </div></div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A ordinary share</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income from investments held in Trust Account</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,248</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">23,129</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Company’s portion available to be withdrawn to pay taxes</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,248</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">23,129</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted average Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        21,500,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        21,500,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per share, Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.00</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.00</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt;"> </td> <td colspan="4" style="height: 12pt;"> </td> <td colspan="4" style="height: 12pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class B ordinary share</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net income (loss) minus net income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,937,271</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4,941,233</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,248</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">23,129</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss) attributable to Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,934,023</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(4,964,362</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted average Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,375,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,375,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income (loss) per share, Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.36</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.92</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 10pt;;font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements</div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of presentation </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K/A</div> filed by the Company with the SEC on May 14, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging growth company </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> 250000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had no cash equivalents. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments Held in the Trust Account </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></div></td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measuremen<div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div> is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2021, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. As of June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses NAV as a practical expedient to fair value for its investments in money market funds. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Warrant Liabilities </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15.</div> The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The 5,375,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">warrants </div>issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,150,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model. </div></div> 5375000 3150000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 18,080,145 and 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets. </div></div></div> 18080145 18574269 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 10pt; text-align: left;;font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve month<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div>. </div></div></div> 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) per Ordinary Share </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">For the three and six months ended June 30, 2021, the Company’s unaudited condensed statements of operations includes a presentation of income (loss) per Class A ordinary share subject to redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of income (loss) per share. Net income per Class A ordinary share, basic and diluted, is calculated by dividing the investment income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per Class B ordinary share, basic and diluted, is calculated by dividing the net loss, less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the periods. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary shares price for the period and therefore the inclusion of such warrants would be anti-dilutive. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share: </div></div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A ordinary share</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income from investments held in Trust Account</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,248</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">23,129</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Company’s portion available to be withdrawn to pay taxes</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,248</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">23,129</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted average Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        21,500,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        21,500,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per share, Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.00</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.00</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt;"> </td> <td colspan="4" style="height: 12pt;"> </td> <td colspan="4" style="height: 12pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class B ordinary share</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net income (loss) minus net income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,937,271</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4,941,233</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,248</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">23,129</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss) attributable to Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,934,023</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(4,964,362</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted average Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,375,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,375,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income (loss) per share, Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.36</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.92</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> 0 <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share: </div></div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A ordinary share</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income from investments held in Trust Account</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,248</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">23,129</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Company’s portion available to be withdrawn to pay taxes</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,248</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">23,129</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted average Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        21,500,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        21,500,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per share, Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.00</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.00</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt;"> </td> <td colspan="4" style="height: 12pt;"> </td> <td colspan="4" style="height: 12pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class B ordinary share</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net income (loss) minus net income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,937,271</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4,941,233</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income allocable to Class A ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,248</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">23,129</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss) attributable to Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,934,023</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(4,964,362</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted average Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding, Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,375,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,375,000</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income (loss) per share, Class B ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0.36</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.92</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> 3248 23129 0 0 3248 23129 21500000 21500000 0.00 0.00 1937271 -4941233 3248 23129 1934023 -4964362 5375000 5375000 0.36 -0.92 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 10pt;;font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements</div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 3 — Initial Public Offering </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 Units, including 1,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Each Unit consists of one Class A ordinary share, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden24951309">one-fourth</span></div> of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary shares at a price of $11.50 per share, subject to adjustment (see Note 6). </div> 21500000 1500000 10.00 215000000.0 12400000 7500000 1 1 1 11.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 4 — Related Party Transactions </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On June 26, 2020, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). Up to 750,000 Founder Shares were subject to forfeiture to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On August 10, 2020, the Sponsor transferred 25,000 Founder Shares to each of Michelle Gill, Lachy Groom, Gautam Gupta, Trina Spear, and Laura de Petra, and 30,000 Founder Shares to Pierre Lamond. On August 20, 2020, the underwriters exercised their over-allotment option and, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-</div> trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Private Placement Warrants </div></div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 3,150,000 Private Placement Warrants at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the consummation of the Business Combination, each warrant was exercisable to purchase</div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> one<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share at </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$11.50 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company did not complete a Business Combination within the Combination Period, the Private Placement Warrants would have expired worthless. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Sponsor Loan </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On June 26, 2020, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and payable on the earlier of December 31, 2020 or the completion of the Initial Public Offering. The Company borrowed approximately $163,000 under the Note, and fully repaid the Note on August 20, 2020. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Working Capital Loans </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $2.00 per warrant. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Support Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company agreed to pay the Sponsor a total of $10,000 per month, commencing on date the Company’s securities are first listed on the New York Stock Exchange (the “listing date”), for office space, secretarial and administrative services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the three and six months ended June 30, 2021, the Company incurred $30,000 and $60,000, respectively for expenses in connection with the Administrative Support Agreement. </div></div> 25000 0.004 5750000 0.0001 750000 0.200 25000 30000 375000 0 12.00 20 30 P150D 3150000 2.00 6300000 1 11.50 P30D 300000 163000 1500000 2.00 0 10000 30000 60000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 5 — Commitments and Contingencies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration and Shareholder Rights </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of Founder Sha<div style="letter-spacing: 0px; top: 0px;;display:inline;">r</div>es, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, were entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, these holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On August 20, 2020, the underwriters exercised their over-allotment option of 1,500,000 Units and, an aggregate of 375,000 Class B ordinary shares were forfeited by the Sponsor for no consideration accordingly. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $7.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks and Uncertainties </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div> three 1500000 375000 0 0.20 4300000 0.35 7500000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 6 — Derivative Warrant Liabilities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2021 and December 31, 2020, the Company has 5,375,000 and 3,150,000 Public Warrants and Private Placement Warrants, respectively, outstanding. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The warrants have an exercise price of at $11.50 per share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants): </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $<div style="letter-spacing: 0px; top: 0px;;display:inline;">0.01</div> per warrant; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon a minimum of <div style="letter-spacing: 0px; top: 0px;;display:inline;">30 days</div>’ prior written notice of redemption; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $<div style="letter-spacing: 0px; top: 0px;;display:inline;">18.00</div> per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any <div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div> trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div>-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the warrants: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below); </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, there is an effective registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> period after written notice of redemption is given. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The “fair market value” of the Class A ordinary shares shall mean the volume weighted average price of the Class A ordinary shares as reported during the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div> 5375000 3150000 P30D P12M P60D 11.50 P5Y 9.20 0.50 P20D 9.20 1.15 18.00 P10D <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7 — Shareholders’ Equity </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares</div></div></div></div> - The Company is authorized to issue 1,000,000 preference with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Shares</div></div></div></div> - The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2021, there were 21,500,000 Class A ordinary shares issued or outstanding, including 18,080,145 Class A ordinary shares subject to possible redemption. As of December 31, 2020, there were 21,500,000 Class A ordinary shares issued or outstanding, including 18,574,269 Class A ordinary shares subject to possible redemption. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B Ordinary Shares</div></div></div></div> - The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. At August 20, 2020, there were 5,750,000 Class B ordinary shares issued and outstanding, of which an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On August 20, 2020, the underwriters exercised their over-allotment option in part and, accordingly, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly. As of June 30, 2021 and December 31, 2020, there were 5,375,000 Class B ordinary shares outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity- linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants that may be issued upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one. </div> 1000000 1000000 0 0 0 0 400000000 400000000 0.0001 0.0001 21500000 18080145 21500000 18574269 10000000 10000000 0.0001 0.0001 one 5750000 750000 0.20 375000 0 5375000 5375000 0.20 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8 — Fair Value Measurements </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30, 2021 </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market fund</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">215,099,354</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Public</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,362,500</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Private</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">7,245,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">December 31, 2020</div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S Treasury bills maturing on February 18, 2021</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">215,076,225</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Public</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">11,287,500</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Private</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">6,615,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in October 202<div style="letter-spacing: 0px; top: 0px;;display:inline;">0</div>, when the Public Warrants were separately listed and traded. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1 instruments include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The estimated fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June 30, 2021, the Company recognized a gain to the condensed statement of operations resulting from an decrease in the fair value of liabilities of $3.1 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statement of operations. For the six months ended June 30, 2021, the Company recognized a charge to the statement of operations resulting from an increase in the fair value of liabilities of $1.7 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statement of operations. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Binomial Lattice model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 68%;"/> <td style="width: 13%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of<br/> December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">25.8</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">36.2</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10.77</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">9.98</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.43</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.88</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative warrant liabilities as classified level 3 for the three and six months ended June 30, 2021 is summarized as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 84%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - Derivative warrant liabilities at December 31, 2020</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">6,615,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,764,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - Derivative warrant liabilities at March 31, 2021</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,379,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,134,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - Derivative warrant liabilities at June 30, 2021</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">7,245,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30, 2021 </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market fund</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">215,099,354</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Public</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,362,500</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Private</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">7,245,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">December 31, 2020</div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S Treasury bills maturing on February 18, 2021</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">215,076,225</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Public</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">11,287,500</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Private</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">6,615,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 215099354 12362500 7245000 215076225 11287500 6615000 -3100000 1700000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 68%;"/> <td style="width: 13%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of<br/> December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">25.8</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">36.2</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10.77</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">9.98</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.43</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.88</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 0.258 0.362 10.77 9.98 0.0043 0.0088 0.000 0.000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative warrant liabilities as classified level 3 for the three and six months ended June 30, 2021 is summarized as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 84%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - Derivative warrant liabilities at December 31, 2020</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">6,615,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,764,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - Derivative warrant liabilities at March 31, 2021</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,379,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,134,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - Derivative warrant liabilities at June 30, 2021</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">7,245,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> 6615000 1764000 8379000 -1134000 7245000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 9 — Subsequent Events </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company (“AONE”), a Cayman Islands exempted company, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021 (the “Merger Agreement”), by and among AONE, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of AONE (“Merger Sub”), and MarkForged, Inc., a Delaware corporation (“Markforged”). </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Domestication Proposal</div></div>” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 (the “Proxy Statement/Prospectus”) and filed with the Securities and Exchange Commission (the “SEC”), AONE filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which AONE was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As a result of and upon the effective time of the Domestication, among other things, (i) each of the then issued and outstanding Class A ordinary shares, par value $0.0001 per share, of AONE (the “Class A Ordinary Shares”) automatically converted, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into a share of common stock, par value $0.0001 per share, of Markforged Holding Corporation (the “New Common Stock”); (ii) each of the then issued and outstanding Class B ordinary shares, par value $0.0001 per share, of AONE (the “Class B Ordinary Shares”) automatically converted, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into shares of New Common Stock; (iii) each of the then issued and outstanding redeemable warrants of AONE (the “AONE Warrants”) automatically converted, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into redeemable warrants to acquire one share of New Common Stock (the “New Warrants”); and (iv) each of the then issued and outstanding units of AONE that had not been previously separated into the underlying Class A Ordinary Shares and underlying AONE Warrants upon the request of the holder thereof were cancelled and entitled the holder thereof to one share of New Common Stock and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-fourth</div> of one New Warrant. No fractional New Warrants were issued, and no fractional shares of New Common Stock were issued or will be issuable upon the exercise of New Warrants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July 13, 2021, AONE held an extraordinary general meeting of stockholders (the “Special Meeting”), at which the AONE stockholders considered and adopted, among other matters, a proposal to approve the Merger (as defined below), including approving the other transactions contemplated by the Merger Agreement and related agreements described in the Proxy Statement/Prospectus. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">BCA Proposal</div></div>” beginning on page 98 of the Proxy Statement/Prospectus, Markforged Holding Corporation consummated the merger transaction contemplated by the Merger Agreement, whereby Merger Sub merged with and into Markforged, with the separate corporate existence of Merger Sub ceasing and Markforged being the surviving corporation and a wholly owned subsidiary of Markforged Holding Corporation (the “Merger” and, together with the Domestication, the “Transactions”). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Immediately prior to the effective time of the Merger (the “Effective Time”), Markforged purchased approximately $45.0 million of its securities from certain of its stockholders (the “Employee Transactions”), and each outstanding share of Markforged preferred stock was converted on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis into shares of Markforged common stock, par value $0.0001 per share (the “Markforged Common Stock”) (the “Preferred Stock Conversion”). Holders of 6,418,667 Class A Ordinary Shares sold in AONE’s initial public offering properly exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from AONE’s initial public offering, calculated as of two business days prior to the consummation of the Merger, which was approximately $10.005 per share, or $64,216,731.96 in the aggregate (the “Redemption”). The remaining approximately $150.9 million in AONE’s trust account was released to Markforged Holding Corporation, net of transaction expenses. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Effective Time, among other things, each outstanding share of Markforged Common Stock as of immediately prior to the effective time of the Merger (after giving effect to the Employee Transactions and the Preferred Stock Conversion), other than (x) any shares of Markforged Common Stock subject to Markforged Awards (as defined below) and (y) any shares of Markforged capital stock held in treasury by Markforged, which treasury shares were canceled as part of the Merger, was canceled and converted into the right to receive a number of shares of New Common Stock equal to the product of one share of Markforged Common Stock multiplied by the Exchange Ratio (as defined below). No fractional shares were issued in the Merger, and any fractional shares that a holder of Markforged securities would have otherwise been entitled to in the Merger were eliminated in accordance with the terms of the Merger Agreement. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Effective Time, all options to purchase shares of Markforged Common Stock and all restricted stock units based on shares of Markforged Common Stock outstanding as of immediately prior to the Merger (together, the “Markforged Awards”) were converted into (a) options to purchase shares of New Common Stock (“New Options”), and (b) restricted stock units based on shares of New Common Stock (“New RSUs”), respectively. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;">The “Exchange Ratio,” defined as (i) $1.7 billion minus the aggregate amount paid pursuant to the Employee Transactions (the “Equity Value,” or $1.655 billion), divided by (ii) $10.00, divided by (iii) the number of issued and outstanding shares of Markforged Common Stock, on a fully diluted and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis (including shares subject to outstanding Markforged Awards and shares available for issuance in respect of Markforged Awards not yet granted under Markforged’s existing incentive plan), was approximately 0.9522514. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The holders of Markforged Common Stock and Markforged Awards (whether vested or not) immediately prior to the Effective Time are entitled to receive, on a pro rata basis, up to 14,666,667 additional shares of New Common Stock (“Markforged Earnout Shares”) as follows: (i) if the volume-weighted average price of New Common Stock is at least $12.50 for any 20 trading days in a consecutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period, 8,000,000 Markforged Earnout Shares will be issued, (ii) if the volume-weighted average price of New Common Stock is at least $15.00 for any 20 trading days in a consecutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period, 6,666,667 Markforged Earnout Shares will be issued and (iii) upon a change of control or a liquidation of Markforged Holding Corporation, all previously unearned Markforged Earnout Shares will be issued. Markforged stockholders will not receive any Markforged Earnout Shares not earned as of July 14, 2026. Any Markforged Earnout Share that would otherwise be distributed to a holder of a Markforged Award that is unvested as of the date of distribution will be distributed in the form of a New RSU, which will vest subject to the same vesting conditions as the underlying award. If such Markforged Award holder forfeits the underlying Markforged Award, then such holder’s right to receive the allocable Markforged Earnout Shares will immediately terminate (and such Markforged Earnout Shares would instead be distributed on a pro rata basis to the other eligible former holders of Markforged Common Stock and Markforged Awards). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Concurrently with the execution of the Merger Agreement, AONE entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”), by and among AONE, Markforged, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-star,</div> a Cayman Islands limited liability company and AONE’s sponsor (the “Sponsor”), and the other holders of the Class B Ordinary Shares (collections, the “Sponsor parties”), which provides, among other things, that 50% of the shares of New Common Stock held by the Sponsor as a result of the conversion of its Class B Ordinary Shares in connection with the Domestication (the “Sponsor Earnout Shares”) will be subject to the following vesting conditions: (i) 50% of the Sponsor Earnout Shares (25% of the Sponsor’s total shares) will vest if the volume-weighted average price of New Common Stock is at least $12.50 for any 20 trading days in a consecutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period and (ii) 50% of the Sponsor Earnout Shares (25% of the Sponsor’s total shares) will vest if the volume-weighted average price of New Common Stock is at least $15.00 for any 20 trading days in a consecutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period. Any Sponsor Earnout Shares not vested as of July 14, 2026 will be forfeited. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PIPE Investment </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As previously announced, on February 23, 2021, concurrently with the execution of the Merger Agreement, AONE entered into subscription agreements with certain investors (collectively, the “PIPE Investors”) pursuant to which, on the terms and subject to the conditions therein, the PIPE Investors collectively subscribed for 21,000,000 shares of New Common Stock at $10.00 per share for an aggregate purchase price equal to $210,000,000 (the “PIPE Investment”). The PIPE Investment was consummated substantially concurrently with the closing of the Transactions. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Post-Closing Capitalization</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July 14, 2021 immediately following the Transactions and after giving effect to the Merger, the Employee Transactions, the Preferred Stock Conversion, the PIPE Investment and the Redemption, Markforged Holding Corporation’s capitalization consisted of: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td style="width: 84%;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">185,251,837</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares of New Common Stock outstanding</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,524,984</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,434,577</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the “2021 Plan”)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">212,211,398</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total outstanding equity at closing, including vested and unvested options and RSUs</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,065,423</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock reserved for issuance under the 2021 Plan</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,700,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock reserved for future issuance under the Markforged Holding Corporation 2021 Employee Stock Purchase Plan</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,666,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock reserved for future issuance as Markforged Earnout Shares and/or Earnout RSUs</td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the consummation of the Transactions, AONE’s units ceased trading on the New York Stock Exchange (the “NYSE”) and, on July 15, 2021, the shares of New Common Stock and the New Warrants began trading under the symbols “MKFG” and “MKFG.WS,” respectively. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Terms used but not defined herein, or for which definitions are not otherwise incorporated by reference herein, shall have the meaning given to such terms in the Proxy Statement/Prospectus and such definitions are incorporated herein by reference. Unless the context otherwise requires, all references to “we”, “us” or “our” refer to Markforged Holding Corporation. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration Rights Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July 14, 2021, in connection with the consummation of the Transactions and as contemplated by the Merger Agreement, Markforged Holding Corporation, the Sponsor Parties and certain former stockholders of Markforged entered into the Registration Rights Agreement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lock-up</div> Agreements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On July 14, 2021, in connection with the consummation of the Transactions and as contemplated by the Merger Agreement, Markforged Holding Corporation entered into separate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lock-Up</div> agreements with certain of stockholders of Markforged Holding Corporation, which agreements are identical except for, as indicated in the Form of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lock-Up</div> Agreement filed as Exhibit 10.8, an additional provision applicable only to those stockholders who are also party to the Registration Rights Agreement (the Sponsor Parties and certain former holders of the preferred stock of Markforged), and an additional provision applicable only to the Sponsor Parties. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The material terms of the Registration Rights Agreement and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lock-up</div> Agreement are described in the section of the Proxy Statement/Prospectus beginning on page 115 under the section entitled “<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">BCA Proposal—Related Agreements</div></div>.” Such descriptions are qualified in their entirety by the text of such agreements, which are included as Exhibit 10.8 to this Report and are incorporated herein by reference. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. </div></div> 0.0001 one-for-one 0.0001 0.0001 0.0001 one-for-one basis 45000000.0 one-for-one 0.0001 6418667 10.005 64216731.96 150900000 1700000000 1655000000 10.00 0.9522514 14666667 12.50 20 30 8000000 15.00 20 30 6666667 0.50 0.50 0.25 12.50 20 30 0.50 -0.25 15.00 20 30 21000000 10.00 210000000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July 14, 2021 immediately following the Transactions and after giving effect to the Merger, the Employee Transactions, the Preferred Stock Conversion, the PIPE Investment and the Redemption, Markforged Holding Corporation’s capitalization consisted of: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td style="width: 84%;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">185,251,837</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares of New Common Stock outstanding</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,524,984</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,434,577</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the “2021 Plan”)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">212,211,398</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total outstanding equity at closing, including vested and unvested options and RSUs</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,065,423</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock reserved for issuance under the 2021 Plan</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,700,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock reserved for future issuance under the Markforged Holding Corporation 2021 Employee Stock Purchase Plan</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,666,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;">Shares of New Common Stock reserved for future issuance as Markforged Earnout Shares and/or Earnout RSUs</td> </tr> </table> 185251837 8524984 3150000 18434577 212211398 24065423 4700000 14666667 XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page - shares
 6 Months Ended
Jun. 30, 2021
Aug. 09, 2021
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q2  
Current Fiscal Year End Date --12-31  
Document Quarterly Report true  
Document Transition Report false  
Entity Registrant Name Markforged Holding Corp  
Entity Central Index Key 0001816613  
Entity File Number 001-39453  
Entity Tax Identification Number 98-1545859  
Entity Incorporation, State or Country Code DE  
Entity Shell Company true  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Interactive Data Current Yes  
Entity Address, Address Line One 480 Pleasant Street  
Entity Address, City or Town Watertown  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02472  
City Area Code 866  
Local Phone Number 496-1805  
Entity Current Reporting Status No  
Entity Common Stock, Shares Outstanding   185,251,837
Common Class A [Member]    
Document Information [Line Items]    
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Trading Symbol MKFG  
Security Exchange Name NYSE  
Warrant [Member]    
Document Information [Line Items]    
Title of 12(b) Security Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, $0.0001 par value  
Trading Symbol MKFG.WS  
Security Exchange Name NYSE  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 306,896 $ 919,823
Prepaid expenses 248,596 314,351
Total current assets 555,492 1,234,174
Investments held in Trust Account 215,099,354 215,076,225
Total Assets 215,654,846 216,310,399
Current liabilities:    
Accounts payable 4,921 115,360
Accrued expenses 2,715,966 24,847
Total current liabilities 2,720,887 140,207
Deferred underwriting commissions 7,525,000 7,525,000
Derivative warrant liabilities 19,607,500 17,902,500
Total Liabilities 29,853,387 25,567,707
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 18,080,145 and 18,574,269 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively 180,801,450 185,742,690
Shareholder's Equity:    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2021 and December 31, 2020 0  
Additional paid-in capital 12,551,921 7,610,730
Accumulated deficit (7,552,792) (2,611,559)
Total shareholders' equity 5,000,009 5,000,002
Total Liabilities and Shareholder's Equity 215,654,846 216,310,399
Class A ordinary shares    
Shareholder's Equity:    
Common stock 342 293
Total shareholders' equity 342 293
Class B ordinary shares    
Shareholder's Equity:    
Common stock 538 538
Total shareholders' equity $ 538 $ 538
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2021
Dec. 31, 2020
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A ordinary shares, par value $ 0.0001 $ 0.0001
Class A ordinary shares, shares subject to possible redemption 18,080,145 18,574,269
Class A ordinary shares, per share $ 10.00 $ 10.00
Class A ordinary shares    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 400,000,000 400,000,000
Common stock, shares issued 3,419,855 2,925,731
Common stock, shares outstanding 3,419,855 2,925,731
Class A ordinary shares, shares subject to possible redemption 18,080,145 18,574,269
Class B ordinary shares    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 10,000,000 10,000,000
Common stock, shares issued 5,375,000 5,375,000
Common stock, shares outstanding 5,375,000 5,375,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements Of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2021
General and administrative expenses $ 11,030 $ 1,104,977 $ 3,199,362
Administrative expenses - related party   30,000 60,000
Loss from operations (11,030) (1,134,977) (3,259,362)
Other income (expenses)      
Change in fair value of derivative warrant liabilities   3,069,000 (1,705,000)
Net gain from investments held in Trust Account   3,248 23,129
Net income (loss) $ (11,030) $ 1,937,271 $ (4,941,233)
Class A ordinary shares      
Other income (expenses)      
Basic and diluted weighted average shares outstanding   21,500,000 21,500,000
Basic and diluted net income (loss) per share   $ 0.00 $ 0.00
Class B ordinary shares      
Other income (expenses)      
Net income (loss)   $ 1,934,023 $ (4,964,362)
Basic and diluted weighted average shares outstanding 5,000,000 5,375,000 5,375,000
Basic and diluted net income (loss) per share $ 0.00 $ 0.36 $ (0.92)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statement Of Changes In Shareholders' Equity - USD ($)
Total
Additional Paid-in Capital
Accumulated Deficit
Class A ordinary shares
Class B ordinary shares
Balance at the beginning at Jun. 23, 2020 $ 0 $ 0 $ 0 $ 0 $ 0
Balance at the beginning (in shares) at Jun. 23, 2020       0 0
Issuance of ordinary shares to Sponsor 25,000 24,425     $ 575
Issuance of ordinary shares to Sponsor (in shares)         5,750,000
Net loss (11,030)   (11,030)    
Balance at the ending at Jun. 30, 2020 13,970 24,425 (11,030) $ 0 $ 575
Balance at the ending (in shares) at Jun. 30, 2020       0 5,750,000
Balance at the beginning at Dec. 31, 2020 5,000,002 7,610,730 (2,611,559) $ 293 $ 538
Balance at the beginning (in shares) at Dec. 31, 2020       2,925,731 5,375,000
Shares subject to possible redemption 6,878,510 6,878,442   $ 68  
Shares subject to possible redemption (in shares)       687,851  
Net loss (6,878,504)   (6,878,504)    
Balance at the ending at Mar. 31, 2021 5,000,008 14,489,172 (9,490,063) $ 361 $ 538
Balance at the ending (in shares) at Mar. 31, 2021       3,613,582 5,375,000
Balance at the beginning at Dec. 31, 2020 5,000,002 7,610,730 (2,611,559) $ 293 $ 538
Balance at the beginning (in shares) at Dec. 31, 2020       2,925,731 5,375,000
Net loss (4,941,233)       $ (4,964,362)
Balance at the ending at Jun. 30, 2021 5,000,009 12,551,921 (7,552,792) $ 342 $ 538
Balance at the ending (in shares) at Jun. 30, 2021       3,419,855 5,375,000
Balance at the beginning at Mar. 31, 2021 5,000,008 14,489,172 (9,490,063) $ 361 $ 538
Balance at the beginning (in shares) at Mar. 31, 2021       3,613,582 5,375,000
Shares subject to possible redemption (1,937,270) (1,937,251)   $ (19)  
Shares subject to possible redemption (in shares)       (193,727)  
Net loss 1,937,271   1,937,271   $ 1,934,023
Balance at the ending at Jun. 30, 2021 $ 5,000,009 $ 12,551,921 $ (7,552,792) $ 342 $ 538
Balance at the ending (in shares) at Jun. 30, 2021       3,419,855 5,375,000
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statement Of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2021
Cash Flows from Operating Activities:      
Net loss $ (11,030)   $ (4,941,233)
Adjustments to reconcile net loss to net cash used in operating activities:      
Change in fair value of derivative warrant liabilities   $ (3,069,000) 1,705,000
Net gain from investments held in Trust Account   (3,248) (23,129)
Changes in operating assets and liabilities:      
Prepaid expenses     65,755
Accounts payable     (110,439)
Accrued expenses 11,030   2,691,119
Net cash used in operating activities     (612,927)
Net change in cash     (612,927)
Cash - beginning of the period     919,823
Cash - ending of the period   $ 306,896 306,896
Supplemental disclosure of non-cash investing and financing activities:      
Deferred offering costs included in accrued expenses 158,237    
Deferred offering costs included in accounts payable 8,000    
Deferred offering costs paid in exchange for issuance of Class B ordinary shares to Sponsor $ 25,000    
Change in value of Class A ordinary shares subject to possible redemption     $ (4,941,240)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
 6 Months Ended
Jun. 30, 2021
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Note 1 — Description of Organization and Business Operations
Organization and General
Markforged Holding Corporation is an additive manufacturing company. Our platform, The Digital Forge, is an intuitive additive manufacturing platform powering engineers, designers and manufacturing professionals globally. The Digital Forge combines precise and reliable 3D printers and metal and composite proprietary materials seamlessly with its cloud-based learning software offering to empower manufacturers to create more resilient and agile supply chains. Founded in 2013 by two
MIT-educated
engineers, we are a company of over 300 engineers, builders and problem solvers. We are based in greater Boston, Massachusetts, where we have our own
in-house
manufacturing facility and where we design all of our industrial 3D printers, software and metal and composite proprietary materials.
one (when referred to prior to the Business Combination, the “Company”) was an incorporated blank check company incorporated in the Cayman Islands on June 24, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
At June 30, 2021, the Company had not yet commenced operations. All activity for the period from June 24, 2020 (inception) through June 30, 2021 relates to the Company’s formation and its preparation for the initial public offering (“Initial Public Offering”), which is described below, and since the offering, the search for a prospective initial Business Combination. The Company did not generate any operating revenue prior to the completion of the Business Combination. The Company generateed
non-operating
income in the form of income earned on investments on cash and cash equivalents in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.
Sponsor and Initial Public Offering
The Company’s sponsor was
A-star,
a Cayman Islands
exempted limited partnership (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on August 17, 2020. On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,500,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions (Note 5).
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,150,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million (Note 4).
Trust Account
Upon the closing of the Initial Public Offering and the Private Placement, $215.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and will be invested by the trustee only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
of the Investment Company Act, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
Initial Business Combination
The Company’s management had broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds were intended to be applied generally toward consummating a Business Combination.
The Company provided its holders (the “Public Shareholders”) of its Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The Public Shareholders were entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The
per-share
amount distributed to Public Shareholders who redeemed their Public Shares was not be reduced by the deferred underwriting commissions the Company paid to the underwriters (as discussed in Note 5). These Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
The Company, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021, by and among one, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of one, and MarkForged, Inc., a Delaware corporation. On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
Domestication Proposal
” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 filed with the Securities and Exchange Commission, the Company filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which one was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”).
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Note 2 — Summary of Significant Accounting Policies
Basis of presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form
10-K/A
filed by the Company with the SEC on May 14, 2021.
Emerging growth company
As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Principles of Consolidation
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had no cash equivalents.
Investments Held in the Trust Account
At June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
•
 
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
•
 
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
 
•
 
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measuremen
t
 is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
As of June 30, 2021, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. As of June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses NAV as a practical expedient to fair value for its investments in money market funds.
Offering Costs Associated with the Initial Public Offering
Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as
non-operating
expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC
815-15.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The 5,375,000
warrants
issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,150,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 18,080,145 and 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets.
Income Taxes
ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve month
s
.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period.
At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
For the three and six months ended June 30, 2021, the Company’s unaudited condensed statements of operations includes a presentation of income (loss) per Class A ordinary share subject to redemption in a manner similar to the
two-class
method of income (loss) per share. Net income per Class A ordinary share, basic and diluted, is calculated by dividing the investment income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per Class B ordinary share, basic and diluted, is calculated by dividing the net loss, less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the periods.
The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary shares price for the period and therefore the inclusion of such warrants would be anti-dilutive.
 
The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share:
 
 
 
For the Three Months
 
 
For the Six Months
 
 
 
Ended June 30, 2021
 
 
Ended June 30, 2021
 
Class A ordinary share
 
      
 
      
Numerator: Income allocable to Class A ordinary share
 
      
 
      
Income from investments held in Trust Account
 
$
3,248
 
 
$
23,129
 
Less: Company’s portion available to be withdrawn to pay taxes
 
 
—  
 
 
 
—  
 
 
 
 
 
 
 
 
 
 
Net income attributable to Class A ordinary share
 
$
3,248
 
 
$
23,129
 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class A ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class A ordinary share
 
 
        21,500,000
 
 
 
        21,500,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income per share, Class A ordinary share
 
$
0.00
 
 
$
0.00
 
 
 
 
 
 
 
 
 
 
     
Class B ordinary share
 
      
 
      
Numerator: Net income (loss) minus net income allocable to Class A ordinary share
 
      
 
      
Net income (loss)
 
$
1,937,271
 
 
$
(4,941,233
) 
Net income allocable to Class A ordinary share
 
 
3,248
 
 
 
23,129
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Class B ordinary share
 
$
1,934,023
 
 
$
(4,964,362
) 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class B ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class B ordinary share
 
 
5,375,000
 
 
 
5,375,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income (loss) per share, Class B ordinary share
 
$
0.36
 
 
$
(0.92
) 
 
 
 
 
 
 
 
 
 
Recent Accounting Pronouncements
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
INITIAL PUBLIC OFFERING
 6 Months Ended
Jun. 30, 2021
INITIAL PUBLIC OFFERING  
INITIAL PUBLIC OFFERING
Note 3 — Initial Public Offering
On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 Units, including 1,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions.
Each Unit consists of one Class A ordinary share, and
one-fourth
of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary shares at a price of $11.50 per share, subject to adjustment (see Note 6).
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS
 6 Months Ended
Jun. 30, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
Note 4 — Related Party Transactions
Founder Shares
On June 26, 2020, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). Up to 750,000 Founder Shares were subject to forfeiture to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On August 10, 2020, the Sponsor transferred 25,000 Founder Shares to each of Michelle Gill, Lachy Groom, Gautam Gupta, Trina Spear, and Laura de Petra, and 30,000 Founder Shares to Pierre Lamond. On August 20, 2020, the underwriters exercised their over-allotment option and, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly.
The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-
trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.
 
Private Placement Warrants
Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 3,150,000 Private Placement Warrants at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million.
Prior to the consummation of the Business Combination, each warrant was exercisable to purchase
 one
 
Class A ordinary share at
$11.50
per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company did not complete a Business Combination within the Combination Period, the Private Placement Warrants would have expired worthless.
The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination.
Sponsor Loan
On June 26, 2020, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was
non-interest
bearing and payable on the earlier of December 31, 2020 or the completion of the Initial Public Offering. The Company borrowed approximately $163,000 under the Note, and fully repaid the Note on August 20, 2020.
Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $2.00 per warrant. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.
Administrative Support Agreement
The Company agreed to pay the Sponsor a total of $10,000 per month, commencing on date the Company’s securities are first listed on the New York Stock Exchange (the “listing date”), for office space, secretarial and administrative services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the three and six months ended June 30, 2021, the Company incurred $30,000 and $60,000, respectively for expenses in connection with the Administrative Support Agreement.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
Note 5 — Commitments and Contingencies
Registration and Shareholder Rights
The holders of Founder Sha
r
es, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, were entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, these holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On August 20, 2020, the underwriters exercised their over-allotment option of 1,500,000 Units and, an aggregate of 375,000 Class B ordinary shares were forfeited by the Sponsor for no consideration accordingly.
The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $7.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Risks and Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
DERIVATIVE WARRANT LIABILITIES
 6 Months Ended
Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE WARRANT LIABILITIES
Note 6 — Derivative Warrant Liabilities
As of June 30, 2021 and December 31, 2020, the Company has 5,375,000 and 3,150,000 Public Warrants and Private Placement Warrants, respectively, outstanding.
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants have an exercise price of at $11.50 per share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $
0.01
per warrant;
 
  •  
upon a minimum of
30 days
’ prior written notice of redemption; and
 
  •  
if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $
18.00
per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any
20
trading days within a
30
-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the warrants:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below);
 
  •  
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders;
 
  •  
if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and
 
  •  
if, and only if, there is an effective registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the
30-day
period after written notice of redemption is given.
The “fair market value” of the Class A ordinary shares shall mean the volume weighted average price of the Class A ordinary shares as reported during the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
SHAREHOLDERS' EQUITY
 6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY
Note 7 — Shareholders’ Equity
Preference Shares
 - The Company is authorized to issue 1,000,000 preference with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
 - The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2021, there were 21,500,000 Class A ordinary shares issued or outstanding, including 18,080,145 Class A ordinary shares subject to possible redemption. As of December 31, 2020, there were 21,500,000 Class A ordinary shares issued or outstanding, including 18,574,269 Class A ordinary shares subject to possible redemption.
Class
 B Ordinary Shares
 - The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. At August 20, 2020, there were 5,750,000 Class B ordinary shares issued and outstanding, of which an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On August 20, 2020, the underwriters exercised their over-allotment option in part and, accordingly, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly. As of June 30, 2021 and December 31, 2020, there were 5,375,000 Class B ordinary shares outstanding.
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination.
The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity- linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants that may be issued upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
Note 8 — Fair Value Measurements
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
June 30, 2021
 
Description
  
Quoted
Prices in
Active
Markets
(Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
  
      
  
      
  
      
Money market fund
  
$
215,099,354
 
  
$
—  
 
  
$
—  
 
Liabilities:
  
      
  
      
  
      
Derivative warrant liabilities - Public
  
$
12,362,500
 
  
$
—  
 
  
$
—  
 
Derivative warrant liabilities - Private
  
$
—  
 
  
$
—  
 
  
$
7,245,000
 
December 31, 2020
 
Description
  
Quoted
Prices in
Active
Markets
(Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
  
      
  
      
  
      
U.S Treasury bills maturing on February 18, 2021
  
$
215,076,225
 
  
$
—  
 
  
$
—  
 
Liabilities:
  
      
  
      
  
      
Derivative warrant liabilities - Public
  
$
11,287,500
 
  
$
—  
 
  
$
—  
 
Derivative warrant liabilities - Private
  
$
—  
 
  
$
—  
 
  
$
6,615,000
 
Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in October 202
0
, when the Public Warrants were separately listed and traded.
Level 1 instruments include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The estimated fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model.
For the three months ended June 30, 2021, the Company recognized a gain to the condensed statement of operations resulting from an decrease in the fair value of liabilities of $3.1 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statement of operations. For the six months ended June 30, 2021, the Company recognized a charge to the statement of operations resulting from an increase in the fair value of liabilities of $1.7 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statement of operations.
The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Binomial Lattice model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
 
 
  
As of
December 31, 2020
 
 
As of
June 30, 2021
 
Volatility
  
 
25.8
% 
 
 
36.2
% 
Stock price
  
$
10.77
 
 
$
9.98
 
Risk-free rate
  
 
0.43
% 
 
 
0.88
% 
Dividend yield
  
 
0.0
% 
 
 
0.0
% 
The change in the fair value of the derivative warrant liabilities as classified level 3 for the three and six months ended June 30, 2021 is summarized as follows:
 
Level 3 - Derivative warrant liabilities at December 31, 2020
  
$
6,615,000
 
Change in fair value of derivative warrant liabilities
  
 
1,764,000
 
 
  
 
 
 
Level 3 - Derivative warrant liabilities at March 31, 2021
  
$
8,379,000
 
Change in fair value of derivative warrant liabilities
  
 
(1,134,000
) 
 
  
 
 
 
Level 3 - Derivative warrant liabilities at June 30, 2021
  
$
7,245,000
 
 
  
 
 
 
 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS
 6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
Note 9 — Subsequent Events
The Company (“AONE”), a Cayman Islands exempted company, and after the Domestication (as defined below), “Markforged Holding Corporation,” previously entered into an Agreement and Plan of Merger, dated as of February 23, 2021 (the “Merger Agreement”), by and among AONE, Caspian Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of AONE (“Merger Sub”), and MarkForged, Inc., a Delaware corporation (“Markforged”).
On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
Domestication Proposal
” beginning on page 138 of the final prospectus and definitive proxy statement, dated June 24, 2021 (the “Proxy Statement/Prospectus”) and filed with the Securities and Exchange Commission (the “SEC”), AONE filed a notice of deregistration and necessary accompanying documents with the Cayman Islands Registrar of Companies, and a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which AONE was domesticated and continues as a Delaware corporation, changing its name to “Markforged Holding Corporation” (the “Domestication”).
As a result of and upon the effective time of the Domestication, among other things, (i) each of the then issued and outstanding Class A ordinary shares, par value $0.0001 per share, of AONE (the “Class A Ordinary Shares”) automatically converted, on a
one-for-one
basis, into a share of common stock, par value $0.0001 per share, of Markforged Holding Corporation (the “New Common Stock”); (ii) each of the then issued and outstanding Class B ordinary shares, par value $0.0001 per share, of AONE (the “Class B Ordinary Shares”) automatically converted, on a
one-for-one
basis, into shares of New Common Stock; (iii) each of the then issued and outstanding redeemable warrants of AONE (the “AONE Warrants”) automatically converted, on a
one-for-one
basis, into redeemable warrants to acquire one share of New Common Stock (the “New Warrants”); and (iv) each of the then issued and outstanding units of AONE that had not been previously separated into the underlying Class A Ordinary Shares and underlying AONE Warrants upon the request of the holder thereof were cancelled and entitled the holder thereof to one share of New Common Stock and
one-fourth
of one New Warrant. No fractional New Warrants were issued, and no fractional shares of New Common Stock were issued or will be issuable upon the exercise of New Warrants.
On July 13, 2021, AONE held an extraordinary general meeting of stockholders (the “Special Meeting”), at which the AONE stockholders considered and adopted, among other matters, a proposal to approve the Merger (as defined below), including approving the other transactions contemplated by the Merger Agreement and related agreements described in the Proxy Statement/Prospectus.
On July 14, 2021, as contemplated by the Merger Agreement and described in the section titled “
BCA Proposal
” beginning on page 98 of the Proxy Statement/Prospectus, Markforged Holding Corporation consummated the merger transaction contemplated by the Merger Agreement, whereby Merger Sub merged with and into Markforged, with the separate corporate existence of Merger Sub ceasing and Markforged being the surviving corporation and a wholly owned subsidiary of Markforged Holding Corporation (the “Merger” and, together with the Domestication, the “Transactions”).
Immediately prior to the effective time of the Merger (the “Effective Time”), Markforged purchased approximately $45.0 million of its securities from certain of its stockholders (the “Employee Transactions”), and each outstanding share of Markforged preferred stock was converted on a
one-for-one
basis into shares of Markforged common stock, par value $0.0001 per share (the “Markforged Common Stock”) (the “Preferred Stock Conversion”). Holders of 6,418,667 Class A Ordinary Shares sold in AONE’s initial public offering properly exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from AONE’s initial public offering, calculated as of two business days prior to the consummation of the Merger, which was approximately $10.005 per share, or $64,216,731.96 in the aggregate (the “Redemption”). The remaining approximately $150.9 million in AONE’s trust account was released to Markforged Holding Corporation, net of transaction expenses.
At the Effective Time, among other things, each outstanding share of Markforged Common Stock as of immediately prior to the effective time of the Merger (after giving effect to the Employee Transactions and the Preferred Stock Conversion), other than (x) any shares of Markforged Common Stock subject to Markforged Awards (as defined below) and (y) any shares of Markforged capital stock held in treasury by Markforged, which treasury shares were canceled as part of the Merger, was canceled and converted into the right to receive a number of shares of New Common Stock equal to the product of one share of Markforged Common Stock multiplied by the Exchange Ratio (as defined below). No fractional shares were issued in the Merger, and any fractional shares that a holder of Markforged securities would have otherwise been entitled to in the Merger were eliminated in accordance with the terms of the Merger Agreement.
At the Effective Time, all options to purchase shares of Markforged Common Stock and all restricted stock units based on shares of Markforged Common Stock outstanding as of immediately prior to the Merger (together, the “Markforged Awards”) were converted into (a) options to purchase shares of New Common Stock (“New Options”), and (b) restricted stock units based on shares of New Common Stock (“New RSUs”), respectively.
 
The “Exchange Ratio,” defined as (i) $1.7 billion minus the aggregate amount paid pursuant to the Employee Transactions (the “Equity Value,” or $1.655 billion), divided by (ii) $10.00, divided by (iii) the number of issued and outstanding shares of Markforged Common Stock, on a fully diluted and
as-converted
basis (including shares subject to outstanding Markforged Awards and shares available for issuance in respect of Markforged Awards not yet granted under Markforged’s existing incentive plan), was approximately 0.9522514.
The holders of Markforged Common Stock and Markforged Awards (whether vested or not) immediately prior to the Effective Time are entitled to receive, on a pro rata basis, up to 14,666,667 additional shares of New Common Stock (“Markforged Earnout Shares”) as follows: (i) if the volume-weighted average price of New Common Stock is at least $12.50 for any 20 trading days in a consecutive
30-trading
day period, 8,000,000 Markforged Earnout Shares will be issued, (ii) if the volume-weighted average price of New Common Stock is at least $15.00 for any 20 trading days in a consecutive
30-trading
day period, 6,666,667 Markforged Earnout Shares will be issued and (iii) upon a change of control or a liquidation of Markforged Holding Corporation, all previously unearned Markforged Earnout Shares will be issued. Markforged stockholders will not receive any Markforged Earnout Shares not earned as of July 14, 2026. Any Markforged Earnout Share that would otherwise be distributed to a holder of a Markforged Award that is unvested as of the date of distribution will be distributed in the form of a New RSU, which will vest subject to the same vesting conditions as the underlying award. If such Markforged Award holder forfeits the underlying Markforged Award, then such holder’s right to receive the allocable Markforged Earnout Shares will immediately terminate (and such Markforged Earnout Shares would instead be distributed on a pro rata basis to the other eligible former holders of Markforged Common Stock and Markforged Awards).
Concurrently with the execution of the Merger Agreement, AONE entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”), by and among AONE, Markforged,
A-star,
a Cayman Islands limited liability company and AONE’s sponsor (the “Sponsor”), and the other holders of the Class B Ordinary Shares (collections, the “Sponsor parties”), which provides, among other things, that 50% of the shares of New Common Stock held by the Sponsor as a result of the conversion of its Class B Ordinary Shares in connection with the Domestication (the “Sponsor Earnout Shares”) will be subject to the following vesting conditions: (i) 50% of the Sponsor Earnout Shares (25% of the Sponsor’s total shares) will vest if the volume-weighted average price of New Common Stock is at least $12.50 for any 20 trading days in a consecutive
30-trading
day period and (ii) 50% of the Sponsor Earnout Shares (25% of the Sponsor’s total shares) will vest if the volume-weighted average price of New Common Stock is at least $15.00 for any 20 trading days in a consecutive
30-trading
day period. Any Sponsor Earnout Shares not vested as of July 14, 2026 will be forfeited.
PIPE Investment
As previously announced, on February 23, 2021, concurrently with the execution of the Merger Agreement, AONE entered into subscription agreements with certain investors (collectively, the “PIPE Investors”) pursuant to which, on the terms and subject to the conditions therein, the PIPE Investors collectively subscribed for 21,000,000 shares of New Common Stock at $10.00 per share for an aggregate purchase price equal to $210,000,000 (the “PIPE Investment”). The PIPE Investment was consummated substantially concurrently with the closing of the Transactions.
Post-Closing Capitalization
On July 14, 2021 immediately following the Transactions and after giving effect to the Merger, the Employee Transactions, the Preferred Stock Conversion, the PIPE Investment and the Redemption, Markforged Holding Corporation’s capitalization consisted of:
 
 
185,251,837
 
   
Shares of New Common Stock outstanding
  8,524,984      Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor)
  18,434,577      Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the “2021 Plan”)
 
212,211,398
 
   
Total outstanding equity at closing, including vested and unvested options and RSUs
  24,065,423      Shares of New Common Stock reserved for issuance under the 2021 Plan
  4,700,000      Shares of New Common Stock reserved for future issuance under the Markforged Holding Corporation 2021 Employee Stock Purchase Plan
  14,666,667      Shares of New Common Stock reserved for future issuance as Markforged Earnout Shares and/or Earnout RSUs
Upon the consummation of the Transactions, AONE’s units ceased trading on the New York Stock Exchange (the “NYSE”) and, on July 15, 2021, the shares of New Common Stock and the New Warrants began trading under the symbols “MKFG” and “MKFG.WS,” respectively.
Terms used but not defined herein, or for which definitions are not otherwise incorporated by reference herein, shall have the meaning given to such terms in the Proxy Statement/Prospectus and such definitions are incorporated herein by reference. Unless the context otherwise requires, all references to “we”, “us” or “our” refer to Markforged Holding Corporation.
Registration Rights Agreement
On July 14, 2021, in connection with the consummation of the Transactions and as contemplated by the Merger Agreement, Markforged Holding Corporation, the Sponsor Parties and certain former stockholders of Markforged entered into the Registration Rights Agreement.
Lock-up
Agreements
On July 14, 2021, in connection with the consummation of the Transactions and as contemplated by the Merger Agreement, Markforged Holding Corporation entered into separate
Lock-Up
agreements with certain of stockholders of Markforged Holding Corporation, which agreements are identical except for, as indicated in the Form of
Lock-Up
Agreement filed as Exhibit 10.8, an additional provision applicable only to those stockholders who are also party to the Registration Rights Agreement (the Sponsor Parties and certain former holders of the preferred stock of Markforged), and an additional provision applicable only to the Sponsor Parties.
The material terms of the Registration Rights Agreement and
Lock-up
Agreement are described in the section of the Proxy Statement/Prospectus beginning on page 115 under the section entitled “
BCA Proposal—Related Agreements
.” Such descriptions are qualified in their entirety by the text of such agreements, which are included as Exhibit 10.8 to this Report and are incorporated herein by reference.
Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 6 Months Ended
Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of presentation
Basis of presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form
10-K/A
filed by the Company with the SEC on May 14, 2021.
Emerging growth company
Emerging growth company
As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of credit risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Principles of consolidation
Principles of Consolidation
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had no cash equivalents.
Investments Held in the Trust Account
Investments Held in the Trust Account
At June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
•
 
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
•
 
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
 
•
 
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measuremen
t
 is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
As of June 30, 2021, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. As of June 30, 2021, the Company’s portfolio of investments held in the Trust Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses NAV as a practical expedient to fair value for its investments in money market funds.
Offering costs associated with Initial Public Offering
Offering Costs Associated with the Initial Public Offering
Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as
non-operating
expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering.
Derivative Warrant liabilities
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC
815-15.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The 5,375,000
warrants
issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,150,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially estimated using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the Warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of warrants issued in connection with the Company’s Initial Public Offering have subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model.
Class A Ordinary Shares subject to possible redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 18,080,145 and 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets.
Income taxes
Income Taxes
ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve month
s
.
Net income (loss) per ordinary share
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period.
At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
For the three and six months ended June 30, 2021, the Company’s unaudited condensed statements of operations includes a presentation of income (loss) per Class A ordinary share subject to redemption in a manner similar to the
two-class
method of income (loss) per share. Net income per Class A ordinary share, basic and diluted, is calculated by dividing the investment income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per Class B ordinary share, basic and diluted, is calculated by dividing the net loss, less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the periods.
The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary shares price for the period and therefore the inclusion of such warrants would be anti-dilutive.
 
The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share:
 
 
 
For the Three Months
 
 
For the Six Months
 
 
 
Ended June 30, 2021
 
 
Ended June 30, 2021
 
Class A ordinary share
 
      
 
      
Numerator: Income allocable to Class A ordinary share
 
      
 
      
Income from investments held in Trust Account
 
$
3,248
 
 
$
23,129
 
Less: Company’s portion available to be withdrawn to pay taxes
 
 
—  
 
 
 
—  
 
 
 
 
 
 
 
 
 
 
Net income attributable to Class A ordinary share
 
$
3,248
 
 
$
23,129
 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class A ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class A ordinary share
 
 
        21,500,000
 
 
 
        21,500,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income per share, Class A ordinary share
 
$
0.00
 
 
$
0.00
 
 
 
 
 
 
 
 
 
 
     
Class B ordinary share
 
      
 
      
Numerator: Net income (loss) minus net income allocable to Class A ordinary share
 
      
 
      
Net income (loss)
 
$
1,937,271
 
 
$
(4,941,233
) 
Net income allocable to Class A ordinary share
 
 
3,248
 
 
 
23,129
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Class B ordinary share
 
$
1,934,023
 
 
$
(4,964,362
) 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class B ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class B ordinary share
 
 
5,375,000
 
 
 
5,375,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income (loss) per share, Class B ordinary share
 
$
0.36
 
 
$
(0.92
) 
 
 
 
 
 
 
 
 
 
Recent Accounting Pronouncements
Recent Accounting Pronouncements
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Summary of Reconciliation of Net Loss Per Ordinary Share
 
The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share:
 
 
 
For the Three Months
 
 
For the Six Months
 
 
 
Ended June 30, 2021
 
 
Ended June 30, 2021
 
Class A ordinary share
 
      
 
      
Numerator: Income allocable to Class A ordinary share
 
      
 
      
Income from investments held in Trust Account
 
$
3,248
 
 
$
23,129
 
Less: Company’s portion available to be withdrawn to pay taxes
 
 
—  
 
 
 
—  
 
 
 
 
 
 
 
 
 
 
Net income attributable to Class A ordinary share
 
$
3,248
 
 
$
23,129
 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class A ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class A ordinary share
 
 
        21,500,000
 
 
 
        21,500,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income per share, Class A ordinary share
 
$
0.00
 
 
$
0.00
 
 
 
 
 
 
 
 
 
 
     
Class B ordinary share
 
      
 
      
Numerator: Net income (loss) minus net income allocable to Class A ordinary share
 
      
 
      
Net income (loss)
 
$
1,937,271
 
 
$
(4,941,233
) 
Net income allocable to Class A ordinary share
 
 
3,248
 
 
 
23,129
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Class B ordinary share
 
$
1,934,023
 
 
$
(4,964,362
) 
 
 
 
 
 
 
 
 
 
Denominator: Weighted average Class B ordinary share
 
      
 
      
Basic and diluted weighted average shares outstanding, Class B ordinary share
 
 
5,375,000
 
 
 
5,375,000
 
 
 
 
 
 
 
 
 
 
Basic and diluted net income (loss) per share, Class B ordinary share
 
$
0.36
 
 
$
(0.92
) 
 
 
 
 
 
 
 
 
 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS (Tables)
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Summary of financial assets that are measured at fair value on a recurring basis
June 30, 2021
 
Description
  
Quoted
Prices in
Active
Markets
(Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
  
      
  
      
  
      
Money market fund
  
$
215,099,354
 
  
$
—  
 
  
$
—  
 
Liabilities:
  
      
  
      
  
      
Derivative warrant liabilities - Public
  
$
12,362,500
 
  
$
—  
 
  
$
—  
 
Derivative warrant liabilities - Private
  
$
—  
 
  
$
—  
 
  
$
7,245,000
 
December 31, 2020
 
Description
  
Quoted
Prices in
Active
Markets
(Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
  
      
  
      
  
      
U.S Treasury bills maturing on February 18, 2021
  
$
215,076,225
 
  
$
—  
 
  
$
—  
 
Liabilities:
  
      
  
      
  
      
Derivative warrant liabilities - Public
  
$
11,287,500
 
  
$
—  
 
  
$
—  
 
Derivative warrant liabilities - Private
  
$
—  
 
  
$
—  
 
  
$
6,615,000
 
Schedule of financial liabilities subject to fair value measurements on a recurring basis
The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
 
 
  
As of
December 31, 2020
 
 
As of
June 30, 2021
 
Volatility
  
 
25.8
% 
 
 
36.2
% 
Stock price
  
$
10.77
 
 
$
9.98
 
Risk-free rate
  
 
0.43
% 
 
 
0.88
% 
Dividend yield
  
 
0.0
% 
 
 
0.0
% 
Schedule of change in Level 3 fair value measurements
The change in the fair value of the derivative warrant liabilities as classified level 3 for the three and six months ended June 30, 2021 is summarized as follows:
 
Level 3 - Derivative warrant liabilities at December 31, 2020
  
$
6,615,000
 
Change in fair value of derivative warrant liabilities
  
 
1,764,000
 
 
  
 
 
 
Level 3 - Derivative warrant liabilities at March 31, 2021
  
$
8,379,000
 
Change in fair value of derivative warrant liabilities
  
 
(1,134,000
) 
 
  
 
 
 
Level 3 - Derivative warrant liabilities at June 30, 2021
  
$
7,245,000
 
 
  
 
 
 
 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS (Tables)
 6 Months Ended
Jun. 30, 2021
Subsequent Event [Line Items]  
Schedule of Post-Closing Capitalization
On July 14, 2021 immediately following the Transactions and after giving effect to the Merger, the Employee Transactions, the Preferred Stock Conversion, the PIPE Investment and the Redemption, Markforged Holding Corporation’s capitalization consisted of:
 
 
185,251,837
 
   
Shares of New Common Stock outstanding
  8,524,984      Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor)
  18,434,577      Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the “2021 Plan”)
 
212,211,398
 
   
Total outstanding equity at closing, including vested and unvested options and RSUs
  24,065,423      Shares of New Common Stock reserved for issuance under the 2021 Plan
  4,700,000      Shares of New Common Stock reserved for future issuance under the Markforged Holding Corporation 2021 Employee Stock Purchase Plan
  14,666,667      Shares of New Common Stock reserved for future issuance as Markforged Earnout Shares and/or Earnout RSUs
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)
Aug. 20, 2020
Jun. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Proposed Public Offering        
Deferred underwriting commissions     $ 7,525,000 $ 7,525,000
Issuance of ordinary shares to Sponsor   $ 25,000    
Initial Public Offering        
Proposed Public Offering        
Number of shares issued 21,500,000      
Shares issued, price per share $ 10.00      
Gross proceeds $ 215,000,000.0      
Offering costs paid 12,400,000      
Deferred underwriting commissions 7,500,000      
Issuance of ordinary shares to Sponsor $ 215,000,000.0      
Private Placement        
Proposed Public Offering        
Number of warrants issued 3,150,000   3,150,000  
Price of warrants (in dollars per share) $ 2.00      
Proceeds from issuance of warrants $ 6,300,000      
Over-allotment        
Proposed Public Offering        
Number of shares issued 1,500,000      
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Reconciliation of Net Loss Per Ordinary Share (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Numerator: Net income (loss) minus net income allocable to Class A ordinary share        
Net income (loss) $ (11,030)     $ (4,941,233)
Net income (loss) attributable to Class B ordinary share $ (11,030) $ 1,937,271 $ (6,878,504) (4,941,233)
Class A ordinary shares        
Numerator: Income allocable to Class A ordinary share        
Income from investments held in Trust Account   3,248   23,129
Less: Company's portion available to be withdrawn to pay taxes   0   0
Net income attributable to Class A ordinary share   $ 3,248   $ 23,129
Denominator: Weighted average Class A ordinary share        
Basic and diluted weighted average shares outstanding   21,500,000   21,500,000
Basic and diluted net income (loss) per share   $ 0.00   $ 0.00
Numerator: Net income (loss) minus net income allocable to Class A ordinary share        
Net income allocable to Class A ordinary share   $ 3,248   $ 23,129
Class B ordinary shares        
Numerator: Income allocable to Class A ordinary share        
Net income attributable to Class A ordinary share   $ 3,248   $ 23,129
Denominator: Weighted average Class A ordinary share        
Basic and diluted weighted average shares outstanding 5,000,000 5,375,000   5,375,000
Basic and diluted net income (loss) per share $ 0.00 $ 0.36   $ (0.92)
Numerator: Net income (loss) minus net income allocable to Class A ordinary share        
Net income (loss)   $ 1,937,271   $ (4,941,233)
Net income allocable to Class A ordinary share   3,248   23,129
Net income (loss) attributable to Class B ordinary share   $ 1,934,023   $ (4,964,362)
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
 6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Aug. 20, 2020
Class A ordinary shares, shares subject to possible redemption 18,080,145 18,574,269  
Unrecognized tax benefits $ 0    
Unrecognized tax benefits accrued for interest and penalties $ 0    
Dilutive securities 0    
Federal depository insurance coverage $ 250,000    
Private Placement      
Number of warrants issued 3,150,000   3,150,000
Initial Public Offering      
Common stock, shares issued 5,375,000    
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
INITIAL PUBLIC OFFERING (Details) - USD ($)
Aug. 20, 2020
Jun. 30, 2021
Dec. 31, 2020
Proposed Public Offering      
Deferred underwriting commissions   $ 7,525,000 $ 7,525,000
Initial Public Offering      
Proposed Public Offering      
Number of shares issued 21,500,000    
Share Price $ 10.00    
Offering costs paid $ 12,400,000    
Gross proceeds 215,000,000.0    
Deferred underwriting commissions $ 7,500,000    
Number of shares in a unit 1    
Number of warrants in a unit 0.25    
Number of shares called by each warrant 1    
Over-allotment      
Proposed Public Offering      
Number of shares issued 1,500,000    
Private Placement      
Proposed Public Offering      
Number of shares called by each warrant 1    
Exercise price of warrants $ 11.50    
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS - Founder Shares (Details)
 3 Months Ended
Aug. 20, 2020
USD ($)
shares
Aug. 10, 2020
shares
Jun. 30, 2020
shares
Jun. 26, 2020
USD ($)
Day
$ / shares
shares
Sep. 30, 2020
USD ($)
Jun. 30, 2021
$ / shares
Dec. 31, 2020
$ / shares
Related Party Transactions              
Threshold outstanding shares (as percent) 20.00%            
Class B ordinary shares              
Related Party Transactions              
Number of shares issued     5,750,000        
Common stock, par value | $ / shares           $ 0.0001 $ 0.0001
Subject to forfeiture (in shares) 750,000     750,000      
Forfeiture of founder shares (in shares) 375,000            
Forfeiture of founder shares | $ $ 0       $ 0    
Sponsor              
Related Party Transactions              
Share Price | $ / shares       $ 0.004      
Number of shares issued       5,750,000      
Threshold stock price | $ / shares       $ 12.00      
Threshold trading days | Day       20      
Threshold trading period | Day       30      
Threshold commencement       150 days      
Sponsor | Five Individuals              
Related Party Transactions              
Number of shares transferred (in shares)   25,000          
Sponsor | One individual              
Related Party Transactions              
Number of shares transferred (in shares)   30,000          
Sponsor | Class B ordinary shares              
Related Party Transactions              
Common stock, par value | $ / shares       $ 0.0001      
Offering costs paid by Sponsor | $       $ 25,000      
Forfeiture of founder shares (in shares) 375,000            
Forfeiture of founder shares | $ $ 0            
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details) - Private Placement - USD ($)
$ / shares in Units, $ in Millions
Aug. 20, 2020
Jun. 30, 2021
Related Party Transactions    
Number of warrants issued 3,150,000 3,150,000
Price of warrants (in dollars per share) $ 2.00  
Issuance of Public and Private Warrants $ 6.3  
Shares issuable per warrant 1  
Exercise price of warrants $ 11.50  
Threshold, (in days, months) 30 days  
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS - Working Capital and Support (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 26, 2020
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2021
Aug. 20, 2020
Related Party Transactions          
Administrative expenses - related party     $ 30,000 $ 60,000  
Private Placement          
Related Party Transactions          
Price of warrants (in dollars per share)         $ 2.00
Sponsor          
Related Party Transactions          
Conversion of debt $ 1,500,000        
Related party notes, outstanding balance   $ 0      
Related Party Transaction, Amounts of Transaction   $ 10,000      
Sponsor | Sponsor Loan          
Related Party Transactions          
Maximum borrowing capacity 300,000        
Proceeds from related party loan $ 163,000        
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
 3 Months Ended
Aug. 20, 2020
Jun. 30, 2020
Sep. 30, 2020
Maximum number of demands for registration of securities     three
Deferred underwriting fee payable     $ 7,500,000
Class B ordinary shares      
Number of shares issued   5,750,000  
Forfeiture of founder shares (in shares) 375,000    
Forfeiture of founder shares $ 0   $ 0
Over-allotment      
Number of shares issued 1,500,000    
Underwriting discount per unit     $ 0.20
Cash underwriting fees     $ 4,300,000
Deferred fee per unit     $ 0.35
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
DERIVATIVE WARRANT LIABILITIES (Details) - $ / shares
 3 Months Ended 6 Months Ended
Aug. 20, 2020
Sep. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Warrants        
Minimum threshold written notice period for redemption of public warrants     60 days  
Private Placement        
Warrants        
Exercise price of warrants $ 11.50      
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent) 115.00%      
Threshold, (in days, months) 30 days      
Initial Public Offering        
Warrants        
Public warrants expiration term 5 years      
Threshold minimum percentage of gross proceeds on total equity proceeds (as a percent) 50.00%      
Redemption price per warrant (in dollars per share) $ 18.00      
Threshold trading days for calculating Market Value 20 days      
Warrants exercisable term from the closing of public offering 12 months      
Threshold market value (per share) $ 9.20      
Class A ordinary shares        
Warrants        
Threshold trading days for calculating Market Value   10 days    
Warrant        
Warrants        
Share price     $ 9.20  
Public Warrant        
Warrants        
Class of warrant right outstanding     5,375,000  
Private Placement Warrant        
Warrants        
Class of warrant right outstanding       3,150,000
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
SHAREHOLDERS' EQUITY - Preference Shares (Details) - shares
Jun. 30, 2021
Dec. 31, 2020
Stockholders' Equity Note [Abstract]    
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
SHAREHOLDERS' EQUITY - Ordinary Shares (Details) - USD ($)
 3 Months Ended
Aug. 20, 2020
Sep. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Jun. 26, 2020
Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent) 20.00%        
Class A ordinary shares, shares subject to possible redemption     18,080,145 18,574,269  
Class A ordinary shares          
Common stock, shares authorized     400,000,000 400,000,000  
Common stock, par value     $ 0.0001 $ 0.0001  
Common stock, shares issued     3,419,855 2,925,731  
Common stock, shares outstanding     3,419,855 2,925,731  
Common stock, shares outstanding, subject to possible redemption     21,500,000 21,500,000  
Class A ordinary shares, shares subject to possible redemption     18,080,145 18,574,269  
Class B ordinary shares          
Common stock, shares authorized     10,000,000 10,000,000  
Common stock, par value     $ 0.0001 $ 0.0001  
Common stock, shares issued 5,750,000   5,375,000 5,375,000  
Common stock, shares outstanding     5,375,000 5,375,000  
Common Stock, Voting Rights one        
Subject to forfeiture (in shares) 750,000       750,000
Forfeiture of founder shares (in shares) 375,000        
Forfeiture of founder shares $ 0 $ 0      
Conversion ratio of stock     20.00%    
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details) - USD ($)
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Level 1 | Public Warrant      
Financial assets that are measured at fair value      
Liabilities measured at fair value $ 12,362,500   $ 11,287,500
Level 1 | Money Market Funds      
Financial assets that are measured at fair value      
Investments held in Trust Account 215,099,354    
Level 3      
Financial assets that are measured at fair value      
Liabilities measured at fair value 7,245,000 $ 8,379,000 6,615,000
Level 3 | Private Placement Warrant      
Financial assets that are measured at fair value      
Liabilities measured at fair value $ 7,245,000   6,615,000
U.S. Treasury bills maturing on February 18, 2021 | Level 1      
Financial assets that are measured at fair value      
Investments held in Trust Account     $ 215,076,225
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details) - $ / shares
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
Volatility 36.20% 25.80%
Stock price $ 9.98 $ 10.77
Risk-free rate 0.88% 0.43%
Dividend yield 0.00% 0.00%
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details) - Level 3 - USD ($)
 3 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Level 3 Derivative warrant liabilities begin $ 8,379,000 $ 6,615,000
Change in fair value of derivative warrant liabilities (1,134,000) 1,764,000
Level 3 Derivative warrant liabilities end $ 7,245,000 $ 8,379,000
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Fair Value Disclosures [Abstract]    
Change in fair value of derivative warrant liabilities $ (3,069,000) $ 1,705,000
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS - Additional Information (Detail)
Jul. 14, 2021
USD ($)
Day
$ / shares
shares
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Subsequent Event [Line Items]        
Exchange ratio threshold amount | $ $ 1,700,000,000      
Exchange ratio equity value amount | $ $ 1,655,000,000      
Exchange ratio divisible amount per share $ 10.00      
Exchange Ratio 0.9522514      
Trust amount released | $ $ 150,900,000      
Percentage of total sponsor shares to be vested 50.00%      
Sale of Stock, Value of stock issued | $   $ 25,000    
MarkForged Inc [Member]        
Subsequent Event [Line Items]        
Common stock, par value $ 0.0001      
Payments for Repurchase of Common Stock | $ $ 45,000,000.0      
Preferred Stock, Conversion Basis one-for-one      
Class A ordinary shares        
Subsequent Event [Line Items]        
Common stock, par value     $ 0.0001 $ 0.0001
Common stock, shares outstanding | shares     3,419,855 2,925,731
Class A ordinary shares | A One [Member]        
Subsequent Event [Line Items]        
Common stock, shares outstanding | shares 6,418,667      
Redeemption Price Per Share | shares 10.005      
Total redeemption price | $ $ 64,216,731.96      
Class A ordinary shares | Before Domestication [Member]        
Subsequent Event [Line Items]        
Common stock, par value $ 0.0001      
Class A ordinary shares | After Domestication [Member]        
Subsequent Event [Line Items]        
Common stock, par value $ 0.0001      
Common Stock, Conversion Basis one-for-one      
Class B ordinary shares        
Subsequent Event [Line Items]        
Common stock, par value     $ 0.0001 $ 0.0001
Common stock, shares outstanding | shares     5,375,000 5,375,000
Sale of Stock, Number of Shares Issued | shares   5,750,000    
Sale of Stock, Value of stock issued | $   $ 575    
Class B ordinary shares | Before Domestication [Member]        
Subsequent Event [Line Items]        
Common stock, par value $ 0.0001      
Class B ordinary shares | After Domestication [Member]        
Subsequent Event [Line Items]        
Common stock, par value $ 0.0001      
Common Stock, Conversion Basis one-for-one basis      
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Number of earnout shares | shares 14,666,667      
Subsequent Event [Member] | Volume-weighted average price atleast 12.50 | Sponsor Support Agreement [Member]        
Subsequent Event [Line Items]        
Volume-weighted average share price $ 12.50      
Number of consecutive trading days to calculate VWAPs | Day 20      
Number of trading days to calculate VWAPs | Day 30      
Percentage of total sponsor shares to be vested 25.00%      
Percentage of sponsor earnout shares will vest 50.00%      
Subsequent Event [Member] | Volume-weighted average price atleast 15.00 | Sponsor Support Agreement [Member]        
Subsequent Event [Line Items]        
Volume-weighted average share price $ 15.00      
Number of consecutive trading days to calculate VWAPs | Day 20      
Number of trading days to calculate VWAPs | Day 30      
Percentage of total sponsor shares to be vested (25.00%)      
Percentage of sponsor earnout shares will vest 50.00%      
Subsequent Event [Member] | A One [Member] | PIPE Investors        
Subsequent Event [Line Items]        
Sale of Stock, Number of Shares Issued | shares 21,000,000      
Sale of Stock, Price Per Share $ 10.00      
Sale of Stock, Value of stock issued | $ $ 210,000,000      
Subsequent Event [Member] | Volume-weighted average price atleast 12.50        
Subsequent Event [Line Items]        
Volume-weighted average share price $ 12.50      
Number of consecutive trading days to calculate VWAPs | Day 20      
Number of trading days to calculate VWAPs | Day 30      
Number of earn out shares issued | shares 8,000,000      
Subsequent Event [Member] | Volume-weighted average price atleast 15.00        
Subsequent Event [Line Items]        
Volume-weighted average share price $ 15.00      
Number of consecutive trading days to calculate VWAPs | Day 20      
Number of trading days to calculate VWAPs | Day 30      
Number of earn out shares issued | shares 6,666,667      
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Detail) - Subsequent Event [Member] - Markforged Holding Corporation [Member]
Jul. 14, 2021
shares
Schedule of Capitalization [Line Items]  
Shares of New Common Stock outstanding 185,251,837
Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor) 8,524,984
Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the "2021 Plan") 18,434,577
Total outstanding equity at closing, including vested and unvested options and RSUs 212,211,398
Shares of New Common Stock reserved for issuance under the 2021 Plan 24,065,423
Markforged Earnout Shares and Earnout RSUs [Member]  
Schedule of Capitalization [Line Items]  
Shares of New Common Stock reserved for issuance under the 2021 Plan 14,666,667
Markforged Holding Corporation 2021 Employee Stock Purchase Plan [Member]  
Schedule of Capitalization [Line Items]  
Shares of New Common Stock reserved for issuance under the 2021 Plan 4,700,000
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Parenthetical) (Detail) - Subsequent Event [Member] - Markforged Holding Corporation [Member]
Jul. 14, 2021
shares
Schedule of Capitalization, Equity [Line Items]  
Class of Warrant or Right, Outstanding 8,524,984
Private Placement Warrants [Member]  
Schedule of Capitalization, Equity [Line Items]  
Class of Warrant or Right, Outstanding 3,150,000
EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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
QKIW#0/)VF_P)02P,$% @ 9HH,4S:Z+#!A M P G@P !D !X;"]W;W)K&ULK5?1$BQ; MY]QSCZ6#F!RE^JYW (:\)"+54V]GS/ZC[^MH!PG3/;F'%)]LI$J8P:':^GJO M@,4Y*!%^& 17?L)XZLTF^;V5FDUD9@1/8:6(SI*$J1]S$/(X]:AWNO'(MSMC M;_BSR9YMX0G,\WZE<.17+#%/(-5I5-2VP>7UBO\N;QV;63,.M%'_S MV.RFWM@C,6Q8)LRC//X!94-#RQ=)H?/_Y%C,'0P\$F7:R*0$HX*$I\4G>RF- M: !H%R L >%; ?T2T'\K8% "!KDS12NY#PMFV&RBY)$H.QO9[$5N9H[&]GEJ MW_N34?B4(\[,EO?+K\N;+V3U//^RO"4/=W>?'I?WG\F[!1C&A7Y//I#GIP5Y M]]O[B6^PH(7Y44D^+\C##O*;;-LC8? [_H5!"_S6#?\S2WND7\!I"WSAAB\@ M0CAMJ^ZC2Y558655F//U._A62NZEAIBLLK7@$7G8;$#Q=.N@[E?4_9QZT"D5 MJ1129VD,ZJBX05X2R23AVNXPW69>07F54]KM?9B-AN$P"+#70].EU^?]I'E0 M:1XX-2]35,G$+[@QK)B'ES;ZJJ*^+*%R4KQ"-K*CL[>%NTH.*X*CIT%3_;A>M)&DSWCK?V. MSPN' T>_UU7Y:V?YSTIJK*ID!!"W+>3Y=:?3':5I4*=;TU#073_F-KR M5!,!&X0%O1%VH(K#<#$PZCR8Q MD&L2<[8#6^E^_-F)&T-)3'IJ*Q7RXGG\>#SSS.#^GK(GOB%$@)])G/+KUD:( M[5?'X<&&))A?TBU)Y9L590D6\I:M';YE!(>Y41([R'4[3H*CM#7HY\]F;-"G MF8BCE,P8X%F28/9\0V*ZOV[!ULN#QVB]$>J!,^AO\9K,B?BQG3%YYY0H8920 ME$#MLHYE>'A]0OZ-%^\7,P2FW@UAAX MVL!K:M#6!NU7!NTZ U\;^*]G@#4&'6W0>6U0YZ6N-N@V->AI@UZ^N\5VY'LY MQ@(/^HSN 5.C)9JZR ,BMY9;&*4J=N>"R;>1M!.#Q\EOP\5D#&;#Q\5?8/$X MO)\/1XN[A_LY^!5,:9:&A('Y!C/"P<68"!S%_'/?$7)J!> $>IJ;8AI4,\TP M6U\"Y'Z1_\C],1^#BT^?>8Y:@35J@ 4U5BW(V [R/4LO@7<.9-( !'6.5C7& MSY^ PK(6N"I'7A.MH:=!JY ^=9\C="0J@"ZM0.-22"!8$&G#LB1D5>&'RK# M#^7(7EWXD1@+$H(99N(9+!A..!>#MZN 5]L),D-C4,@19L+G(91 MNM;NNXO%H[MDF/;"C2*,>?@!E FR<9":ORL #R;;\6Q9M("B0;<>*1")C!%Q$J29<&8F]$P>^\E\A56>''3&^*AE?61E/ M#4VYV2M=$%YRR$[\ZH21EU.J9@1=4[+<_\])[G]E>2H@.X<;>NS J77(,=6# MZ@KM&[Z5^4:9)>.@D4KX 5H)C5A"NZ3E11[,6!2<3:*)AE(>.\J/=HV_C!I" MNQPVUY6)1FHL+- ()_0;UHU<7<"VF4_\D_"!J(:*D5EHUUE#13"TI"%LZ(AA8:W=/4KZ-AM!/:Q=/0"*3VDS0@\D-4 M3F\'@KZ;N]&6-D8?H5T@=89+7TSECS!P)YN,711F.+:V1T;KD/O^28^,/B&[ M/IWDFU SK AC\#_"GT2_T M1OUZBS]/!A#VKT)>ELCAXP:(;N( M/*SDKBHM#"@7\J<$CD*P? ;&V55MR$2#=AKFC%$A]'%M&GI;G^89[?+>OT_S MSC=ASL%IASI?^QVS=91R$).5M'$ONW(EK#BR*FX$W>8'($LJ!$WRRPW!DHL: M(-^O*!4O-^I,I3PX'/P'4$L#!!0 ( &:*#%/1VX%FU@( &X' 9 M>&PO=V]R:W-H965T+,SX*^:I2 $W> M,IZKB9-JO;]U716GD%'5$WO(\#C ' MS@T1ROA5<3IU2@-LCD_LGVWM6,N&*I@+_L(2G4ZZ5OE0P/@]\\ @@H0_"\@K "A+;149LM: M4$VG8RF.1)IH9#,#ZXU%8S4L-[NXTA*?,L3IZ?+^VVQ]OR#1;+G^2=;+V=-J M-E\_?']:D4\DDNQ -9"(TQAPZS1YH5+27"MRN0!-&5=7K6&?R/-J02XOKL@% M<8E*J01%6$Z>R1G\4M3VJ.LC# MFCRTY/TSY$]%M@%)Q)8<3]8SI0I(VFPKJ0:6RKR^AVGH#SS\C=U#TY]_QWW0 MVJ^U]CNU8A_$\$'J)>YS(CBG4I$]EF$[X:I->LD\;$@*VL4,:CC$/Z!+- M2SU1L>$L)C1/ZEX]-7*;EI+8]QMBAKVP7WY;^K\-YWY[]] QDQAXC\WJ2U]R35JIO=[@W8%HUK!J%/!.D4#4L&3 MZ[(MZ#N>!)G(=:I:.Z*;+?0L0]L;YC9.0_,E>J1RQW)%.&R1RNO=H*VR/-W+ MB19[>T!NA,;CU@Y3_"""- 'X?"N$/DW,F5M_8J>_ 5!+ P04 " !FB@Q3 M!MVC@5\# Z"P &0 'AL+W=O4XDZ"*+"/RQSTRL1\ZOO-\ M8TXW6VUON*-!3C:X0/TYGTG3R$N*[[;Q+AXYG%2'#1%L*8BX[G"!CELGH^*\B=>HY+?"T_+&9% M%$X$^TI3O1TZMPZDN"8%TW.Q_P>K!94"$\%4^0_[P]A^WX&D4%ID%=@HR"@_ M7,E39<0)P.^= 005(+@4$%: \%) KP+T+@5$%2"Z%!!7@+CT_F!6Z?24:#(: M2+$':4<;-MLHMZM$&X,IMY6UT-(\I0:G1_.'#^/EPQ1FX_GR&RSGXT^+\63Y M[M]/"_@;OIJBH'P#$Y)331@0GL*BR',A-5Q-41/*U!LS[O-B"E=_O1FXVBBR MO&Y2S7Y_F#TX,_O[@M] $%]#X 5>"WS2#5]@?@.A=Q8^O6#V"NZWP!_^#/[8 M#1\7&[/V5O&NV<1Z)X-Z)X.2+SRWD\B(QA1F1.H?L)2$*U*^O:J#/*S)PY*\ M=TYL:FJ/*BV)#0+ )Y-L"I79>UE-F]MIV_;@0!R7Q#;G=J/0,[^!NSNUNCDJ M?C'JA>I>K;K7J7HFZ],>XX:#0;M[_5I,OU/,(C>+$K)C6;W97 MD]]URIP(OD-9?NF,<2FN=%L.W37<\2/O?(7YWC$_O<[IYZ?U#UQH5-=@/N%* MF[2TX;DBC/ $6]/-:Z@ZI^6'KU]C_C%)_.XH^4B>:%9DL!+28.V^)B0G"6W- MO/N*+/HU],X9> P?/_I-0(@$,56PEB)[F;W &E968J+F9L9A4XQ[3=_PR,-![=#1(B\/%BNAS3&E;&[-X1:E'6">KX5Y&ZJ./:O4 MQ^71_U!+ P04 " !FB@Q33Q:M-Q # !]"0 &0 'AL+W=OSG9"F;;"J:4B '?N<>^ZQ?9W1@?$GD0!(])RE5(R=1,K\RG7% M-H$,BP[+@:J1F/$,2]7E.U?D''!D0%GJ!I[7=S-,J#,9F6=W?#)BA4P)A3N. M1)%EF+],(66'L>,[QP?W9)=(_<"=C'*\@S7(Q_R.JYY;LT0D RH(HXA#/':N M_:NY'VB F?&+P$$TVDBGLF'L27<6T=CQM")(82LU!59_>YA!FFHFI>-/1>K4 M,36PV3ZR?S/)JV0V6,",I;]))).Q,W10!#$N4GG/#C^@2JBG^;8L%>87'P(05(#@LX"P H2?!70K0-,F0:MTB=4K_M:)A>;-Z6*/KU1S-;E M5_4-O!;XS [_6= ."D_#YW;X&O)3<%=Y51L6U(8%AJ][@F^)GTE69(@6V08X M8K':91FFD4#J$*J3L"-"02#!_;\X;YE[-W+,RK^KU*"D1$:* J&V_E42]1FZ],KGVW/JU M@KY5@:I#,1!9<- J8F;L/JHY([1JMIZ@_@=)H9'4KFA0*QK\LZ(V%8,/B_XJ MH-P6MAEO) YKB4.KQ-L]\ N:TWU MK!H>FPI:2;J_0BXGJ#&8\;DL:,OU/J-:_(74$L#!!0 ( &:* M#%-;HAI\A 0 (T1 9 >&PO=V]R:W-H965TLU%H:\[:V,VGZ-(IVN64]V5&U; G:54 M.35PJE:1WBA&,P?*143B^"+**2\ZHZ&[-E>CH2R-X 6;*Z3+/*?J[88)N;WN MX,[[A05?K8V]$(V&&[IB=\S\O9DK.(L:EHSGK-!<%DBQY75GC#]/R< "W!,/ MG&WUSC&R0WF2\MF>S++K3FPS8H*EQE)0^'IAMTP(RP1Y?*]).TU,"]P]?F?_ MW0T>!O-$-;N5XI%G9GW=&710QI:T%&8AMW^P>D")Y4NET.X_VM;/QAV4EMK( MO 9#!CDOJF_Z6@NQ \#]/0!2 \BQ@%X-Z!T+Z-> _K& I :XH4?5V)UP$VKH M:*CD%BG[-+#9 Z>^0X->O+"%1 M^!P^)&Z!WX;A=VS31;W]\$D8_J4L&CAN@4_#\ E+ 8[;HD<@=Z,Y:30GCJ^W MA^^1*D4+HP-4O8:JYZCZ>ZB^\8+G98[,&E[+6HH,;14WAA6HD(:G#&V8XC)# MX"C0UAG+-ZX]Y1)MRB?!4[1MS:42-1SZ(D89?0L-HM\,HA]DFBO^0@U#:&B9(@6&2K85KPAKG4) M#U3 ,ZH1M062 O&GMK&$L\(XZ<;QKP&%!\WX!D&F^_?J/4=GO'!E=8YR69BU M;LTKS-8[6)A735Y70:99P0VG LVK7OEKN81N*E8!9AQ[WXU/+5"\8^(XW$$? MFQE*9,,5=:UNF,I;_3K,F* W1E4P.V]WF!SW>NT$YNRJ+CI8B=CR72FI-12E M3!G+M"U?(PW(SKZ7W+SY&X<+]D B27R@8+'W71QVOX4WTZJ;(*UW_:LBED* M@.ZZFS7;$ZZB7.S:Q:#=++"W4QSV4Z^W432#@G7]X.: E(JT%% 9S\_X/ $L5/?N[9[=N#5_SA37'7QU8>_/97@YPT\_&@Y,-S!LM#COM_U.RMP>BX(,E2[Q_D_B8D@UQ>?LF^%0I MR<[B,FQR=_855Z;4MJBKT3]1=L2;(PF;8ST='2&1]S32/UDB;S0,A80/Y80%\C'3>!,CER=+Y MKB?AQ=5/23>M27>EZV&KW'^EBW9VLO:'"FCX%2\T$FP)R+A["12JVOM7)T9N MW.;V21K8*KO#-:,94_8!N+^4TKR?V/UR\PO,Z%]02P,$% @ 9HH,4]11 MXLM( @ TP4 !D !X;"]W;W)K&ULG53O;]HP M$/U7K'S9)G4D)-!-58A$@8E.^\%@W31-^V"2@U@X=FH[T.ZOW]E)(]B 3N5# MXK/OO7OOB"_>2;71.8 A]P47>N#EQI17OJ_3' JJ.[($@2ZO']G?.>_H94DUC"3_SC*3#[RW M'LE@12MNYG(WA<:/$YA*KMV3[.K*K=5NP;%&!I M_+0I=ET7"T\4>U^)#HF""Q(&8?<(?'0>/H84X5T'#P[A/MINO8>M]]#Q1:>\ M&YEN/ MD+^EGLLX$-EO1?:?)1*GE3949$RLCRGM/ZGT7$:MU-^[&ULO5AKC^(V%/TK5M2JL]*4Q"'AL0*D&1@T6W6UTZ&S53\:8L"=)$YM![;] M]6LG(8_!.&$J%0G(XY[KDZ"I!9?"7XR&O'0(6RIO15G7P*II:C&.$0;X1R@>3? <]Q&"I/DL??A5.K M'%,!Z\!G,&G$\I^$?)!#[J36R0("W* W%,ST^XB(@7_G;T)!GO^!8 MV#H6V*1[S9&697B"!9A-&CX I:^E-'633E:%E@DFL*FLEF+Q+)$[,5H]WSP^/ M7WY=/#RO?@(/O[U\^OU/\#/XP@(2RTH#JSUBF(.;!1:(A/R#O/>R6H";'SY, M;"''5U[L33'6?3Z6>V&LNW37 ZYS*[^NHX'/S? 53GJ@?QF^,,-_2>,2#C7P M!S-\@3<2#B^.ONPPNCO0P6TY9>6\N>6\N9D_[X*_.8TBN3!E?6Q>;P'/9XFG MZ[_DB@6" MESMIB(E.%;@#A (,%L@V,!Z!80SE,< !0'0/8:+N0!B7&Y+TG)$.R_-*S?WT] MH%3L*2/_XD"7#?\L2,\I/F_2T<6RP7I0LAY^6_+[-S.';O^L'^![:AD.[J>;6VE MZRB/.E(^MS-2'I>4Q_^)\NT[5OOXG"KT=>7=P; 1%'0J<77^YQ96#-BAAVDM M34T,UIX98(>P[J]H8[#2-?@.83,WLL)C(U)](^MBV>1=B15L4:ONK:SPU-K+ MVNV:7"L5@BTR=%4[NR^\U;/F#_WS]"YTAOW,\FUD[8;-T"H9A._0P9;>!\_U M[0+M=L,F[4H'82G-Y3Y9_DK@?Q$T"3;PJZID!OB['"/D1PYU'E^<,^W.V,?N./AGFUA 6:YGRO0:2XSHF S/RI2IS[3 IOK9_9I43P6LV(:;J3XSM=F-W+Z#EG#AN7"W,OC9Z@* M"BU?(H4N/LFQBO4-P.CR&IX=Y+N(O]K)OJUTWU"[[N!;XO< !!*/F?S/.5X GYSI1BF6FA M#FKJH* .+NE5J\)*54 M>I><4<%IS>-H.Q)KPC'Q3Z!%DDB0R?WV_2AU* MRK#17I^&WF 0A-WS_>W7V?2OZ&_04M>@9AJ\52NI=_(][R_W\6[ M^NI6WU2!S6O=#WJ#WP+C,XQ11%\POJRPX>ST&H&L"RE^8 ;(7+ $[/VYPI#H MR>RH_V;RG6R0!G]#ON W5<[*%U>!UZMR,E/:[J;+SJ*#O]HBY2>"-0@L@)E< M\6Q+NN.*,7EE7+_+] M\)4*;F, LN,J>OV69YH(V"#6Z_2P)ZJ< ,N-D?MB)EI)@Q-6L=SAU S*!N#[ MC93F>6/'K'H.'_\"4$L#!!0 ( &:*#%.@+PE,R ( *4' 9 >&PO M=V]R:W-H965T<_K, M,CEP4J7V-YXGXQ0R+%V^!Z;?;+C(L-)3L?7D7@!.+)11+_#]KI=APIQA9-<> MQ##BN:*$P8- ,L\R+)['0/EQX+2,;0T A5D8!Z\:3I72@.?CD_JMW;O>RQI+F'#Z@R0J'3A]!R6PP3E5"W[\#.5^.D8O MYE3:7W0L8WT'Q;E4/"MA[2 CK'CBI[(.9X#6J0>"$@C> MT+0%@"H=UHX#D!1B&XQ$6B%:0YH#ECF M G2?E40?IJ PH?*CEGN'/"13+$!&GM+&37HO+DV."Y/!!9-=-.=,I1+-6 )) M#3]IYEM!@X"G*U:5+3B5;1PT*G[)F8M"_Q,*_*!59Z@9GT*L\9;%_08[8=7% MT.J%E[KXTH ID3'EI@<2_1RMI1+Z2_G5D*-=Y6C;'.T+.5:KXIZ9:Q;&>LV&EL0N;O:" DL*KUULS[;K]?6]A_8>VPJ:Z] MRGZO46=*#B0!EJ!G K3NRQPW\[[KU_\O_ALK['MG)V$&8FLO"(EBGC-5'(K5 M:G4'C>S1Z[V$%Q?8'(LM81)1V&A4=UKW7Q270C%1?&_/U357^I2VPU3?HR!, M@'Z_X5R=)B9!=3,/_P!02P,$% @ 9HH,4ZP\N$_1 @ )0< !D !X M;"]W;W)K&ULK55=;]HP%/TK5]$>6JEMOB!T%2 ! MI5HGJ"H8W<.T!T,NQ&IB,]N![M_/=CZ:EH^GO22V<\_Q.?V=Z\I5@AF1-WR+3']9=%;D8H<_I= MN_8L^EV>JY0R?!8@\RPCXN\04[[O.;Y3+UWMV2#/J3QBKI.;<.Q+@F>:IF?/\-2S]M MP[?BJ;1/V)>QG@.K7"J>E6"M(*.L>).W,@\-@.8Y#@A*0/ 9T#H!"$M :(T6 MRJRM>Z)(OROX'H2)UFQF8'-CT=H-9::*)S!RV"R&,-T/)@O M9N/I^.G''*YAE!"V0: ,'@@5\$+2'(&O88([3"%LKDZ1R%R@+JZ2<'&/BM!4 M7FJ.*O8:%O-[N/ARV765%FVV=E>EP&$A,#@A,(0I9RJ1,&8QQA_QKC9;.PXJ MQ\/@+.'WG-U Z%U!X 7^$3VC\_ I$1KN'X-_D!/6!0@M7WBJ '4:KV @)>H, M$A;#A)(E3:FB**OTQJ"/_0Q7N1"4;6S4$V>B7A@2227\FN@-X%%A)G^?D=>J MY;6LO-8)>54%[U'0'3&_'.R)$(0I2!L2E[BA[%AQ"_;(LIN.LNO?AIVOGN=U MW5TSZ8=Q4>2WFW$?Y+=K^>VS\M\/\=KD>5<=XOBLG6-&BGW:#8'7OA^V#IT< M!OJ=J'72250[B?Y'(9#%Q]1'!^GM!*WVH?C#N,_E*L2[C8Z3H=C81BQAQ7.F MBE^Q7JU[_<"VN$_K0WT'%"W[G::X0/2/IL^4A!37FM*[Z>B4BJ(I%Q/%M[:O M+;G27=(.$WV/H3 !^ON:^K[(2*Z(NQ1:Y.2F$K(@VIMSX:BN1Y Y4 M,3\,@I%?$3/.V2B&7L#;[^QH)M2VPT_B;=D M@TO4J^V3-);?L^2T0JZHX""Q&'OIX'8RM/[.X9EBHP[68#-9"_%BC8=\[ 4V M(&28:>WJ< P/,+V7SV^$:&"5KRLQK0'7L MKEN=D=.Q4V.77$3!Z"8(@MC?'1;Q;\?!=7!UZ-=FXA^\YPKEQK6Y@DS47+=/ MN]_M)TGJ&LC_[=Z.H3F1&\H5,"P,-+B\-FTEV]9N#2VVKCO60IM><\O23$.4 MUL&<%T+HO6$%^OF:_ )02P,$% @ 9HH,4[QJ:1S.!P )BT !D !X M;"]W;W)K&ULM9I1;Z,X$,>_BA7M2;O2ML& H5FU ME9JFI^OI=B_7;+L/JWMP$[=!"SAKG'0KW8<_&VB&%&Q(FO0A#02/_]CCWXP' M3I^X^)'-&9/H5Q*GV5EO+N7B4[^?3>S'NZ]G+B)'N=2 MG^B?GR[H(YLP>;L8"W747UN910E+LXBG2+"'L]X%_G05AKI!?L5=Q)ZRRG>D M;^6>\Q_ZX'IVUG.T(A:SJ=0FJ/JW8I-G:;2W[E,WK'Y_L?Y[?O/J M9NYIQBYY_"V:R?E9[Z2'9NR!+F-YPY_^8.4-$6UORN,L_T1/Y;5.#TV7F>1) MV5@I2**T^$]_E0-1:>";&KAE _=5 S3VZ'DZM_;J^^ M?$57=^IS@H[0Q6P6Z5FD,;I."U_4<_I^Q"2-X@^G?:DZULW[T[*38=&):^CD MSV5\C+#_$;F.BV\G(_3^W8<1?7Z'^BB;4\&RXK/!\&6;X?08>4YNV"D-&VV- MNMO"':1=VX[CNT]OU5*%B]W+=0@4#1>V::D;!^Z\096";D9*WBQ*IBS,14+085XA!_ M0))+Q;!LP=.,EQ.1J9/HGJ$5RR2;-6FS=T"<8\?YS;*^!FNE ZNA"8USC1/) MIS\^HKO)"I*9<5X+J@HV- 8K0I+X<8J4 .(#2,( MS,1V:([ILTJB9(94U$0W;+$4:D%F^;R6\O+I-BT+7*>G;^44!GAB.SW'*O]B M0JBI+1WNDJ2U_/J%[L EH6?2#^S$=G@:/$7)OD!_JVGM M@"X7L.@Z!W$=%^#HXH--Q["T71WEP, M>#P(#&( J:X=?V8G'#*%189&/%%91C0MMD]=?!)0Z9+#^"0 T[7GDEN$T])2 M5TRY@%2W!:GF9?X@E2MN/\! 2/?D, ,,#'-;&+;% ^V&F /T.;9,[YJ4M(M M)6@QV"TE\(",7@L9( W[T [Z,H6VHZK+5*"TE)K2M!^W:96H)G7 M0K.WI 2E[6H,(EZXL2:3K85&50!&CUNJ"UMK#>$+P\8*MW&+9ZP%9O;VSU MMF.K#VSU6]AJ'.$=@YBZQ;!J\5@)7CI MAP^O;6S*K)0M[6"M3T:'J0;L^8=)!'U@EV]G%Y"449&JB ".;-X"E#:K*,5^ MH/\,NQ(?R.7;R64<3R7HCL?+A!T]Y8^'%%*I<@E="RQV"53JJJ1$V#TFCKIZ M4A8&)\O%@@N)+AZ%VE=TG2+ G7\8W/F .]^..]-MY_-3W'SC) UJVR,]-(:2 M.("/V,$'#C-5X\NF2_TH$$E!\S1B1I_S&NR4QM-E3"5#=]\NQMJ;1O2YL4SN MU*L(IK(]$)+8\TK0N+NN^K[;,^D"KA([5_=0OV[IP24M!6P" "8MUP_L"&A\L;A= M> CLX>'MU&CIH)4: 82)P!XF;-38K#2K$^/K\16Z3K5J+FRY8P#A(#A,B2( MA@=VQ+Y]VSPL>]A8;-CVU"H :@\^L2VG$&@; MVE/C/>6(%F3&%]4*N<3$! M;,.N=9#===6K(L;%5'GOJFOJO,MBJB?*06.9IE]YQ52_0?R9BLRBT.)%_D;YW>&PO=V]R:W-H965T7'3/A1]H*5KBPLE MJB1E-_OUNZ1DQ4GDK,A6S ^R2/&>>\[](#G9276CXD*! MKHN"J=L+%')W[H7>?N**;W)C)_SII&(;7**YKA:*1GZ'DO$"2\UE"0K7Y]XO MX>N+<& -W(I/''?ZX!VLE)64-W9PF9U[@66$ E-C(1C];7&&0E@DXO&M!?4Z MG];P\'V/_JL33V)63.-,BL\\,_FY-_8@PS6KA;F2N[?8"DHL7BJ%=D_8M6L# M#]):&UFTQL2@X&7SS[ZW@3@PB(X91*U!Y'@WCAS+-\RPZ43)'2B[FM#LBY/J MK(D<+VU6ED;15TYV9KJ\OEC._[B>?_@(\T_T7,(K6%+JLUH@R#4LI#:O9D)J M7FY@QBINF.!_,1?1%V_0,"Y>6I-ZI?%;C:6!^=8^O[S'8H7J*WU[S]0-E<\& M,W@K1>: I*JD:E#V*R>^(3V6E9^VW"\:[M$1[K_5XA3"^ 2B( IUSA3J^R ^ M!:.+2-1%)'*H@V,1.5#_0/"7=[06+@T6^NL3G@:=IX'S%!_SY"A;/Q^H>F>R M*,C'TLCT!JA_M&&E#59?7!K%X,)KXVQY*<4D.$NYVD.@Y,P"4Z"( "!&X[6%?6G%94BF^90:@$ M2[&PU;+; ^0H,EC=PK*2I9;J99_X^)%XTAZ?C>-^Z4DG/?F/IBHA M'L3)Z$@A#+MH#)^,QD=)=7]/+;4W-[? #*3-=G!":4U%[3YN41O2:E7493MX M&)X^^L-']*,PBL)P<#;NYS_J^(^>FTV:1[4E@I0@X%K7C.)^D+LNXGV$1X\) MQ\$PB:-!/]]QQW?\)-^#@IDS55+@H95@P[>?\WK6>3W[R7M=&-P= M-,'_DI'6[;T6B(?V=Z0%PH.S,?S1I!SMXGE1"7F+V$I9U"K-Z9;0M/ /I"J\ M.Y?"GWTPA7OQR16/ OM[D"O_X$ICKX>4B@VGS43@FBR#TQ%! MJ.;&U0R,K-PM9R4-W9G<:TZW5%1V 7U?2VGV WMQZNZ]T[\!4$L#!!0 ( M &:*#%/>?IEY= ( ,D% 9 >&PO=V]R:W-H965TTA%OK@[R2=M^^?=(JVBC]:'( 9,^%+,W8RQ&K4]\W:0X%-\>J@I)VEDH7 M'&FJ5[ZI-/#,!172#X-@Y!=K23BVSL!9802$C1(G#ZK6$*4EH@HO'48GI=2ANX:V_1O[C:J98%-S!5 M\DYDF(^]$X]EL.2UQ&NU.8>VGJ'%2Y4T;F2;UC?P6%H;5$4;3 P*439__MSJ ML!,0[@L(VX#0\6X2.99G''D<:;5AVGH3FC5T*BL-X?C.9 MSW[I!P#27F M@"+E\@,[. /D@@R"J!<&GFK:9;.U'>^OH%B ?J"]*ZX?Z3:M(&/G2F8.6.E* MZ09UZQGY2/59EG[:UC)I:@GWU/*UEL>L-SAD81#V3$[DS&L0G\3I% H[A4*' MVM^GT(X:KP4X9+.G6N +N[^D&':!4)B'=S+VNXQ]EW&P)^-4[0X=IV7,LW" TZ0H-W"25:K#D" M2R1/H;#'V3(S>T[K599AEV7XGX0>=1E'_TCHT5]"]WO#@+X_A/9W.M,^CF:"J7+,N%%+K.S.GMQ:T=:#]I5*XG=C^[U[O^#=0 M2P,$% @ 9HH,4T :*OY' P _A0 T !X;"]S='EL97,N>&ULW5AM M;]HP$/XKD3M-K30U0-I 5D#:D"I-6J=*[8=]JPQQP)+C9([IH+]^/CN$E_H0 MZX<5E@ABW^-[[O'YDACZE5X*]C!C3 >+7,AJ0&9:EY_#L)K,6$ZKRZ)DTB!9 MH7*J35=-PZI4C*85..4B[+1:<9A3+LFP+^?Y;:ZK8%+,I1Z0;F,*W.5;.B#M M^(H$CFY4I&Q GLX__IH7^N9#X*YGG\[.6D\7-[OVGT Z67+'"BS M13'Z^##Z?>08=?= Y7N%8^2]@\CW4&/$R3;Q.H-.Z?F6 2'IMA"2+0+K'-:E M->QGA5Q76$2:X-VFO MWL0;E/RYT%_G9CK2]J%:V;UB&5_8_B)K!&#L;9R=EJ58?A%\*G/F)G]PP&&? MKOR"6:'XBXD&I3(Q!J9(\,R4YI--RV]%RT>VT*MR6F2XYLX):OZW>9XRR105 MFZ)-[1]SEM^L..J^EV3[5-D5[-58O^>/7>3U*8B,CU]DE!R_QGJO=>PB>Z<@ M\A26N_MN3_:](L-Z)[2QW=K:;#76 #:U _(#MLAB'308S[G07-:]&4]3)E_M MN0R]IF/SXVZ+WXQ/64;G0C\VX("LVWOV=YA>.VYVU"86 MERE;L'14=]5T;)N!:9BH]0$.N\BM/?P(YN,P/P(8%@=3@/DX+RS._S2?'CH? MAV':>EZDA_KT4!_GY4-&]L3B^'T2<_AGFB11%,=81DF^"L%FBE2>)?;2P.>&"K@-4. MQ/?'@9KR^T01K"JF#;N#<21), 1JT5^C<8QD)X;3OS[871)%2>)' /,KB"(, M@;L11S %H %#HLB^!W?>1^'J/16N__$<_@%02P,$% @ 9HH,4Y>*NQS M $P( L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/ M:(7->=I3W;+T]!;X"O M.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_ M'S^+ # !=&0 #P 'AL+W=O0A)&,I@11(JMF7E0>LH>U[N6?"M&RE:J@V1?4T M:O>*T:K=,::;>A2,Q]>CAG+A??YTZFNE1G9!:E9J+H6I["HVG+VT_[9W1?3, M6_[(:ZY_3+S^NF8>:KC@#?_)JHDW]E"[DR_W4O&?4FA:YZ62=3WQ_&/#ABG- MRU?5>0=9T,>VK]'T,:,&9.)=CTV'6ZY:W=_1]T\-XS,S-Q]+!RUGO-9,3:EF MRZ>NF[,6XRLU^CCFT(H^L>ZES%-(=7Q!;$/+OP((, 1:T$/%]1'R-:X%>0E 7KXAY""2 M5P#DU5M"AA;D-0!Y[19R&N=11E8%21.4SE":S7%"_L)]&2=3"_(&@+QQ"YFO METNH-7Z;D$BPSJ+,Y+, M+;B/ -Q'MW!9O,!%/$4KG!4/J,APDN.H&^3<7K_'T (^=KPXILLE*99Q4N3= MQ$-1:D8VF<=)1.(!)&@9QYJ9FB'=F#_')D9?<99UDW!!\!U9F*$?4D*:\1U[ M)K_'67R?+@QM_@[%7]:D>+#9(+OXCO4RPR1#&[Q8QV@9XWR=Q?V0VWB05WS' M8LG7=[D)F$%"\>97,,@EOF.9@$O@P'@^9!/?L4Y@3-MY/N03W[%0SLQ"=&%2 M[9JU-B9D%-^Q4E[-QA/@'S8AI!7?L5? ]&$P+0-(+H%CN<#3\M+&A/02.-8+ MC'EE8X+;&,=^.9/IH(LITY37-B:DFL"Q:L[G/.A/-),V)J23@O (24.!:0+_))/M9R;9, M,6%C0A8*'%OH#&:J*BZH^F$?K$ 6"AU;Z%S6858CPVE',X0L%#JVT'G,+PYL-C\'$5<4'T80L%/[?&Y\3H+F1UO:"%$(6 M"IUO@UYCYJ;?ZE S)+&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/- MV$UNPC 0AN&K1#X SLSP6P&K;MA67" *AB#RI]A5X?:-PB)\41?=(,\JLJ., MW]6CR-LO5V;AVM2^N+8^N5=E[7>F"*']L-;GA:LR/VM:5_=OSDU79:%?=A?; M9ODMNSC+:;JTW>L,L]^^SDR.C];]9V)S/E]S]]GDWY6KPQ^#[4_3W7SA7##) M,>LN+NR,O9?CMK?#@V;]9),<3CO3'4YD;.P@AB".'R00)/&#YA TCQ^T@*!% M_* E!"WC!ZT@:!4_: U!Z_A!&PC:Q ^B%&5,%21-L%:@-2'7I,!K0K!)@=B$ M9),"LPG1)@5J$[)-"MPFA)L4R$U(-RFPFQ!O4J WH]ZL0&]&O5F!WCSYV5:@ M-Z/>K$!O1KU9@=Z,>K,"O1GU9@5Z,^K-"O1FU)L5Z,VH-RO06U!O4:"WH-ZB M0&]!O46!WC*Y+%&@MZ#>HD!O0;U%@=Z">HL"O07UEG?J[<.C='[L>:[Q_'=2 M'?IOW7C\L'QN3M@9<+9P#;W_!5!+ P04 " !FB@Q3JF<489@! +%P M$P %M#;VYT96YT7U1Y<&5S72YX;6S-F,UNPC 0A%\ERA418[NE/P(N;:\M MA[Z FVQ(1!);MJ'P]G7"C]2*1B J=2ZQ$N_.C+W2=\CD?6O(19NZ:MPT+KPW MCXRYM*!:N40;:L).KFVM?'BU"V94NE0+8F(T&K-4-YX:/_2M1CR;/%.N5I6/ M7C;ALRMU,XTM52Z.GG:%K=@8I*\^'[73SB@[TSM<[Z>VRVX>CG7+]7?\?<9'_0MS") <$B3'#4B.6Y < M8Y <=R Y[D%R/(#DX".4("A$Y2A(Y2A,Y2A0Y2A4Y2A8Y2A[9=DUJ5S<&?=?_ 9U]02P$"% ,4 " !FB@Q3!T%- M8H$ "Q $ @ $ 9&]C4')O<',O87!P+GAM;%!+ M 0(4 Q0 ( &:*#%/ V3J[@ "L" 1 " :\ !D M;V-0&UL4$L! A0#% M @ 9HH,4SH$G"+?!0 FAD !@ ("!#0@ 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 9HH,4S-8X(?L P M9 X !@ ("!C!< 'AL+W=OU\$ "@#@ & @(%A(0 >&PO=V]R:W-H965T&UL4$L! A0#% @ 9HH,4ZUKN]=." @A0 !@ M ("!]B4 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 9HH,4PRUE"U5" UA4 !D ("!?44 'AL+W=O&UL4$L! A0#% @ 9HH,4ULXJS&PO=V]R:W-H965T&UL4$L! A0#% @ 9HH,4[_8>:K5% WT, !D M ("!]G0 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ 9HH,4Z(6$8W4 P G0@ !D ("!&PO=V]R:W-H965T&UL4$L! A0#% @ M9HH,4Q'G1/!A P 1@D !D ("!&Y\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 9HH,4UNB&GR$! C1$ !D M ("! K4 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ 9HH,4[S![_=/ P DPL !D ("!A< 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 9HH, M4[P5D<9A @ :P4 !D ("!$LH 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 9HH,4]Y^F7ET @ R04 M !D ("!A]@ 'AL+W=O&PO !?&PO M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !FB@Q3JF<489@! M +%P $P @ $>Y0 6T-O;G1E;G1?5'EP97-=+GAM;%!+ 4!08 +0 M #(, #GY@ ! end XML 50 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 110 256 1 false 34 0 false 6 false false R1.htm 1001 - Document - Cover Page Sheet http://www.markforged.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.markforged.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Unaudited Condensed Consolidated Statements Of Operations Sheet http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations Unaudited Condensed Consolidated Statements Of Operations Statements 4 false false R5.htm 1005 - Statement - Unaudited Condensed Consolidated Statement Of Changes In Shareholders' Equity Sheet http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity Unaudited Condensed Consolidated Statement Of Changes In Shareholders' Equity Statements 5 false false R6.htm 1006 - Statement - Unaudited Condensed Consolidated Statement Of Cash Flows Sheet http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows Unaudited Condensed Consolidated Statement Of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Sheet http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperations DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Notes 7 false false R8.htm 1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.markforged.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 1009 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://www.markforged.com/role/InitialPublicOffering INITIAL PUBLIC OFFERING Notes 9 false false R10.htm 1010 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.markforged.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 10 false false R11.htm 1011 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.markforged.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 11 false false R12.htm 1012 - Disclosure - DERIVATIVE WARRANT LIABILITIES Sheet http://www.markforged.com/role/DerivativeWarrantLiabilities DERIVATIVE WARRANT LIABILITIES Notes 12 false false R13.htm 1013 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://www.markforged.com/role/ShareholdersEquity SHAREHOLDERS' EQUITY Notes 13 false false R14.htm 1014 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.markforged.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 14 false false R15.htm 1015 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.markforged.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 1016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 1017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.markforged.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.markforged.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.markforged.com/role/FairValueMeasurements 18 false false R19.htm 1019 - Disclosure - SUBSEQUENT EVENTS (Tables) Sheet http://www.markforged.com/role/SubsequentEventsTables SUBSEQUENT EVENTS (Tables) Tables http://www.markforged.com/role/SubsequentEvents 19 false false R20.htm 1020 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Sheet http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Details http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperations 20 false false R21.htm 1021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Reconciliation of Net Loss Per Ordinary Share (Details) Sheet http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Reconciliation of Net Loss Per Ordinary Share (Details) Details 21 false false R22.htm 1022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 1023 - Disclosure - INITIAL PUBLIC OFFERING (Details) Sheet http://www.markforged.com/role/InitialPublicOfferingDetails INITIAL PUBLIC OFFERING (Details) Details http://www.markforged.com/role/InitialPublicOffering 23 false false R24.htm 1024 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) Sheet http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails RELATED PARTY TRANSACTIONS - Founder Shares (Details) Details 24 false false R25.htm 1025 - Disclosure - RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details) Sheet http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details) Details 25 false false R26.htm 1026 - Disclosure - RELATED PARTY TRANSACTIONS - Working Capital and Support (Details) Sheet http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails RELATED PARTY TRANSACTIONS - Working Capital and Support (Details) Details 26 false false R27.htm 1027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.markforged.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.markforged.com/role/CommitmentsAndContingencies 27 false false R28.htm 1028 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details) Sheet http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails DERIVATIVE WARRANT LIABILITIES (Details) Details http://www.markforged.com/role/DerivativeWarrantLiabilities 28 false false R29.htm 1029 - Disclosure - SHAREHOLDERS' EQUITY - Preference Shares (Details) Sheet http://www.markforged.com/role/ShareholdersEquityPreferenceSharesDetails SHAREHOLDERS' EQUITY - Preference Shares (Details) Details 29 false false R30.htm 1030 - Disclosure - SHAREHOLDERS' EQUITY - Ordinary Shares (Details) Sheet http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails SHAREHOLDERS' EQUITY - Ordinary Shares (Details) Details 30 false false R31.htm 1031 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details) Sheet http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details) Details 31 false false R32.htm 1032 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details) Sheet http://www.markforged.com/role/FairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details) Details 32 false false R33.htm 1033 - Disclosure - FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details) Sheet http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details) Details 33 false false R34.htm 1034 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) Sheet http://www.markforged.com/role/FairValueMeasurementsAdditionalInformationDetails FAIR VALUE MEASUREMENTS - Additional Information (Details) Details 34 false false R35.htm 1035 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Detail) Sheet http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail SUBSEQUENT EVENTS - Additional Information (Detail) Details 35 false false R36.htm 1036 - Disclosure - SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Detail) Sheet http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Detail) Details 36 false false R37.htm 1037 - Disclosure - SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Parenthetical) (Detail) Sheet http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Parenthetical) (Detail) Details 37 false false All Reports Book All Reports d187897d10q.htm d187897dex311.htm d187897dex312.htm d187897dex321.htm d187897dex322.htm mkfg-20210630.xsd mkfg-20210630_cal.xml mkfg-20210630_def.xml mkfg-20210630_lab.xml mkfg-20210630_pre.xml http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 55 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d187897d10q.htm": { "axisCustom": 1, "axisStandard": 15, "contextCount": 110, "dts": { "calculationLink": { "local": [ "mkfg-20210630_cal.xml" ] }, "definitionLink": { "local": [ "mkfg-20210630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "d187897d10q.htm" ] }, "labelLink": { "local": [ "mkfg-20210630_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "mkfg-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "mkfg-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 305, "entityCount": 1, "hidden": { "http://www.markforged.com/20210630": 1, "http://xbrl.sec.gov/dei/2020-01-31": 6, "total": 7 }, "keyCustom": 54, "keyStandard": 202, "memberCustom": 18, "memberStandard": 15, "nsprefix": "mkfg", "nsuri": "http://www.markforged.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.markforged.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.markforged.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.markforged.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - DERIVATIVE WARRANT LIABILITIES", "role": "http://www.markforged.com/role/DerivativeWarrantLiabilities", "shortName": "DERIVATIVE WARRANT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - SHAREHOLDERS' EQUITY", "role": "http://www.markforged.com/role/ShareholdersEquity", "shortName": "SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://www.markforged.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.markforged.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.markforged.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - SUBSEQUENT EVENTS (Tables)", "role": "http://www.markforged.com/role/SubsequentEventsTables", "shortName": "SUBSEQUENT EVENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "mkfg:DeferredUnderwritingCommissionNoncurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "role": "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P08_20_2020To08_20_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "-5", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P06_24_2020To06_30_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Reconciliation of Net Loss Per Ordinary Share (Details)", "role": "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Reconciliation of Net Loss Per Ordinary Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P04_01_2021To06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentIncomeNonoperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "mkfg:DeferredUnderwritingCommissionNoncurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - INITIAL PUBLIC OFFERING (Details)", "role": "http://www.markforged.com/role/InitialPublicOfferingDetails", "shortName": "INITIAL PUBLIC OFFERING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "mkfg:PublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P08_20_2020To08_20_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "0", "lang": null, "name": "mkfg:NumberOfSharesIssuedPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn08_20_2020", "decimals": "3", "first": true, "lang": null, "name": "mkfg:CommonStockSharesSubjectToForfeitureAsPercentOfIssuedAndOutstandingShares", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "role": "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_26_2020_PrincipalOwnerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "3", "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn08_20_2020_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details)", "role": "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "shortName": "RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - RELATED PARTY TRANSACTIONS - Working Capital and Support (Details)", "role": "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails", "shortName": "RELATED PARTY TRANSACTIONS - Working Capital and Support (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P06_26_2020To06_26_2020_PrincipalOwnerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-5", "lang": null, "name": "us-gaap:ConversionOfStockAmountConverted1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P07_01_2020To09_30_2020", "decimals": null, "first": true, "lang": "en-US", "name": "mkfg:MaximumNumberOfDemandsForRegistrationOfSecurities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P07_01_2020To09_30_2020", "decimals": null, "first": true, "lang": "en-US", "name": "mkfg:MaximumNumberOfDemandsForRegistrationOfSecurities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "mkfg:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details)", "role": "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "shortName": "DERIVATIVE WARRANT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "mkfg:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - SHAREHOLDERS' EQUITY - Preference Shares (Details)", "role": "http://www.markforged.com/role/ShareholdersEquityPreferenceSharesDetails", "shortName": "SHAREHOLDERS' EQUITY - Preference Shares (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn08_20_2020", "decimals": "3", "first": true, "lang": null, "name": "mkfg:CommonStockSharesSubjectToForfeitureAsPercentOfIssuedAndOutstandingShares", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - SHAREHOLDERS' EQUITY - Ordinary Shares (Details)", "role": "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "shortName": "SHAREHOLDERS' EQUITY - Ordinary Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "mkfg:CommonStockSharesOutstandingIncludingRedemption", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details)", "role": "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails", "shortName": "FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_30_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details)", "role": "http://www.markforged.com/role/FairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn03_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details)", "role": "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P04_01_2021To06_30_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)", "role": "http://www.markforged.com/role/FairValueMeasurementsAdditionalInformationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P07_14_2021To07_14_2021", "decimals": "-8", "first": true, "lang": null, "name": "mkfg:ExchangeRatioThresholdAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Detail)", "role": "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "shortName": "SUBSEQUENT EVENTS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P07_14_2021To07_14_2021", "decimals": "-8", "first": true, "lang": null, "name": "mkfg:ExchangeRatioThresholdAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfCapitalizationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn07_14_2021_MarkforgedHoldingCorporationMemberdeiLegalEntityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Detail)", "role": "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "shortName": "SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfCapitalizationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn07_14_2021_MarkforgedHoldingCorporationMemberdeiLegalEntityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCapitalizationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn07_14_2021_MarkforgedHoldingCorporationMemberdeiLegalEntityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Parenthetical) (Detail)", "role": "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail", "shortName": "SUBSEQUENT EVENTS - Schedule of Post-Closing Capitalization (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCapitalizationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn07_14_2021_MarkforgedHoldingCorporationMemberdeiLegalEntityAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P06_24_2020To06_30_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Unaudited Condensed Consolidated Statements Of Operations", "role": "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations", "shortName": "Unaudited Condensed Consolidated Statements Of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P06_24_2020To06_30_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_23_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Unaudited Condensed Consolidated Statement Of Changes In Shareholders' Equity", "role": "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "shortName": "Unaudited Condensed Consolidated Statement Of Changes In Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "PAsOn06_23_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P06_24_2020To06_30_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Unaudited Condensed Consolidated Statement Of Cash Flows", "role": "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows", "shortName": "Unaudited Condensed Consolidated Statement Of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "role": "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperations", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.markforged.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "mkfg:PublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - INITIAL PUBLIC OFFERING", "role": "http://www.markforged.com/role/InitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d187897d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "mkfg:PublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 34, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "mkfg_AOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A one.", "label": "A One [Member]" } } }, "localname": "AOneMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_AfterDomesticationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "After domestication.", "label": "After Domestication [Member]", "terseLabel": "After Domestication [Member]" } } }, "localname": "AfterDomesticationMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_BeforeDomesticationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Before domestication.", "label": "Before Domestication [Member]", "terseLabel": "Before Domestication [Member]" } } }, "localname": "BeforeDomesticationMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_CashUnderwritingDiscountPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the cash underwriting discount per unit.", "label": "Cash Underwriting Discount Per Unit", "verboseLabel": "Underwriting discount per unit" } } }, "localname": "CashUnderwritingDiscountPerUnit", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "perShareItemType" }, "mkfg_ChangeInValueOfCommonStockSubjectToPossibleRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) in value of common stock subject to possible redemption.", "label": "Change In Value Of Common Stock Subject To Possible Redemption, Value", "negatedLabel": "Change in value of Class A ordinary shares subject to possible redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemptionValue", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mkfg_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of adjustment of exercise price of warrants based on market value and newly issued price.", "label": "Class Of Warrant Or Right, Adjustment Of Exercise Price Of Warrants Or Rights, Percent Based On Market Value And Newly Issued Price", "verboseLabel": "Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)" } } }, "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "mkfg_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants", "terseLabel": "Minimum threshold written notice period for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "mkfg_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "verboseLabel": "Redemption price per warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "perShareItemType" }, "mkfg_CommonStockRedemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit number redemption price of stock.", "label": "Common Stock Redemption Price Per Share", "verboseLabel": "Threshold market value (per share)" } } }, "localname": "CommonStockRedemptionPricePerShare", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "perShareItemType" }, "mkfg_CommonStockSharesOutstandingIncludingRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock including shares issued for redemption.", "label": "Common stock shares outstanding including redemption", "terseLabel": "Common stock, shares outstanding, subject to possible redemption" } } }, "localname": "CommonStockSharesOutstandingIncludingRedemption", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "sharesItemType" }, "mkfg_CommonStockSharesSubjectToForfeitureAsPercentOfIssuedAndOutstandingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of the company that are subject to forfeiture represented as a percentage of issued and outstanding stock as a result of partial exercise of over-allotment option.", "label": "Common Stock, Shares Subject To Forfeiture As Percent Of Issued And Outstanding Shares", "terseLabel": "Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)", "verboseLabel": "Threshold outstanding shares (as percent)" } } }, "localname": "CommonStockSharesSubjectToForfeitureAsPercentOfIssuedAndOutstandingShares", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "percentItemType" }, "mkfg_CommonStockSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on common stock subject to possible redemption.", "label": "Common Stock Subject to Possible Redemption [Policy Text Block]", "verboseLabel": "Class A Ordinary Shares subject to possible redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mkfg_DeferredFeePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the deferred fee per unit.", "label": "Deferred Fee Per Unit", "verboseLabel": "Deferred fee per unit" } } }, "localname": "DeferredFeePerUnit", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "perShareItemType" }, "mkfg_DeferredOfferingCostsIncludedInAccountsPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs included in accounts payable.", "label": "Deferred Offering Costs Included in Accounts Payable", "terseLabel": "Deferred offering costs included in accounts payable" } } }, "localname": "DeferredOfferingCostsIncludedInAccountsPayable", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mkfg_DeferredOfferingCostsIncludedInAccruedExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs included in accrued expenses.", "label": "Deferred Offering Costs Included in Accrued Expenses", "terseLabel": "Deferred offering costs included in accrued expenses" } } }, "localname": "DeferredOfferingCostsIncludedInAccruedExpenses", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mkfg_DeferredOfferingCostsPaidInExchangeForIssuanceOfClassbOrdinarySharesToSponsor": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs paid in exchange for issuance of class\u00a0B ordinary shares to sponsor.", "label": "Deferred Offering Costs Paid in Exchange for Issuance of ClassB Ordinary Shares to Sponsor", "terseLabel": "Deferred offering costs paid in exchange for issuance of Class\u00a0B ordinary shares to Sponsor" } } }, "localname": "DeferredOfferingCostsPaidInExchangeForIssuanceOfClassbOrdinarySharesToSponsor", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mkfg_DeferredUnderwritingCommissionNoncurrent": { "auth_ref": [], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting commission deferred, classified as noncurrent.", "label": "Deferred Underwriting Commission, Noncurrent", "terseLabel": "Deferred underwriting commissions", "verboseLabel": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissionNoncurrent", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "mkfg_DeferredUnderwritingFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.", "label": "Deferred Underwriting Fee Payable", "verboseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeePayable", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "mkfg_EarnoutSharePriceRangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnout Share Price Range [Axis]" } } }, "localname": "EarnoutSharePriceRangeAxis", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mkfg_EarnoutSharePriceRangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnout Share Price Range [Member]" } } }, "localname": "EarnoutSharePriceRangeMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for emerging growth company.", "label": "Emerging growth company [Policy Text Block]", "terseLabel": "Emerging growth company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mkfg_ExchangeRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exchange ratio.", "label": "Exchange Ratio", "terseLabel": "Exchange Ratio" } } }, "localname": "ExchangeRatio", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "mkfg_ExchangeRatioDivisibleAmountPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exchange ratio divisible amount per share.", "label": "Exchange Ratio Divisible Amount Per Share", "terseLabel": "Exchange ratio divisible amount per share" } } }, "localname": "ExchangeRatioDivisibleAmountPerShare", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "mkfg_ExchangeRatioEquityValueAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exchange ratio equity value amount.", "label": "Exchange Ratio Equity Value Amount", "terseLabel": "Exchange ratio equity value amount" } } }, "localname": "ExchangeRatioEquityValueAmount", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mkfg_ExchangeRatioThresholdAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Exchange ratio threshold amount.", "label": "Exchange Ratio Threshold Amount", "terseLabel": "Exchange ratio threshold amount" } } }, "localname": "ExchangeRatioThresholdAmount", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mkfg_FiveIndividualsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of number of people receiving 25,000 founder shares.", "label": "Five Individuals [Member]", "terseLabel": "Five Individuals" } } }, "localname": "FiveIndividualsMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "mkfg_InvestmentsHeldInTrustAccountPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The accounting policy on investments held in the trust account.", "label": "Investments Held in the Trust Account [Policy Text Block]", "verboseLabel": "Investments Held in the Trust Account" } } }, "localname": "InvestmentsHeldInTrustAccountPolicyTextBlock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mkfg_MarkforgedEarnoutSharesAndEarnoutRsusmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Markforged Earnout Shares and Earnout RSUs [Member]", "terseLabel": "Markforged Earnout Shares and Earnout RSUs [Member]" } } }, "localname": "MarkforgedEarnoutSharesAndEarnoutRsusmemberMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "domainItemType" }, "mkfg_MarkforgedHoldingCorporation2021EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Markforged Holding Corporation 2021 Employee Stock Purchase Plan [Member]", "terseLabel": "Markforged Holding Corporation 2021 Employee Stock Purchase Plan [Member]" } } }, "localname": "MarkforgedHoldingCorporation2021EmployeeStockPurchasePlanMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "domainItemType" }, "mkfg_MarkforgedHoldingCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Markforged Holding Corporation [Member]", "terseLabel": "Markforged Holding Corporation [Member]" } } }, "localname": "MarkforgedHoldingCorporationMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "domainItemType" }, "mkfg_MarkforgedIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MarkForged Inc.", "label": "MarkForged Inc [Member]" } } }, "localname": "MarkforgedIncMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_MaximumCommonStockSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the maximum number of common stock shares subject to forfeiture.", "label": "Maximum Common Stock Shares Subject To Forfeiture", "terseLabel": "Subject to forfeiture (in shares)" } } }, "localname": "MaximumCommonStockSharesSubjectToForfeiture", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "sharesItemType" }, "mkfg_MaximumNumberOfDemandsForRegistrationOfSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the maximum number of demands for registration of securities.", "label": "Maximum Number Of Demands For Registration Of Securities", "verboseLabel": "Maximum number of demands for registration of securities" } } }, "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "mkfg_NetGainFromInvestmentsHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of net gain from investments held in Trust Account.", "label": "Net Gain From Investments Held In Trust Account", "negatedLabel": "Net gain from investments held in Trust Account", "terseLabel": "Net gain from investments held in Trust Account" } } }, "localname": "NetGainFromInvestmentsHeldInTrustAccount", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "mkfg_NumberOfConsecutiveTradingDaysToCalculateVolumeWeightedAverageSharePrices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of consecutive trading days to calculate VWAPs.", "label": "Number Of Consecutive Trading Days To Calculate Volume Weighted Average Share Prices", "terseLabel": "Number of consecutive trading days to calculate VWAPs" } } }, "localname": "NumberOfConsecutiveTradingDaysToCalculateVolumeWeightedAverageSharePrices", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mkfg_NumberOfEarnOutSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of earnout shares.", "label": "Number Of Earn Out Shares Issued", "terseLabel": "Number of earn out shares issued" } } }, "localname": "NumberOfEarnOutSharesIssued", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "mkfg_NumberOfEarnoutShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of earnout shares.", "label": "Number Of Earnout Shares", "terseLabel": "Number of earnout shares" } } }, "localname": "NumberOfEarnoutShares", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "mkfg_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of shares issued per unit.", "label": "Number Of Shares Issued Per Unit", "terseLabel": "Number of shares in a unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "mkfg_NumberOfTradingDaysToCalculateVolumeWeightedAverageSharePrices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of trading days to calculate VWAPs.", "label": "Number Of Trading Days To Calculate Volume Weighted Average Share Prices", "terseLabel": "Number of trading days to calculate VWAPs" } } }, "localname": "NumberOfTradingDaysToCalculateVolumeWeightedAverageSharePrices", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mkfg_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of warrants issued per unit.", "label": "Number Of Warrants Issued Per Unit", "terseLabel": "Number of warrants in a unit" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "mkfg_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The accounting policy on offering costs associated with Initial Public Offering.", "label": "Offering costs associated with Initial Public Offering [Policy Text Block]", "verboseLabel": "Offering costs associated with Initial Public Offering" } } }, "localname": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mkfg_OneIndividualMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of people receiving 30,000 founder shares.", "label": "One Individual [Member]", "terseLabel": "One individual" } } }, "localname": "OneIndividualMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "mkfg_PercentageOfGrossProceedsOnTotalEquityProceedsThresholdMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The aggregate gross proceeds as a threshold minimum percentage of total equity proceeds.", "label": "Percentage Of Gross Proceeds On Total Equity Proceeds, Threshold Minimum", "verboseLabel": "Threshold minimum percentage of gross proceeds on total equity proceeds (as a percent)" } } }, "localname": "PercentageOfGrossProceedsOnTotalEquityProceedsThresholdMinimum", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "mkfg_PercentageOfSponsorEarnoutSharesToBeVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of sponsor earnout shares will vest.", "label": "Percentage Of Sponsor Earnout Shares To Be Vested", "terseLabel": "Percentage of sponsor earnout shares will vest" } } }, "localname": "PercentageOfSponsorEarnoutSharesToBeVested", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mkfg_PercentageOfTotalSponsorSharesToBeVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of total sponsor shares to be vested.", "label": "Percentage Of Total Sponsor Shares To Be Vested", "terseLabel": "Percentage of total sponsor shares to be vested" } } }, "localname": "PercentageOfTotalSponsorSharesToBeVested", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mkfg_PipeInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PIPE Investors [Member]", "terseLabel": "PIPE Investors" } } }, "localname": "PipeInvestorsMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_PrinciplesOfConsolidationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for principles of consolidation.", "label": "Principles of consolidation [Policy Text Block]", "terseLabel": "Principles of consolidation" } } }, "localname": "PrinciplesOfConsolidationPolicyTextBlock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mkfg_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant [Member]", "label": "Private Placement Warrant [Member]", "terseLabel": "Private Placement Warrant" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "mkfg_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "domainItemType" }, "mkfg_ProceedsFromSaleOfUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds from sale of units.", "label": "Proceeds From Sale Of Units", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromSaleOfUnits", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "mkfg_ProposedPublicOfferingDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "INITIAL PUBLIC OFFERING" } } }, "localname": "ProposedPublicOfferingDisclosureAbstract", "nsuri": "http://www.markforged.com/20210630", "xbrltype": "stringItemType" }, "mkfg_PublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about public offering.", "label": "Public Offering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "PublicOfferingTextBlock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "mkfg_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The members stands for Public Warrant Member.", "label": "Public Warrant [Member]", "terseLabel": "Public Warrant" } } }, "localname": "PublicWarrantMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "mkfg_RedeemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemption price per share.", "label": "Redeemption Price Per Share", "terseLabel": "Redeemption Price Per Share" } } }, "localname": "RedeemptionPricePerShare", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "mkfg_SaleOfStockUnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of underwriting fees incurred on sale of stock.", "label": "Sale Of Stock, Underwriting Fees", "verboseLabel": "Cash underwriting fees" } } }, "localname": "SaleOfStockUnderwritingFees", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "mkfg_ScheduleOfCapitalizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Capitalization [Abstract]" } } }, "localname": "ScheduleOfCapitalizationAbstract", "nsuri": "http://www.markforged.com/20210630", "xbrltype": "stringItemType" }, "mkfg_SharesSubjectToPossibleRedemptionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares subject to possible redemption.", "label": "Shares Subject to Possible Redemption, Shares", "negatedLabel": "Shares subject to possible redemption (in shares)" } } }, "localname": "SharesSubjectToPossibleRedemptionShares", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "mkfg_SharesSubjectToPossibleRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of shares subject to possible redemption.", "label": "Shares Subject to Possible Redemption, Value", "negatedLabel": "Shares subject to possible redemption" } } }, "localname": "SharesSubjectToPossibleRedemptionValue", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "mkfg_SponsorSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sponsor Support Agreement [Member]" } } }, "localname": "SponsorSupportAgreementMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_StockTransferredToOthersDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares transferred to others during the period.", "label": "Stock Transferred To Others During Period, Shares", "terseLabel": "Number of shares transferred (in shares)" } } }, "localname": "StockTransferredToOthersDuringPeriodShares", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "mkfg_ThresholdConversionRatioOfStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to threshold ratio of conversion of stock.", "label": "Threshold Conversion Ratio Of Stock", "terseLabel": "Conversion ratio of stock" } } }, "localname": "ThresholdConversionRatioOfStock", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "percentItemType" }, "mkfg_ThresholdLimitationsBusinessCombinationsNotificationsIpoCompletionAndTransfer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period including; not transfer, assign or sell shares or warrants, completion period of IPO, completion period of business combination and written notice periods.", "label": "Threshold limitations business combinations, notifications, ipo completion and transfer", "terseLabel": "Threshold, (in days, months)" } } }, "localname": "ThresholdLimitationsBusinessCombinationsNotificationsIpoCompletionAndTransfer", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails" ], "xbrltype": "durationItemType" }, "mkfg_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The threshold period after the business combination in which the 20 trading days within any 30 trading day period commences for the transfer, assigning or sale of any shares of the company, after the completion of the initial business combination.", "label": "Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences", "terseLabel": "Threshold commencement" } } }, "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "mkfg_ThresholdTradingDaysForCalculatingMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold Trading Days For Calculating Market Value", "label": "Threshold trading days for calculating Market Value", "verboseLabel": "Threshold trading days for calculating Market Value" } } }, "localname": "ThresholdTradingDaysForCalculatingMarketValue", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "mkfg_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained to trigger the transfer, assign or sale of any shares or warrants of the company, after the completion of the initial business combination.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger", "verboseLabel": "Threshold stock price" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "mkfg_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days for stock price trigger considered for the transfer, assigning or sale of any shares or warrants of the company, after the completion of the initial business combination.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days", "verboseLabel": "Threshold trading period" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "mkfg_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for the transfer, assigning or sale of any shares or warrants of the company, after the completion of the initial business combination.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days", "verboseLabel": "Threshold trading days" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "mkfg_TrustAmountReleased": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trust amount released.", "label": "Trust Amount Released", "terseLabel": "Trust amount released" } } }, "localname": "TrustAmountReleased", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mkfg_ValueOfSharesRedeemedDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares redeemed during period.", "label": "Value of Shares Redeemed During period", "terseLabel": "Total redeemption price" } } }, "localname": "ValueOfSharesRedeemedDuringPeriod", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mkfg_VolumeWeightedAveragePriceAtleastFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volume Weighted Average Price Atleast Fifteen [Member]", "terseLabel": "Volume-weighted average price atleast 15.00" } } }, "localname": "VolumeWeightedAveragePriceAtleastFifteenMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_VolumeWeightedAveragePriceAtleastTwelvePointFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volume Weighted Average Price Atleast Twelve Point Five [Member]", "terseLabel": "Volume-weighted average price atleast 12.50" } } }, "localname": "VolumeWeightedAveragePriceAtleastTwelvePointFiveMember", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_VolumeWeightedAverageSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the volume weighted average share price.", "label": "Volume Weighted Average Share Price", "terseLabel": "Volume-weighted average share price" } } }, "localname": "VolumeWeightedAverageSharePrice", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "mkfg_VolumeWeightedAverageSharePriceAtleast12.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volume Weighted Average Share Price Atleast 12.50 [Member]", "terseLabel": "Volume-weighted average price atleast 12.50" } } }, "localname": "VolumeWeightedAverageSharePriceAtleast12.50Member", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_VolumeWeightedAverageSharePriceAtleast15.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volume Weighted Average Share Price Atleast 15.00 [Member]", "terseLabel": "Volume-weighted average price atleast 15.00" } } }, "localname": "VolumeWeightedAverageSharePriceAtleast15.00Member", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mkfg_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The warrants exercisable term from the closing of the public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Warrants And Rights Outstanding, Exercisable Term From Closing Of Public Offering", "verboseLabel": "Warrants exercisable term from the closing of public offering" } } }, "localname": "WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "mkfg_WarrantsPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per unit price of warrants issued by the company.", "label": "Warrants, Price Per Unit", "terseLabel": "Price of warrants (in dollars per share)" } } }, "localname": "WarrantsPricePerUnit", "nsuri": "http://www.markforged.com/20210630", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "perShareItemType" }, "srt_RangeAxis": { "auth_ref": [ "r122", "r133", "r136", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r246", "r247" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r122", "r133", "r136", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r246", "r247" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r112", "r134", "r208" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r102", "r202" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r147" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r61", "r62", "r63", "r144", "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r55", "r94", "r96", "r100", "r104", "r163", "r167", "r188", "r233", "r240" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r27", "r55", "r104", "r163", "r167", "r188" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "verboseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "verboseLabel": "Financial assets that are measured at fair value" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r57" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r138", "r143" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r132", "r135" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r132", "r135", "r159", "r160" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r18", "r46" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r8", "r47", "r52" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r41", "r46", "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash - ending of the period", "periodStartLabel": "Cash - beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r41", "r189" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Federal depository insurance coverage" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r53", "r55", "r73", "r74", "r75", "r77", "r79", "r83", "r84", "r85", "r104", "r188" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/CoverPage", "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r120", "r137" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Warrants" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares called by each warrant", "verboseLabel": "Shares issuable per warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Number of warrants issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Shares of New Common Stock subject to outstanding New Warrants (of which 3,150,000 are in respect of private placement warrants held by Sponsor)", "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of Warrant or Right, Outstanding", "verboseLabel": "Class of warrant right outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r120", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r24", "r111", "r235", "r243" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r108", "r109", "r110", "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A ordinary shares" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/CoverPage", "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B ordinary shares" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Shares of New Common Stock reserved for issuance under the 2021 Plan" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Common Stock, Conversion Basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding", "terseLabel": "Shares of New Common Stock subject to outstanding options and RSUs under the Markforged Holding Corporation 2021 Stock Option and Incentive Plan (the \"2021 Plan\")" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r116" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Shares of New Common Stock outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r88", "r239" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "verboseLabel": "Concentration of credit risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContingentConsiderationByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of contingent consideration.", "label": "Contingent Consideration by Type [Axis]" } } }, "localname": "ContingentConsiderationByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ContingentConsiderationTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of contingent payment arrangement.", "label": "Contingent Consideration Type [Domain]" } } }, "localname": "ContingentConsiderationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r48", "r49", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "terseLabel": "Conversion of debt" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "verboseLabel": "DERIVATIVE WARRANT LIABILITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r28" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "verboseLabel": "Derivative warrant liabilities" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r52", "r59", "r172", "r173", "r174", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "verboseLabel": "Derivative Warrant liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net income (loss) per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Denominator: Weighted average Class\u00a0A ordinary share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r52", "r80", "r81" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net income (loss) per ordinary share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r61", "r62", "r63", "r65", "r70", "r72", "r82", "r105", "r116", "r118", "r144", "r145", "r146", "r157", "r158", "r190", "r191", "r192", "r193", "r194", "r195", "r248", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r44", "r114" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of derivative warrant liabilities", "verboseLabel": "Change in fair value of derivative warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "verboseLabel": "FAIR VALUE MEASURMENTS" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r178", "r179", "r180", "r185" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r178", "r179", "r180", "r184", "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "verboseLabel": "Schedule of financial liabilities subject to fair value measurements on a recurring basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r178", "r179" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "verboseLabel": "Summary of financial assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r131", "r179", "r210", "r211", "r212" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r123", "r124", "r129", "r131", "r179", "r210" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r131", "r179", "r212" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r182", "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "verboseLabel": "Schedule of change in Level 3 fair value measurements" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r131", "r210", "r211", "r212" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r52", "r186", "r187" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r34" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r31", "r52", "r149", "r150", "r153", "r154", "r155", "r156", "r268" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r43" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r43" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Increase (Decrease) in Derivative Liabilities", "verboseLabel": "Change in fair value of derivative warrant liabilities" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r43" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNonoperating": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.", "label": "Investment Income, Nonoperating", "terseLabel": "Income from investments held in Trust Account" } } }, "localname": "InvestmentIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r21", "r55", "r97", "r104", "r164", "r167", "r168", "r188" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r55", "r104", "r188", "r234", "r242" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholder's Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r23", "r55", "r104", "r164", "r167", "r168", "r188" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r178" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "periodEndLabel": "Level 3 Derivative warrant liabilities end", "periodStartLabel": "Level 3 Derivative warrant liabilities begin", "verboseLabel": "Liabilities measured at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsChangeInFairValueOfLevel3FairValueMeasurementsDetails", "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r20" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Sponsor Loan" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r41", "r42", "r45" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r29", "r30", "r32", "r45", "r55", "r64", "r66", "r67", "r68", "r69", "r71", "r72", "r76", "r94", "r95", "r98", "r99", "r101", "r104", "r188", "r236", "r245" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss) attributable to Class\u00a0B ordinary share" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator: Net income (loss) minus net income allocable to Class\u00a0A ordinary share" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "terseLabel": "Net income attributable to Class\u00a0A ordinary share", "verboseLabel": "Net income allocable to Class\u00a0A ordinary share" } } }, "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest [Abstract]", "terseLabel": "Numerator: Income allocable to Class\u00a0A ordinary share" } } }, "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r58", "r200", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "terseLabel": "Related party notes, outstanding balance" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r94", "r95", "r98", "r99", "r101" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r171" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "verboseLabel": "Other income (expenses)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherOwnershipInterestsOfferingCosts": { "auth_ref": [ "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of offering costs allocated to the other unit holders.", "label": "Other Ownership Interests, Offering Costs", "terseLabel": "Offering costs paid by Sponsor" } } }, "localname": "OtherOwnershipInterestsOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-allotment" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "terseLabel": "Payments for Repurchase of Common Stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Offering costs paid" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r11", "r117" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred Stock, Conversion Basis", "terseLabel": "Preferred Stock, Conversion Basis" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityPreferenceSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityPreferenceSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityPreferenceSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2021 and December 31, 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r5", "r106", "r107" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrincipalOwnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Owner of record or known beneficial owner of more than 10 percent of the voting interests of the entity.", "label": "Principal Owner [Member]", "terseLabel": "Sponsor" } } }, "localname": "PrincipalOwnerMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r36" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Issuance of Public and Private Warrants", "verboseLabel": "Proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from related party loan" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r0", "r29", "r30", "r40", "r55", "r64", "r71", "r72", "r94", "r95", "r98", "r99", "r101", "r104", "r162", "r165", "r166", "r169", "r170", "r188", "r237" ], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r130", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r199", "r203" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": { "auth_ref": [], "calculation": { "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.", "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party", "terseLabel": "Administrative expenses - related party" } } }, "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r130", "r199", "r203", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r197", "r198", "r200", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r118", "r147", "r241", "r251", "r252" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r61", "r62", "r63", "r65", "r70", "r72", "r105", "r144", "r145", "r146", "r157", "r158", "r248", "r250" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of Stock, Price Per Share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCapitalizationEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Capitalization, Equity [Line Items]" } } }, "localname": "ScheduleOfCapitalizationEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCapitalizationEquityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the equity component of the capitalization of the entity. The table may be detailed by subsidiary (legal entity) (if applicable) and include information by component of equity as may be included in the Statement of Changes in Shareholders' Equity.", "label": "Schedule of Capitalization, Equity [Table]" } } }, "localname": "ScheduleOfCapitalizationEquityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCapitalizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Capitalization [Line Items]" } } }, "localname": "ScheduleOfCapitalizationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCapitalizationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the capitalization of the entity comprised of its long-term debt and equity instruments. The table may be detailed by subsidiary (legal entity) and include information by type of debt or equity detailed by instrument.", "label": "Schedule of Capitalization [Table Text Block]", "terseLabel": "Schedule of Post-Closing Capitalization" } } }, "localname": "ScheduleOfCapitalizationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Reconciliation of Net Loss Per Ordinary Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r56", "r201", "r203" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "verboseLabel": "Stock price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "verboseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "verboseLabel": "Risk-free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r137", "r139" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share", "verboseLabel": "Share Price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at the ending (in shares)", "periodStartLabel": "Balance at the beginning (in shares)", "terseLabel": "Total outstanding equity at closing, including vested and unvested options and RSUs" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r10", "r11", "r12", "r53", "r55", "r73", "r74", "r75", "r77", "r79", "r83", "r84", "r85", "r104", "r116", "r188" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/CoverPage", "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r26", "r61", "r62", "r63", "r65", "r70", "r72", "r82", "r105", "r116", "r118", "r144", "r145", "r146", "r157", "r158", "r190", "r191", "r192", "r193", "r194", "r195", "r248", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r61", "r62", "r63", "r82", "r220" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r116", "r118" ], "lang": { "en-us": { "role": { "definitionGuidance": "Sale of Stock, Number of Shares Issued", "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of shares issued", "verboseLabel": "Issuance of ordinary shares to Sponsor (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r116", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "presentationGuidance": "Sale of Stock, Value of stock issued", "verboseLabel": "Issuance of ordinary shares to Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares", "verboseLabel": "Forfeiture of founder shares (in shares)" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r116" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "verboseLabel": "Forfeiture of founder shares" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r15", "r16", "r55", "r103", "r104", "r188" ], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the ending", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholder's Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r54", "r118", "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHAREHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsTables" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r196", "r207" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r196", "r207" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsTables" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r196", "r207" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail", "http://www.markforged.com/role/SubsequentEventsTables" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r196", "r207" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationDetail", "http://www.markforged.com/role/SubsequentEventsScheduleOfPostClosingCapitalizationParentheticalDetail", "http://www.markforged.com/role/SubsequentEventsTables" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r206", "r209" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CommitmentsAndContingenciesDetails", "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails", "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails", "http://www.markforged.com/role/RelatedPartyTransactionsPrivatePlacementWarrantsDetails", "http://www.markforged.com/role/RelatedPartyTransactionsWorkingCapitalAndSupportDetails", "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "Proposed Public Offering" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.markforged.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense classified as other.", "label": "Taxes, Other", "terseLabel": "Less: Company's portion available to be withdrawn to pay taxes" } } }, "localname": "TaxesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [], "calculation": { "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "verboseLabel": "Class A ordinary shares, $0.0001 par value; 18,080,145 and 18,574,269 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r7", "r115" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Class A ordinary shares, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r7", "r115" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Class A ordinary shares, per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Class A ordinary shares, shares subject to possible redemption", "verboseLabel": "Class A ordinary shares, shares subject to possible redemption" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.markforged.com/role/ShareholdersEquityOrdinarySharesDetails", "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasuryBillSecuritiesMember": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.", "label": "US Treasury Bill Securities [Member]", "terseLabel": "U.S. Treasury bills maturing on February 18, 2021" } } }, "localname": "USTreasuryBillSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/FairValueMeasurementsFinancialAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r148", "r152" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "verboseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r151" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "verboseLabel": "Unrecognized tax benefits accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r86", "r87", "r89", "r90", "r91", "r92", "r93" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/CoverPage", "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Public warrants expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/DerivativeWarrantLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Dilutive securities" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "verboseLabel": "Basic and diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.markforged.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfNetLossPerOrdinaryShareDetails", "http://www.markforged.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r269": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r271": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r272": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r273": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r274": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r275": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" } }, "version": "2.1" } ZIP 56 0001193125-21-244894-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-244894-xbrl.zip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

S,?0([2_YO'+Y6P_ MZX@@AE\5-5344%%#-Z&&I$]F%=T1KU $)D"R&LU#O3XKP]=8.RKH?!#ISQ/* M,S7W1':MSL,.J[\*L]/J*_PVM?:LOHMW*RJEJ)2B4FY"I?@A2U$IZ/5$\B,. M0U8.Z47:/YA&D.=CM6N;W"!N?XO-P]IE_3_TX:8[1M42WC1C^E*N?XI2*4JE M*)6;4"H<"PGM 7=M<"NP>"T1>H&G(1JKRO W\+.ZY?#FKN_JS=Q?X2_]1>.K M+[N>\13^%C,QK]9CT2%%AQ0=;\! .W?U58*I9PW_1+46W%-UR$[HES:_FC:CP M5031EP1LZ M3\F#J#Y&P=!P/QIP'UP7-P4:CN3"[#J&0I.^=?9K_/!CY:O'^(^>K@3K*3==<:*FB:8JF*9KF)C1-(IPSX(^Q?L.L$^3A(/09\LK. MQ=1^T05%%Q1=C URVS/ : #?^M4[P5,HO5-AKBV8HFN%V-$,Z[ZC@DG]Q,-)K([J0 MLFV5@/R965+A]GTU>&CH@8'.K^CZG,,05I5?):OM+X%J[PK=Q+X&E"=8(#8( M'YGUTB,$.L8R<+ZTJT">'P-&C6&];TD/[:39L!D< *C,6&RG7OEPZL/$(,^8 MS8X@OM;*K)A_ IPJ0Q.>E]$EZ\WLC!V@$!L,:>#)@(;(R)N P)2F1UBFQ*2I M\'[@,IWES#PKQY45BN_)U">.:UE:+.7G"<)1V."VXZD&6:NPK21RSZU_ZHI1 MA/*H'%YN11)#E[X8F=?0#B'Q<_WN*Q05F,'&,' UWI<&B*< M/PO_P\<[M?_Q1>%_N"'^AU^Y-'[+U$^19W$!R9@YCJY@A<[Q_9?A0I47&8U> M?+7MQ*S=N[X[X3?;2ZZ!=V(C^+DI)6Z%PN^OLD$6S'DJ)3%N.4_LTKZKS='I M H/%!EN 0J,_3K+YR7$MX)21P&ZQP>A2VH3[T&X&(8,-;F9C'^H#&INP#V// MI&T7E'<&K8Q- -\7>69R/8;XDRO&2-UMH^;^#!/90\4;LK^CU>/S11[.5V%] M8*J.W,^0&Y"S/X?MRM\G$DB0,S@"W[YERC!0Q>IS5$8UAK.\"UT2QIFJB='# M$?@?\07AR'7H-05MI"@+3F%B07#)N["O'YJ.N:93#<6A^?_9KC3C,).<9^5' M9(2(H%I]39>NJ]5_U_=Y?[NEUW?.E)C4&R&84_9RK>>$Y&!1=_>E(+2@, MJ-X3CVQPGPJ%!84,S+/ D-2.X".)6 X:9;7P7'@0==".T&<;*]4[]/58I^^N M8E7B7#EB!:5/S+\"CA1'?!OIP16I73W^%$EP(W2,-NR^IP9$Z0.XY/'CIG6F MSFO1*K>),^K;#RX>@BGN\H8<78HMJ?Q\FFVJ#Q"Y?D&O\Q6>? M_[LJAY?_\Y(4-ZY+;\?(0IOIF/2K$JDJV01K9W)!&\C),1SO6-O:YZPET4;V MT&G4>@C@>^ 1O+]S>'KLVL-9;J01) 7N?^HQKO=R];>I'R9,!-+'K_#T=)-_ M^\RN_P,@"9B"'->*S[Z6*%I"TUH?BL0%SZ&__//?>05HG>O^+(OPN\^Q"%]\ MQD%P"GN53%Q8,^_"KFY7?PEW??J=_LR2QYX1TRB2VAH2-EO1(^@+I!"'DUH,4_XG4@@>*%)G[J="6V1/51$@7Y56A%F"Y^NV92DYB,NDLT%-D"8=7(N:GM(8U"%OX.J?8#:^4];?R 6]7# MO>OY+(CF(64F(5!S*0GE#G2^$*D4W90/5/[FG:WG1/!RGT;IE]I)W ML0EH?)_IB6Q45Q?1.S?#U/=T%9W5:P;AI^';,\,,*Q@/T5H;%6O&]]8N3 ^G MWHJ*?C:)V\=1&89.H:W9Y3#*//O@9^\89=:J9WBO4 M.%W=E\4%3;[,W$0GOZ;$]]?C^Q]R M\F0//"(*4$",:*.V!T"4'!O&$!EFD?NB5_3I1>ZM4B2JY_<%>W[TOZ0_Q4#( M'[[J-IL7?R$]^GKU(_R0[TD?A''U'5*R1[6[[3 =,P8FC$'+SVF?Z+*?B9OR M_9^_I'WH[J%74=/P,PQ\#-/P-1L&#C"US2=N)J,_D)E$WS#;&+B)%WM>J<)H MTE@E5&C@XXJ22CQ]!<7*22X0LJI(]MCZ'_[1F8<\U!30<@BV/H!Q M7M0LUW!FC\'06O'UR)_>@88K)(B*K\*Q6T.'K&G9[Z>[ SB^.8>\ZPS#B\Q\ MPT1/D;AKP7D5#V+^!E=X4MDTT2%9<^A1/Y!?$I$V$+STS5IU>?X"#=_DS,NY MA376JM<$5SSFU^(RSUFN_"P+/O<5H:Y/4>:,=:LK@3PV"H\T[7A&OFM*[V1OQ;ZHZQ]7#!^)SA4ZK'1]\,#8I<%&8[+XM?@ MY>K[AF?^+)SG"F+#&3&%>(O4:I @Q]@'UD,$E5S-I!UMME(3%;$:C#V#9."Y M#T-?[YG6DM=HPCI1E,?FCTWZ!CBS,54:)0.$=3*&2ST',F-0@FU LXJDOZ \Z?"&4S/MS M+?,%5?;W3)) R_XWQXT8R?@,/N.OL49?.+3?8=5?93C1,"VJY+-PQJ7DA;K" M_'$Q))*_KF*FW-7,A)0B*-X2Z> Z:YN+: >2\4L9,CE\\C=6XW15TJV^H4Z/ M:/8,[Q33?$S/[4?/"GU])Y2G5NQY6C/3F'C?RDAS-Z3(UE#=K*9%[RY/6V%3 M,)55B0';A@WT5B79K4JGKSSSY]GXRU>JM]B?>$1L35+:A927KG*V=ME2BJGAK6SCM-ML:^\X>>XV^)&ANI>J M2=FRD[&<;Z)XN/%9.:'C 6+;B5.>"+@3^CR[HL)9_<,^9-NA03J["4_C@)K3PN4L]:F.EE#-IDG@+C! M2APYOX_O/:\XW;\@(6A'52!,^VK"U0Z1^E4?%NY2:K]2WS)B3J7. G8:Y9AV MDS C7S(O_X:3$!QNO,#FGWWQ1C(C:) *_6_EH)W0617/R_7L06F(^H@-4;\K M#5&E(>J7(HVOUNNN1Q1K]/*/IH6KY11FI;%_IS4))?>^S&?"RIFZEP9H*+&$ MM^>B:LFA(XXUML>Q*PS,932BC$9\]-$(%]1I!.= [ACF.P9TO7':PU.S=.$A M>%=Y*Z6Y,E19]$/1#[>F']PY)_=@U]='L?BI/<(GU8L.*#J@Z(!;TP&B1:TT=6UZ:3CJ)H78RC7OKSG89MPT*;L,H(8E$ M)$BJ2,""6_B>H#PUS?X*?WC?-VA=3#Q&1CE0O)2BH8J&NB4-13Y(X)80_&4: M)5J!EMI)6X1O'LK=&,N+9_KK(EFQNFLX)T)7'@=.[[>NVD%_W'#S0NO&(R07 M ICP6AHS&=XWEH8ZK1!PT=HJ/CK=G)ZPJ*BBHHJ*N@D5A8/-G7%:ET1WW )T MIO=F,-3ZIA'JQH6O%N50E$-1#C>A'.ZFS2Z,=<] VXA[FEE;(DI71^X/=;AY M-0]9"$8':13>R\_^R*":%COQ9Y__$9K#D&N.H1ZXH4^GF.QV:.SK!JGKL#1S M.,6 'A1)J7;2YL*E-@DH+BT'T<,T(_3V@NLL: HKJ*XBN*Z"<45&WA( M:U0V%JS4 MQN5+!>+AW^J=@?XH8P=7A2K,0_\2UDUAM<]$C1(T6/ MO%\]DA(8#.6PU/CK$[6Y=\!)UXM6PY![,KG3HITCW/I(?SIA8%TID70@UA#Y M*O1;3CW#)@SU,#+^ ?>J2(NQXH\84TD&X%?%&^ %WGM7X9??_N/KKUY\_@<] MH_?T5+BM1Q$MVJEHIZ*=?K5>CL$U=H!GD4[TH'V_\EE-2G/=W/-TC&I.AL\1 MT!9N_S:XGVX:(4H1'*ECO,>DHCS:DLYJI/DF/QPP3'?F)75]@1]]FT[)]NQ& MTUS?(CFQ];'#1 NVC!&>,+$B2$C7YRN0Y;>N>1Y*B"A(VYXY/C%XH !(-O:8 M1M6PE08V93!4C#-711@E#&C0^[*%K<]B>X^8!&7)B-!*=7A+Q3SBP$$29AXWSQO:4G^"$_5]G U8R-YW2 M7NY@UCP'3;[UBE-S84<>*ZTGN[0R@L*X*CP&2T_$$0]UR^\=*-=[IXW;UJ MDK8C.D+(BP@DEH .6O<3J:BS<^"9-IDB#0:*"KUI$YL6PQR3SCKQJ!()X6!U ME,6)144GHD?G_G7K6G?C13*IE4-(SL'YO%F6=6>DJWBH^B H0\.LM R&(VN= M?4FB)YO@7M6-F#/TZ,(K,.)8W6\.F-?2G&J])C^Y7I\%H'E3'X%SFDWIW=E& MFZ%QG-22G1% %"R<6]]7Z.Z%7+,(*O[U"WM*]W@1KX515;@K!Y0N;%#JU;!O MMB-*WFJ;#; R*@H*>38G.@DZ]R"V/Y56T0-![8> A_<[FU",II=I#/]0G MXV=0"O06.J"L0$0,+S&?#*?U.6)!ZCY#W5L8EI26YY3#YH$LO)F<.?;4>'XV M.V5:Q->H] KTP@4HK)^;_S3@$5^MCFCF>L&4/'- =Q4;FS[)\=036 &W5F"' M&=T*> * L(.EHG=J-I-7(=6*KM@*:J?Z+O!Y#*'KPJ5VLD&?2A.'#*U>>5A( MKSZVZ6B 9B4=2%?>0;0=5'K,G;QDL _\=472A]J*((_I5^#:33KC75NG/J_< M'7F4 _NQ*TP?[O:"=!17+P[+XK@.@ ;37^;J._,U1'L+EA;RMOPPN#]C1S3R M@;;EI=%(><:7.]:O^5T$56F^!C] M=W-_#!>CS-.F&8=K# ]^!PK04[Z6%VP89K](4=+9YX7"XCI$433&A26GHQ,\ M7XJ!&XPENUQ$Q>D.P*]T:XO[Y),U8Q)Q):VN53Q-5BD&G#G; M&P,2A.,8!'NQWH3_G<"RW6U5J;KMB B0LW6MV!UDV*36S%QW6 WG80S'''W6 MI]\][>,I-L!&C;4$WB;:[CK\:%E.%XQD:((;%*3./OK"@$%)2ZI MC0-YJ9NS\,FD7Y$+,NB%Q+R9JA<;HNK%4068N= K;^87-K%XN?IQ#^3!DX G MRNM'+X9B[X;!U7RU9'9VHD%F-ULPC_)T5A^J+^4V1QL&7AGB&^"NDJ79X:#>- MO2@N0H8ET/8-W*X#XMSZ$*;\MK M.$P((@=+($E"$]W;',Y*/C&80YZ^BFCL#ACAF.& <&\Z:=>.^#3C_E+AJC&< MH]?F-I(D6_#[ MFNU_@/5.FTEK21:I1SVZYK89BU)UJ[NJI%M23>U^&DL 3);0"8F$TF*_>MO M^''W"(_,! BJ*%&BTFQL6D4 ^8B'AS^.G_.9!68O$Z+L)'\19 VL!\^1KCXQWW<9S9TT[_?,F;ZQ&;J+',?*38<0 M^?#-.=AE$V;_6X>PE%5Y$%]!AM@$A=T8XDM;B7 M34RC^,/.G7,E 'H0^!E7.4,@D76Z0#FB,:5Q;T^Z9[WQ/)1Z_4W=;L"I_HL[ MJS8*5#J9L;^MT\)I/@Y/^2$#Z:\2FC&7Z,R\7F23#;S!0].;5)0)#5F>-7\9 M.A]&1,^(Z!D1/1])*]PR"GMSK4JFE@A3J[(4?04D M,X+WH#62]9[8Y]D[B@'RC42+'A6LHW_S16.(-T) M%"<[*IS;U(I74B43Z9=H5IK-P13 YJVAU&AE1BLS6IE[864TLQ2@<>*9>-M@ MRC>VF#M;DIPK)%0 &W+9VU?U(M)Q=,B\Y;;G!EU0@"Y!6)QZZ2OI4ER4S968!X04$B+ N,(ZAY[MW6D 4 MG^$R(?$F&!WD$2D\*-UEED+M\+7>_ @17NN/AA((O:'),MM4>68.)Z\95^0' MI+5H"VI:*>INBX)D8I/NA!XTF[%UYI6#L)PPC18,MZ&)FT*5 -%S)'0#; M0_ U6)L+Z! *F)97O&Z@5<RFUEE1;O;A\8S^5,I'*BGH9L '<7@ L*/HE[[*,_3,E&V6P M@O:5V3H$0<-)RR!7PC&N2'"=>BA$SRK(6.EX1T.W1=.*I!^K1%0:5P>H XW3 M.I_A'EM97J05#I:[*,^YP8,1CB8S2H/=6P5]3:NT92W:22JS7ZU%=LS82^TW MXHXXMLU)X^RJFI, IVB!%A!;38AK(LTG1H[<&?G6A2M98_K!'>^PXM =VC49 ME:P X'C8E;/5V:1N##X5I"X?E85C?QY(5<[^2N%%NDU@4F;.Y M6^341A(DT6%YTON3GUE8X=S0%F*OM*4+3]I04@.G[97&8>*.76.PS#L &=]$ M:7)[VZUY/3GIE@)KCB<>?4/B]M#:*+JKU>6@IXQ'*^A*W+;$F,UY;Y[(7V?% M21KQ](37ID)O,*ME&YI_" KIG^^BJ(P+: _V 5[,I&O^(O>>$HAF>L12V:1H MFE:V<$!V '4>ZBT,HQ=*'&!5)(7">8Z>[FP6._E1&8[(<2-K?-_]_)>=-;B= MRBOXYG3@:AS0WUY\U$2]O3/&1G4XXT,C&G+?NL#]QJ<;P-T-%IX[$HKA7F,+ M=9)+=39 LO:!['K5;@3Y-&84Z34RI$*DL^[(AM@?[C>?(P M2'GH)21+J=1-7"OS0>AYL998:>"!1I,UFJS19-T+DZ5I4^'ID![S<8./&WS< MX/=B@TL)DNA=EA.W6B^KJ\#U<5[4Y$X$]IMQVX_;?MSV]V+;:R@2H*_,?>1O MT1*M:%N#1T^YC9"?;,M-/4HCC49@- *W;@1"S?:#D"90,5P6<@#K198F@?Q) M&=2'^N450.]?^6^,>WS_ZP/^G5;$X(D)4G+A%6->"J55"W@$)B]DI$& M%!1$9,N()-]_W)EM90CG 6 :^+>#D!7P6:MBT\-&*1HR$V)4%GGI?4U47A;9 M(-\<34""0V$:QX JB8(;6TB$!]ELWP=6>G^G^R1@>XAV^I(98C>X64T#)UC< M?:"I%KNM'6J"':MJ?Z7I,K Y*C<(8Q$[6BGF,ISF;ZKE/*)9A1EJ &;+BVWO MQPU89>90(ZDA(D"5CAI]!&;YM ^?Z,@ 28CNO MIET 9(N%M5)DWXI75NQ*A M>C$C_.,B8+'RN@;"GMG_^=']FT2R]*'WP+,Z(C&E;2< OT9&J1D<)V;NIDGV MP^D7D[\*#]VEDSVTI-0*[^%J36B\MN1?SMM:::J\G2V9G6KD4/R$.12?CAR* MNSD4DY50E*2.R(-Y#;MB',&1:O&3ZVSY%8#67Z,0S$]%H/4E2_=30)7?O'OD M_0?W!O3VG_+@LL! )H!\[6R18Y&00M05EC>;S/8?)I(LQ.&[)+$?\M.5%'VR M#'-TETT]O[N=+Z4LU$@SQB?N'*!$QVZ^9Q#4\2<#CL3/>>V=AT='Q]]FDV>N M>>L?=?*S\].0^4]GAY,'@K]*/A/M=OBCZD#2'TEWFQHM_]G#=-/CMO&[^?M1K13V%]:$0UX#06F?[7^<^ZHO,Q]+..6F)A_M-X%HO$F1[7 ^^'IB7B:T; Z+#LO!6+N_DA=%+D??3RH=]GFS":1;P117U;IM[7_ MIVG\WG%SN2+>M2&EK;E]Y:F?(JRWUVZ]<5#ZPDM3#W9>^^TSQ)#% 5J<%T/] MJ9+CVG3F][/T=BP@+\R-JYN-L-\'):#) _JU+.+7\0LG^@5=RQ,PKZNK21:H M):&>J=M<.LCQ.*S0E[--I2^##63^\!V',^U4]'+\ )S4TT(Y3Y^Y%78LO>D_ M3GY^/3QUW":#T#2L-S, BF :>I4),A@Y-_%\$&UDRI'2'_-:J.TU69I$6GZ" M"C)//JBF, &]]R$U0N_S\^'?#G\ZG'CS\MWCD\/.^WR2Q[[5@K*5UMN9E:UODX=SD6D-WNS[P=E]7_Z(BO;-<$]6_C MWO0;=#"1S-+D1S>M6V]?.)1X]'5&/S^.NT$O0;U2+=KV:-N6KH 1NJ2&\+HS MK.A+I]:VI>L.24%H-:0FR%RG.\])_/ )]#X@U14Y&NCA8 GO?V/4 MBV#+:6;(7R_*EOB'3RL""A1D/9(C=/ K]BB5FL*$2;RDB?'%/#^O!@]+=.^5 MT!%]O8&JV+-"BB.G.#&U;3+\&=0*2U(_<^]YN!HIE$W^UF'ZXQF3'!=!? %6 M<>J6A;L0CM:AD>@>6?2,-!!+]>"TC77EK\N'8!1C@7HNK,Q95=-EY\H@(>\U M/#W8TO[U#R=_]XOY@I(2Y$_E9= G\F=@3O*%($'(XQ)O-S/1-0HJ-7ID=,1K M\EF4$XDR9O]JYV?2UIS:-ZLT(ON*A!"3/DJ]M#@;JHKIGWE9E6="7<'L!M%D MD#P?)2JCZF]MGX*PMD%#=MXZ?=/0I!T^W5RE?JCQ?L18$BGVEY+-3&A0]G![ MH6)%CGXF_,1&U _ @HR'EK9.QN?;K%WFM3;5BZ%F?I6AD(:WS^'D9V^B*RQI MM+2&!+IV-Q>B8VOU8YAN@WZ%7)VN VKNG9- ;;46[G?^9L/JHN',%3%RNS2XP&C=..& M8BD6$?#16@.C.^S7HI0/?Z/Q(SACV78KZ@-) ;YOADU)4J>B!B.=X.85+%E% M,.9Q[T^9=F!S7M1S.6F[%15&232%_;[OSS_-_> M,E1,N3&K5=:9V2>$&T#EG#4N74V7CK>/2(1.\J*>U?G"[U"J*8*KT%%+/ZB# M6O^C\D-/83@$H"%,\-]0JH7 #^"?791>Y<2M3#N*&B5OD<\J_';NP#0PF0$TN6C2AIVC3$Q5$ZR@ERF- 92=>1439E+-K<> M*'J_[,#?0189)L2XCC!(U,1/MJH&;XJ5^^.7I08#FLN##P XL MKZ[M!(&_ U-%CJB2;#>[WY@6,<].]^>5YQ=5/6 M-AC(TO=)=Q_6=>C PIW%_S8[C*_'W^*8E;2-6+1(/ MV2_.MYR<9]8I,10U?2[T-"3C1H54TGX[\1/EC6'.;!5@E]&@(?5]A"BY9%_"91=)/"#]8> M\LN"#0B-< @GF(2KSY5AQ*H-;PR6A1Q(*B0("(9RN)0=QAR$4,3[&/_L)TAB M*$I-\WX(2TU#0^A*03U5Z'28^MJ//*PB^5,!CX'K;424-@PEG?3-H%JG2N!6 MD//3AT'*#T:T224^U"5G>JVZNLS4*H&;CA9"U]4,Z9*!RZM32X>9%#" M[0>>4H<\"H;9-YP0:4H)\[+>!-)R5H:-$\W)">/7\I P90ON)"J,0\^Q50XZ M&8\0ORX40Z/2+8/NZX]%J0+G.Q\4D1B,A;7(TQH=H,8PLXZF/J1I^.QJ5H^^ M\AZ^,HY#8R?8A&Z)H2/6!.F*AI<2%DBPL]PMC.2)CU"1"ZK@BW^)6N*G85AH M=;<"AWO\C( M+-TEA?+,M\5,3,.3O]JPMFXA1NG3Y&I!+K:/ZI;2!'X9< MF2%;I<3&)=U3ED1G[?#%6Z&0LSQ@+(#70U+A%F39T!J&DS8SZ"H]=%@-?'$Y.A=HY84JFB@%6'5EMY@^ET$&ZEDA3Q1D17> MNP_+G,=N7IS1[O1&,\A4I!/?>Q(YI<#&)KX7AH44RM/?SZGT,@_:M_YNLH!Z M,0 E764USL,8P,I>Q44J_GM%HTZ^':\I\>F2#&U ^1E9<51BI/#AIXN"3N\L M\[)"O,2>[5L6A*>S21XD/!?^IA.GZZ/LA8K=F5*^.(D9.5:EFN@,R;"! =YQ M!KW7$33"XSY!>-S7(SQNE!B^/[BW-R%CK=2/>D90-8OJ_U+0)^UX1/$:.A+F MI%$:4#)?/5;-+\A5ZP_C>XY=9,8OR@658,'TNV9X]<(1!S\A%4%73W%5*]SR MY8+.'4X'VKN&PZFR-]%8=YSTM(GZ 3GMELC$/IV3E0D<;SWVM;D7\"UVR23(B6P[E ' F"A\T4' M S&2<5* F@-7SF'ZW#LJC^+)B$1 $R8=(63X.I>E'0LA)EHR!3KUT''CB'(CWYY7CC).BE;X,Z@4"J$ M!,K]3S :,D*754T)_LB0'+_YMB03Y&=7#+DQEMSUJ%-\.'F6-M*1.=6%,O5V MNM$:NU:U]EHOEL2>ODE0JDHJMZ MGD>_@N';\9FDD5=SSG3#E\@AT/3HE)\TC=LT"#4H1Q3GNJ=*=,HE$Y?IX>>/ MR/-B"@ >CF!7GN5G7-_E7C7%?L6B?=#10\56SBQ%74')2'+^NFX(2N/\<;^I M:O0;QODX;:=Y-GGA[Y--7E_Y,S2;_.+'_WSR3_]F>7B14Q*]R@EG(WF(W]Z2 M+^4208*L<^2GN""9V+Z2#K(9Z#E(2II&-P@P(L7H^+O9O@2:Y'.7"Z&S)#MB M,N5%J4T05RZOFP&XHVDT/,\9C%.Z2X#Y9RT,D3QY0.5W4Y.3Y_P%G?U?'2C< M3ABU!,"Z,4945#UKB[FDFORZ8HD,F$A=[.8%XTX81BD5#$24>5FPXSE\@:K< M(L@HV%+G5R:6'NH@M+\4* 211A_FV6 CJO>0I0KX7BEB^@.ATSX4$J)6I*\8>YZG^J/=OW/[Z57/ M%/E_GIY[;SN;_-HV#9D3_WC_Y>?ZWZU;YCK'G;-<20\)"##W[W"&,(]4P2(9 M*ZF"?K!1E??!CJH:>^("+!-@CV& 8^W^"Q#O^%T.^]*YI P.WR1B.'E?'"BJ M:<@)BU[Z"PK<@WCLFYK*#C.ZR@F)! UMSA=OXNX,R S2<1(EH:BMUHT[%?V! M"+8;[0=HR-0!C)U:JPG=U2H36N$AD13P=P=4DJK[_HQ!23T3; I$ ^5%<+JK MEV0. RV^:(!-YR9%V! 7X3NIQ=[R[(J-P83H,S".F@KPC9'HR[K*0XS6 **; M\P"7_8B7B^BJ9A@=*OCZS:;IV.PO$K5=) LZI%#4/G;S(?VS<5D1GFHX="F# M^J-U<)N4<%HJ57CW(J_AS@:0F4(YXIIB5JHNU"C(P(>0(S1,N(U$.W[3;7]8 M!D$N).+O!6I7$2XXH-.T"[Z1J&65P!,E.!.H '46\Q?30" Q&:&:N&L0Q.-) M1#T0ZQ@1MKU"Z-!X:'[8#_>PYHSSGTW.M2]&C"K@6'#^,;&QXASJT*J0)O8F M?"4TZ9E6,Z[H$IT.=Q%7]$]F5G4JNG4&K_!!C'L")4DES@73^Z2[]"&V#KMU7B>/I5DL'UQ9#X>[PX1LY"\:FJ3M7>PL.@F]F$+&%).<3A \;#8K^*B'[ZM_;7Y@H M"S.N<>"HIWO1.JT:(22$N=H^[F M&MU*ZK5\SWGP5=$TZFSZ&\_.T9[E+Q6[!BT81!D<47G*J V)3N_+'&<=^Q5$ M\&P[VBD;4[9KKI_Z^6#\K'_"8I/684"!$+X16GT5HX#<4;,NEMUVJ1!FA\8= M'D'7'T#!.:?#&'9I?R'*G@V1%'J5*;[)=A1#MZZJ3-IY4.TQDNV]%3NX)V*[ M^>'D-U44W[)&LX3.RF98PE: Y/J*A^PF2\X6?1E%0],#]['3$0E6RZL&L&;X MV#/IP&%4NH[^]$/6"I2$_&3&6&&#=E?XL-3@JMF,HNR-+*J9MO8S:3E*-IJ&G//3(=)A'!\*!@-9A=6UM/\LF>>R5[QNZ\&Z:5YI> M"2T)B+Q%DSGY27@XB4T5J( > T"HYS%.QQC5C-J694X&Q'766U>9WH8GWF8Z ME _TQB!OG9/]?NNDY9XR&DQ=3.\4&9%"\MJ,NTK,V11;3$!T)=!C$MOLB1@Q M28,XY1&R#GUUPEMMD@XI!L+'H]4LQ'!KRI-LM-&/,^23TE$8E->:Q6/&BC2- M9RP&P'B]M/N*!LM6BC%P\X**C\Q'.SM'*V!T'#I9B>%T/LV6F1C.J$1R$W G M,&U&):"^ Z%8$*ZCOG588< MS2P^CILT]$1XV",.F"CYN-+S:G/R:RJ&=%P)&%M(GH-D!CF";/*OJI "<$-9 MO@X[R ++$.N9KT\N7";\0,K8@;9?VQ#-1!\XS+'I;8.T[4CE"> ">ECYG(+F M!E&ENI';QE'GA6\LE)_^E;,=I9SV\K]H:WN'I'4R.JRZR?T#"D"3VRVUJ>0R MLD2C@U$>%]0;G!L,&4 81LJ]+=$?4G.S\&HJGD&*80N'R358MD$0I%*3;,-! M;L_&QUS'%U'_[!O.H:W1\97],,_$:U>@AGBY!H&1.!R#VS^LV2P48V+G=#: M:'E3O?-!Q^MX!06F$")%RZEO7I^>!+"#.H&_)C[Z\XM\V]V<[P0HET0-3M6%U5OA.A&Q7W7YFQ"T0E5-.B;7.& MHK\*K7H:M_JPOZ/D<72/%6=!DG MY?7N*[;<-+X=7,T&8Q94"G#5,R#8Q(#%:U:3,_1SXWA0WZU M?:%@5HT[P;:D5Y/PLX6+74JY6TYM?D;S#%]&NO_-.: V.NQITNN:]-6Z+B[R&7>LS/--3J2_;8W4 MW6F$$G&Q)S&H*.JT/AZ:F3X3>\3B:L)_H5,N=\NBED4H6"$+Z4.X31"[6 /? MR64T5WH[/ N,Q4'I>]C8"_QEM49*B'(FBX5"!"-I!I_[6M(.G<#3G,\3$+M( M?D+&."$DT,;[B&;Z 2RVC#.YS@'9,3KR^$P:)3G7ODDWIZ0:\"^S/>*<5%U, M.(>F*Q[3*?EF.3!>DD SE<:(?4NR:EE4](DZ,&'B#R>O&,6%O,-B^+Y([ )Z MY;^UO$IV(YW\R]S80%T=M ]*:MLC&YZBBKK0^B_E"$YPW73Z78!X*QZBU]@V M[M4 F6;,?U->>?@9^)K[C^*OZWW',V286\V2*@QQ MH^?NY$G&.)4V_^_7.414YQ SH[_2)D2V$A[982_?3T51I, M-/2<2K/MO3O8DH!"0#K&$M;AOOX:PW6%@!96ZA^ @+[^_@JP@8GCW .]BSZ)"+S!$4Y1 M"1&YT:$YAV'>B)H9PP=BSY3V>9!!G^H)8(H%NF(4>K#M*8MFZWW(C0L ?/81 MW[IE<5Y5%T-B;\T ?7LW.Y!D&LXT?H-/:KBQ JV5"?#&(*[\<0 M,2@=4.$0L$RZ6=KL "''KHUM56/C!@87=AT:]?B- MO;WON3X1&N>V5F.D*T?^32(OH7S2@_%Y2R60O"2?RIO MT/SU6_!@'KR@TDTY9U]&,_<]&L[GO\5&3W;/_ND7[[Q:A6O^]L^8]3P!^!H> M>NC][#2;_(V9,R?/R+R]BL%:;(>9/'C^VT/RO[[^ZNMOODM\L+\]>]7ICU%H MSHJU0]@G*^@8("N-<-8>('DY#WUS_PQ""MUGD8YE[_^IJ^L/*_]&.HHZN-W? M_91?QK'8]2TB%P-5JUK?">G_C M_'BD!O!^J#"$@%Y5,G;"T\F>#;M!&PV3R+GLQSA:)M!':;K-TFTIHAZ3J+#% M[#1G;4[>?( #2=GI\U# MX IH_:#UJ5Y7W&W2+N6!13/%O^$_6H)^Q8'J&!T;//W#F!YN904=.]COE,DW M&0EMQ"-\LI^9JW^SWD]^^UB26[_@S#MG!].K _K?Y 1GD@<4UK!L_,IJ9#ZP MPWL)+/^=E0O13M+XSS0)]&?\B@MOA'II6!7'[.C0AR)!W%H4][45'9 M6X-\FC$BB1&JP+"33-*,PT]M9;4^-O:83&4=4G/IGCZ$OHPI 6PH7 M/4V@K MSG+9T?TP(!*8!6J[\K4CV6 MQ-:3/],7D*ZZI(<\JRL8A[*%U#JZP3(*D*9+F-1X I#] HVO @$Z3P*J(CI[ MB(ZLD?XEBI?I>Q]$&\VO\D411-'JL[P,/:0TR9@:E4LB]LKS?+D(6T1AC7;APTI'W1P[,G(Q\6: J;1R$7R?L_#:CC2KG]*"M#)E3X2+J,KIOFPA0C*C8'J.J@VF!, ^4=%R.C/I"T7OH4R[;(X M=J#-]E$Q 6::34(8&HH:6#=1D\:$PU*66/@=B"2: ANU9QJ.F!]_E-=G^=J@ M-']WRH=_Y8A??HDS3;KG% ^1S_35C-H-UW[H2$U*0+(1A:0]G@VA-ZE3"$PQ MBEW7*"VO].$=Q,[+0HXA#Q.?BT%MUG>."ADK.E5TSH).D9152+4'N77ODNC\ MSXRSD9P3:?4V-!(C-9HXA/1N0-3.6(1>TIC#5T5N+Y*]]O+5@UM$MX8"I36A MO66GZ#F#L0 W/UKK]=51CO,[R#N-+.)I\!49,18N#LR^-IC5WMQ;A!VO(U4S M"[)%2H@BLE3>U>M.I%UCV-@NDD #2%&3HZCO9#3<)?.(7U^SM$A/%)7E$A(([D5G,XG81UX3GU ( U./7 M#!UGH2?>*)2VMFJ9'A8+87@*MHSJN$NR?O-@M;(4*&.-UU>,E;%,,XS 2'NG MOY3T-4D"H\1.CB&-Q+R:M<"88%M'34=&'_'R#:>%-T.F9=65?%G-LW01XV#0(B&5: H5\0L$\(U4\@<---&5I?UI ML4+"&3; M+2HP]/*W"Q7O4Z'N0.0Y8*\T-*OR)HQ[SYB=E!%+MW7E9.R;XA3-=+3;0TF7_-MJ*P+EV M%:"JP!.1GQZA&_DV6!;-KPF^(^A.+[8#W?TI$*!VANG61B;ITZC(92'SCIR; MD$(;"COD1#!++>*KFKT)-1[>)HA2/ 4$%:%LB= RT#(!CVSY=9*P@XGKN+]F M'L0\.E^1M^+MCT1K(.@+VU/5NWJ=>$)*U"<1U,H(D/R-R^L9HT>-/R:Y[Y?7 MCSTOW@DA,=@.&BFYH5597MEU*1T4\6C"H;4J>JP_,A(P[$)1FUS;S"2UQ2Y2 MTN'KUX^RT(5.RJ![ C;7L JNR$,MRBBY:0>MYV4S9[F-$)?$5LG1@]2J$PY+ M\86Z#(YJ[DQ5:U1".N1;#23RR/&Y^A%46_X MN"%1L1YJ<>X(^3L1Y J75IB?%"GLV-.V\P&@L4*M:CEUIETFHD\Z%.1+^2C7 M<;^4ZB .'%/;3[6PCFQK2](V-F=-(3I3;SWO=_KROUX\.SC^+FA=>O=Y56(*Y3,BT5@',J#>=M4;5"<6^7@.*%^YJIV,B_8GZE:ZD6[ MI HDZ[*M5FVI(JE)LT3G:N9'Y'9>36FL-_GL[1>0@^R1]/A16FNJBGHP4D9; MZ<> ,^GV,$M=>TZ&M44C1_R<,O9NHVEJ;^[]?TA[N5OETGTA@#IJA4_G->"P M_<]HT0B#?G!W5]X((?5G$@ AR@^&1E>'Y-'2%1$;#?%\D?$[G@&R8Z^QT0G8 MAU4]$&!?_P&TE+G"+2# _N__ZS]%5-,MEVLZN,JS__6GHS_A MO^7"^&]YA"G\3MQ FXR 8.I@Q6XVP7S1 THLYVL:0_U7^"AYQ>\9700PU9_X M%0+0RL"RBI)JCW^9Y!=5,=L>UCK=<:\=3['GKK1 MAEQ]8"XCTCAV!PIMD[CXSDQ MEU>(/!@^.UATKSEO*55YZ8U;!Q1(H^__?XW_3SLC'5=PY?[%O_CY]ZO\G;ZO M;-5QSX][?MSS=[GG24Z,B2"HQY4Q7LR?TBG+^WASZ4JANJ#BI)N/IF T!:,I MN!>FX-(E? 94AJO[S#U%8ZL=U< M^XP#Z"QA\N0SQS+B2SKU:BWD"X%8DKNN@=-4H,'&,,NU:XC4S7:(6 ])N+D>L[_)?#?.O46FU^%E.16M PB0 M3LKU$>DGLWZ&U0QP9*GT#SVP1O;,&X<<-V$W"'514*60WCI]9A0FW9)A9\) M!X@FTKOA^2K[8,,%/:@#"TC43ZPRYXP=I9]P1^EW8T?IV%'ZJ:Q&RP9FSB(" M9:\*_;>"L0B%JS2C 8N6&MS$N';HQ0R@<8BPP_9APL@91IO8/94!5%!J=R;L M=Z,&UYPL"BA16LR KK0 8VT75$'PLJ'_:IL@X!%?,R(FHH/0)3*#^8Z($RK0 M22&01=0Z8]0YZ/#K^,#V.9FG@*N<;4C M%S]W"\>S287_8M-E2J4V4A_%T@>AY,5(3W*8*"JPG1P$AB^#9S"@6?^E5!$% M9]*MGW,M ?5I5!)FS'A2!415 /1;&4B62_]K7X4J5,9[NCZ#%PZVJ01RO." M818L@ %R&&[&M1#)Z_7\0EB%=H,((9J .3T6T!4#PF'58.=P50<6F)E?,J#G M9%07P:([VV(_MM=M!=@O92&I%J9"$Z]Q/15IIUW(13UG]%7*_I^R25?M7%8J MG$_;;,4-;9U%K%U9"E&$F:3(,L4 =LA]+53K8('7I[>I"=S0,G=T1]N#;>*% M,_S2>,!JV49HM@&8!I7P% ^"!G,-G9(5S8XZT")SU\Q((YU4P"JB9&\W@8B! M^[XC,!# FP!480XH=NJ%=+Y[ $RX+8%B?J*VQX93B+:BS4#W3D?!X/SZ._BW M(8Y[OV/[7:<%*P)&#Z+3(#:6P^\X5:O8$;FK51RSV23?Y MH')CH)XOB[7R;G24 95P;!":1'D&-;N269Z!M+>-.R]I20H'\Z> NWYIGPZ2 M),K@Y-Y=8^XZTN@[;,:*V'Y!*PDX(CF(0B%V^]#*:5LL-P=%*0,H>2$N$ER( M":%\PEHS%_Z07E*[2UU4\V(F,$I_QL_!K@V7DCL_1 @Y8RT1PV3)GURM-X$X>LL#K/RX+:Z0(Q(P'M@!R K'!TB;\B(,6SBH91LR]3 % M N@*S 9W83+*Z&.58X\QPN5TPH72EDSQ$*GH(*M>R1 LV$]B;$Z()*E9\ M5JW9RB6:O!X2R8X2?\PK@=2@/1>>G M63 ;L&](Z%=6L:]*,..=VX#%0I&E[];+"NPN:2S%*10^H.7"42$BLKRSJQJU M)I2&-^<4,NZ$-F_,\J)=?@$ Y>'L.LQ$;;993UL\,0?:^ZC'VDUSZYV0.@UI M^4ZD',)MA&9Q[C!P^JQ9_TF9 \IX39P:H-.GLJWA*5^F894.B^F:F[#F,M$> M<%YLZFC7"ZT/[.8\$V8?&2WCO]EVJYK3SP.>0$(/O*UU84"%=W0 ]W, 7UH' MG%@[F=/)/03JVZ"W?ENE5YQR*$=ZN0@N/6[UEOF&?%&D%@J>P**(383*)+]FR[;AE"J'NSTRA7!30=<3]!ZO*Z/&\D> ]\ M%4G^>PJWB5 VG(X,C0@3YLU1YY/U"[!D#B<_R]0C9ZR9\_B<\*[#@-&Y,U/N M\8&7"7:/RJ2MPRZ5">R59%EV#: MZ!8O2:)Y3 0B!?49 N37-IG*/@=I?;Z;B5=!' 5^.N,0)G9;3#7;[3@*O);D M"!Y/VUL_;7^%F?PUIA5?^"@-!$1D\5^I--W-S\_W']H;G*6?\LC^/FC!S*&E M.5$Y0 .46OL&PRP$@4!A3)6SC"D :Y-,N.LDE5@U.JI#0ROT$NA$R2;MFLLW MP,9$9=I!##EG7N*+O92\>7]0*#19>)M-29ABI?15(%?C<#K?,*Z%_V$I7QO5 M0(890E:D-'_84 7)7Y%R(\D'LVI]Q7.1D:0T'4-EOJ+S^-9396_]#P_.J\M, MYA'C@LI60_WHDNH0 ]Z6\5P![5QOL5D:@MY0;H^]1QC,W7GRWQV-,)C=,)AD M)12P.CR8UP!DX@C>7[0,VKJ^1[Q4:/Y@M%<#3D0G!%<8V)?AEZOT,OD3RG<3@@M.L5(\ MN1!@J1(DFC@*(1E>#ME56I)JJ.('3F_7-)DIG# MPRR_IIB90R B#%R2@@:&\=L6=Z'"I%AX_*\4K3GA<:W4'3'TY (SRF"KB9 @0O7UQTSW/*J"5-XXE M8R@_;K(XG*Y!%A=D8X0PR>NZ$#$Z7B9ZOJLR#+89!?K"P-U[*+AJ?$?F<3,8 M;U*5E#2:LI-88AVB#&\.,W-U @V%Z=!L2+M! MCSJOIMP+MJ);%AS^3UC+F@+ MK#F/H^VV"'K#O L%[F1U?!U+0]3YI;DZ'DVV:GI/$S;)NAMZ-=QM$Y*"$S]" MQ-'Q+J56CG4#OQ&4O%:7=2#G8\Y5M>\#"SF<7$;,HQN[)42_^#I8E3#O\?G! MED\73C"+U64I@V3FB2TY&)B$#@T#)EBW'3.72?T-7.N!OW;A(U;)P%XJ8)$7 M=CPS I(QYH1D[?N[S(22?>M][W\1[U0$@ /_MSV6D:+3H]GT@G22Y=D$6Y@M M2U&&%I)46B2RE#'2RC:RX&Z4+5.>-7.WP*"*G=C)KO+QL)6U>7+AW9TY2G_B M?AVF0:-0+9,2L+.OI>0,@MU:2(02X"% MA&.\A]W"HX?R E%:Y\MV<(OHOGQ-1_G2K^B2.08O"B3/;;BL187NT9DA#8!G M58F&;("..YUQ(Q?8(4,,E=X0RX>A7SJC'8D%0#@FN4R'=SS ENUW69L]2,(( M6E:=TX%YDV70Y*M@246112\YH("I:,B@R;ER-(%%LV)ST>F*Z@CZ7I?QPCOH M%HGO$KCW=<-Y=ZQA"V9*!4).:#99O *738(*L( SV9\ST-V(V0"NI(PY(V7% MCN"(\ U:P?ZE=!&7^84V"MBQ[#V3Y28<1/\:J.6V+**N\+ @$C=8;\G"#$(R MW/_CP10E\PG7Z;/ /"R.M&J"&I@E_-@=0*2;Y/P2Q,S<&\M"""8%19*9VD5; MZA&J4*STN8 1(S"MOQRH\M;907L=%NN 2Y6;6T=#I! N8\8:71UR+&BUS;55)IHG"6P9<5W\ VLI1]K4_5$"GJE0190?*V$VAL6?-BK(C$,NO* MMN\]%#*J)$4%]Q]3S8R";)6Y.!G8T>E/U-C33)AK4,VS.D'VM.K(P>]Z#JU9 M[&&KK4$8\C;$T4"6A!P/*TV,Z+/#*\^\.W1N&+=SH B<-B.%7:,U?.Z\5;D. M9KV5=J\ DDVQV$(0FZDZ!"]F P7M?U/;>UG.*2P2UN%5N0AEHXW]WE;:)C-+ ML-*NGF+#S1I^KQ)L&/T\($?5S)J..0,K]6@*SX6 \%]*"KJ5@7;8)*E':<1X MS1RSK%=R/)D0EPU#_=9M;C@(&KJQQL\T]C[IZ<2SJL_&BCCQJ:Y#30R!)I+5 M'2],LG'QPITBOOD%NR37-F&/U7K3-)>N&\:!;'4_(M9"LL+B@>P^9I,6F!TT MGG?,12]R0"DDNN^,IRI2 DS1$9-K\+#-!X=LG@ZY(MQWF_XWR+:2:!CR9%DL M&2=D"D.7Z'*7VS@IUP:)#IPMYJ-,$+^ET!4IHL/+AD]+>ESKJS1 M3"19"[(R QYU=P#U.-UY9M.Q@ 9E[P/ .I(O0N\!F-+6C'VZ&1[$.L$'4@%$ MXMU_7U8Y'9Z!DD,RHN?>;K"(F*1>'F)-IAN5$A_[#]VU&[8+XXIR)GO>Q-2G M4CQ!#N+W4 ;99P8C8FW&^6Y42^J4CYZS9U%BSIY#7#=:D@1N2-_:-^7]WME6 MV;7[JO><*/,,R1IH[]! *"@GEI75XM9=!=EO2V0D(<,UU8=(#9-Q[<8[@HW# M8) (CFTV_\LUD(V1PFRD,!LIS#Y@_N(Z@5\X]I1J&.E/QST_[OE[L>=96ELT M_=!;P?HKF83 (5430*XJG%.9.@]+ 9=1LQY,$EHOV)(6'JW(:$5&*W(OK$BJ M0ZT-^K5C)@+ZEZ/ S3FA(N*6U&WF!&U8"V^," @S6HG12HQ6XEY8B7F70>ZZ MXLW(D#YN_W'[WY?MGSH)IC.AKJ[R):-08M!A\/FQ09K""JX\@!.3.BX,N5TP M)WNA4$8*]=V\+M?,"IPTK1-G"<"D0UQ:E4* -51_)2U=T^@76O.3'', $O2I MT%#L<=PNG4IV6!"-4$%D:3\,:N>-'YJEZS2^9.R."@^62B4!4M%=B/7[TV.W-8.8.8YM4% ))2RAH@$7!C[70YSIA"$?C^6( Q!-* MH(%'=T#+)%?:3H.^$"R.[#\IBY-P-'S\'4,!/W_1 J;M5D6[ I1A5A=,@K-P M'8'Y@,UP[\YS$E(0D5WV! 3R0PNU):X)(3RD4; *REMFI5/MU3D,2LJ-?]=F MD4<\IRF@>->$2F5Q.$>:]4^XO_1X["^]1S3KM^\1?7X8&:FP1TSP$.M"O3>B M,#".]QH8E21)*]\!TF2.WT" (-U;H/ !Q(-I-Y.&IH"V21NVUOX,Y4*]T)WM MU?[S9=)>"9WG10763L-)DZ""R2NV2!OM]4K+_=JS3 ML[JZ]/,(@BB&T1A.#/%IMH!$MSCEO[O =HT&S&E1!ASF+D*+X=>0MK!P4P%* M M,9)7C.05'Y:\8N1\&#D?1LZ'D?-AY'S84[$J>%;7]7%PE_T6PL=HL?KM#9U] M@!QZQ(TUW@B116 C(.%G]^>:Z^[NI?#C:#![>X(!*'[MH8_@!J_,2'@Y=LBE M/*OHV$-%H)%UUU?F#'8T5++9WL95#*F'FCI)>3EH#OQRNSS6>S/"WH-%>AEX MM[L<"S?HL,ZBP 3:E4V?51;ZJ2IV.ZYB8U5&19MJ4T257M&IX?9KJ'S,3:WD M,.6;C9M'BQ:0; U?[PH5:"L$.Z'B=DK?,J2E+IP>EJ&:8T2WIE>BT(>(*\%3 MD+((6D/I+FG7,[G\V#\X^%@KN'1+? 8J8ZSL4#"IA(=TCLT0FZP&]\H.Q;?K M1*F^E!5^TD@'&GN>IA89/ ]:GRT^Z??7K'7^W_BE*'C&$ L\FIEEH>!666H5=<]A=$ MW,)Y@=T>DI>DOM$V3(?3SU(*?T(W=WB-=1%&^HF_Q4YUPV'5K;$S>+=JQO4- MGZ(AT"3RAGZ2R@-.C?OH<+&Y5 ^[*CGU"X,C@@]2XO#3A64'Y4!&)[ I U$1 M2]D.7E?3R!&4L*F+/JM-[$3W\]:1F+A;CNL;#'(Y>3%(?;6R?)'PDT^0:S M*ID_'C+[!+'P$TFI!MMF]ST' DV'?0#&O+ BR9845Q#Z"QW+Y@HIK0U MQ;0-(?W0B$+,E[;JTD<7CN+8*#54*F-KH@,;C%*\R-1Q-U!_Q.C191LLKPSG M&I*?_K>4E$_R)3:'8'G\V.45+I/H1D19+YIW'V,JOPHKTM*0)$PEK)3\!U9@ M@6JC<(IXZU<2JYCF#3)9.?KY\ KJT*3$4E/-Z]/8$:*?,PMD(.41'@PV)R%< MLH@OD.>J[T;^&(VDW[,XQ@K(C/3>.5"9*/"NV[Z=TH9597>I7+O^!P98Q7KE M67MB;DD49&&AFB%"9E:H@/CY 2A;51SG$$>8-^1+ZOH_@VZQ4)GAN951>G".-.B1 M0%UCT?BNA#(M0[$GQ)"-:D7ZPS.'-12:("S,CN\VY3[G3=UR;C*G@H*%L4"N MJRL_%N_%JY/]ORU11M\-#*]@R\QG;8X29UR=PNL2FBOG6TT:+R)KXMBTR:6T MR*PI#]YQ2TLRVOL1I_9)@"1)1ROK193UXN#);Q@B>!K5-SY)=.2C$1TYHB/O M#SKR;Q*8D>[7Y$?17QW5O=Y'W0MG@Z499@?$5C;(_\AQE+(;QP>V5";P@03( M4ON/S'HVYUQWO&9@&Q-HH])E$6&@\6L+[RX4:*'X$K&@)T/C"Y8\FB;;Z@(Z M] RN6,LXVUCI8G87%RGCYL5_]I?A0_1U7D_STE_J MY;NENYJ+J5TLLFS2W?L8Y:6 %Z45J\C5+E*L3\?P=>^+> M J]\9-)H$>.7___UY7!!T(/.+T2UJ*)EOZ>GNAV?D"?2XIR:.LC7_DPTVX%:^(7;5WZ#8>#@Y"#2C)M=D55AD1; M7<8=QGBCN"CY]R"GB3N:='G]4#3"WBOWJ,K]K^9CG*:5WH%?Z])-[-T@[5#W]=2N_<99G4QI7L2@_$\#($KS_(SC;D%APUC6,W:2!M* MVA?YQMUTE4B-KIE0%Z\MJ2O&VG\+!QQH?CDWB2=3DVP]HKF;$XC9Q0C-[$I9&?<<@? " 8^KA)#ZVXA]I^,_\OMG$X6>^_O7R-K0BBQ4(2">@G7D MQ1974)]\'0V+FI2'S&"[/MO8^.1Y$VT%GYC[[\5 T8SS<(:27-" M#RNJ%J67\"Q,W]U KYOQB4*#KYCB62 NKIW))7%&,EZ'C)DV50SD\M4<#JFC MKYP+OH+Q];8)JXO]7=(4(@U)KN-8?=\W&CR-0D5FU0\Z:0*O]D_CU_M&'#=L MN&J1]99;6R[R"^\KTS29*WM;7)\YR:#:4H#$ :&$5C9\'&K.\4L, ^.P27<9 M)UXU"PMIHD[X@ZUE6,-K=U&XRZPS;[C.6>L-/FUHYCO8;A5[YI#AQ-RJ8$-/ M[MC:=*(P6*GGIP2YYK5&AJ7_:O0R\F:[5QI#A.S:\<[_DKI"F(8,MB?EB];% M!6!FT>@R*YM*^ZV&3==H1?;'\)@(.HF98YW --)(O;Q671KJ?G%U+47S7-3% M_$':WBE7_]WU C.4V7%*;8^AQ2Z0?JPK[5X4HL[814-'*+%MA/)UH?$&E,<6 M%--4D"$AE$0 H;#3$7(U(?U#?M;,.W\MPP:%9GS5EG"=X5/'N"\3NS%#2T9L MPYP3*G?EAY_UMO =>B)I 1%O _D0CB::"<0'%P4'$O!%PGE%[QH@7; ZOQ/4 M88GP)G1R[C&@ \YH]SN97\S41D#XB_/J$LHV!VB-\?X;OXKHM\T9Z:L8BJI, M5$HR\850$89(CJ0K0MYD4G$U],(U$2?!SJ0T_P 6XC9:B2]*LI:4("2\2\P# MP7-E[RUG]16^Q[_:^9GVT?FU-X.8X &3PRI(>9'[H_U*F>S]CU -FE>7)3?3 M5;,9Z'D$5K(@*)8/!7A?"_2 &@=[LL,ZN@J&-GVOFC;T)U/AAZYE8;LH#]L7+Z" M6!B6GH-$H=^W"!WP-;@*G?3V76,CW_?YJ5>4&J[F,=L#JR'"8TBBI&^*1M:& MNR)5EX%1IP&6&G'X#+PC]#<:H%N[R2WS!6SCR,FC?[?*SK6I-F M5O0+[S;4OJ$LGM2L9.J$F*X1&/() D,>C\"0$1AR?X A+P=RK,WV M)&O$M NR&0E'T7@"QC)(==/%B/<@W]PT!]MK/=$*2RA"4](R)GMO\/R2J:OG M[U6F"?A&$KGLP^#1P"HP3I0OR*>G=,I0?B0T24I+C3"_T-:QWDEHQ\Q#SW7( M1#LY8[HZ;E]BR*^QXB R8T+9LN7D'ZT?[$='CXY[6 /R6%,E88.36( S[IQ6 MS'QP40VZ<$,X'Z;=T)(--87>-%+-NV5P# M[H'*G"JC-)$AAOQJT(U>J1BK#'CBP0X-\Q 98,"S<-N!/I*1Z0Z/-&CYMJ4Q M"K4+5A^&C%>HQVQ_^![P6\#14@8(.Y[0/=%R!(Z8:U*P68==5YAR!YKDN]JV M%IB0<3_LC0$1V39$0X)FR BV0Z.BPH[E&5->5*AN M+'3 Y+&DXS:,]Z5WR$HN]3(7$/)E?31&<4,TQI<"H7D3THH<6&LE(WH'K!9) MZ531[%:6$1OPAAK_S2K!VLA*D3^;KWYGTF-2)AV&.**F$L>",E M?>N$L$O1-604H\_W$'#@B)H)$)$(-0VCA-RK-[+ITN/]Y8U+\("L=IJPC MC9M_;+-)HV=>EI1CE Z6]T7[6(*_VT/\P-K="N+GQ98B/*VW@+LI&)$8K<^6 M(37D*JBU1?P'YYDM7'-Q$U>U,">+-*E40B<5SM<(6,K> ]@+D"B.L\# MUZK%XGS:EM(<@;KE-"U#9;9Z592"O>K$#W\[.7F%A:N%$NV%_" =QW0W34JY MO F50>8.)OI*"HT8!!;ZOR)SOJM1SP*:\W?&WJ"I]",]LL'*Z,,7 BE3XOXV MID3+'K#LTWA>X!2LF_="- M]D/?P?M97S9DV]'\5@%+;9%,T;%-/%#+%Q7*IRE[T[)X2Z_=57R($2W*EG7. MQ*O$0Q9$I*N5=QC]H%2SM[=./K9?4>D/IV0^Y8204FD;OW?0+;ZAYRMNTY5> M]\IV[&ZY020V %NPAE37)X"NQ;D*4<[N,"LLN&O"+&1RML5^I%/"E7=O"P:# MP&W9FMM>W)]R1B^!?XT+/\.9F;C5U-;M= MCX\SRB$=D1I/[Z:"/F&:;$4C#+>Q<;1R:&$""*;&V7%:7S5^N MV!JW;*9(.9M &]8AN)C.CL&S)B-JP] MG+QF/-HL4!8M\]E;,K[>V"FH0<)KM5PQNXS[/"@>\D+(TWSNDMA/D=N+H2M1 M22_=G.A+##1%F, YH4.>>;P*:CGY\NK?+A/\G5(-,0C0@G$UB=,O 2T%^O6@ MN.Y9PP-R.T]\QB2%':?"-*4H(3$ 6"E,#$PO?ER9"\L,;-G2T49_)KI@AR92 MXBQF[T@B7CJA$GH.9;F@%I[P3/9U#)I9$0YK^A4N4O#9C+1RP?(@6U9*1.YE M:)9Q*S"/2$EQ.'=,_8KA]1IW5KNS>/*V>O/8<>%THD)V0SIT&LDA]T]YC#+Q M3'%FBKD\Z2R#H[O3K^T>=J-(ZWA@C@?F'SLPKSFY>L=68[E:/P@NC2.^ U?. M>XF6:-S$;*L,R*,LK9F*_1X=-&$LJ'9Z4QWPT0I*P)G')Y5)W83K M9YW8/5;+>H?+Y>[Q3U$9W1"/3P?JLS$G-4Y:_T3+PL @_N5M-EE5QUHU=MSL M2-EC:-#\Q\!Z-+ZC\1V-[QT;7\VWS,(V[?IC5?UA$_YU1?AGE\F.:KW$7O )DNRK2CVP)9&W.-@:AG+PM*0\8F.Z91XV!A MI)IS!F\$=DA[7RZM-(3FX(PZTNA*2_J!+>,] C=LR6LE09-?(20#\J^VV01M M]C12&$BU89/Y<,BM?*00ZW;"1I2EY$32+D%E_,X7J/ ,96G\E[::X] TX,[92C<;?G/E MG[Z9,.7E<"X77W]T=/S=0-B\9:I[! &]]*JA)J)D $-DD7/EW1HH2L6K$J:I M_G4'\[=:7^_E;Z\?(7.?72G=4;S[$^Y">#)V(7Q^70BC*SZZXI^6*XZ(W/:X M&SV+!\)A]N*-8?P>V8=BC]7G?( 8PQ,%W)>=8J[:=[70F5NY!\_*!Z2 M&WY6YRMEJS PTN1IS=WT64FN=+CCWXR&7AZID'R3!P ]-_JE[MR+-ZF0+RMR M!X44RQ4#KX5A;9Q<#)"IEHB!WG+:_,C ML4?=B-@%Q1:^.G!*Q47!.D=R,\(^Q$R2&8!,AT\:6S& :9F%."S1JA'('O%* M^DX4B+4;5UL9KX%W8[HMJCO, $3=^+CK7]54)!B91IWI$^39I1:=E'L2(6<\ MZC2?O6W7\MUT1L)%OY?ZSH4\\<; A7']B^[&T25EA58[KT+$KH&EW'Z/ZOY+ MYKA "2SIW_#++RVQL',0,+&!QE_F\ %+$3?DR\JVM_M)3*##QJSP MKJ(;-^UZS0U! V/$=N^ ;3D]-'X7J4.:AY;,WZ"DDH5A6?QX5K'8E\O!J#:$ M/)U,\BW%/'\LS#D!H!>$ 5FW*'7G +$T)C9KX_+]S"G %"88W^PZD_)\EMI$##H("CCFO_ M3K-\'=*EW1S86# XV2KC1[%LV&2=2V]L4/E1'O!+^1 M;0U2V(YTDR4C[&"T(J,5^0LMX\]8'1$T7$(Q8>H_G09)W)Q)J-$RC81H-T^T8ICTMQ'4PGD\ MZ&3Z>+?&2T.X5FF#L(':>T! <26WJFIB#-%4JF1P&)-!-QF=JM%VC;;K(]BN M]\&?2QE":2@^&93]!P*DC[9HM$6C+;J_ =Y 3F>[5>G!4#)A=()A0>5V#<4P M;V,L8 ,HLB8%6#19Y^(6V-#!*&3*3]B#%B@(0? =#$_X&!'@K1HT\1!$!O3'J/A:HG7%?USYM$!0'9,ATQR/I$8D?-I)$: M"DDH6*9' ;Y8@,M9Y5?;555NZ1\X/IR<;)C%C*8;<,597K)8$XO6$'N"G]V5 M6'P6"N8GX#T_%8'JFKM'NL0XBC/]?(TX!SQM!FXL%YZ^,G_LZS#K&F\^M@WB@K=8<53+>\E00=Q6*ZU]M% MUFYP?E30.[.\KJ^\F;J$N2K)K&3OR,V328S"$R" M*MXRL!"UXPVRX@%U: F.XL6K2W]D-.?%6L&R7R8U.=.IZ>:VBN4T773.M+7& MR'YG@V9;Y5_,;$]]!+K"X"\*CKSD'"V]2Z8\:=XPM*6 IB!.# C@NPTSBK*2 MO2545!0@+010FYG*^,6[.IY/I\LW!RNB%_@G85-;ARY'^]@ M:;WE_H^OGQX^YLOXV5Z"A]!_B5G@_N/XZ>%1\F%7UD<>T3_>1>Y/])8-?$-N M3U$*^Z]_ML>/V23^Q].CSMUXT+$"2KD<[Y*YMN"K1:87(16YX5I7E'O,BC;VB^EK2E"2Q);^ROX[TV MJF7-#R%"BLX3GS/6J&)#,_'8@\O1K7N)1;XYHI(][TTJ%-3WL MV7W49[G9$YC1P="8618J8V&R)KSGC2[PZ+O=H_ME<(/_&'=OD_@\WH#PE'+# M9MQC^8(@7$,+[_@;B4*H:6WR#XHAZBO^@KAF>J3I]J(P&:L^)W&LA:#;+USW M[FOJ<464",M%)HOW.![;&X-&IO4]GOK1D25/MD]V./E!% OY=R@/>4M1VI< MP9Y$;;+FSMPDPZ(L1O0!2Y,>!R]. '_I0NT[#G0^_^S'L8(3N;#3%,'B_,:Q M]39=BHU$:?/6;^8HD8UI2!ZJXZSX2?WVZ,_Z>IT!8\SX M\HJ;@M]GRIAWO6]U!R6#4QKYV.NLBHPO?GV=&1,)+RPR9G55OTL-OC-1%14> M\$:>\-M'N-;C;Q_KBCZMYD3UXH_ZVH?WTLQ$IA^_/ZN0J9^(G]AUT\1I)%_" MO)C5PB2R=4I2&5>4C1C3G=;N0-)?F"<><;&5S76.@WR=1N%';N#VNV'=UN1Q M8@OVW$H='1+"(W*;AKI/:M>!YC/30?PMK1/3D(V\ M19"0LP^%]8I)"Z/B5I]R\E1..;\E MJ0V5!/S658$V<:E2^-\N?8CG;QHNT?N)B+[F1N55&Y$X)\'+V+TK^(\Z03HY MLJ>VS+N:/0@7Z!'6=_-Y:;-8O2RXP7GKAQ?@2]WUDP#=SZZ/1+*N!ZV+M/O2 M'/"32&M;"V$"FY2H6K5[JW4VK*SKCL1.9P&BU>0J.J-D1ZIVTXB:JM#>4O*G M+P\_-#(WL S!E/6F'C[FU(G$E9/V(K%2R_RRTRQ#BLA]%0 =9M,!@QQCY//M MW%HU%4*SC6H-]]^24F?8Y+5J!/=#XAA' ;'0?4_#Z. M3MO*0MS,_@;^M)24'02?_YUDB>4UIO[L610;498&(2BN/":U]DUJ4>-O[;T ;^OF=%L[0YV9WRJAT\4E!8_0*33KTP_=$C=<)IZ8*;BH69X)2Z M,I]M1(4YG0D[!=(=CZI%JI:G!YUL)#(?NE/"Y%#JFGU;;D:.AR,NF%"YD@-! MQLH/"4O1(!1@71:NO["O%5Q&+!K_WX>37ZH-^1'0F=(27_R]),RV_IZ'AP:& M#*\V*R\DM1]7ILVR1:GFZQ;B;COW9F!B4@T$.FHQ5;;4V9LAOF)S_4S82BA2 MNY) "=/HC=Y&R8S(E'XQ"0KV GDQ&"<.&R(/YY6*EH0&:"R"V,(>%^4KRVB% M.2:-%X9^$GQHR9Y!YK\H?Y[\0/\3W=L\GK&Z*'"=K2N97?1'QW^FVS[Z]L_9 M9%Z1'HUN":E#P4DI0Y>MTGS11Y11H3HIY:N+>9$SY2:&A!:&4O7Y,?ZS_T[= MN1++E_%6\-_Q49+WZXI5N]);7E;UZK2Q(A+D%C42D,1%R: M(:"FXR1!3)HQJ1TMAR$& _'SI/09]&8GG4M2)(=%-2_\XJE!0>ZOT:*H0S_P MTW&JTX9GM0:&"ML%:Q9R;91F-6S*J=M<.F?OERSB$&RI->*P4T^SH<4\$KQ] ML@1O3T>"M]T$;\E**$#0PH-Y#?5;',%1C7Z/V.WC+/?(NCGYM6C>-I-?8R3_ MTJ9L*7%UR@IPKY%/(UOY6S-Y&1(DT(-^Q=I[RBEUD]#O_>?@!F'@IQR/LT3Y M%L4]/OZ$+EBSQ1<5N2E+]P5&VKW!2A=GI*NBSWZWX[98^J 4,JR2@\J!,7"< M?5KX$[Q*>JA&KIJQ/V#L#[CS_H".N^X=C[9A9QRQ)A1.74@)S?R'/JZM U3X M^['C>K0$HR6X#Y; ,EH\WLGZ$*3+Y1(=QOB!6W]N^''#WXL-;XY^E &X M4?BL72HZ)C!!4SU8ZRVC 1@-P&@ [H4!H/A<]GK!",B(R_'_ $5"4).EQ(#Y MFY#=&\_ X#I'&S':B-%&W L;D5-2#Y1*$80_#\D^M1T4)/Q/F]<;XF[G+S.G M>1=K.%J&T3*,EN%>6(8U:E(!.1.:TD1U@5#%%DU"FO,-FBRJEE17R$IT<@M MM2#Y@"3DU6@L1F,Q&HM[82P0/L!@A&XBOR8""I8,P1K:,B2PE:,S"O$(@.[\ M0_(I*H*IBBXFM>1 ;FL)-%'HYG_]_'0T'*/A& W'O3 KYY$5YX1IV*A;:)LRX50A*-T-@D-%LC&9C-!OWPVP( $\(!8D- M==/*MG_K$E7&<<^/>W[<\_=@S]-1[B0^\/L\XR89PC$XZ3[+)J11(?R-$>+ M/7349R]-@]Y?&.W":!=&NW _[$+$.:!DF:\)*NX?I*8B1JV$ 'D32>>:-M]B]"NL,_3M$':%G&1%TML M ,B@<[:2,A*LH3X:A-$@C ;A-@V"3ADFU0FE@#OT6O%%DJ&CBT1ZEXQME MO+EU6OK3E__UXMG!\7>R"WP8,7?^Z3*T8C<-/Q TWHGT#-W3/B*I9M)&7RJ3 MM!(H-$2]Y9;W;)0;*K?NLV7(B2BK7VN:$CSK!R@;)%F=[QJQU-=K8CDM)_3WP)) >ZI$7^[:3QE(O/REB*UDWC"YYCF. M=3_ACH]XQ A?8&NH'[.94E*88:L=>"@,$YH2/$3*;%(0!0>%$_Z?6@C,C)H+ M*QCD96-X]1(&HGTF3 F&!N;KI+S2!U1>OES+SW2E>!%EL,Z%N;5H9OXE[6-5 MQ#Y'^A^%M^S8[X'Y>N[6]'@]M8!P)F6!=H^NIOH!9+@E+JW=_[1%S55N?'GC M387RU)4TV$Q;*R^3G]7.E,3ECN#RI0A7+A-&M$@)6#3DE5*(9IEF9NQD]X!=HR=Z #8R' M1([C142C16X WLN-,BU-JE+XUPS]NJ+=A.%3IEDGK#^M(("455U69[Y-W/]E]'(=*]E-/#@2E"[C4B! MF3Z7Q5MBK@IKRS_\ O31\K3ZI)GHJ@P/?%B@S! 6NH_M=[:N;G*]POU?,\E6 ML+GT(?A6:6_UA]4,/-UFS<]+%V_CX2(TJF0RBR6.C[";>2U4$)SA5JJ:R/M' M2[FW6]8G;#8)V%B]R:0WO6#5(69X9+%.+)V"PENK447RNN472I_Y9DO8D>RG M#O<)#6:F2WZ=-YM,*F.0> \B(%&^?:X_I1!3R;\Z-Q4 #NXGBG>NW#+7LV5. MCA]#!./$PW[*LS(E9'WF#*GEU1IW2NI\9MN"MKB_G+P7E9._1/NV2P9L!6Y8 MYPK>:'>%!5QC6&G,6E>'S)J+-LM$%S'=K7"WJ&8&M.1X8H_78SWK\R(;9 MSUR^Y$QM;X&S%L6V,-RL/K\6Y[6W_X86ELCM?,!2XN2PCEI!YRY81]UR>9?F MY55;4^$J,)[>>H)KZAM$7:^DNS8]\Q"\F'#8N#4*V1T>"&J,HBW?^'4 ZH2:]>>)IAM4 M7@Q#!+"Y[J$1D\7ZX(/,GPAD_)1,XVL\@2JK>0/9HHG#S.W4G>60B#A=5DTA MJI\4Y1Y_>S29YU>-"(W(Q\S]^S$77U?8LFD)W^7F[F-L T@B(KD[:3B2('W# M,N7'_X9/*#^&NDKYIC%\SR"A-0>WUF)RTIZUS4:4?[Y13:JI)&]!+7WR\I?G M_0UB=8 $/2];A/[#^6V&I24KX07KC4Y^PL,$=3T^FLR+;7D=-TDO0*N9_V_?R6"V(VHN_S*NL'!4H0FY%N?3>R&WW0V MPPWOOR;IWU5?,XB0B+I>$'63B8E*9%2M(%7F[H[KK\.>!;8ZM]L,YHX:Z[E; MS@7@O%WQ) ;Z2#)B1C J.\S M.!'$OK,6/4/V<*YNK[D16YG]A^ZD07XPFP1_*D^!&M#:NO)R%945GIQ'#NO2-'9-G)HK_&X_CVZ/#XS\%:&X]C^X".),>?,,GQ MUR/)\6Z2X]U4QKN7RD=G+[ZMU?@F6FP]Q7:>E)H"JT@A!H[U\+%L;/>'=G$A MM)0&>7O%=SA$$E>]*B5 IP B4\ZIZ/<%AGH?LRV*I;-#H.$'I5Q%AUPKM')- MU564X<;Y"6EPBHC]_W+TEN*UVD;<%[Y"+3J'4:A1+LSI8;FR8:J/R!($=U$\ M2_!C)B>&) -=@,^7<,1=BPE(*C92%K+'7BS,&N]!'A7G';E-X.6HY4#U1Y+Z M4P'(H*>DC''XX?6N\)A\HDUNY-%(-:N:%8CHL#NF#CZ<.D+29:#]"8G\$">T MG1*RP9]+OA"4YO&-H22W9A=77-BF3"4G(Y,"8R@^?X$Y\9.F-QG0V>C(G[)M M@=P?2&QB:5Y, KL\S]^)GM_)3()V\0SY/U[G]33W8W[P\MW27=&7X$9N^ZW< MIA$Q7\XE+813)S-$.\AZ\=8/Q:>>_DKG+4.>^GJ=L3?;GS]]T$3MBA+Q0']P M2;2[XAT!T;@XBL5;E!R-!3D/0;DMTZIH?, P'3A<)X68A0=+ K'\I MHCD<0-;MTO7Y+&-)IU6A;L1:9C*BII'=$#HQIORSRM^2AT9*S#0Y'#:S^*U_ MLP/():UTN='/J Q,^K_N7>XOQQ['UB?%FI%2.NY4;/CBI,)3S.@M\!#TIUC^ M9&<&=!I3["F%[O":IU]""U9QH(5_QCHN.+H'>YZRK;%B_<[QP;=$R RRG8G* MJ&3=(3@:1.P9+JG+2SGVXBD:$U3^!.)% M*T>TC_[((*O(_,;O&-/,N@T=$Z#X?5G#AT)SN,4;PMQA^ M8&D):_PP+EUMW(3P<<9%:?;>L9$[948 >V4%0\J*(BM-"NHIL,4"R)G!.LMU M@@:&#Y!PYX1'.OSB/+VA%2CECRT+407C;[H>Z028L^'AR(J_]X^7/[R.*U8T MIFF)[K="B:6U IYHT UE+ZM.T@%D9@=G/WX;KL7691W(50@YNL&754-\4V62 MJ3:/,@\>S%5,!N3^"CA]-B39SN%]UX.6JM+DR=$336OTGX'I)P6 M'#B+$.+5!)Y>56Y[),!O*4+G,)XSPQ?Y4OEJSNC/ ![FL_-V0R"<*[YSQT7E M'Y+D:G)JAER#32M%U.&,.E)LU;TH83Y$>-5="8[.K43[$I!?PH 3#1<>P _D M)HAS%VDMP[M/\^N,W=0Q'./2\6]JN+BE>$9Q H BA*\5;[+/]?,X')I4\;=@ M3V[@-IFHQ#*8D'MN!I AXHHLJTLMHV"TL-\NBT8ESZ?LXM4!K)3+\XFA'X:? M)H2)\QL]$$Z'8>6J^^ON!VE;M2/'1X\>3!\^.'ZHUD2-KTQTL\/H89_O-FNE M?X.*EI'?X\X&"2; 1!&'E.LG] =T;UU0E3O>Z %+3V/%5< C*9R.]^=\D@^= M,!IS#V5+D1O,Z8EC(.T?- $:"Z0N[6GGRSGZ95O..=':STMPWG27L;_1R)C4 M@LX/_Y>D=?6<"I[AC+S&I60TJC4ADS M^= LQ3DYMF$D<<^F:?VOS>!+-'?N#6"4;17W )^C"/@=]H1E]1J3JT"?G_16;MCQ:JW45;^#"^I6D4_$*]Y M?Z\\>.,9(Z7S:0/:(A?E]C1]&_ZID>:F0,\O+-J$X8:TZ.'" MX79-MV1..5=@$4,[TQ=8UGJS:Y9U&3S[V^E/89J(RGC6 M8 KA1P!8Q^N%X6ARY.T[;0FW*YV8NDZ"(F5Z$=J$)OZ*NO?^459%NU*00$!; M*\[,O#J_-4QP7,=?+LI6T]%(^2AY46ZP^B6VXEF,YV*&K@>:C0$ M^74OWMN*0-OZ])HL3%/E^VQ#.^SLWOI_Q.Y? M!KXHA(-TK4M@5!H$7(E2/8 M77CG@29BFHK\;1&*A;.J]@'$Y.!DN/.[8!7S\9P)! M&E6)1Z:=D6GGDZ#>,E[$%EM"OB,%O\;2>CM*W38('F%HHS&1G/]TF9=OO3UQ ML[>:Y^_\2 M+2A/AS&$0T0/TF8! JH +L_?CJW*@1C_SGC!22VALR.#@4J1H M3'/( :?-@?ZLH8 .54S;CN9'8DF)88"'+TMO=\^+-8.@_2-Q$R>CP>N1E7 T MC:-IO#>F<8B ADJ!:OP?+A?U+M9$CAR;G))=;;JO)CZT-<;(B#I+ISZ7!*;AZ)-BOQB7TL@ M;1W/T[M_54W_[D;07(T*"+L9-6ZAK/+Q[,[8Y'4G35[?C$U>GU^3UW@RCB?C M/3T9<7 EC8$1XDTJ*)KU+XB-F+,'\F4&B:4DEHIP'MWGT4B,1N+>&(F]DJGY MRHFMF%X1!83M(LR)(F3';P4Y$>K\6K-#KRXJ@E0.;,N&&D@82!SJNB#09M^] M\ZQ:0:Q=/?2 (!;VH[ D ^BVWX +QZ,:PVC61K-V;\P:8%HS%*2I,N/#_YF; MMTS5LSD?1 JTE*ED?!'@GES%-L'[1+2HMQ2NP3NPKL#]3P_;*-X,V5.P"P&V M:N\J_;::ETQ+.]XT4X&(A/4@B'B?"L.#S7G247]M0/D43.>/;P-2U\2 MHJ93/M]"8"X @BN+OB$LC@-1F<$@!IN,)Z6.X9;+]/E$S&_P1T%WXTS*!!9> M?A]ZD8D:IUE*;B<9\XCK$"LND MI(S1IY;[^P2AA<5VCK,5YY4OA0]Y49XY1 M]1U0EA[D6EW4 U807'&-A5FI]UAY50KG& %^^Q-.& 2+A'X_L%_$F$ENB/(& M1MN#VY6F0D_]9 #5=7I.1K0.U&*O-[(+ X!0X\>%FT-T9UXPPPBMCCJJZ?Q6 MPNG"[QE;KO@BXN3%U^C1VD)8N <09L'L /&C/(GR(UM:)QS:!6=XPS7I,>-_ M")WO!OH-0_$M6PQ0*B* 1L5^26P$Q6(1C+:ZHF3FF<*3ZF;%BFM3__)/ PO, M0ZM\9%?I[T[:X)9[$1/)G_%2@ M6VU8P75R61=Z!*"%W.;T*5I8BD22+OCLILO]054'WFLV=XQ;9.0S769>N2:V MU?RKK8MFSO1&V8Z-$JB*GNF?[5WUI./^A<[6ZCWDPZ!1@C&HE@*I[NSU!?H6 MI+<10& L7MZ=#XJ'RE1R93>4,&[#W'N/RF'#3>NJ!C*Q715%A@-PM@IZ08_'"V1EGV(-D5 XK'W>F[J,H%E,,S*](-@>'6* *F5 M"9:%[__K-"U:O4B*5@^(68![3[1%<,5M(@.T50\,)/9<.%+61'? R^["GQ%S MU?9R)?A6@^TBF&FU>$AO??%PLO-]E59Y4T7QY(+5#Z1G;7)&)WX9H9^!KB5? M+/*"9&*JF5_?I;!*/+C8.X0P-5B T#JFZ0XZ]GB/Z=+9T57' M]Y/E N<[-99_Q FYF^GA>"F./^5-E[FBL,D.@[35:(]23J3PR\YR-1POHWM MQ+_TJEV>\<*CQ8JK98F-^U%L:C">ISN<#SOG^L/N9(9U5\WVJ3=7?![& ML/,MPZ&=L,YNA@]#-B0,DZF87FA#4C^U7R 8U#3ZF:E'Q[1A(B)(^@0IS#RH M&X-]E56;>$=KAZG@RKGK NO*!2*-;2,0IG#+>!Y. IMPLAT?!:9HN_ GQ)%' M,V76HUS7'J?,_$2,TNS5Z2E$L23;. P&'QJ6V88OG[(P]&FV=.T/+LJX$+^7 M<47;>]#Y$K+>SNA>YN#5,QU286W]=OCZ,+QEAVOWF@T2G^5+:>KK=3C0"8GN MR"3); 0\F%](&RPT T+]+71TZ[YA+TX,=#G8YG+[0[W5^WU"RCCC(M0QRM/T,,BLCG^=JZ?OEV\>PQ,^7'6WE*H [(](4RYCO/ M"?Z;WU2ZSTGD3F[(+C0]J5AA2ON#7PJNCUISOK[M?5,6AH)N+M-)?A+<0R6O MT%:4E@GT_/96^T)SM]7DO=EN#Z5FTE3OLVK1:H-3-\RH\3@+=CV"E[<4ZBT, MA%!Y+7;9:KK"HFH9Y$[@\M)<*U."FEY?J)"?=7@MX3E<,(\:2D5(5O+8O$>2 MX4;G?!ACCB5BK[O?%F?2#QNEO\#5P>0<=K[MEM85@!63I'%#FUKH:]OH+(,, M9(81\73_17DVCFCP(MV8Y@.= M#/LER_YPJNO33[0Q:8'_9"9MSJK02ZM7R%VY%=^QJ!W89^1;QC5!GCW\Q!\* M5/P"0P)%3V3-6L>5!&IMB2Z$R:.:+V+="]D%=Z2SW8X2K+&"*VJ#U-Y.XBCA MR!N6ZNIU'6[/8=WO5-9O.%+@O?WMY.15((FU;?J.9@,FS8]:6!E)"Y$>-3B= MFW-M[-EKS0@+H;_?YBK2BI"2&-6.YO&0"+<>:.Z-*6'C)TO#P"P/A*_ MCZCQH;VM0RP;)%;S\I?GVE7I?2I_C:(,XV0(*C3:C'MG]Q[AW<%6,T^^L'VW M1&(#_K6X?=/&OS[MV^%]% 5I(-Z[2#86/39O(]U6\G2\W_BL\\=\S@[D\!VJ MN"G?/LA*8+. MT7*_L1$W\W0^UA%G6,!>J]C/;X3ZGP_LFY$[]4 M7HSM\CA@,$]?>W*PKN1QIB.=G.TF_??;C[Y MS.SFD]%NWK'=_)FR):_SA?.^Y[- ]STZFCB+B]K^#ZNJO*/Q2$?5'OZ9N7WO[^.C@?P_ +;8"+61N'OWQV.W1'<5N M_)!L\/D<^=2/ '-M^FJW\WSOA_S3D'7=T9+.\WB#4=AU@^_(D;GQE=CN]$=C M'P,"GW?O_OUM+R^3Q?]Y8)ROHVQ"__>P^Q7UW,PBD$\$2D9=R_/O)T/;UQYK MP4_Z>+9,#H+$'$SKKS[B$_S2$J?[#1T"G2K9_-&176^"R=B;#.%#S_O@%-\L MKMK7$.T5-AY_,L[+>\6HSX ;@_[--<[+-I/*JR1=%#H4\#AN8+3ZJ\PO'/\N MY?_Z4T3*W,;%_XA=Y//IO0TCN=^#QNM/?WUT>+S_#KOQSF16DQ"!GF\VZ[]\ M]=7EY>5AXV:'9]7%5R?U[+RX<,U7;GZ6UU_-\TW^U?&WQU]_??SXJZ.CH^/C MHR=?/_WNT?'1-]\+7/TJOWLZC.TY,%Y8QS?CVY:>V_M2O!%/A9_=/3H...>TKEJU5.' MXFG>K M_(;[*Y'4[I2;-0X9F_YS7;[V'=^;F&?Z*)LPMCN*FFHBE5E#3,9HH M2Q?SM_]-_NW>.#8UKI?_KKSH9A6NU^22ZP)"=_ M%_'94]M2O,\"G3SFM;G[6F'9GDH'=C?JH05SJV'/MP?__,^OZ*I_#;M@J5OX M:-P&^VZ#1Y_S-GC$VT [Z&]MP3\:%_P]7?!//A>[W_%OYM_Y!?_DX"DO^-=$ MY>7=@:3EIDL?<2M[XP]T>/'G_S]=/Y\1'6_Q->_[]+#U#P\5.'_J0]:QOQK(^_P=KP!G+J-I?. M[QFB+2-_G0I>?FV51'_ &^@-J0DOC M6K]NK7\6Q\76M2[Q 4VVF/B7ZXW2T_AHF4AT+IPFA_C!KW&;Z)<$F,)!DX?- M8CE7]MXX8YAQCW?.X\]CYSQY^O73(Y-'/?[OYDE(HSZ+Y\3K=AK2]-;ODB2I M.E?4C:R>C:1>Z4_8&:1&2:*9?*4I:8+GM3+.^9VP_X'SS>A,W9=M\N3SV"9; M#AB)QY/E]RL46[?%)M&:'C\9+#3L/@^R#["63PZ:35YGNIJ#SO?"K^L"S#G^ MN3_4;?6NH)>3.PMU9T)R) F-FQ=8R& \'0_:^VM!GGX>%F3G0?L#Y?2JLJ&> MSW:-A=>S'WN5*3_$-GUMMNE//YUF7 L5#BT1-#0T=: $D1S+^V_9XV[><3SC M/]L=^O7GL4.WG/'?\AE_^^OK)W^\'?RVUA5V[K7 ;LO"%7G/QOJ&W< MU /_]K,]4,?=>MUN_>:SWJW??:C=^DM5'CP7QGA=9L_T^*/Z@"L;/IM>D:;- MU?Z;Z;MQ,]W;S?3M9[V9_ O$!*HN?LFDOF+F<[N_7'7VVJWWT]*Y=[M]] MWLM=:F/"OO/\G9NU*!#$4L%IWIQ/?JC*MKGINO]\JV3CNK\&1'=\>/S_?KR% M/^>$69@&_E-#\P:O:+]ABG2_['SXDDQYD:WZ%M,#M MK[CCQ_G!\9,'^4.;^/L MWDZ3V\3J.0MJ58B,N&'[?B[QT^ \3B95VO:T'9$ M$J&*QT>/ CMY7D_STC4'+]\MW95>ZM'1T:-QYUR_-]*XD>YH(SVZJR/HT8<[@HZ_!8_ZZ6%'LNOQTZ/]UM9W1U^/ M:^LVUM8=&>E''\U(CTOMDUAJQT?'AR]^>?WA5]L+'&^3_^^'7W_RP5VS@7#& MLVK64OY]G*"=$_3Z].\?=X+>Y.^JLEI=^?-BXTI($KV>G;M5/L[8?C-V>O+3 MG<_8:;ZB?$O*$N/\[3=_SY[_>.?S]XP$5(MQ^MYC^GXZ^>'.I^^G M?.J6X\S=<.9>_?K\SF?N5>U(?P ^/+3V%Y.PK__3>C=RXFJ3Z?#C[ M+-_D/@)9NLD#MYJZ^5SD#T48R\[X7";RH1W*_[PMEK;/G^OK4V?VVGOE"KG0 MD_VI'/>V1R"D/NU=5DTYU'-^O7S4];_?>\(/VC1B= S*:]R M88U4X:!UVS">.LTS?!LNO4=.-??V8DZ(2C^R).>]7+),8-27WL50"(4[0G9; M'?9)*JTKMWN*V6Y.HN]S(W\.]6_LCJ5E>31JWH??:G-,]&NI)]P.2+7]^9,L?A+;N!D<%[EEX.U1NE!OSLV##C+MW\TR?SDJZI563.*XW7C8?9]!M28!.4A'Z#6JW>YWJ_,/0 M-GE.U?=KZGP,O>@<->$S*&$@/C] =H@S6D> *^['ZPH(?B=F+@73_;=M7WN-33 M#_. Y@GO. 7QI[\^(U_[+T(]X]#44H'=4<*[*-]^ZXS:UT^YJ/#;Y[V7F;WZMM^C1LM^,_B47ZX M^LL-GN9]^:GE=KLHJF_Z1A_T4;YJOIJ\/L^+R1OOC*P^B87]1\WG75WZEWSE M;K#$;GS]+V.:=OD6MS62;XK-\@--5?@%E8:*N5)?Q>15$X+J,J\W__XT]LL'66(W'?A/X2$^_!'_(?)T?U25Y"-) M1:?K?F^1D2]E$]R.6-3GY$#=!HY\SSKF!(7,B:ED;L^;WDYQ\P8IV3LI=]Y1 M,>GCV)KCHZ-]JZ$?\:EV/)+?,%]-J_F5__!\LUK^]?\ 4$L#!!0 ( &:* M#%.K/^A+# @ -0L 1 9#$X-S@Y-V1E>#,Q,2YH=&WM6FUSVK@6_LX, M_^$,.[N3S$" D/2VA#!CP&W8H<""TVWGSOT@; &:V!:5;"C[Z^^19(,#>:'; M=C<[2SX0;!\='1T]SWD1;MPX[WO-QHUM=9KY7,/I.CV[:7\LU:IGU4;97.+] M#OK.9KOF+*(EN2 NK8=\)@7-CYW-CNWT[ZCI=7++]L7UC]=_98+4=&+R%ZIO: M11&L,5B=P="Q.Y"Z"=!+?XO=:*P&2:URK@S$!<#8&K6LOCTN#3[V[$^IZ><5 ME/@K\-SL%F$\)PP<*FA0!)>*B$W7$,U)5(<=!VT5OT*].^[:,Z30_"6X.R'H7[3H1OW<\KV+&I"W.R MI"#HDM$5]7!?F83?8B(0DOX:1G3!100\A+=(()]Z,UHT$!0&>!Y'#2&/P$6]A(5 MPC7$821BB@XB$0TP>"K\$#0.0<:(#U/BXBT!/& 11-S( C*1X5@$QPYR!C];$=O\*( MF2A1*PB8]"G1R%ZQ:(XKE OJ:@N5W@6:QCU3!99_WP&/ZSD?](@"<) M4/LG$8#"E(6(, 76+:**B'X4Q\9S4\)4 M/%\@ZA1C%)-\?\N9!(QR9VYDG<>4YJ*2B'T40!IPQ*J>3VJ#7"+G,/7Y2J8< M$73&9"0(3D3436,XFEG,0%VFQNR9>T3[-Z/]X@6BW;F'C%]^JEZ\NI()G).R M4@5'/ITRO#38Z@(15*,3T<8FZ"%555#DQ,1GJK"&X;W0M!'>IA[U1Y73Y*$O$"2=*AD,P5+74T\ M#^6BJG1<$LO#AZB*8T*1)^E4IHCAL4 -&)N73.J(CV(TU(I4L[?-%=F$(ZB/ M7Y"%216S17$Q24;J(<.\@<9([C./1-K2">XH(X*I%3!3:^D4&"I-L53UCXX, M4A=+.C]P2=&@"/.1&K3 IH*YL4]46L-U:2.V=12.,%59MIID,I^;4"6)J0<5 M4._86/Q0ADU>(,/^.R2"S# :SW6'H."XB(6,5>1%[(WM-G:]6*DCVOIU,8\#AZW()#IIPM([0TB>8AMU1I\=D?]Y%AL1[[XC(/RN><\]!3_CE77H?W] MY0MDV)_K[_7/#UY*SN(V;JLTDF7(-H2CBGSN8$H6]WN3U#:"[4G$$U.4B+Z! M&@-=&-+'D^2$$Z$3DAZX^.CL] M=O?_ON[>\GU033=#"JA^0YU!N8PB8I.J:M-DK] SJDJB,@WOIEW7/VRDYZ\* M@ _R()][*#>9AM@Q!/I%4ZZP<,G])54U M2XB>,K_SB22=T&#A\S7%IZLY-RF$W",6$D&5<_G<8?6I" R:]O:F KN _G)\0\- MJGWKI!NK]>YMUYM//-Y$@01.K8'C#-[7JXLOH,]NX:>*_CM@IAU@/JZI+,N9%XRV6_57 M;M/S?OOG2!Q]^?TDVG-&IV!_H6ZL3JU@8%J7HV._5>)D*!@FV@5FVCWOGF;# M]2;=JJ^=[@>\G[QM; )Y6;V6C#?UV\S_!U!+ P04 " !FB@Q3F2JT?Q0( M #L+ $0 &0Q.#=87\XOBK\>M-S[$*+Y',@U&%AQ&2KV>U])!/G<]^^*JRY%RT:;\\N>%@@ MU.?S\*K@LUE4T+I&J5A Y9R'I4@L&Y5E=$F2ZZF((A&86S,11B7%_V"-ZNYZ M1@/N;QH.#Y@B [8F8Q%0F,GJ]]X/K@J2SQ=:]C.;WA8&O$]_="QH31[7AR:PV/=' M_2WKO1UT[3%Q;NQ\;F)W;L<]IP=+MC]U;JS!>YM8'8<,KTGU7?V\2*P)L;K# MD6-W2>HF E[Z6^P&8S5(ZI4:&@@+(!-KW+8&]J0T_-2W/Z>FURJ5OP;/K5Z1 M?*#RCDSV%)H_11.U?)2*\$P M9+7[=JJJ/1S#+I8@XO2MT<1NI%^>-7A_=05BU%P5*@72L?O]D=7M]@;OM]>3 MD=5)KW_M=9V;JT*U4OFQ8.P9$Q5M?$:N2&%)YZPTE8S>E7BHN,<:="6XEPAV MT\'G/Q;(QV1G8=W;73;1KWH&P;6;#LD^NCC+9]C MH0J1,PTS&# ' 1NA._Q<$XZ0L+D-.("S$:0:._!QQ@_ M$"Q'[!V,O=HKQ%Z;*MANP%:P(7> ()]Y)X #:&(B MZ*0\)#3D4@8.4+SN?L2(7.94E1N4":@ M=TR#=:M4P3T/K($Y?:PH48SY> M.F0,,LGW=YQ)P*CVY@;6>1PU%U$B]D$ :" JWH^I0URJ5J0F2_6*N6(9'.N M(DEA(HHWC>%@9C$#=94:\\#<(]J_&NWGKQ#MSCUD_/1#]?S-I4K@G)25&!S% M;,;ATF"K1ZAD&IV -CX%#V%5P8 34Y^K!N+U0, S%K M2.$;74LI7.;!;45. )8> YP;[-F_NPL:SAFQ(!Z/8Q\D#NN0+D[8MM?!*0[K MD'#4Z7Z5E.4,:,*JK''DP4$\V"YJA_CDX<6S)*&OD"1=IO@<8:FKB9>A7,1* MQZ6Q.GP(5AQ3!CQ)IS)%C(@E:(#8O.)*1WP08Z%6A,W>+E=D$XYD/GP!%B95 MS [%Q209X4,.>0.,4<+G'HVTI5/844XEQQ5P4VOI%!BBIEAA_:,C@]+%DLX/ M0C$P*()\A(.6T%1P-_8IIC58ES9B5T?!"%.59:M)KO*Y*4-)2#V@@'G'QN*[ M,FSZ"AGVWQ&5= [1>*$[!(3C,I8JQL@+V)O8'>AZH5('M V$.@/37PKJ+PK4 MZZ6WM?K;F.2:3[PEU]Q5" MW5Y1/]8!%R,CF\V@Q.MN"0'$>WT@P[H-G+'3.9IKV5SHK,>$(?)6FZ';GP';G@O4(N= W,'C2; M^D0I*?_UD\HZM+^_>(4,^W/] MO?[YP4O)6=S%;4PC68;L0CBHR.<.IF3Q86^2VD:A/8E$8@J*Z!N@,="%(7LZ M24X%E3H1>1S,TSI.@$>0DA2F//B//5)*??9;S,%ZS?,X=/71V>FQN__W=?>6 M[Q-LNCE0 /L-/(-R.0/$)E75MLE>@V>P2F(J#>^F7=<_;*3GKPC 1WF0SSV6 MFTQ#; [4'@GVU(.1BFUC_5.DF7*?1WH$0%](X*PNU134:2H.P&/@&[V8),$^ M>E1]+,/^G=VW!=763$*<+0(B%,"J'WB 5$P'(NGSNLGE-/9H^S+RE5]$L7?PZC^]#9AU86 M2ED(?E-LM_"-+H/35O)EAT/ FO'#]DD*(K.VG8VIX$,@/SO^L4'UKYUT:[7> MO=WZ4L<]P4+RA8Y[8D5=P'2#6/$\ACJF6C.O.V3-W!_PD.G/.>G+1[ M;Z- J?VT'&&'QK5Y>]$G]V2'RKZ[X"9]H#YM*:R*M]_QVBW6W_E3KWLNG^. MQ-&=WU2BL^!L1JZWN6%H&IBC8[]6XF0D.;AT"3[=>1?+0LMU11SJFC5Q]FDV MAF]S,'[M]C["_>0M9!/=R_BZ,MS4;SG_'U!+ P04 " !FB@Q3YK,%+H@$ M "1#P $0 &0Q.#J?_#%=.F5LH/ M2-NM(P2)!-KPE(8LH=OZT0TFL0:&@;,V^^O?-8249*^OKUJU[<.+(H3M:W/. M]3G78 S]JY%I#!W+-@\/#-_U1X[I?&Z>=%J:T2Z;V-_>!(#1]^P;Z%\.O)$W M[2F?AJ[O*"8<'F#0@')!,].PW8\P\V]&3D^Y8X%8ZN>M,\85(!%;\)X2T5 H MQ5J3*BPFV8+QIDA274U%%S;MVT2()"Z[PH2+9LZ^4UU[:(N?$&B=%X0P+W)2 M8!@X4]^]< >6[WICF%Q/9]?6V ??>PK02Z:DAD<[A^O6K#5HP==H7YO'@#$7218CG0L/=Z$RU9() MVLQ3,J) ME/QK/!K@-F"V) Q\C(\;,%@R&N+B^##!OE'PPI#-:=8 O @6KAN0KK)\1;@X M/! )U)1:9KWD4AHX3D1#3H[7\ 4SBYE94!VDHFK%ZD$L;U$K>Q;X05R*64(H%I$5UNJ/G&JI MOC>UG6D3B^G(FLPHBHP<$:CB67;[OARVYY-K$'5_N3: M_K"G:*KZ6BGQ3"$7ZXA"#Y24+&CS-J/D2Y/QG 54)]\2%FP"[6KRZ6L%/FZL MBKRWMBT+^Y%VC >'7U(X)VS$ [.PJ.MUIZ,,O6*"BHPP,"6E&*62'CA,]E/RX8L&)IU-#A 8:MHE*824K+\R.O M=+@Y.5I/2^W%#T,;>>A@K1:K7(#6*0\6V#^#:TMVGBGQXFUR]WWN0?7[8MP7 M:Z4OU&9=TR]J%E.^^Y;"-S%3%X1&'P3,Y[($K3(CIP-QBZV0_8WW/][TK74OO(4\B?-HKM?@]WX*;+NDI M76NI*HV[(.B]0#(!^D5O5IW/$F4[;]=>-W9-\2O2M]E;>=O[/82>AOMTQ-$D8UBE4RS3/[ ZKKNUJL!&&ZM8L5IQ M8[0WG\JEF]ORFQH[BT_QOP%02P,$% @ 9HH,4T+Y1NF/! J0\ !$ M !D,3@W.#DW9&5X,S(R+FAT;>U7:V^;2!3]'BG_X8JJ52+Y 4X?*<9(V)"8 ME6-'QF^ZX\QT 1M^S;Z!_.?!&WK2G?!FZOJ.8 M<'R$00/*!^$. M+-_UQC"YGLZNK;$/OO<4H)=,R0X>[1RN6[/6H 4S9U!BTL[>J0VP9F#9WL1W M[-\ 9 WMH_H>O OPAP[,K&G?&CNSIO=UY-R -?#E2$=5?\[.FBZ'(.67<$SGO MS2OM[8>N<6T.TB0C?"7;YUVC?6V> L98GH6X4(* \1P!]+3M_PVR+KGN$F=]2.U@!20,1B'-RP MF-%@F3/!D#+A(3@/P8+P.4782<**0J+&?QD9$D%A07.*//>)5/QW>#3 ;92Y M@%FPN$=0WQLP6# :P07CA >,Q.!%$0MHW@#\$2Q:-8Z/LF5>+ D7(%+8$6N5 M^(I*I5BD0<(T$TAD=\Y>I!00(BTYDOR6<%HTO8>8KL *RKV2 FK@.!$-.3E9 MP1TF%Y,SISI(4>W4JZU>WJ-<#ESP-WTI9@6A7$066:L_HJGJ:Z7" M,X5"K&(*/5 R,J?-VYR2NR;C!0NI3OY,6;@.M.O);U\K\'GM5N2]<6Y5VT^T M4SP[['K.[MC>K-V4PGX6X4=]VH4#4'+GU\Z,EC':-$"_Q5+H&_'G]-N2Y33! M\E-(21Q([82@(W/0WIV$IQLM;?VR\0H*ZO@(Q[6/9V^[I8WDSI<9P9^I_)$* M^%]0_UU0G=]44(QCL4VJ:HZ'@B",8Q%B586LU4:8/!6RG!926 TY3.(8X6!Q MEJ4/!S)46M$H9T6;DH@+AJQ<&C5T?(1AR[@29IK1Z@@I:AVN#X_6TU)[\?/0 M1AXZ6,OYLA"@=:JS!0Z/X9TE.\^4>'FAW+_2;55_*,9#L=;Z0FWN:OI%S6+* MZV\E?'/]L!&VUD%3E!NR&:D56['=^J<.W%_@_$/=7^[H]E4UAT<N="U[@"*-\6VOU/+O^19<=TE/Z5I+56G2!4$?!)() MT2]ZL^Y\EBC;17O_QK'OBY^1P?7VFF.24'UW8P\#:J4_'G' Y%>P\)F(?Y3& M(W>^7T/H:;A/1YQ,PL/]'_ E!+ P04 " !FB@Q3UH5L[Q\0 #$EP $0 M &UK9F'-D[5U;<^.V%7[O3/\#ZI>F#[(L.[O)>N)D:%G: MY8PL*9*\F[33R4 D)*%+@0H!^M)._WL/0%(BQ8MX,^U&?O%((G#.=\X''!Q< M"/_PT^/:0O?$X=1F5R>=T[,31)AAFY0MKTY8&03=V(:[)DR@%EH)L;ELMQ\>'D[-!67\NMNB"$O,$@1<8OUQ_72SSB5/E(T4?+DZA(!0YZ[1_N1U, M%=9 L$79UTCIQ[EC!>4OVO+Q'',2%'^,E?>E=SY\^-!63[=%01#-$$U]=L+E M3;&M$"[\KNT]W*'(D/O+( 3"Y:TEQIMM\07F73Q(J,$P- MGEQ#/8(JG>^B53@UDBO @P0-X$OQM"$\T-A1D6MO/4A^];A]B,N>MD(:9PVA)Q&PJUH!1Q MJ+&M=[A2M )W1-PE\&.2-QR1YL/MHW U&70P8[; ,GJI;YL-90M;?I2]\%*Z M80;5D/QP-]&SHH=R6=>&8#O&2^B0%%R\^[H5:1*(F%0I[$ P@? 8"JRJ/)(5 M?FCOEPX$N)R8(_:C^@QDZ]?RBR35V G,5][ EN%:Z0K:$3]5<1PS M"0.Q\ '&$VK*-GJ-+1GK!<+> M:-AW[QA##!8K(BA@RLM)M%(*01=E"$+?1&3_[=@(NV/8-:E0OH^3L'4G'RU& M&YG>R33-8ZU4S13JOMVC;BL[C<2=>#1:H)V"-_H221@MNBO,EH3K;+J"]KZR M+1-R[-[O+A5/A>C,EI1"[[O2]$IV?84PDT!AE7]%GM(WRM.(PGS5M^R'8OTU M7"^%SO?5Z 3Q2,D_-N9N"#<,<+X?90O626'L M.YDF4FY8-G<=(K_TIMV)/I[IHR$:]=%H\E$;ZG_7U'=M>(.N[Z;ZL#>=HM&X M-U$_3X^-K:F[AI^?1HLI73*Z@.R "U7M'1XHN06%K[,[!I:/% M F9Z;.EQD/PHQ>4?]EVN#_69K@W0^.X:/ N>[_C1&QYCZ+B!@' /:N[) M%^Q XQ4#BN?4 J1D.]9FE$CQ^7E\9)WHGV'$_-Q#7[3)1,;M@:Y=ZP.(+\?G M]+391NZY0^268.D6%28\ MSR8_2G'NM_O.[6OZ!'W6!G<]=-O3IG>3GHH>Q^;?J3OGY'<7C.G=[UP;^S7% MJ^_B^=SU%!HJ>!+U/A^G/_/DQV5RZ@.Y=>=]^=P:?1,(/[I5P7R^G^&Y58PM MOT8*5[%9:A&N/-%'QU1BN \3DU4@A8?8?#1E5#A:I^\/!-&.D/@LQ=6Q>6AL MJ#A:)Q=;^;HA E.KU*)94#69HO/8)+;$VAGZQE=R="SF&Q>VI2;$L&&.:U'L MD39,X*H1$^TBA&BF\Q!81TE=Y92[I2?;B&7_C:M_S8[4&2<86-E2N[B]% MYJ/M4.44!F,+%ID,^DK05@L*U+RQN4_(%]OY"I&MBS=48 O2SZF[V=B.R,7F MH0DQ\=21A[T>-2('8HT\K MXCZ/S&H/$91<.)F>B]C*2 H]T3GL$9.3N!;;!]_ B $#/.=$TB]CR1WJ["(- (11H"P,I'.@BW$K"6-Z:3(0: M[]RSSK8/1XM*K:2_'6&@JU!LTT%51LA?K68=(S MJZ5PF_=4"#S9B8]T^:.E;G_W+\/]R=N%6152Z#I\W.0@44?/DWP?VW0M"(EC MFXLNN'*W\.+O'6:QEK]Z"H<)QU3B' 9:9/"4>EJ^(A35]$9J?E8B+_]59#A) M5@K="2==*M =?8/QCT*__"-O/9B0!5)W&ES*%["O3CA=;RQY88'Z;053_ZL3 M>3-#*[A^X3ESD6GA]JA&PC:T;L)P!BY MIL\2+T9)NQ7$NU-E8!M*3$85^:T5U&O)GUJ=\]9%Y_21FSZV @!V5A4#$-0K M""#YFI.[/-HRKS])4:H4)E9L$TOPX)?63E1NN[-N54E"P[,J!E\J M 4FZIB4?DG#-[;3"L:VE/E71'[\<)A> 737O8VLGH3"$_>MF<@$( M*LD/5>R/74.33WM02WUJ[>J7B48?O+C-R%)NTN8+"Y;C1&K)V/!!QJ/.^TH0 MN&\GABOU85'"K/'ZA#"5Q>H#>TF3<(0D?U4EIU']SEVH; @)TG79"UG'.= M(#SGPH&N>76RP):Z:4X5A"R3VN9,5?62.Y#$J&7)(^E7)\)Q_8NJ9%K\6WXP M'&;7@@IUZ]]'QW8W 3(*B +E<^^BGJL3 V12D6C_D(B/F+*^8Z]U=D^X=Q;C M$[%,G%NJ4W?^+V*(F3VVP=< ;4),LE8' MX-6*<#/FY\52S'B3S,O:[A6(&L_5;XV;'D Y8'N"E<&VC;]E(SL4B!.V\?5U ML%X%7VW=( @]P5'BKLT%UYEAN2:!S@?]#D";D'C(VVEX,XXIBJFN;G%8KXQ! M?(R?).S7XHLHIF?UQ1A3T-F#J9ELN7W;T3EWI21HO1;F?!X]!3.SIQMYFY'S M@JXJ#[DN3XX=>V-S8NX=V=\N8FN^\7O15LA222[RK"[EH?Q0BD?;J,P9>137 M%H2RP"KOVM)+$?Q>-_FIZDM8 A(,NK$(ET$YN(U+[E/ )^.I>=-RXREN:V:V M]4+V%L-4W.9(?- XMPTJEQJ^4+%*?+OFA=Q0&6:)C"E7"O)"_B@)KK@7>C"Q M7X)#H?2#6(':#69/+V1T/BQE8IQM$&)R.>.:8KD[>P=MJJ'\+E5Y74-N\%H- M1$Z#C(DCQ6\9 [HV_@M:-4_CD]46)V?HKN?$&2V\E$0F+#!D1ZUXSBE9IOKR MU@3>>3%[4@!4"Y/1Z2ODEPL"LB"5DN]%&^I:4$^?QLR1*V03DB34JO>R_(2\YD]$BOB\!M7C5?*D 97&@J@*6YK(!@&:KID(V=* M+$MC_JQBY 1M3UL(XL@P;A$I&SSN#>7!Y0KP: [3$;7P(?&J4#)SZ'))G,H1 M+(>3&C'C-7AWMH*:\@T.$"U;^0U^VFN%E D"<%^_AY-->55.EM,68KCRA/L? MR-]I5I5P?2#2"T,*3()FG7U946,UW1!#_7^=D%8Y+:!,&A9_Z F50X%\TVO/ M[8$+:_=[LR85]_DM?J1K=YUGA*P\/!T>J NA*6YL7[W@8M)[:KH \I;(E&AO M$F/::TP3VT&%):<4Q25F[2PDISG\B6HK=/ !75/O:!E/Z U\: MUX8KZHF_L M742"I"P(90UWX'H@E^Z@0?I^0]:0D'+H!Q.RI-)"+U!/(00[_F6T^590JWBE M!*@2$PS,5^&]8+E"JQ:_&IO*'D108C:@9OHJM(4E]TE3VTJ9 .K>-P&IS;&5 MI+0X04FG$*3$VK:[RAV$"$.H;=O36SKUD[_F1I-$M:5V*))NJVG0CFP E994 M0FNY_CJ:ZC)-S'[SH"AAF]QGW"X_C9P)7:[$+65R'-D.LE^@L0O"Y&"JM %L M-:@$*';+5\V,_K6#+M'*O54IO(2H#34X#]:-1VQF"VP%-V-X/VY!^2"KKJWE MZ045 =;4E#3S7ZZW7S9:]!X!$^5$-=J=^_V2P4+?-5;O$-UBYRL1ZD0)I&I# M\F ]^6NCLG8##FS6G)K;LFQ$S/<:'5<+]%2F SXJSE%I;_=N%HL?_/=9IP1EU8:]@%"6GV#BC! MAUV;;& -I3"B"MVA:S/_OWM/)$7^O.+Y-W0. BANDW_^T'.9= \\-,.[(LU, MSW+ J"W]]TZ4K.6,=@)/Y/C1C)&)BNL[U.VO2O2PPVQ7-+>WEJ*XQ-D+_Z"> M:M/;MNXYK!F&LA'4M4S@M>_T6HV;NT9[)ZV$J.6;;EK\H7(I(>8&HR%, ]3QB?- M7IZ%B8,0RA^62=Y:G-E!DDL.Z&YF;[5&M.5=]7_@G^:=(@?B43 0>[/@IO. MF/IJ*T!J1<4_G!^+^W.CZ2:E;[82![U4G8>PE+!$IKS:(\U]5*$" M]"SE*::8XM*D@)_["Y4%C&J.DFS]-06"<'>;/1#KGHQM2!+E::87C@8YD#V# M#_H4!AW2X"!7%%&)\RA^!N?]RPYMZ1#UM#D3#P HD4C2#?%>GK.=!H_X):HM MPW= M.O3C_P!02P,$% @ 9HH,4QE]]:S%!0 SSD !4 !M:V9G+3(P,C$P M-C,P7V-A;"YX;6SM6UMOVS84?A^P_Z"IS[)\6=/&:%HXM\Z8DQA.TA88AH 6 M*9L+17HDY0N&_?>1LAW(LFY.4U/N^A++\CGD=\YWR'-XR;L/\X!84\0%9O3$ M;M3JMH6HQR"FHQ,[E+[SUO[P_N>?WOWB.!\111Q(!*WAPCJ_[%Y;7TX'/:M+ MA0340]8Y\\( 46DYUEC*2=MU9[-9#?J8"D9"J3H0-8\%KOK]T[)#:]"JU=57 M]=1H.9UP% KI-.O-AO5'H]E^?=1NO?G3^J=S]:_C: P$T\6N!>VE9'LN\(;TK+66;;A?KGJWWA@%P,$K0YZT=#-I>HWC MXV,W^E6)"MP6D7Z/>4!&7BS$965*Z&_.6LS1KYQ&TVDU:G,!;>T#S@@:(-^* MNF_+Q02=V ('$Z)A1^_&'/DG=O#HCR)7UH]:=:W]ZHQ1B*A 4#TH0C#45)X" MHDV^'2,DA6WIUN\'W0T3 L ??040P8@]+>*6:1E]$#Q_&-WVXZBH:(SX0PVB@A,(9 3!1 Z99=Q&1 M8OU&>[ONU!NK\?)J]?JA(T04DY)+\M;A MFX@!]]:-J<MRWT_4 Z%"H/R[^#O$4$#W0._(,<+Y0:>\3("'*(:.D M?@5(2@16DJN2AJ1SV#3*89^C"<#P8C[1,TWQ ,J0KSY'&<#3.6D9Y61ISV^( MP"Z]XZJ2NV;4*SFU96A5@)_\B2X#=SH]OV[3XR:R[_\D(?B.0B)UZ*5?<=]S%$Y7 ;CNNRSD]&_(8%Z1'^VN@$% -8G!'2 MA*M"2PD&"C+!D=E,X'DL5*5$'RS D)1(SUD*52&D($EGP4_GYHUI;GB(X$YC M)4?G!LLME*Y^ MO_RX@WY5"$DRL:,9Z:P<&QTZYXBK19+$4Q2SLU216ZA95=9*&Y"QT*\;)>P. M!1/& 5\L"YOUNK83Z-FZ(R7'PU#J&?N.]4$!A<]HJRJD[E3E/=HV>I7$@Q&3BS^#'[%;# $F M*8(7@%.5'85:7X2!=C""JL;%'LXK)I;DZ&>"KL*IYK+J_G$%4O=F" M*1:21RNVU=E1#C.%FD99RHFR)%>%AA2>93I&DDDT8:KEE%S<<4 %\#3 6T14 M5Z,"F\2EW>Y&5L:&L$+Z455..G:Z=(J6,.+'R:LSA:P- MX?+ZU25D1T-*'SE6J8R,W[&UL[7UK<]LXE^;WK=K_D,U\3F+=?.F:GBG9COMU31)Y;*\+D)1$23BXD !QE'J_=#LV0)[G/" NYX9__?G;?_^W__[?_O5_O'OW&XE)ZN4D M>//P^N;RZOK+F_\ZO_WTYCK.BRQ_-SP:#M[\[\'P ME\GQ+Z.3__/F_TX__[]W[Y@,41C_^>!EY V5.K9J]8[]Z-QB^&PW>_\B"M5RT39"O7]-\ MP.1#]<>W3%UI$I%;LGA32OI+_OI,?GV;A4DL6O;Y=_+AY+K1\= MCX[8B_[E(J$CXL9[I W90[[>7F^!6GKIGPOZ1A*4?+(F'QI=/G1]>1R0.",! M_8$.G#!@0^[_$BRZ_CNB>KT*8D" M.D%]_*L(\U?C$"5OZPCYKGC(R%\%?<_'%Z;/>^\A(AH\0?T[BG5),C\-GQFM ME.'TT8O#OTN2IW%P7F1A3+)L0_PER;TPTI"ZY>,[ZWI)A7F=+>["QSA^GQ1Q3I?/&\J\'Y)LW>J6^$GLAU'H57)^(?FG),MN2#I+Z7I+VY3C01N\ M93%Z49(ET*9 7,=A'GK13?% GSM;+$A*7Z(ML_@I'46\)1&;9NB:D+_>IUZ< M>7XYV*^H2NC\4G*JKV:]IUJ"<).&+_0/-Y'GES/H-R^E?\W-H9&^P!*P;TGZ M)QT"%]YSF'L1G:ONBN?G),V- 9.^H//F9[D,\W+AI@^GRQW[^.CYH YT)\S;R*CVLZ^2YMT'8FJ-;3)NJ#^PH^)47IK][44$^ M$R\KTFIO=T5?1/FD S'+Z/:U_E,PS=>MM?%T?8\-F-7V[CI>_W&V^$1>2#3B MMC8#N>4[#6\VIP'=_])YQXNN8RKVLMQA5"]KOP,5/M0P &8)"(J(:N\FR?*+ M*,DVLV>]H^P*1^,5_8/;.E'V@)3[OMX.?5[V=!4EW\V?8K>>W>O)R=:1J:=C M@.G]OYV-?\<=O[7M9/?]HLT-H9&=H-4MH)F]GX5-7Y?]G9T]3L?MBO&UK?TJ MU=/,9FN&,S;3<7G2M1X*'V+\L[BA+0G=0#![N*'3$/A(&]K]SX)22G=#;!YI M[&UOR:/'#F6/UD\-)@2PH1C!EK\K9/&C>YD*]$WR.D\M(7BIOT)1_]A\T=IC M&,;YAR!F=-R4FJC?%H7<>C/=(]-^7D7D(571+E! MX3C/-B1JLO3"V(ZD]:,["5H^X]V2+!](:E+*[>=V$?&)2I/ZQ0-YMX9N4%#N MT[N(&R?YU.AWLWI@*10=G6%0H/5:Y@T&G[Z,J(B\;<> M&;$8AB3=%SQ;:2 C_OO'Y.5#0$(J_?"(_< FP:-W1X,Z3N%?Z*_FJV"0QBQ+ M 9!K>D#.5H^/O <2E2^=R[K,!T?CT\E@4&NE5[G+F55=YK)Y)>_1<(_%:;HM M.1U%JT?7 TIKFEZDR5)7@_7K$QT4U1C]Q:=G,3KL/D;E8DK'.7ED/VS^'B49 M"7Y]FZ<%U5B143#)<[7M;;0Y7JEAXV4.ICR)[]^AYSQ6/),JS MU6]V":U_/5\;9BXB+\OH0IHG_I_3'R%O)$K[U$H96:%6,/=)J=ZE;(MF#5A\ MVH;]T]84\7)K6>7PM=^X1C2V0A2TX&]8TM XGRH1(CY'HX/E:+Z]"[/&U?8^ MLA>R-M#XI(T=D)8LETE]OXW=/G2C9[K$DML)T-GD3G)K9ZVQCX M2C^QKO0I%25@XEQ%WB.@]:TVM9[T?\D7GI%?R,[*.^TKF&<'2HG(!S@''G4 M,RW5F%$GIM&^PC)TLD*;HX8+""#'OJ7F(W-=O-Z2QS#+V4;BB[>$IC!>TQK! MX- H$6,!V- ^O+=DXX("2IEK)2 __H.\"NG8:5MC.+@-E00,0(CV2;TE(5=A M1+X4P&&"UZR6_. V6# .@ 'M8W=+!NZ]']7=$XFBBV3Y[,7B-:?9L);>B16K.S%\) /]@_RF^DWO:"#Y#%)Q41LM:SE M/SE,)@ H !7VS_;U^%AZ4;2*XQ5_$\V6M?P'=ZX70@&HL'^LKZ3ZN"3I8Q@_ M_I8FW_,GE6F*VZ/&R5(@,_1_A&_ENY'&05=JK,ZY8KYV6M>(1D=W %? MC@=@IJ_S_30(4OHQU_]CF 9":CCM:RP'>K(4 @+(Z>NX7PMU4:81WB??>;Y? M0>L:QX&>9P1P %KZ.O37DI7;]5EZDR8O85761LK-3I<:T8&>7628 );Z,@S4 MXK'<."_Z7^&S])C)ZU"C.=!#C!@1P(]]>P#[I*-EM7B,YN!.A' _ 3%_G M]>N8CA=6)^.%7'JY5T_+$LXP(WG(VV[B$&9H<14?L/YR$Y0 M%S<;5:*R[>$KD/>?>:>;##1+CA*EE%,116(NN3!^FA136[X1 ]FE(S@3CH_C MI\DI'4WPIY-JLO,3)I&ZL<=(O@& $K[T:+)&&_*=ZU!QO@+C)-R[*Q5-Z0UE MC7:GHBHY/'U@R1D^[W3(;SAWXSYLM4WC2&XH?]24^NNSD#(+.^WG;KR) OV* MB. );RBOU# ?JCS,W5BOY&I5H&$.6ZJTO5@&%@8O>V(E5.G_6'W#%R\BK 9> M?N&EZ6L8/Y;E\41KA4K_N1L[?5NZU#&9RCOMSN--2IZ],/CXXYF93^2?$[?] MW(VUOBU/, 93*:>FIK=_D"BXCN_3(LN_)+&O.-EQ>\W=F(5;+CTP!%-YJ*8H MDK(Q'Q_2FE]*:RJUM+N.&]6OV1TS;"._555782.F^HBYFSBC5AME+4RFTE2[ MLWE/EBSC+WVMI%RMB],ER_R;YGD:/A0Y,__=)]7]#0):M9\UGSA=I+0HX[/> M#K*IY%<31NL6GZ] 4VZBH@P2*L%F*O?5E!FH%%>ZL=]I.I\X/7))5"PR!>U@ M,)4!:V#CL:XT?D.WL==Q??.-:"?"[S&?.+8-M>!&!,549FQWBFY9W?>8!!^] M-*93=#;U_6)9E%>C7%)5^Z%HRI-WGD^<[BE;$:>(RE1*K8WE2FN9FD\<[R=; M< 2@,)5#:\1TH(367>FMGU@;=E"3> 0*]JP!XY7;L,T*B$T%2FKM%/4MU]!7>:N\D) MLO,9\K"9RMXUL-&O[N+);KQ7=JQ7<'9Q.\S'3G+WF4^P?%=:+ G F$KXM3$%:DU]\PD62Y,Z-0 *4RG W3G9W'39$%7) MRR7I.9\X#3HRL$"I #2526STXU+[JN83IVY]LSN($HR)[.+]2__8;^A8J(Y] M7V/ZS.]IR/::Y08T8X&BPN]%J_]\XC1JL@,I^C EZ</=C?,DKQRV25XY_IN258[S)*\=F1]I8$]!=,K)LT],D-24OYU:D#'C _P19XJ4R@"!&:3)E& M-!,]5,[2$G!0>I 5.%3H/3]Q:G#3(E 5#IY$F]V23],B?TK2\&_"JR2NT&M^ MXM3ZUI8M+@P\>31[DEYG6:%'4=5C?N(X-J4+/0T(>%)I-.O(J72;GS@.:NU" MTBX./!DU.ZMKB]5*\0GS$VQ)T\#\^'#VCAJ(\*3L M; NML0,1=YR?. UVZ, ;%PF>'!N>L-*M"-QI?N(T\J$S3PT4>+)I>(*J[4DD M/>G!3_LU]HH@S$L_[;[#=@TXFRUFSZ2ZR_#@*@V>.DD% M;.>L/;4SP'6=M:>@(98C[S^=M1O_SJD=2U$79VU)D9A++HR?QEE[:LD>9,!9 M>PHZT@$:L/87]YWSI?QIG[2DV9ZT2%4WIT3AK M?R,QW>GV*PU\$9.!0H:3^TM*?.H;[PT M?RVO.6!E])/XCD01NQE7#"6[HIIJ],J^A?E3\XD"PNV^>'Z&S4H$CY<>-('& MHUR?=>/'ZYB>E,FGA'L1N*#U_ R;60DF%A(?C8=XEC^1]$L2)]N"UD-+(==3 M[0'S4VP^+P%GZHCPN)"OO# M70'3X(\B*_.+9XMO7DJG!6&9.6&_^9E3DZ & M$7PFY>!,.)J!W)LO)/^-HF23\W7\0JK7-VL3UEFJ''*T^L_/G ;0M"9)'R0> M7S,56VGUVFHW/W,:.]/Y:]H'@\=C_(V$CT]TOS-]H> >Z[MKZ9&*>08:CH%S M+PM]NH^Z#*,B%WJUVCUP?H8M_@9>YCH@Q.-A7M6#6CG U0F6])R?'8 MAH>>2B\F !PTX\U:ONRL>_B!^?I_< MT(-"^!"13:8+5'11HS?%@&UKQN%%&Y !7UI;4JH&K5FI&E 4V,*B6]/21(3& ML=;.YC 88$MP%$QB'-'1>,G:!IV=V?%:Z@:="9>./8$-1ITY\#"M =57'23+ MYR0N"VXJ1I[Q^E$-VMF*=PD_.Q/<#B#%@L8'M2.B-.*)VYYBLA0?H!^*!NL< M,.# @/!XF(RQA"XVS1A=LB U)W>!\:\\D$9)"?M1L$XW>X(/AD^9 AH\WJ7= MRPZD7/$[4%A.]W[:)(E@X'$UF8UI'QS9,;9:WE7P<>#Q"W6-H!X/5/MQ]<(3M.O?U9P'0 V# %Q M?V]CE1I/.HE8CA^".F2XGB M/5!XW.7[DDHWW&"?&I^E" ?U@Y%,^\JD[<)"DUUJA38TQR5+_,G.33V&.UZ2 MS$_#4H#98I8^>G&]6D_CX+S(Z%)"][[KLA^7S/05.=DOAD'HI:]W'MM7E%MQ MU5TCW'$^.'/AH5W+-$LKV^-GDC\E09580$A#TO/7_<:K9BI;%%.OF0\L91Y+ MMS4R\N /T"SV Z]OPM.DPG:(VX5WLS9)ABR5#BJ@'/?G_ T7EML1')W)$F- $D2#J- MHJ3*A2X%DI(%]ID/+3FO>^%+ @M?X*F9> -+Q3-P[C'%:D 3L-K9&6ZK3H.) M2(4SV)L'($$3F&J %S1[0G,$28,3' 2G @64LO/7YE\DLZ;Z0Z@:,-0B[6D: MU=4+GN#7IGS2#WB_,87CNKRIKN[E##:A88IY[-R$]J[#2!($H M8M8,+UAF23,$F0V4!1*H+^O+)K[&])G?TY 5SV*1B&'&H'Y)8K^@?X8KN:GV MGP_=)FSH^P5;P,,3/=M7'8FAVRC;#MY>#7R2"-P^:6WQG:6WK(CC MNG8CH4LMU3O)+KPH(L'YZZK8;=U0>#+K]F2J*+?.N];T&P$.C! M2PHPGZY> MN)K%V80"3::\MO.AXX)^[692& J@:R<7E6YF^]6TH51V6]R1PG1;]J_]5*J M"Z#/18QU+P4!AXY+,)G>__/@ 9SV&&]]5RR7S""WN L?XW 1^G3 U<7#F>1) M%/HA*_I5M[HE/CV8AE'H51':7TC.BDY1A+,T"&.F+;99=A67W;GN[&0P&CGX MHK8J>$WS/ T?BIS91.\35EZ-+-G/S"20Q#FE+2K+D.>$GE1RA;LF##R]5,WX M&%]5U9HP_I=H%#B:Z.E-Q?\*7+,XO2B83]"M1NDTT]PH6?SQH*8"-#'4]]X/ MDI7W#PAHW32J$3@UO/1 (@\PFG#I#OCM3."UCIS:A'H8%$8TA"8V6W(S@<*2 MK_B$&CNV&P(ER[HV.#01WUCN6RDU<^)TN=,LJ[0S'J=-[0UI1 :# $Q?>MFI[-278(42_=+MP>H(D-YE9[R*U MWG"95:J5B9V%ITNIU0U;8FYA0'A"N+N7]&20+/E*C-1J)/@^ (@$.1&'9G6NP4DC'3@,T.E&SAT,2 MB(W&%7R@KMWAV%TB+,:HLPFV2_J&<-%((V#1N&_;GJV&8SLF/-USE8 HGL2' M7[;57*6RX1C?4:HBB4^G& @:IZOM&E7#L?/3E9@)@#Y%9&CGB9. [3[<0)!PH:UZ%9 M2^YPC*%:@/K60PP$C?.PJUUP.':=\2_1M+(9L$2"QI]H@!'5CHN1/K/RPCNN<:AVW.P/%X[:\\+*GJ\OKB^LX M*U**:,FLCJ)/EM>^7L3=9I[K6;;$,/ X*>_)\CE)Z7&EJMNS-[H$5,FZTAVP MVT(/6HRIH<'CN/P:I\1/'N/P;Q+<>S_.24QU+#0M STH,+>%!;1H$H+ XZ $ MQ*R"@^@O;@B5D-FVIW&P#HGW_;00!H1V>"I5$+8P0WV6U8%B\X>6^[5F"1*I M4W2OQWR(+DM/M "*0+AWB5ZSAWG13?$0A?YLL2 LG?.RBVE!?1:1. MW%H,%50/&4#4\>%Q;9JM(>4V0:4#=V)(:)R;5JH9N4TT:4^:')4!?Z?ETE\G MF(NN<70O1V/ -^F\.N4)YH)L$"MZ\ QX&@&:MA+Z5G.JN)B3H N5%G.Q-8@, M*2(#_D.)_E=!55H,<#M1B3$7]I%Q(,"$QG6H&3#WT?.?MMN:BSS:* M=X(M@B'HV)R7VS)^_$%2/\Q(N7'=#/=5,.5 =VC(GCPQBO'^(<-WFIY@O].T_+#X)$I@X?$7 M&PND/G'K(^S$E@@3'H>N7B3UT'$-MDZ$[,!P[[:%KI*[2@IFSJS,:([&KI8[1Q[7FI>CF!36AH_-L&B,*RO-ED3+;>.2FV&\9^^.Q%L^\Q257, M5WO-Z9KA-"X4^CI 8Q6 (T/N.M%],-3#!XXTZL8!!2/']7$S>;#4]=^-$C/ M*JPT0>#Q?1KB!LN_4B2_,&2?1?NP317\WOPYQ-$M=Q$+Z$0>%% MP'P'MJ63MQU/EYOI3H+3FKNR'5G?PORIA,40/H7/]\G'.!=]9"V>0H%;SN/%2L>8Y3:EX3M(?3.H=A 5H7%6Y)5U%Z$\7.4GI*'R.")."S51E[O]YD5&T64;_]!#&Y6Q5@BL# M_._3\/$1GH)[>#55G].,MM8CI#?= ,YR+8--;T/KGKXO>TJB@#Z:S6F7WBLX MC?3S=JI$I^EZB 88K!Y@C&D9G_H?8Q=TXT7\(J<[6;?#C2\(5:W3H$B,(T^D M*6 0:AG6H$&X>G^U2<\2\CK\]A?[3W3/QPT5(FM\)V^V',=/"_A^KA[(= M((E]>-O4JQ#ST_EH"!Y^(F +8%J"[\)L$LK3)QE3;FFD^@P)U& MT'>*/-6!"'#KXG8 F=B_>U$AOD]%Y0$4MM.245:9;2 $B'40=66X:M39P6T: M%$$!C#D(E.JK>MOHZ.#6X#8( 6)=% [96.$H:KIS9<&WU:RA\%$J]*: #W;= M5(8'\.D@W*HTNI611\S"OBJ!FJTJ6,Q)(08,O2'N:!9R0:+4@S&F"XY+$#E_S!(<:+)B/1=KV2D:WKS@P4 MGBF9 .A31(8F@[$''ET'A/5 *,*,1U,E3$9#[ 5GR@^*SYX($YIL2-Q51$=# MW)$Q@HV6(?!H\B9QU!$=#9W6V38^(-0 &\C)E/E\/X7+,*_"-#F.Q.Q+DH>+ MT*_^;FUI#=)U,] MX39%FUM!^- -)* "4\?J?2LGEJA6/*\ME0^WD1+ZD&$P>-)&F_=MK&XYV2PO MPHVXJ".%B3OR7/ YJ2"3Y)Z9K1T17@KOB^3E)\Y_1G#QR M<1$[#G/RR,YYMZ,Y>01;*-K#/&QSK& 04C^W60+&:T/)9* MZS$@(TL>0Q.Q/"/X$C!%9'@JXO5 )):5SB*C/930$;?Q96X8& M\B *RA)UHQ!QI_D(J)3CPG-MV$42OY"4K36KM6.9%'%>_9H*+HR;DO6E8)'[ MU6$2%<&9J+UGALDO24ZR&^^5;<<;P%E81I&F=)F8QL&7)/:K?PAHU7L050-R M/SS,<1ND%LO^=0]C&2./4=VG0@+&1%T]JU[6:E;(MG9P^FY6WE.H I 'F,(? MEC9,$_7XK/+,:BK1'=AO)"9I&?0R#9:4DRQ//58./9WIB(^62OQ4KLRHZ M6C]1?V@8>C%5,_)85>W19%0SDJI]/81;L4SCL+P1.*-8Z#XCI^!([(?.K@Y= M7X7V22&6:K_Q?#1Q$3VUDD,:%K75D KK(-X)4AI@MN%(?-BA2X;-YQ,,@4D\ MDG3MXA-, 4;6K:D3UP%($B;:&U$GF.*/>N#Q *SB70E%&)XT>R'I-(J2$YQL,H8P! J\H%OEK+=WJ?=H@B'D1OW,( :")BZJZX7P MHXGS4!FQI@&G$8 $3XR3 6*PS'L&&9*&NKBXUG/O]GJA*W;OJOO1L=-8".A3 M@+RM?/GQ1![U5H/XV&G<@ZY%4AV3B<@D<4G354&"2[+TXB"[2M);\EC[ THW M_KI0 >15U7X0A>8TPD&-KB[8\$09]7C9PK'3D(86WZ J*#R!1[U=KW#L-";" M,)<-3!9O_;SPLJ>O,7W>=S83Q(^78>8SS[TD)D72C8KM-*!!8ZY40F(Q$JAA M!&V*<44$ESS"7:BX3GW_&HJ7HK!XT>8EJ>Z.I"^3#/3]EE0XMU9S=15#PEN\ M$G/URAU*Z\@[F9;YO:C03E/96FA%)]KUYU$]QJ$-2&AB5^Q0AD68[8- M[A"&JM2B2NW96^TH%J=G>.DGPF>'@\% _ FPQ;XI'J+0EZD7:DH7;@S. E4- MBV$8" :!E,R_2$FB;E$G*K%3)P($3V/\)(/EY CI.3K!LM0P2)(T;<&%GV+C2ISIQ ]/U!.[4HPE] M"0 M@/QXPC@,I[BH=(T[Y$O=3MT&>BA^4GSZ1)CPQ'EU;D6>[%01@_ZII/&UTI5*=!'88=4GO(+ 9Y-*X69R$_R_(EJQ(H9= 6 M&&@C[3D?G3D-^="G10N8Q2@0KN2?J0:7Q7)];]JW-,QS$K/[T4K1PB0H RE7 M(@OO-[+Q&JK1@^3;AA;PU))!-Z"+EM+QL>V)V,0 4:%EE M(&<:_8[IJ<5[I%_Q;VF29:NRF;/X/LF]Z.-?19B_KGZY7@WJU0'TMG5Z*@6- MSP\J7T9-@ :8-I&>PX]M"/XHLJI,PT(RI]?PSKV,!+/XLY?^2?(R$)Z59R3? MH]([;K8Y4:+Z(DHW^9+:KPGMEB05*^APLI0.< M>;K*O-8#K8TZ/G(17+4QKU;*FQ;Y4Y*&?V\X 6-$N+WFXX'3\Q*D6,">) ." M)YUD(^F-E\[2$F>5_"OP#6CTIGBQE9E0(TX,"$]ZR>Y0J\X^.E]9U8/BPE9@ M0N<+:X+ DTBR*Z6B*U30C2+$5C)"AZ8])&@21MJ6\QX?V=G1ZY;S%K# D]A@ M%J23FAXFH^W'1PBB[;DDB>GD T%3HK1K)/?X"&^$?:EIH3-Q#PF:5!4#O*") M1C1'$,("I%T#[,='&+RV>Q^":*NP+S^>Q)2.91+' PRN6GTVMN0WD7TBCU+; MVRM>QWY4L!\VW@&%D#65QU!8V,IV<79R[9'AR4]IB/][PIP#H"=,TH,"PU;> M2^T(M _"1"Z*N%3EWJ"Y*Q[^('Y^GUPEZ8*$>0%'?VH\@L+!5OD+^HRT42'* M,^FM,.5X@*W*F/!\JP$*3VY)7X4IQP-L]F)8S M^F?B9?3S+V\EO0IC+_9#+YIF&0;PL*,N1+8!/_ 2L#[HGOA MI7TI)*=.90O\\.=314V@"2< Y6W#-L7F]!"BJ'Q-YBI4:.('&@-7CS9Q1XK2 MZ:&C$WB 02TB #29EL0$.@CB^WMVGY?3S>AY&T>8N+2F;XHYT=7,: M!:KZ9?'95,&&)KICO;2 MQ\]%GI7 !])%7-"+KG).$P1:?)42>B&,> JY\D0=M2)QM ;H-"K-*HE;&/$$ MUYB]66D\M&/_Q+?KDN@ 3[R-^6M]QB-+H1<&;F(JE:_!6!,2GJ*N5CC#L@6R M09YTCX/T>IKQ"%\AA.8GP0FS4 !D,=*EXSU,XQ&^,IXR?4,P3!1I-3-=?4YB M\EH5O;DJXD!NC>-W8!$Z@^,3?!7B8(94 4EJIKH*.;IX\N)'NDE=_W&VJ/:J MW-;_##_2\9=.'!RKK84U3)R:QRTPTRX$8@)??>/"N^4SLS^Y)-7_K^/-%=,- M($(7E](3*&X9SMT)!%&A.4/O@)060^0TK_7A(-&C+4-B%(=]]C1;*K$:L':H MU2N7**:,3[,<%IJS8MKFYB-"<[ QQA.6<9H$LA.>P MKD45*V08G.?'C0)/2TK7 8H4(PQ64[9C9PV$K525+\P8K]%^[C-!? M;6:#.Y_$7AHFP)X!;%OAL&1\M+974(!C*W5$C99:I*]Q]DS\&&'==[ SLTF4W$ +DSLDB20E],5#[6MAG:2TM->]'(V)O = ];\G4;$D MWP@+V"/!](6DWB/9W+<[S2/B9?E@^'YR).9$^T$,WG#H)G6E/5D=8)I(;NC& MXN3]D1D6-P^JX!T[L;5:9Y$'$T^ZP^Y.55XX!>A1JNIT;,=!:-]0)P.%I_0G M1U2I*0CL4P.TM-%0M]K)U*_,VBXL$_D0B'ESO5NW3:!TW^X@Y6)':*GAB-N^ M!NCV)@CYYZ-$VRXB2<:%,E79"F-&_/>/RUW2:UQ):.6M+51ZC#?77S M)0=TK1T T9>N7:\8!I0N6Q2&9FXS645E7<>^^+S#:5J+ZB3#%!ZKG$.,4'9 MO29,!M-93"3VF76+6B G?A8M9?)$!G3HP,&_NB]]ZO]5A%FE0/%1#^A1G6,M M[5VL'_6DH #&'!S.>:*R'U,B/SI(^]: 7=?!E-*ASB( #^#3P=&]%SY=+_!] M$2O=!70_XRMYX&Y9'K? 5;W^>R6X)?^G5?>_WKQF434IQ;:E3%#6:7*3.S" K@P<=BVQ87KJ<@V M*=+IRIIWO^GBO/].HA=RDU %784O$MK:/:T&["0(5N,3X=#8%2] K#6'?U.T MJW"1$R*)H]%[2@7LU(G?PS*1 $Z 0 ?F!.;@F2VFK+S68QE>)S'_<-M7P,X. MU,\O@01PY)O?W-.?,L]G8LH+OFD^J5:&ZX@ "5%\=EM#!7AW M$"7@G'?76R87 T"ZC=(R:P"K[=TS?6^2WA7/STF:3Q]34DHE7ER%G6KQG19? M;_W)<5981; 1PYNTF K4!B$7OIZYT5$,=,5ZE,#M&./[R6 3@(+R'1U<:LNO[3A0H ;C40 B0ZJ#^0T^D8ED?>V!7MBR.39A^ M;L)G4MW!E:3PI@9J6HHZ/G);I4/C<^&L>D)4@.*-F'6JHL/E03B[)0%;;(/+ M@E7$NR%IF 00#=*.U5IQXK2\NFYA#EUD #$FS#+W:9'ETV52Q/DM898% E+! M:5J%85JZ"\2F\H58 '5K&5$ =7\I&)C9HFD8 ATQW,9UY.M!E0I200,HW<1] M#A]_^&7]\UN6JG9/FV9/2114[(,&?T&?"N:ITZ-0*PK40 %,.+!/W'BO5=F] M)+TEST5*I<_HE-FH."789]?W/BCS+O3B@ MBYZ 2E&W"N;Q09*HA@N@SX$)XH8^BZ0I"30+WPG[U4 /:@^A"0PHZ60BO*/: M.):/+MU#@H*2PO;U9M-IR=56:YH<$*!](V$=S07UXU]%F+]6M<'5]Q9[O>J% M^* F-"U8 !]&0CN:(ER&+V$6/D2U +(O0Z5O#<)I$:;NW$C! 0R9, 1L":)$ M19W=<'@''@ %H-P>BBIH!55LNI4&HB.WU^ZVL["HX@(H<5$A@>TCKK.LV#8% ME?/H%_*]_(NXM*E"_\I">'R0Y:(U 0+,FK JK.P9=->7$;]@=P?=IQ[;NE]Z MK]E]WNG6B MOBML@&\3,19-@^9L9="LIB85B^Y.EUKDP_-C*&$":-"R84 ^/9+Z5%@Z .AH M27(O6D5VE(+<)^?D=Y+E,">J_2LPH\/;^^L#!*H9F[!7-(6IY=AR".CQ)7Y" M!>@ 725M( *^"*S-\JZ MU/ .RM"EC@F@;+43M;A;?H!=7:A5691J57S\A[U]#LG./%-]&H:QWX?G30&;RAQL5R M:++HY7 \QI!]J\4>?P#(,**],JIS*46*SU5Y &7M*Y.V"PO/Q5 V:,,4CVN# M/VD0KG,>VQ? I/@PF<%X'X\2:[N(#-T7U5_]R^'X^+#7,"$N0S=!]5&AD0KL M:B$2JG!?VWS)#5WMU)>J72\>!G0N6Q],F-4W12+_D43,]G^1I,])JG#)AKQG MC0--IE<*>^3S4 ,FNW-NGOIIB1 MZIRE.UPDRV>J$:]2]2:O]OQUTZ8.,BY1;:#%P4WDQ2S[2+ZAMO"Z6JV6HA>4 MCU U< 6SJH>3-PR]<_AM:-6UZLUNG$FO1W!;"'L_76/M?ZX?(Z25T(JRWN= M]L#D;;\S4'ALI8(S2Y<)*AX?K4XAFEL0+9V9N O,5/H)W7]1=<4YBR@*J1PE MFO-7A4V+M&\-&,/EX=TW,AIH35P29I5>)=.?M&\-V/65XQK$:#'+ XKGXK!> MF,6RXO='L71)-Q$GNUE'MF)8Z&)4__LV*[)J]5-=Q!4?5,-T&E*G\;D)UV!M MR(CN(M/(].2F00XG [--9)1:YBKTA0925](<)6D5T5>I(0% M)WDQ-YVD];-JA;@-YNI*E:PW4;N->93V60IBY=,_IMSO*G.N10_P/E]ZT!NXUO M-_B5RE!*KG/#&:!Y0^'$%!B[=SW"%:U961<^=8C9W'E"197>]0L',G>.W5:[ MT-5_EQET#-:_<.&?Z"4D=V*I(%JKD%Q-4K4P&@S,=1#8R1V_,BLPU*<>[!@N M]M5B4/W+WD:))LZ3*ZO<* CWJC&ZNEI'@P,-\G:AH0GOM$8?&FNN11YE]EL3 M%2MOTO#%RYECSR^G]UH>6?5<8:]:?K>&697/A&.2547F*@ZT?5CN9'1 05B< MU4N(ZY!B12>64KK:A^5.]C,A8&UL[7UM<^0VDN;WB[C_@/-LK-L1U7;+O9X=>W;VHO1FUYU:I96J[9WM MV)B@BBB)XRJRAF1)K;FX_WY(@.\@7L@BD93W/LRX)2'!3.#)!)!(9/[+__R\ MVY(G&B=!%/[IBY.OWWU!:+B._"!\^-,7AW3S]@]?_,]__>__[5_^Q]NW/]*0 MQEY*?7+_0LXO%]?DWT]OK\@B3%(O7%-R'JT/.QJFY"UY3-/]#]]\\_S\_+6_ M"<(DVAY2]H'DZW6T^X;]_6?Q07+[_NMW[$?VKY/W;^>'AT.2OOWVW;Z\]X&F2 %%7331G?R_??? M?\/_RIHFP0\)I[^*UE[*1]'(%U&V@)_>YLW>PJ_>GGS[]OW)UY\3_PL8@SC: MTENZ(?SS/Z0O>_JG+Y)@M]\"V_QWCS'=M/.PC>-O@/Z;D#[ /$+_WT/_)[^' M_G^7_?K*NZ?;+PBT_'B[4(KS?:VOC.@;1SS>T#B(_(NP'[--:K=G![! M=Y7>%>>K*/6VO7BN4KKB]IKV&]^2SMFX,D-(^XUKA7)(;E.9T\Z#61O%+?S[ MBGV_QAG]G-+0IW[.&U!J+"?OF%MN,=Y30]=^LT[X]+P+_REY8VI9 U MGF*:1(=X33L)*(:M_E7OONVK;(EB+6"1IN';CW=?_"O_._F4M_C/?Q&]%?$Z_Q+[IX&[K,4WZXBMC_OT;8W131SME*.3?3)2"O+-N!.:;TH6X2:* M=WR!7GGWI4XTYE;=W-$T:_AMSGBQWZJT)9]X:[39-PUW%0BFL;;%1 Z)C9?< M?@Z0%)18T M#J!BP[ED(: )B3:$-V*F@C63@'(TQVEE77+'M@M\6Z,E![DU5-PAO;3S M@E #\;;&#K'=RJL)':(A$JR'Y-@EHM6H:$)9#0F'&(YVNRCDG,P_T-T]C748 M;FGL$L-MO,I;-VA$!##FY)-HB(5A*XXS5J/8#T(O?B')H\71Z*V &=+M@N MI6W+:R;!.QQ5^;8[( $%X213.B5)XV\X*4F#/SI85JQ? SA$$\=@R/A23C[\ M'7NBJV/7-K'5@1MM(N?L2SY\[7+K/2AFLM'&T50V.6O.9?%W @VP)K-U_*JS MV3IXH^ME<9EQSDZ9!@5MM'6LJ4U.E2HK&A+6DD!3;.UM'>$V-6X=WM$!#K7V M*("HXT\QX]"&B$:X1K]\<&"B=@LD.GN&GPJ( );T6R9KAX:!M4>?K; M1M3!UB(^8T![B&+]=#=:.M]@5+G4[#&8%=NHCCSG%SL:/P3APX]Q])P^ MVIAW!853#*BX5F A;TY$^VF8?NW(R^#0#OO8(/F\BKTP"6#W(1Q<>H2T-'<+ MCS9^5=CX3,K&F?<1&1C*T6Y!A7*H1X;$W/?9W"79?ZZ8R3K18J*UO5-0M'.L M0$76:I;_@T![L@R1CP^:49>QH1ER-^ X8_]Z/?JIT RA-GDTP$>T)(YB 9THW[DJ(M [Z>"_X MX,,Q]320J#=Q]7ZOSI<44A/ VR/<4JL&LSJYJ)$>;X3NZ/L0,4B??WJ^"5/DH4V[F:(9; M^&O.,/\]O.8Y^?;-_5*.- MHPEN?U(QLLJHDH:F_J6'L;?#;G.&]& M\G:H$46ZP6U3XK:1'3NBZ!#'-$QOZ3Z*4X =.P(HXPSU)&[CBU1\J\*,1'M2 M$!!!@1QMI!W]EJ C[="/#17^U(Z_%KWC+P27AQ22+(&UT@-&2^@6-GH95. 1 M;SHY&3OKO@A$*U"D;.TXN%GF5AG: M7#3-# YV7+-BH-NBFA6C//Z3M.):PPH,_9 M%",]>EP;0Z&W3H,G>NZE7K;T:1<:%8GC2#8%W\H0MJ(]/)#R\JT*=MB:;O3; MXM5T0S^>@U!\IWR@HW\ZIV[NRG&HYE=R(F8[UNK#*>Q'=*;AKKD7#6.-D!%J MN;D,0B]KALY1IXHO3S2V3@G P]704AR2N1T03 M$YSMT]T$9OM!H M1[("&4B M@4R'H#-P!T>K96J#KV9Y*4AR+J&U'D2.>X(R1#/<=UP9ATM.L",'=Z581$^T20%[T%"'AD-"4+"J$! M<(_1UF=6 K8XZ8N%S\.^"X<8[2"7]+*E).6;<$$PD0OAKO/5Q%G7R7*'Q!7= M08:G^$4PDF^JYSM80N9I&@?WAQ3N!%?1C6?8#/3HRR$V^T@J6;6\CPR>L_)8 M*/J9D6I/)(V(Z&MPZ_Q$X_O(O*<80FA%;989^8=W7[][]^Z$[+V8/,$I[(_D MY ^S=W]X-SOYI^^X$K,?O_OG?YI]^_OO,R*2'.[_2M71 M7UN4YU)'JU33:O36)Y=WGCV6KHDL5IV6IVKC+_/%J5W7T9WZW00#'1.-OTPR MP5#]^]U7URFMIY4G#4;/J=34>1!+C4]%"$OVXH2WFI%%DARHE*K(D?O3FN<$ MVN!'KL@P:(];D3'@\*CK^SPVT=O>> $[>Y]Y^X =W71G7Q6%R\.PDFOI=%RT M)- 4W"198R0O3Q_.P4'XEG&^;N?/O),_;@>/XTNUDD+X59-RT\YDH;SQX$SO>6;' MN]2+TT%8/_78CVM^GD\?*;FG#T$8MKQ<'HCQB] ?@VV*]MK:K)GF@Q'*/?F& MQC'UKAPU(5S"GC6>?%F[#?PO]QKYQW2QR@._D[] M/Y(0T=N=[+UJB^GVU M )'NSRK9D6KL2^]V(>PB?TSAX\B"$J\*-U4,$(Z5# M<)NED)+T%12%#7\9]4&"9?C@49(\>S&OISX13;#$5E,M+(&%8N;M[#N68==; M='1#;N.RFXCEMC#977"X^W7S .@Z>??[]^\XMN W#.G"W?TQ]&G\' ?@A^'. MF22!>M(Z*]R1W@$>NTHDV['LAJ=*2TIBO.=B@TEVJ$JV+HB'UTS#8N-<(!=: MW$NCK1TK6^9,)?MM(O 1R0=YGM^S)(Z4I\7DELXUJ M1B':AW,P(VMXG!!L KB,3.!N,OOVU]5)1WM.8Y.CWIX4[[&,39YZ^6V,.4F] M&V=$#V&4;UZLGK%,Y+6/>T$1G]D8RPYTU3,THW%;#.]-'*SI#8TYC_:F0]D! MG@%1RV0V(R4MX<10+EG8EDF8$WO1E+I6O'6;D#X94&C0*@,$4=[CW'CQ,N8Y M%WT>S&.A6%;4.*]V--+H'_(P0B@2*TA%Y!JV1ATE5B+$*L+7L,,?+-&F>0ED M@AJ*]HAU:@3!E6K+5P.0]8Y'-S= MT.-89-T#GL.APSE"]CA,\(C47SRUUV$*)Z:.8#2X':9SI:E4'EX2)$$V++$[UDO9,Q#=QA""V'@I7 MNU0'HN IOZV_Q4Y'<)7=Z'71$2$KN=)_H5+PZ3PGMQ9@:CX8,X9LM #+$]/& MBYTSQDB)K MZ+X!*(="=,L>(8NV:P=8/"X>&);S<:+5)9G".T)+@#45Q!)=+K,F\BQT M-UZ$>W[%,/!G:32S8N%:KDER!]K/:HT;.Q/^PT6^/(8RAG M>A0Y$?G?2868;:3$1V?$; D2 K"NDB?DF7V$CG[2:&O"5Q-AK[ MMM%PFW[2A:K*J2M=Z*D[@[?<4V Q?!![E:LHT;VR:VWMT+2T<]L$;]&*9-O( M-]!PA$RO-B_P[%B&7PO[$XGV2,]X+U @-)AS".'VD\7441G5F,KVS.![9 M=N 2[+8R2?@'0E*E+!0A(_YJS-1'EC[H(\4+,HGRI4E2;Z?JT@E^D@9UPIX[ MI;KT@IA?@,W]OQY$[;WEYA?QREVW2ACH'*J028(FM*!]=CU;4D!T3DXSG+)\ M+R0(Z0.L_B9EZ2K(V2/[B4+R_PV()%X>,CG\3ND*7)D"'.E<&@@K56K:!2L] M.N(!_#5-?_2"$#:EE>J:E9*465:K%E7O2._J 7P'B9J88J0$: D0DVJU42!G MO]!7&QWW'#B$< \@'-]B!EU+J8YMY9#%<_8^OJO"U=['HVB;U?OX(V;NENX9 M6WRJ(-F\QTN]@2D/NTTITO-W)KG5N;G1SN$.J,EAF^K43LF3*A%APWU^$-B. M<\:W<<_9L GL8>VO.@\C\1H@X$&U__B[D]^_^^-I([(6 [T^0&V Y89?(E?ND$^])%C/0_\\V!Y2; M,C>1F7=$LIZ(Z I6"#E&8D9XAZ((@^@22^,&&X!2(E^T(<_YD'C9D$PKPN(X MN#=U]SBLNU/RO))5'BILK\U&2H=J:Y:B"<^BMEH1S>Y"":T6Y>["R+H62@OC M)%)76**MJ4R64'-98'D-:G:\?;V+E=\!<NM0(JW9 M.HB@5\W^P O=:1!NH,.OH%U(8*BC_;:LHTT^"2(D[ \GR 3+:MX7[VLH^R\JX M26ZZ5(^V8%E5/)J\8?9;>/R&O^RP+R3=70)11WI4]JWLB%5J9UX7H5KH5Y0< M!UG6VRCAON8@7&\/_(]P-YD5!SZ$V0_17D20PR]O[SZB!I]8/W.;P,,V[A@0 M[T_/#S%CX89CDH?!7--G_A?]H=R*WNGAW$XBV24$6: $(1&41) 6];IB._+-T&2-AUD\.^LQ M@;U&7P'+6VYM9HFCI?#9^2@,CK.&%FBLFT/I"K\][\<$#*+">%A:1(7E.")@ M5_1X)TI4K**;K$!%F7R>&^$6&]>)VE6PKK4TBJ29=V6ICIR6E,39LHL2RGJL M9-,K0M(#?K7@503L686N]IZI[&8AV.V]=5HQU/JIZQRFVM<0B :]+4%./AE3 M4,C3TQ:(9M,T!B;9])#2[7*F8QGJ>.QF&D8 XS"V03EQTO9M8*LP>/3-F9<\ M7FZCYZ1;T$T+&4ZL31O_VA ;(""<8GJ!-0,]D2#\BI19 M#,K>QGRV;?O2X7C!*\K'7_>T2?H#\K."GE!N>7O0$\&>)F@5YXT"CO)NR#+Y MHX$U[LR=BI_O9VLHEL*,@5;6GN5M(J&6SK'^9S32*U1 MQDN.BRH^ W:A^!"1GT3" [A7ME#C#&)<#&*8F2[X+?Q[#>-W$$-&RKPTWC06 M_#%55 YB&T\_G2:@C:F7T',J_EMA+XO*L\M):]V)VS2U]K*U9*[E1.1-3OX5 M0+XT$D44*;*%.$I*D8$E:2ASDM!4A+Q4TJZ@*G9WF+;D\.V(44PEO(GIW@M\ M"]P M)%S%GM]-3]H[0-46A4R6.I-3DXQ\1G@'4UF5+(4KI-B+=M/2'QWJS%JD@QRR M+L4'9@W+Q;ZK)DGDV'HDRV.O14!+KD9,I]=?@\QBY?Q/<_U1(\U*>Q0PF^+E MR""7(A.]#!GF$@0M%=5Q4AH](*_CQN/XFPZ$"M^,,?@?!.T\>5MPO=Q2=F@+ MUFPO#W^8AW[]%Y66&H4\LE^7-<*/'(&V*[R94-Q*PQDI^Q!_Y,]?&K^K$&"^ MPAIC2,C;RDNM:,,?/@F6\-YJC21G]IY+*Z1+"S:(CDN%S(=0<(>[##94C >1 MA!-L;NA?!J$7KB&G>$IW5I$7]GVXW&-TD$Q:? 4M*8BY52K(":='=\<>(^'= M8;_?\D@@;TO\(($WBH>8Q]R'4?B62Q_4I-\4TD_D!J8S=*7]1U?<'A%^*[S? M"Q$B"%8!PH,B855+?QT43B:_ZF0J M0+(6NB(>E+IYE4!=;MA_X?8K2M)$Q%O!02_SLN25KE2&KFLOKHQ;9^F: M\Y=W0/(>".^"Y'U4?807"A_;N#N-@>6,_6U*O9?IV)2&=#UM2NWV;I(VQ59./031[_>.P&Q'FS(:8 >R M*2-,Z*@V1>2+N_B\YENVRRC.4PBP;1OLM^^7V6Y;O.E:15D.@4XFI_]'4"W2 M$6-C:[#@$S#G^4?()HI)-8L#_] IR;^49P88,15,3[,VQF UE&2?#1:M#E;0 M'*SV8ARZ(<.UD,=JH-F 3D+]^MO7*2!K;4!6(CZ)]&#U*&^\R,G1C Y@PRW> M"^7C?NNE](*-FM9'[IJ1UW)1V&>,1[I9G&7YCDA+N,Z,%"R5*Q(P1017. $& MZ"//@Q0*?R0XTU_M?5YO91_T K"WICNLFQT_>&'P=[Y:G8%MWP8^_X')=1.7 MR?*6F^PRQ=L6K\YM;A,'ZM]EU>V!1D1:DR_NSFX7-ZO%\IHL+\GR]L?Y]>(_ MYOSG^?4Y.?UXM[B^N+LCRYN+6_[K.]2*UD,"0RIX/20J7HFRG!?7LBOZ.3UE M;/XZEMZT?NJUJ%#[.$DUX"N?8+N%ZD?XSJ#Z&=C8%A\BY9=(^2GR"3Y&^->0 M[O\=#-I_)1.D4;=!K9%&UQR^,!>N-,@\R)A?6[X3UQ"Y?.VMXUT*=/GXX+R\79_'I%YF=GRX_7J\7UC^1F>;4X6UR@ M<\'=*;8.-<.$P+ M%3R$P298>V$JLV6S=MEVX#)5E*U,$N!*0E)2DIQTW'7#-HUN;^%>A39UPZ.4 M(ZL3&(^X=KB)HSV;+/_F<,\ZSSU[Y?*@L<@=Z5U=%G202'HC=;U8+>97Y.;C M*0,0 ]CEQ2W#$YI'NNODU)S-*#-CY4<^8H:N(U(F?R;>DQ=LA[R$JW.D6S7T MS9UA72WKN0J[U4%/ 22P)O294NM[L,YL3 ZW->M&UHZG! M5F=/[7$[ 5_5\=(N/WQ8K#Y<7*_N^)W%V9)[JBZNL=U4_;#:2R$1EY%S=D)Y M8F>7)[H(F54XY)S^1/V'6I*'3HO*4;TZU-7CI)>C]/+>2*4[KL-9A]6$LI-; M@ : 0A/] ^!@TJI@LU0=U^VTE4%[.=U;&R:PK T]%A>WBY_GJ\7/%^27^>TM M7,I<+>:GBZO%"GF5&P+T V@]X@K(W_<^1EN?G91%$;#K*+59Y$R$KNN*ZF1H MK2>:$7Q)LMIG0#.1M<7L_AT3\=\^+E9_GIXZ=3#IG5'H3LDNO2#F.1A*;FRN./1D#E7)P'\3 M6M \2[%2(9B(V;:9BR:T;"8"%TTV9MI AXPGG:U2 6H"N_#.HLP7M^3G^=7' M"_+A8G[W\?:"^Y6FIA%&:VL%)H?;F,-]0O]V8+OXBR?+9R)J$I>;%#7?%M3-)F)N.@7\BG[ M[P3V!+9"T+P))J+;4=&$<3LD7-[*,F'"-.8A;+=!\NM93/T@A7]IKV U5$[O M6W7KE=8$&LV((,A^F![BCQ$04D (Z6+6'/[4B+"CXON#," #W+!PR]9ZGB_&6SY)5OL_8"?I#:9J^>2<04-A#8T4@4830A'>D=)XRQ MD:BUC "/5Y(SMTQO31U:2.S,*M88;$N(8@W (Y9;D<>=7P7_1+?^(ES%AR1_ MPF>YY';KP]6RVU$RN?Q804Z 'G+U0 4.WDO^1G4*NN-,6+1%N0]&:PLS&D"M M%N69?X JIS4Q\JDIGQ2,Y*A'B+64NS-DR1:!Q"D_TN0/B[@\:.W MK3_ILC0M1W?KRMH<+[^4>J6>4] K^B3/K%.2]4JD=Y(3L4A3&1 TJS601M0, MV934PL$#Z7Q2QN)U.)3HB% "4BUVYI7&4SQP])2%_.+%,>0J MV:JKT.*$B]J>+\Q8.J9NDU6%%LLM0,_.G%5KZBEKV_,BJ2I3VEJ5:0H*-*SL M62FF9EKRJ99B.@;>]2I,Z-BV*\ TT#S?TKW(\Y;P@TCK,CYFQ:5AUNY%R'BD M*^^S_]D=(A]LU2-)&34T!^<[$>35$5NLL%V<<#H15OMLRF?@4UA1LU M"# UQ1)O386Q!)O#&L'TN9((+XY"]L^UR&4J>+-7I.Y=N:P8W%U.&9+/M:2/ MM4ZFJ'4#R'Q+(89"+39JC>">T)5*!??$K3LE/?62(%ENJMF'YZ%_=&;6X[IU MJ+Q'RM\$->\.0@!J:<'A7A8UOZM5>.Y80[&O=(BIU$- O:G@0^#\"#?3Q8[& M\'+YQSAZ3A_9(77OA1;+:@=:5TXD2TFD/6I&1AXX'9R=@7 BH6'#"H7F[>F" MLIISQSG$K'PY/6?%)@R,ML\*U5J2=027P@1-8LXI;T&$\(#1)IGA+6 M2G14:*>XRQY W _4 \BB[Z@[85'Y[- &B Y?DJT?J7_8PAN)QMD;M@5KMA$X M#[:'E/HK2'AM]']\\YSUR#;)T"?>JC[" M&!QV._ ZL2%@!V*F2\$V*%Y(@*?J*DK$H-2OAE"?PQV'>^FQW'&@1UA/K\H[ M[\R^^LN03=\AAH *?B;X&$;W"8V?@.5%N#^D]=GM]')_T,]AK-;#CI=ZM9N1 MRI?RI<^'.[7B8]RHL,6^^CW"/]C4/P>VINLV8-QQK)KCLCKG%7UBDKXG&QCE M)[ZGV$UM3S&"/BJW(",H(X(%FR<)394"=+).UEUA6!Y[.7561?2B,RA3M!;] M9:]L2C;%6BEA:W-N!7S"?JX8!W!WDK@8G7OXUB2,1$?(*PU 1[RC M*3?;-^EM%6MP'85QG7W;D\H8'\,S$,.,E>4Q?%8Q'G"XJ78\73LRSA!5]QRE MJ:G$E%8#H!1;D*F;G $5T6"4!M1"M'P\G!V=BZ2U.5X6GIQ?4P*>3+.GD7KG M6*81D^_4\&'(NU,#!QJBKX*0+E*ZTR7?49/@(;O*MQDHT)KPYM. ^&#<(V)= M0HX![Q)L,'SA9]X^2+UM5N:ZF]=;28OBWU9+HMO&U*DFZ++N)]9-E*1OS[91 M ENL>A?3\$4;<*?V.AM A[<38M^;?PXZ+!LE!>)^J.3::':A+?D$K:>Q9@S$ M.^;NJ($9TP:I 1A4K)]'.R^0HC;TLN8TN'@O.+=$C6@_'

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end

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�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